
<html lang="en"     class="pb-page"  data-request-id="facc9c33-b8b5-437c-918d-874244909a0b"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2010.53.issue-14;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/jm100541c"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of the Dual Orexin Receptor Antagonist [(7R)-4-(5-Chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone (MK-4305) for the Treatment of Insomnia" /></meta><meta name="dc.Creator" content="Christopher D.  Cox" /></meta><meta name="dc.Creator" content="Michael J.  Breslin" /></meta><meta name="dc.Creator" content="David B.  Whitman" /></meta><meta name="dc.Creator" content="John D.  Schreier" /></meta><meta name="dc.Creator" content="Georgia B.  McGaughey" /></meta><meta name="dc.Creator" content="Michael J.  Bogusky" /></meta><meta name="dc.Creator" content="Anthony J.  Roecker" /></meta><meta name="dc.Creator" content="Swati P.  Mercer" /></meta><meta name="dc.Creator" content="Rodney A.  Bednar" /></meta><meta name="dc.Creator" content="Wei  Lemaire" /></meta><meta name="dc.Creator" content="Joseph G.  Bruno" /></meta><meta name="dc.Creator" content="Duane R.  Reiss" /></meta><meta name="dc.Creator" content="C. Meacham  Harrell" /></meta><meta name="dc.Creator" content="Kathy L.  Murphy" /></meta><meta name="dc.Creator" content="Susan L.  Garson" /></meta><meta name="dc.Creator" content="Scott M.  Doran" /></meta><meta name="dc.Creator" content="Thomayant  Prueksaritanont" /></meta><meta name="dc.Creator" content="Wayne B.  Anderson" /></meta><meta name="dc.Creator" content="Cuyue  Tang" /></meta><meta name="dc.Creator" content="Shane  Roller" /></meta><meta name="dc.Creator" content="Tamara D.  Cabalu" /></meta><meta name="dc.Creator" content="Donghui  Cui" /></meta><meta name="dc.Creator" content="George D.  Hartman" /></meta><meta name="dc.Creator" content="Steven D.  Young" /></meta><meta name="dc.Creator" content="Ken S.  Koblan" /></meta><meta name="dc.Creator" content="Christopher J.  Winrow" /></meta><meta name="dc.Creator" content="John J.  Renger" /></meta><meta name="dc.Creator" content="Paul J.  Coleman" /></meta><meta name="dc.Description" content="Despite increased understanding of the biological basis for sleep control in the brain, few novel mechanisms for the treatment of insomnia have been identified in recent years. One notable exceptio..." /></meta><meta name="Description" content="Despite increased understanding of the biological basis for sleep control in the brain, few novel mechanisms for the treatment of insomnia have been identified in recent years. One notable exceptio..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="June 21, 2010" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm100541c" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Â© 2010 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm100541c" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm100541c" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm100541c" /></link>
        
    
    

<title>Discovery of the Dual Orexin Receptor Antagonist [(7R)-4-(5-Chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone (MK-4305) for the Treatment of Insomnia | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm100541c" /></meta><meta property="og:title" content="Discovery of the Dual Orexin Receptor Antagonist [(7R)-4-(5-Chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone (MK-4305) for the Treatment of Insomnia" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm100541c/production/images/large/jm-2010-00541c_0012.jpeg" /></meta><meta property="og:description" content="Despite increased understanding of the biological basis for sleep control in the brain, few novel mechanisms for the treatment of insomnia have been identified in recent years. One notable exception is inhibition of the excitatory neuropeptides orexins A and B by design of orexin receptor antagonists. Herein, we describe how efforts to understand the origin of poor oral pharmacokinetics in a leading HTS-derived diazepane orexin receptor antagonist led to the identification of compound 10 with a 7-methyl substitution on the diazepane core. Though 10 displayed good potency, improved pharmacokinetics, and excellent in vivo efficacy, it formed reactive metabolites in microsomal incubations. A mechanistic hypothesis coupled with an in vitro assay to assess bioactivation led to replacement of the fluoroquinazoline ring of 10 with a chlorobenzoxazole to provide 3 (MK-4305), a potent dual orexin receptor antagonist that is currently being tested in phase III clinical trials for the treatment of primary insomnia." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm100541c"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm100541c">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm100541c&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm100541c&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm100541c&amp;href=/doi/10.1021/jm100541c" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2010</span><span class="cit-fg-volume">, 53</span><span class="cit-fg-issue">, 14</span><span class="cit-fg-pageRange">, 5320-5332</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/53/14" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm100308g" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm100623e" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of the Dual Orexin Receptor Antagonist [(7<i>R</i>)-4-(5-Chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2<i>H</i>-1,2,3-triazol-2-yl)phenyl]methanone (MK-4305) for the Treatment of Insomnia</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christopher+D.++Cox">Christopher D. Cox</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael+J.++Breslin">Michael J. Breslin</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David+B.++Whitman">David B. Whitman</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John+D.++Schreier">John D. Schreier</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Georgia+B.++McGaughey">Georgia B. McGaughey</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael+J.++Bogusky">Michael J. Bogusky</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anthony+J.++Roecker">Anthony J. Roecker</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Swati+P.++Mercer">Swati P. Mercer</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rodney+A.++Bednar">Rodney A. Bednar</a></span><span class="author-xref-symbol author-aff-symbol"><sup>Â§</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wei++Lemaire">Wei Lemaire</a></span><span class="author-xref-symbol author-aff-symbol"><sup>Â§</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joseph+G.++Bruno">Joseph G. Bruno</a></span><span class="author-xref-symbol author-aff-symbol"><sup>Â§</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Duane+R.++Reiss">Duane R. Reiss</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¥</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=C.+Meacham++Harrell">C. Meacham Harrell</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¥</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kathy+L.++Murphy">Kathy L. Murphy</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¥</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Susan+L.++Garson">Susan L. Garson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¥</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Scott+M.++Doran">Scott M. Doran</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¥</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Thomayant++Prueksaritanont">Thomayant Prueksaritanont</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¥</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wayne+B.++Anderson">Wayne B. Anderson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¥</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Cuyue++Tang">Cuyue Tang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¥</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shane++Roller">Shane Roller</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¥</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tamara+D.++Cabalu">Tamara D. Cabalu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¥</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Donghui++Cui">Donghui Cui</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¥</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=George+D.++Hartman">George D. Hartman</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Steven+D.++Young">Steven D. Young</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ken+S.++Koblan">Ken S. Koblan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¥</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christopher+J.++Winrow">Christopher J. Winrow</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¥</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John+J.++Renger">John J. Renger</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¥</sup></span></span></li><span class="comma-separator">,Â andÂ </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul+J.++Coleman">Paul J. Coleman</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="affa"><span class="aff-symbol">â </span> <span class="aff-text">Departments of Medicinal Chemistry</span></div><div class="aff-info" id="affb"><span class="aff-symbol">â¡</span> <span class="aff-text">Chemistry Modeling and Informatics</span></div><div class="aff-info" id="affc"><span class="aff-symbol">Â§</span> <span class="aff-text">In Vitro Sciences</span></div><div class="aff-info" id="affd"><span class="aff-symbol">â¥</span> <span class="aff-text">Depression and Circadian Disorders</span></div><div class="aff-info" id="affe"><span class="aff-symbol">â¥</span> <span class="aff-text">Drug Metabolism</span></div><div class="aff-info" id="afff"><span class="aff-text">Merck Research Laboratories, P.O. Box 4, Sumneytown Pike, West Point, Pennsylvania 19486</span></div><div class="corresp-info"><strong>*</strong>To whom correspondence should be addressed. Phone: + 1-215-652-2411. Fax: + 1-215-652-7310. E-mail: <a href="/cdn-cgi/l/email-protection#abc8c3d9c2d8f4c8c4d3ebc6ced9c8c085c8c4c6"><span class="__cf_email__" data-cfemail="98fbf0eaf1ebc7fbf7e0d8f5fdeafbf3b6fbf7f5">[emailÂ protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm100541c&amp;href=/doi/10.1021%2Fjm100541c" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2010</span></span><span class="cit-volume">, 53</span><span class="cit-issue">, 14</span><span class="cit-pageRange">, 5320â5332</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">June 21, 2010</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>5 May 2010</li><li><span class="item_label"><b>Published</b> online</span>21 June 2010</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 22 July 2010</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm100541c" title="DOI URL">https://doi.org/10.1021/jm100541c</a></div><div class="article_header-article-copyright"><strong>Copyright Â© 2010 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D5320%26pageCount%3D13%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DChristopher%2BD.%2BCox%252C%2BMichael%2BJ.%2BBreslin%252C%2BDavid%2BB.%2BWhitman%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D53%26issueNum%3D14%26contentID%3Djm100541c%26title%3DDiscovery%2Bof%2Bthe%2BDual%2BOrexin%2BReceptor%2BAntagonist%2B%255B%25287R%2529-4-%25285-Chloro-1%252C3-benzoxazol-2-yl%2529-7-methyl-1%252C4-diazepan-1-yl%255D%255B5-methyl-2-%25282H-1%252C2%252C3-triazol-2-yl%2529phenyl%255Dmethanone%2B%2528MK-4305%2529%2Bfor%2Bthe%2BTreatment%2Bof%2BInsomnia%26numPages%3D13%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D5332%26publicationDate%3DJuly%2B2010">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm100541c"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">8752</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">236</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm100541c" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of the Dual Orexin Receptor Antagonist [(7R)-4-(5-Chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone (MK-4305) for the Treatment of Insomnia&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;D. Cox&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;J. Breslin&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;B. Whitman&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;D. Schreier&quot;},{&quot;first_name&quot;:&quot;Georgia&quot;,&quot;last_name&quot;:&quot;B. McGaughey&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;J. Bogusky&quot;},{&quot;first_name&quot;:&quot;Anthony&quot;,&quot;last_name&quot;:&quot;J. Roecker&quot;},{&quot;first_name&quot;:&quot;Swati&quot;,&quot;last_name&quot;:&quot;P. Mercer&quot;},{&quot;first_name&quot;:&quot;Rodney&quot;,&quot;last_name&quot;:&quot;A. Bednar&quot;},{&quot;first_name&quot;:&quot;Wei&quot;,&quot;last_name&quot;:&quot;Lemaire&quot;},{&quot;first_name&quot;:&quot;Joseph&quot;,&quot;last_name&quot;:&quot;G. Bruno&quot;},{&quot;first_name&quot;:&quot;Duane&quot;,&quot;last_name&quot;:&quot;R. Reiss&quot;},{&quot;first_name&quot;:&quot;C.&quot;,&quot;last_name&quot;:&quot;Meacham Harrell&quot;},{&quot;first_name&quot;:&quot;Kathy&quot;,&quot;last_name&quot;:&quot;L. Murphy&quot;},{&quot;first_name&quot;:&quot;Susan&quot;,&quot;last_name&quot;:&quot;L. Garson&quot;},{&quot;first_name&quot;:&quot;Scott&quot;,&quot;last_name&quot;:&quot;M. Doran&quot;},{&quot;first_name&quot;:&quot;Thomayant&quot;,&quot;last_name&quot;:&quot;Prueksaritanont&quot;},{&quot;first_name&quot;:&quot;Wayne&quot;,&quot;last_name&quot;:&quot;B. Anderson&quot;},{&quot;first_name&quot;:&quot;Cuyue&quot;,&quot;last_name&quot;:&quot;Tang&quot;},{&quot;first_name&quot;:&quot;Shane&quot;,&quot;last_name&quot;:&quot;Roller&quot;},{&quot;first_name&quot;:&quot;Tamara&quot;,&quot;last_name&quot;:&quot;D. Cabalu&quot;},{&quot;first_name&quot;:&quot;Donghui&quot;,&quot;last_name&quot;:&quot;Cui&quot;},{&quot;first_name&quot;:&quot;George&quot;,&quot;last_name&quot;:&quot;D. Hartman&quot;},{&quot;first_name&quot;:&quot;Steven&quot;,&quot;last_name&quot;:&quot;D. Young&quot;},{&quot;first_name&quot;:&quot;Ken&quot;,&quot;last_name&quot;:&quot;S. Koblan&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;J. Winrow&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;J. Renger&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;J. Coleman&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2010&quot;,&quot;month&quot;:&quot;06&quot;,&quot;day&quot;:&quot;21&quot;,&quot;issue&quot;:&quot;14&quot;,&quot;volume&quot;:&quot;53&quot;,&quot;pages&quot;:&quot;5320-5332&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm100541c&quot;},&quot;abstract&quot;:&quot;Despite increased understanding of the biological basis for sleep control in the brain, few novel mechanisms for the treatment of insomnia have been identified in recent years. One notable exception is inhibition of the excitatory neuropeptides orexins A and B by design of orexin receptor antagonists. Herein, we describe how efforts to understand the origin of poor oral pharmacokinetics in a leading HTS-derived diazepane orexin receptor antagonist led to the identification of compound 10 with a 7-methyl substitution on the diazepane core. Though 10 displayed good potency, improved pharmacokinetics, and excellent in vivo efficacy, it formed reactive metabolites in microsomal incubations. A mechanistic hypothesis coupled with an in vitro assay to assess bioactivation led to replacement of the fluoroquinazoline ring of 10 with a chlorobenzoxazole to provide 3 (MK-4305), a potent dual orexin receptor antagonist that is currently being tested in phase III clinical trials for the treatment of primary insomnia.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm100541c&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm100541c" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm100541c&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm100541c" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm100541c&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm100541c" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm100541c&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm100541c&amp;href=/doi/10.1021/jm100541c" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm100541c" /></input><a href="/doi/pdf/10.1021/jm100541c" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm100541c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm100541c%26sid%3Dliteratum%253Aachs%26pmid%3D20565075%26genre%3Darticle%26aulast%3DCox%26date%3D2010%26atitle%3DDiscovery%2Bof%2Bthe%2BDual%2BOrexin%2BReceptor%2BAntagonist%2B%255B%25287R%2529-4-%25285-Chloro-1%252C3-benzoxazol-2-yl%2529-7-methyl-1%252C4-diazepan-1-yl%255D%255B5-methyl-2-%25282H-1%252C2%252C3-triazol-2-yl%2529phenyl%255Dmethanone%2B%2528MK-4305%2529%2Bfor%2Bthe%2BTreatment%2Bof%2BInsomnia%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D53%26issue%3D14%26spage%3D5320%26epage%3D5332%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">Â»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291171" title="Antagonists">Antagonists</a>,</li><li><a href="/action/doSearch?ConceptID=292462" title="Central nervous system">Central nervous system</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291155" title="Bioavailability">Bioavailability</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/53/14" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jmcmar.2010.53.issue-14/production/jmcmar.2010.53.issue-14.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm100541c/production/images/medium/jm-2010-00541c_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm100541c/production/images/large/jm-2010-00541c_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100541c&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Despite increased understanding of the biological basis for sleep control in the brain, few novel mechanisms for the treatment of insomnia have been identified in recent years. One notable exception is inhibition of the excitatory neuropeptides orexins A and B by design of orexin receptor antagonists. Herein, we describe how efforts to understand the origin of poor oral pharmacokinetics in a leading HTS-derived diazepane orexin receptor antagonist led to the identification of compound <b>10</b> with a 7-methyl substitution on the diazepane core. Though <b>10</b> displayed good potency, improved pharmacokinetics, and excellent in vivo efficacy, it formed reactive metabolites in microsomal incubations. A mechanistic hypothesis coupled with an in vitro assay to assess bioactivation led to replacement of the fluoroquinazoline ring of <b>10</b> with a chlorobenzoxazole to provide <b>3</b> (MK-4305), a potent dual orexin receptor antagonist that is currently being tested in phase III clinical trials for the treatment of primary insomnia.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06324" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06324" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Insomnia is characterized by difficulty initiating and/or maintaining sleep, waking early, or finding sleep nonrestorative. In a recent poll of American adults, over 50% reported having at least one symptom of insomnia during the previous year, and a third reported symptoms almost every night.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Insomnia is considered primary if no known underlying mental or physical condition leads to its development, and has been directly linked to significant daytime consequences such as irritability, inability to concentrate, reduced energy levels, poor job performance, work absenteeism, and a greater risk of traffic and work-related accidents as well as a higher incidence of health problems.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> Insomnia is also commonly experienced as a secondary symptom of comorbid disorders. The direct and indirect costs to the US economy related to insomnia have been estimated to be well in excess of $100 billion per year.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> It is believed that a significant number of cases go undiagnosed and/or untreated due to an opinion by many sufferers that sleep problems are inconsequential and a pervasive belief by physicians that currently available treatments have questionable safety and efficacy.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Notwithstanding, one-quarter of American adults take sleep medications during the course of a year, and the U.S. market for sleep drugs is estimated to reach $5 billion per year by 2010.<a onclick="showRef(event, 'cit3a'); return false;" href="javascript:void(0);" class="ref cit3a">(3a)</a></div><div class="NLM_p">Despite the physical, psychological, and economic toll of insomnia, treatments that improve total sleep time and subjective sleep quality without risk of next-day impairment, dependence, rebound insomnia, or safety concerns remain elusive.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> The most widely prescribed agents for treatment of insomnia are central nervous system depressants that enhance signaling of the inhibitory neurotransmitter Î³-aminobutyric acid (GABA<a class="ref internalNav" href="#fn1" aria-label="a">a</a><div class="NLM_fn" id="fn1">a<p class="last">Abbreviations: BDC, bile-duct cannulated; Boc, <i>tert</i>-butoxycarbonyl; BSA, bovine serum albumin; CSF, cerebrospinal fluid; DORA, dual orexin receptor antagonist; ECoG, electrocorticogram; EMG, electromyogram; FLIPR, fluorometric imaging plate reader; GABA, Î³-aminobutyric acid; GSH, glutathione; ICV, intracerebroventricular; LPS, latency to persistent sleep; NSB, nonspecific binding; OTC, over-the-counter; OX<sub>1</sub>R, orexin receptor 1; OX<sub>2</sub>R, orexin receptor 2; PEG, polyethylene glycol; REM, rapid-eye movement; SORA, selective orexin receptor antagonist; SWS, slow-wave sleep; TB, total binding; TPGS, <span class="smallcaps smallerCapital">d</span>-Î±-tocopheryl polyethylene glycol-100-succinate; WASO, wake after sleep onset.</p></div>). Developed beginning in the early 1960s, benzodiazepines decrease sleep onset time by binding to GABA<sub>A</sub> receptors on postsynaptic neurons in the central nervous system but are associated with issues such as daytime sleepiness, dizziness, impaired memory, and risk of dependence.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The subtype selective benzodiazepine and nonbenzodiazepine GABA<sub>A</sub> modulators developed more recently, such as zolpidem, zaleplon, and eszopiclone, address some of the issues associated with earlier agents but questions remain about the overall safety and efficacy of these agents.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> The FDA recently mandated black-box warnings related to the safety profile of all sedative hypnotics, underscoring the agencyÊ¼s concern with the currently available treatments.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> In 2005, the FDA approved the melatonin receptor antagonist ramelteon for the treatment of insomnia, representing the first novel mechanism to be approved in 35 years and the only hypnotic not classified as a controlled substance.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> However, questions remain about the effectiveness of ramelteon relative to GABA<sub>A</sub> modulators.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Clearly, novel mechanisms for the treatment of insomnia that simultaneously address the need for improved safety and efficacy are of great interest, and an increased understanding of the neuronal circuitry involved in the sleep/wake cycle has spurred a rational search for such targets.</div><div class="NLM_p">One of the most promising discoveries in this regard is the orexin (or hypocretin) system that is highly conserved across species and intricately linked to the regulation of sleep and wake states.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Orexins A and B are neuropeptides derived from the same prepro-orexin peptide that is produced in neurons located in the lateral hypothalamus. These neurons project widely to regions of the brain involved in regulation of arousal. Discovered in 1998 by independent research groups, the orexin peptides were found to bind to the previously identified orphan G protein-coupled receptors, orexin receptor 1 (OX<sub>1</sub>R) and orexin receptor 2 (OX<sub>2</sub>R).<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Whereas OX<sub>1</sub>R binds orexin A with greater affinity than orexin B, OX<sub>2</sub>R binds to both peptides with equal affinity.</div><div class="NLM_p">A number of genetic and pharmacological studies have confirmed the central role that orexin signaling plays in regulation of the sleep/wake cycle. Mice engineered to be deficient in orexin peptides demonstrate a robust phenotype consistent with human narcolepsy, a sleep disorder characterized by excessive daytime sleepiness, sleep fragmentation, and abnormal transitions to REM sleep.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Selective knockout of OX<sub>1</sub>R in mice revealed a mild phenotype characterized by sleep fragmentation, whereas knockout of OX<sub>2</sub>R produced a narcoleptic phenotype but one that is less severe than the peptide knockout. Simultaneous knockout of both OX<sub>1</sub>R and OX<sub>2</sub>R produced an acute narcoleptic phenotype similar to the peptide-deficient animals.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Additionally, a colony of dogs that naturally suffer from narcolepsy possess a mutation in the gene coding for the OX<sub>2</sub>R,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> whereas the disorder in humans has been linked to a reduction of orexin-producing neurons, resulting in low or undetectable levels of orexin A in the cerebrospinal fluid (CSF) of narcoleptics.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Consistent with these observations, direct intracerebroventricular (ICV) infusion of the orexin peptides into rat CSF leads to an increase in arousal and a decrease in REM and non-REM sleep.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></div><div class="NLM_p">Because hypofunction of the orexin system leads to decreased wakefulness, orexin receptor antagonists have emerged as a potential target for the treatment of insomnia as well as conditions resulting from disruption of the natural circadian cycle such as shift work or jet lag.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> However, on the basis of genetic studies, the potential for orexin receptor blockade to cause cataplexy, a condition closely linked to a subset of narcolepsy sufferers and characterized by sudden loss of muscle tone, was identified as a potential concern. A number of laboratories therefore embarked on a search for selective (OX<sub>1</sub>R or OX<sub>2</sub>R) as well as dual (OX<sub>1</sub>R/OX<sub>2</sub>R) orexin receptor antagonists to better characterize their therapeutic potential. These efforts have resulted in identification of potent dual orexin receptor antagonists (DORAs) as well as selective orexin receptor antagonists (SORAs) that have enabled pharmacological studies of their in vivo activity.<a onclick="showRef(event, 'cit15c cit15d ref16'); return false;" href="javascript:void(0);" class="ref cit15c cit15d ref16">(15c, 15d, 16)</a> Most work to date has focused on DORAs, likely due to the fact that genetic studies suggested a more robust effect on the sleep/wake cycle when both receptors are affected;<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> however, a recent publication revealed that an OX<sub>2</sub>R-selective SORA promotes sleep in rats.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></div><div class="NLM_p">The most fully characterized DORA studied to date is (2<i>R</i>)-2-[(1<i>S</i>)-6,7-dimethoxy-1-{2-[4-(trifluoromethyl)phenyl]ethyl}-3,4-dihydroisoquinolin-2(1<i>H</i>)-yl]-<i>N</i>-methyl-2-phenylethanamide (<b>1</b>, Almorexant), a compound currently in phase III clinical trials for the treatment of primary insomnia (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Developed by Actelion Pharmaceuticals, it has been shown to significantly decrease wakefulness in rats, dogs, and humans, with no evidence of cataplexy.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> In a phase II trial, Almorexant provided clinical proof of concept for the orexin antagonist mechanism in the treatment of insomnia, improving sleep efficiency in primary insomniacs, and showing no significant next-day effects on motor function or reaction time.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> The second entry into the clinic was the DORA <i>N</i>-{[(2<i>S</i>)-1-{[5-(4-fluorophenyl)-2-methyl-1,3-thiazol-4-yl]carbonyl}piperidin-2-yl]methyl}-1-benzofuran-4-carboxamide (<b>2</b>, SB-649868) from GlaxoSmithKline. It showed positive results in terms of efficacy without residual next day effects; however, preclinical toxicology findings have delayed advancement of this compound.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Importantly, both compounds have been shown to induce a natural sleep architecture characterized by increases in the time spent in REM and non-REM sleep, differentiating them from GABA<sub>A</sub> modulators such as zolpidem that reduce time spent in these sleep stages believed to be important for consolidation of memory and the restorative functions of sleep.<a onclick="showRef(event, 'cit15c'); return false;" href="javascript:void(0);" class="ref cit15c">(15c)</a> In December 2008, Merck presented preliminary phase I results indicating that DORA [(7<i>R</i>)-4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2<i>H</i>-1,2,3-triazol-2-yl)phenyl]methanone (<b>3</b>, MK-4305) decreased latency to persistent sleep (LPS) and wake after sleep onset (WASO), with no disruption of sleep architecture, in healthy volunteers.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm100541c/production/images/medium/jm-2010-00541c_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm100541c/production/images/large/jm-2010-00541c_0013.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. DORAs studied to date in clinical trials.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm100541c/production/images/large/jm-2010-00541c_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100541c&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The favorable clinical results obtained with three structurally diverse DORAs underscores the promise that orexin receptor antagonism holds for the treatment of sleep disorders. In this article, we describe the discovery and preclinical profile of <b>3</b>, a potent brain-penetrant DORA that recently entered phase III clinical trials for the treatment of primary insomnia.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62475" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62475" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">A recent publication from our group described the discovery of <b>4</b>, a novel diazepane-based DORA identified by hit-to-lead efforts following high throughput screening of the Merck sample collection (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Compound <b>4</b> demonstrates low nanomolar affinity for the human OX<sub>1</sub>R and OX<sub>2</sub>R as measured by a radioligand-displacement binding assay (expressed as <i>K</i><sub>i</sub>), as well as excellent potency in a fluorometric imaging plate reader (FLIPR) assay that provides a functional readout of orexin receptor antagonism in CHO cells engineered to overexpress the human receptors (expressed as IC<sub>50</sub>). It was found to promote sleep in rats when dosed orally at 100 mg/kg by increasing the amount of time spent in both REM and delta sleep.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> This observation is consistent with the profile of clinically studied DORAs <b>1</b> and <b>2</b><a onclick="showRef(event, 'cit15c'); return false;" href="javascript:void(0);" class="ref cit15c">(15c)</a> and opposite to the effect seen following ICV administration of the native peptide.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm100541c/production/images/medium/jm-2010-00541c_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm100541c/production/images/large/jm-2010-00541c_0014.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Previously reported diazepane-based DORA <b>4</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm100541c/production/images/large/jm-2010-00541c_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100541c&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Though <b>4</b> has excellent brain penetration, good physical properties, a clean ancillary profile, and produces desired effects on sleep architecture, it suffers from high clearance and low bioavailability in the rat (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). In the dog, <b>4</b> displays moderate plasma clearance (11.6 mL/min/kg) but low bioavailability (16%). In light of the observed clearance (calculated blood clearance accounts for â¼50% of hepatic blood flow), maximal bioavailability is anticipated to be â¼50% in dog assuming complete absorption and primary elimination via the liver. Thus, the observed low bioavailability was unexpected and suggested the possibility of poor absorption in this species. However, screening a number of vehicles did not result in any improvement over polyethylene glycol (PEG) 200 used in the initial study.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Pharmacokinetics of <b>4</b> in Rat and Dog</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Â </th><th class="colsep0 rowsep0" colspan="4" align="center" char=".">IV<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" colspan="4" align="center" char=".">PO<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">species</th><th class="colsep0 rowsep0" align="center" char=".">dose (mg/kg)</th><th class="colsep0 rowsep0" align="center" char=".">Cl (mL/min/kg)</th><th class="colsep0 rowsep0" align="center" char=".">Vd<sub>ss</sub> (L/kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center" char=".">dose (mg/kg)</th><th class="colsep0 rowsep0" align="center" char=".">AUC (Î¼MÂ·h)</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>max</sub> (Î¼M)</th><th class="colsep0 rowsep0" align="center" char="."><i>F</i> (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">52.6</td><td class="colsep0 rowsep0" align="char" char=".">1.08</td><td class="colsep0 rowsep0" align="char" char=".">0.35</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">1.50</td><td class="colsep0 rowsep0" align="char" char=".">0.65</td><td class="colsep0 rowsep0" align="char" char=".">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dog</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">11.6</td><td class="colsep0 rowsep0" align="char" char=".">0.86</td><td class="colsep0 rowsep0" align="char" char=".">1.28</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">1.81</td><td class="colsep0 rowsep0" align="char" char=".">1.44</td><td class="colsep0 rowsep0" align="char" char=".">16</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Vehicle = DMSO; <i>n</i> = 2 in rat, <i>n</i> = 3 in dog.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">Rat: dosed as the HCl salt in 20% TPGS; <i>n</i> = 3; dog: dosed as free base in PEG 200, <i>n</i> = 2.</p></div></div></div><div class="NLM_p">Bile-duct cannulated (BDC) dog and portal/cephalic vein infusion studies were therefore carried out to better understand the reason for poor bioavailability. These studies revealed that <b>4</b> is well absorbed when dosed in PEG 200, with 78% of the total dose recovered in bile and urine as products of oxidative metabolism. Hepatic extraction, determined by comparing plasma AUCs during infusion via the portal or cephalic vein, was 80%. Therefore, despite the moderate clearance of <b>4</b> in dog, hepatic first-pass metabolism was the major factor limiting its bioavailability. As the dog was predicted to be most like human in pharmacokinetic profile based on the similar intrinsic clearance in these two species, improved dog pharmacokinetics (reduced clearance, increased bioavailability) was required to advance a compound into development. We therefore began a rational approach to identify molecules with this potential.</div><div class="NLM_p">In vitro metabolism studies of <b>4</b> in microsomal preparations indicated several sites of metabolism that we sought to eliminate or modify by synthetic modifications. A major metabolic pathway identified was oxidation of the tolyl methyl group on the 5-methyl-2-(triazolyl)-benzamide portion of the molecule to form the benzyl alcohol and further oxidation to the benzoic acid. Additionally, complex metabolic patterns were observed on the remainder of the molecule that indicated oxidation was occurring on both the core and the quinazoline heterocycle. Interestingly, when <b>4</b> was incubated in microsomal preparations fortified with semicarbazide, mass spectral adducts consistent with structure <b>4b</b> were identified (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). Mechanistically, this is suggestive of oxidation at one of the four positions on the core adjacent to a nitrogen atom to form intermediate <b>4a</b>, followed by ring-opening to reveal an aldehyde, which is subsequently trapped by semicarbazide.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Taken as a whole, the metabolism data in hand suggested that removal of the benzylic methyl group, alteration of the heterocycle, and chemical modification of the core, especially blocking positions adjacent to the nitrogen atoms, were logical tactics to employ in an effort to improve pharmacokinetics in the diazepane series.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm100541c/production/images/medium/jm-2010-00541c_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm100541c/production/images/large/jm-2010-00541c_0015.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Proposed Mechanism of Semicarbazide Trapping When <b>4</b> Is Incubated in Liver Microsomes Fortified with Semicarbazide</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm100541c/production/images/large/jm-2010-00541c_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100541c&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">With this knowledge, we began an intensive synthetic investigation focused on identification of novel diazepane cores that had substitution at one or more carbon atoms. During this effort, we identified over 15 mono- or disubstituted diazepane cores that provided potent DORAs (<i>K</i><sub>i</sub> < 5 nM on both OX<sub>1</sub>R and OX<sub>2</sub>R). In general, substitution at positions 3 and 5 of the diazepane ring was not tolerated by the receptors, whereas substitution at positions 2, 6, and 7 was not only tolerated but often potency enhancing (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>).<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm100541c/production/images/medium/jm-2010-00541c_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm100541c/production/images/large/jm-2010-00541c_0001.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. General scaffold for examining mono- and disubstituted diazepane cores.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm100541c/production/images/large/jm-2010-00541c_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100541c&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">With a large number of potent diazepane cores in hand, we combined these with the optimal triazolyl-benzamide substituent and various heterocycles to assemble a large number of potent DORAs for pharmacokinetic evaluation. Our expectation was that reduced IV clearance would predict improved bioavailability as a result of reduced metabolism, so we studied many compounds in parallel by dosing IV in the dog. Promising analogues were then followed up by PO dosing to determine bioavailability.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> On the basis of the overall potency, ancillary, and pharmacokinetic profiles of analogues made with a methyl substituent at the 7-position of the diazepane core, these analogues were targeted for further investigation.</div><div class="NLM_p">Surprisingly, a search of the literature revealed a dearth of practical synthetic strategies to access a simple orthogonally protected 7-methyldiazepane.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> The most promising route involved conjugate addition of a 1,2-amino azide to methyl vinyl ketone, followed by an intramolecular aza-Wittig cyclization and subsequent reduction (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>).<a onclick="showRef(event, 'cit30b'); return false;" href="javascript:void(0);" class="ref cit30b">(30b)</a> Although short and convergent, this route is unattractive for large scale synthesis because it necessitates the synthesis and use of a potentially explosive alkyl azide.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></div><figure id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm100541c/production/images/medium/jm-2010-00541c_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm100541c/production/images/large/jm-2010-00541c_0002.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Previously Reported Synthesis of the 7-Methyldiazepane Core<a onclick="showRef(event, 'cit30b'); return false;" href="javascript:void(0);" class="ref cit30b">(30b)</a><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm100541c/production/images/large/jm-2010-00541c_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100541c&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Et<sub>2</sub>O (70%); (b) PPh<sub>3</sub>, Et<sub>2</sub>O (72%); (c), LAH, Et<sub>2</sub>O (91%).</p></p></figure><div class="NLM_p">As illustrated in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>, this route did, however, provide inspiration for a related strategy utilizing the commercially available <i>N</i>-Boc-1,2-diaminoethane as a surrogate for the azide. In our modified route, conjugate addition of the monoprotected diamine to methyl vinyl ketone followed by in situ trapping with benzyl chloroformate provides ketone <b>5</b>. Boc deprotection and subsequent intramolecular reductive amination with NaBH(OAc)<sub>3</sub> forms the diazepane ring. A Boc group is reinstalled to simplify purification, resulting in a 38% overall yield of <b>6</b> for the four steps from methyl vinyl ketone. Importantly, this chemistry can be readily carried out on large scale to provide access to quantities of <b>6</b> for analogue synthesis and in vivo evaluation of leading compounds.</div><figure id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm100541c/production/images/medium/jm-2010-00541c_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm100541c/production/images/large/jm-2010-00541c_0003.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of 7-Methyldiazepane DORA Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm100541c/production/images/large/jm-2010-00541c_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100541c&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Et<sub>2</sub>O, then TEA and benzyl chloroformate; (b) HCl<sub>(g)</sub>, EtOAc; (c) NaBH(OAc)<sub>3</sub>, HOAc, CH<sub>2</sub>Cl<sub>2</sub>; (d) Boc<sub>2</sub>O, TEA, CH<sub>2</sub>Cl<sub>2</sub> (38% for 4 steps); (e) Chiralpak AD, 60% EtOH in hexanes (0.1% DEA as modifier), first isomer to elute is the desired (<i>R</i>)-isomer; (f) HCl<sub>(g)</sub>, EtOAc; (g) 2-(2<i>H</i>-1,2,3-triazol-2-yl)-5-methylbenzoic acid, EDC, HOAT, NMM, DMF (87% for 2 steps); (h) H<sub>2</sub>, Pd(OH)<sub>2</sub>, MeOH/EtOAc; (i) 2-chloroquinazoline, K<sub>2</sub>CO<sub>3</sub>, DMF (75% for 2 steps).</p></p></figure><div class="NLM_p">Subsequent studies indicated that the (<i>R</i>)-antipode of analogues in this series had superior potency for the orexin receptors.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> A chiral stationary phase HPLC resolution was therefore carried out on racemic <b>6</b> to provide the desired (<i>R</i>)-enantiomer as the first eluting isomer. To complete the synthesis of analogues in this series, Boc deprotection followed by amide coupling to 2-(2<i>H</i>-1,2,3-triazol-2-yl)-5-methylbenzoic acid provided <b>7</b> in excellent yield. Removal of the benzyl carbamate followed by reaction with 2-chloroquinazoline provided <b>8</b>, the 7-(<i>R</i>)-methyldiazepane analogue of <b>4</b> in 75% yield from <b>7</b>.</div><div class="NLM_p">As illustrated in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, <b>8</b> displayed excellent potency for OX<sub>1</sub>R and OX<sub>2</sub>R receptors in both binding and FLIPR assays, but a reduction in dog clearance did not lead to improved oral bioavailability relative to <b>4</b>. Synthesis of <b>9</b> which lacks the benzylic methyl group of <b>8</b> provided an analogue with similar IV clearance but with diminished potency on OX<sub>1</sub>R as measured in the binding assay.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Installation of a fluorine atom at the 6-position of the quinazoline, a substitution we found to impart improved pharmacokinetics to a number of analogues in the diazepane series,<a onclick="showRef(event, 'cit25b'); return false;" href="javascript:void(0);" class="ref cit25b">(25b)</a> provided <b>10</b> with improved potency, a further reduction in IV clearance, and favorable bioavailability of 37% in dog.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Profile of 7-(<i>R</i>)-Methyldiazepane Analogues <b>8</b>â<b>10</b></div><p class="last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm100541c/production/images/medium/jm-2010-00541c_0004.gif" alt="" id="fx2" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center">R<sub>2</sub></th><th class="colsep0 rowsep0" align="center">R<sub>3</sub></th><th class="colsep0 rowsep0" align="center">OX<sub>1</sub>R <i>K</i><sub>i</sub>, FLIPR<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a> (nM)</th><th class="colsep0 rowsep0" align="center">OX<sub>2</sub>R <i>K</i><sub>i</sub>, FLIPR<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a> (nM)</th><th class="colsep0 rowsep0" align="center" char=".">dog Cl<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a> (mL/min/kg)</th><th class="colsep0 rowsep0" align="center">dog <i>F</i><a class="ref internalNav" href="#t2fn3" aria-label="c">c</a> (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">1.2, 29</td><td class="colsep0 rowsep0" align="left">0.59, 27</td><td class="colsep0 rowsep0" align="char" char=".">11.6</td><td class="colsep0 rowsep0" align="left">16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">0.39, 30</td><td class="colsep0 rowsep0" align="left">0.36, 30</td><td class="colsep0 rowsep0" align="char" char=".">6.0</td><td class="colsep0 rowsep0" align="left"><5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">6.2, 26</td><td class="colsep0 rowsep0" align="left">0.47, 18</td><td class="colsep0 rowsep0" align="char" char=".">6.4</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">1.8, 27</td><td class="colsep0 rowsep0" align="left">0.17, 27</td><td class="colsep0 rowsep0" align="char" char=".">5.2</td><td class="colsep0 rowsep0" align="left">37</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last"><i>n</i> â¥ 3.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last"><i>n</i> = 2 in cassette (<b>8, 9</b>) or single (<b>4, 10</b>) mode.</p></div><div class="footnote" id="t2fn3"><sup>c</sup><p class="last"><i>n</i> = 2 as a single in PEG 200.</p></div></div></div><div class="NLM_p">Similar to compound <b>4</b>, <b>10</b> is not a substrate for Pgp efflux (BA/AB = 0.6), has excellent passive permeability (38 Ã 10<sup>â6</sup> cm/s), a plasma free fraction of â¼3% in rat, and possesses a clean ancillary profile as determined by an MDS Pharma off-target screen. In vivo analysis in rat indicates <b>10</b> demonstrates reasonable rat pharmacokinetics with a clearance of 33 mL/min/kg and oral bioavailability of 47% when dosed at 10 mg/kg in 20% <span class="smallcaps smallerCapital">d</span>-Î±-tocopheryl polyethylene glycol-100-succinate (TPGS)<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> and maintains a favorable brain/plasma ratio of 0.4â0.6 and a CSF/plasma ratio of 0.02â0.03.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Compound <b>10</b> possesses the overall profile we were seeking in a development compound, and it was therefore advanced into a rat sleep assay to assess its effects on sleep architecture.</div><div class="NLM_p">The preclinical sleep laboratory at Merck makes use of radiotelemetric recording of electrocorticogram (ECoG) and electromyogram (EMG) signals to assess the time spent by animals in various states of arousal, including active wake, light sleep, REM sleep, and delta or slow wave sleep (SWS). Upon dosing <b>10</b> orally at 10 mg/kg/day to telemetry-implanted rats during their active phase (lights off), the amount of time spent in each state of arousal was measured and binned into 30 min intervals and compared to vehicle treated rats (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). Similar to the effects seen with compound <b>4</b>, <b>10</b> produced a significant decrease in active wake with a concurrent increase in REM and delta sleep during the three to four hours following dosing. At approximately one hour post dose when the greatest effects on sleep are observed, the plasma exposure of <b>10</b> was â¼1.0 Î¼M, which leads to an estimated 20â30 nM in the CSF. Thus, compounds <b>4</b> and <b>10</b> induce favorable sleep effects in rats at comparable plasma exposures, as predicted based on their in vitro profile, but compound <b>10</b> works at a 10-fold lower dose (on a mg/kg basis) due to its improved bioavailability.</div><figure id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm100541c/production/images/medium/jm-2010-00541c_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm100541c/production/images/large/jm-2010-00541c_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Effects of a 10 mg/kg dose of <b>10</b> on rat sleep. The duration of time spent in active wake, light sleep, delta sleep, and REM sleep in vehicle (closed circles) vs drug (open circles) treated animals following a 10 mg/kg po dose of <b>10</b> in 20% TPGS administered at 09:00. The open area in the bar above the abscissa designates lights on and the filled area designates lights off. Values are mean Â± SEM. Vertical gray lines represent statistically significant differences from vehicle treatment as determined using mixed-model ANOVAs at each time point. Significance levels are indicated by length of tic marks (short <0.5, medium <0.01, long <0.001).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm100541c/production/images/large/jm-2010-00541c_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100541c&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Excitement over the favorable attributes of <b>10</b> was tempered by the discovery that it undergoes bioactivation to form reactive electrophilic intermediates (reactive metabolites) that can be trapped with glutathione (GSH) when incubated in human or rat liver microsomes. It is generally accepted that reducing the potential for bioactivation of drug candidates during the lead optimization process is a prudent strategy to minimize potential risk for drug-induced idiosyncratic toxicity in humans.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> We therefore next focused attention on reducing bioactivation of leading diazepanes.</div><div class="NLM_p">To assess bioactivation potential, we employed an assay wherein test compounds were incubated in human liver microsomes fortified with GSH. Upon quenching the reaction, GSH-drug adducts were detected by ultra performance liquid chromatographyâhigh resolution mass spectrometry (UPLC/HRMS).<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> The area under the peaks for all GSH-adducts was measured relative to an internal standard (IS), and the GSH-adduct/IS ratio was used as a semiquantitative measure of bioactivation potential.</div><div class="NLM_p">In this assay, compound <b>10</b> had a GSH-adduct/IS ratio of 3.3. On the basis of mass spectral analysis of the GSH-adducts, we believed that the fluoroquinazoline ring was largely responsible for the bioactivation observed in <b>10</b>.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> We therefore decided to hold constant the optimized 7-methyldiazepane core and triazolyl-benzamide while focusing on heterocycle replacements to maintain good pharmacokinetics and reduce bioactivation.</div><div class="NLM_p">As illustrated in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>, replacing the fluoroquinazoline ring of <b>10</b> with a difluoroquinoxaline to provide <b>11</b> maintained favorable potency and IV clearance, but had little effect on the GSH-adduct/IS ratio. Believing a change from the 6,6-fused saturated ring system was required to reduce bioactivation, an analogue incorporating a 5,6,7,8-tetrahydroquinazoline ring was tested (<b>12</b>). Though potency remained excellent, dog clearance was adversely affected by this structural modification. Importantly, a significant improvement in the GSH-adduct/IS ratio was observed, indicating that progress toward reduced bioactivation was being made by alteration of the heterocycle.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Profile of 7-(<i>R</i>)-Methyldiazepane Analogues</div><p class="last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm100541c/production/images/medium/jm-2010-00541c_0006.gif" alt="" id="fx3" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm100541c/production/images/medium/jm-2010-00541c_0007.gif" alt="" id="fx4" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last"><i>n</i> â¥ 3.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last"><i>n</i> = 2 in cassette (<b>12</b>, <b>13</b>) or single (<b>10</b>, <b>11</b>, <b>3</b>) mode.</p></div><div class="footnote" id="t3fn3"><sup>c</sup><p class="last"><i>n</i> = 2 as a single in PEG 200.</p></div><div class="footnote" id="t3fn4"><sup>d</sup><p class="last">See <a class="ref internalNav" href="#sec3" aria-label="Experimental Section">Experimental Section</a> for a description of how this number is calculated.</p></div></div></div><div class="NLM_p">Analysis of the historical dog IV data collected on the program to this point identified benzoxazole-containing diazepanes as generally having reduced clearance values relative to other heterocycles tested. Installation of an unsubstituted benzoxazole to provide <b>13</b> resulted in an analogue with the lowest plasma clearance in dog observed to date for a diazepane DORA (2.4 mL/min/kg). However, despite inclusion of the potency-enhancing methyl group on the benzamide,<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a><b>13</b> suffered a nearly 20-fold loss in OX<sub>2</sub>R binding potency relative to <b>10</b>. From previous SAR knowledge dating back to the HTS hit that led to the discovery of the diazepane series, it was known that addition of lipophilic groups on benzoxazoles and benzothiazoles provided significant potency increases. Indeed, installation of a chlorine at the 5-position of the benzoxazole provided <b>3</b> with excellent potency and pharmacokinetics as well as minimal GSH-adduct formation (GSH-adduct/IS ratio = 0.1). We therefore decided to further characterize <b>3</b> for its potential as a development candidate.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a></div><div class="NLM_p">Like its predecessors, <b>3</b> possesses a favorable profile for a CNS-penetrant drug. It is not a substrate for Pgp efflux (BA/AB = 0.8), has excellent passive permeability (37 Ã 10<sup>â6</sup> cm/s), and possesses a clean ancillary profile (>10000-fold selectivity for OX<sub>2</sub>R) as determined by an MDS Pharma off-target screen of 170 enzymes, receptors, and ion channels. Because of the added lipophilicity introduced by the chlorobenzoxazole relative to the fluoroquinazoline (the LogP increased from 3.0 in <b>10</b> to 3.6 for <b>3</b>), protein binding increased to â¼99% in both rat and human plasma. DORA <b>3</b> has a brain/plasma ratio of â¼1 in the rat, and its CSF concentration is well reflected by unbound plasma concentration, suggesting a lack of concentration gradient between plasma and brain.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a></div><div class="NLM_p">When studied in telemetry-implanted rats, <b>3</b> induced significant changes in sleep behavior at 30 mg/kg where, as expected, significant increases in REM and delta sleep are observed with a corresponding decrease in active wake (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>).<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> In this study, the plasma exposure of <b>3</b> reached a <i>C</i><sub>max</sub> of 2.1 Î¼M, which leads to an estimated 21 nM in the CSF.</div><figure id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm100541c/production/images/medium/jm-2010-00541c_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm100541c/production/images/large/jm-2010-00541c_0008.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effects of a 30 mg/kg dose of <b>3</b> on rat sleep. The duration of time spent in active wake, light sleep, delta sleep, and REM sleep in vehicle (closed circles) vs drug (open circles) treated animals following a 30 mg/kg po dose of <b>3</b> in 20% TPGS administered at 09:00. The open area in the bar above the abscissa designates lights on and the filled area designates lights off. Values are mean Â± SEM. Vertical gray lines represent statistically significant differences from vehicle treatment as determined using mixed-model ANOVAs at each time point. Significance levels are indicated by length of tic marks (short < 0.5, medium < 0.01, long < 0.001).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm100541c/production/images/large/jm-2010-00541c_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100541c&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Along with the rat sleep assay, another powerful tool that aided lead optimization efforts was an ex vivo occupancy assay designed to measure orexin receptor binding directly in the rat brain. Because of low levels of endogenous orexin receptor expression, we developed a transgenic line of rats engineered to overexpress the human OX<sub>2</sub>R ubiquitously in the brain at relatively high density (12â14 nM).<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> This assay allowed us to determine receptor occupancy in the rat brain following peripheral administration of antagonists. Following a 30 min IV infusion of <b>3</b> over a concentration range of 0.1â2.0 mpk, we found that a 1.34 mg/kg dose was required to occupy 90% of the orexin receptors (Occ<sub>90</sub>), corresponding to exposures of 1070 nM in plasma, 1180 nM in brain, and 13 nM in the CSF (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>). This suggests that in the rat sleep study at 30 mg/kg/day, <b>3</b> achieved greater than 90% receptor occupancy.</div><figure id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm100541c/production/images/medium/jm-2010-00541c_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm100541c/production/images/large/jm-2010-00541c_0009.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Plot of occupancy versus dose for compound <b>3</b> in transgenic rats. Similar plots of occupancy versus concentration of <b>3</b> in plasma, brain, or CSF can be generated.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm100541c/production/images/large/jm-2010-00541c_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100541c&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As illustrated in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>, <b>3</b> has high clearance in rat but low to moderate clearance in dog, with a short terminal half-life of 0.6 and 3.3 h, respectively. Compound <b>3</b> also has good bioavailability in dog with a rapid <i>T</i><sub>max</sub> but lower bioavailability in rat. Investigation of <b>3</b> in BDC rat and dog studies following IV administration of <sup>14</sup>C-labeled drug not unexpectedly identified oxidation of the tolyl methyl group to the corresponding benzyl alcohol (<b>14</b>) as a major route of metabolism (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>). Further oxidation to the carboxylic acid <b>15</b> was also observed, as was oxidation of the methyl group on the core (<b>16</b>) and oxidation on the left-hand portion of the molecule (<b>17</b>).<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> Further conversion to the corresponding glucuronides was also observed. In rat, dog, and human liver microsomes, these same oxidative metabolites were observed, with rat microsomes displaying the highest rate of metabolism relative to dog and human. On the basis of the in vitro and in vivo data, and an assumption that oxidative metabolism will be the primary mode of elimination, <b>3</b> was predicted to be a low to moderate clearance compound with good bioavailability and a rapid onset of action in humans.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Pharmacokinetic Parameters of <b>3</b> in Rat and Dog</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Â </th><th class="colsep0 rowsep0" colspan="4" align="center" char=".">IV<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" colspan="5" align="center" char=".">PO<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">species</th><th class="colsep0 rowsep0" align="center" char=".">dose (mg/kg)</th><th class="colsep0 rowsep0" align="center" char=".">Cl (mL/min/kg)</th><th class="colsep0 rowsep0" align="center" char=".">Vd<sub>ss</sub> (L/kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center" char=".">dose (mg/kg)</th><th class="colsep0 rowsep0" align="center" char=".">AUC (Î¼MÂ·h)</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>max</sub> (Î¼M)</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>max</sub> (h)</th><th class="colsep0 rowsep0" align="center" char="."><i>F</i> (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">44</td><td class="colsep0 rowsep0" align="char" char=".">2.6</td><td class="colsep0 rowsep0" align="char" char=".">0.6</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">1.7</td><td class="colsep0 rowsep0" align="char" char=".">0.48</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">19</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dog</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">4.0</td><td class="colsep0 rowsep0" align="char" char=".">0.8</td><td class="colsep0 rowsep0" align="char" char=".">3.3</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">16.9</td><td class="colsep0 rowsep0" align="char" char=".">3.2</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">56</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Vehicle = DMSO; <i>n</i> = 3.</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">PEG 200, <i>n</i> = 3.</p></div></div></div><figure id="sch4" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm100541c/production/images/medium/jm-2010-00541c_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm100541c/production/images/large/jm-2010-00541c_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Oxidative Metabolites of <b>3</b> Identified from a BDC Rat Study</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm100541c/production/images/large/jm-2010-00541c_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100541c&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>3</b> is a semicrystalline solid with good thermal- and pH-dependent stability and modest aqueous solubility. It was not genotoxic and was well-tolerated in preclinical pharmacology and toxicity studies. There were no cardiovascular effects in dogs, and neurobehavioral changes in mice and rats were generally limited to transient decreases in locomotor activity that were consistent with the intended mechanism of action. Results from one-month general toxicity studies in rats and dogs supported the safety and tolerability of <b>3</b> for short-term testing in humans. On the basis of the overall profile of <b>3</b>, it was approved for development and entered phase I clinical trials in 2007. In late 2009, a phase III clinical trial was initiated to study the long-term safety and efficacy of <b>3</b> for the treatment of primary insomnia.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Additional preclinical as well as clinical results will be reported in due course.</div><div class="NLM_p last">In conclusion, we have described how a diazepane lead compound was advanced to provide a potent, brain-penetrant dual orexin receptor antagonist for the treatment of insomnia. Efforts to understand the cause of the poor pharmacokinetics of <b>4</b> led to a rational search for chemical modifications that reduced metabolism. Identification of the favorable 7-methyl substituent on the diazepane core resulted in compound <b>10</b> with good potency, improved pharmacokinetics, and excellent in vivo efficacy. An in vitro assay to assess bioactivation, in concert with a mechanistic hypothesis as to the site of bioactivation, led to replacement of the fluoroquinazoline ring of <b>10</b> with a chlorobenzoxazole to provide <b>3</b>, a potent dual orexin receptor antagonist that is currently being tested in phase III studies for the treatment of primary insomnia.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33135" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33135" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12">A Biology</h3><div class="NLM_p">All animal studies were performed according to the NIH Guide for the Care and Use of Laboratory Animals, and experimental protocols were reviewed by the Merck Animal Care and Use Committee.</div><div id="sec3_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i13" class="anchor-spacer"></div><h4 class="article-section__title" id="_i13"> Radioligand Binding Assay</h4><div class="NLM_p">Membranes were prepared from expressed human orexin 2 receptor (hOX<sub>2</sub>R) and the Ile408-Val variant of orexin 1 receptor (hOX<sub>1</sub>R) in CHO cells according to the method described by Kunapuli et al.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> Confluent CHO/OX<sub>2</sub>R and CHO/OX<sub>1</sub>R cells were dissociated from flasks with PBS/1 mM EDTA and centrifuged at 1000<i>g</i> for 10 min. The cell pellets were homogenized with a Polytron in ice-cold 20 mM Hepes, 1 mM EDTA, at pH 7.4, and centrifuged at 20000<i>g</i> for 20 min at 4 Â°C. This process was repeated twice. The final membrane pellet was resuspended at 5 mg of membrane protein/mL in assay buffer (20 mM Hepes, 125 mM NaCl, 5 mM KCl, pH 7.4). Bovine serum albumin was added to achieve a final concentration of 1% and aliquots stored at â80 Â°C. Radioligand binding assays were performed utilizing an automated Tecan Liquid handling system and Packard Unifilter-96 as described by Mosser et al.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> Assays were performed at room temperature in 96-well microtiter plates with a final assay volume of 1.0 mL in 20 mM Hepes buffer (pH 7.4) containing 125 nM NaCl and 5 mM KCl. Solutions of test compounds were prepared in DMSO and serially diluted with DMSO to yield 20 Î¼L of each of 10 solutions differing by 3-fold in concentration. Nonspecific binding (NSB) is determined using a high-affinity ligand (1 Î¼M final concentration) and total binding (TB) is determined by using DMSO (2% final concentrations). A solution of receptor (30 pM final, typically 2â10 Î¼g membranes), and tritiated ligands (â¼80 Ci/mmole) were added to the test compounds. For the OX<sub>2</sub>R receptor, 0.15 nM of compound <b>18</b> (<i>K</i><sub>D</sub> = 0.3 nM) was used. For the OX<sub>1</sub>R receptor, 0.7 nM of compound <b>19</b> (<i>K</i><sub>D</sub> = 3 nM) was used. The OX<sub>1</sub>R assay was also performed with equivalent results using compound <b>20</b> at a concentration of 0.03 nM (<i>K</i><sub>D</sub> = 0.03 nM); however, in this case 920 Î¼L of membranes was added first to the compounds followed by the addition of 60 Î¼L of the hot ligand. After 3 h of incubation at room temperature (20 h for compound <b>20</b>), samples were filtered through Packard GF/B filters (presoaked in 0.2% PEI, polyethyleninine Sigma P-3143) and washed five times with 1 mL of cold 20 mM Hepes buffer (pH 7.4) per wash. After vacuum drying of the filter plates, 50 Î¼L of Packard Microscint-20 was added and bound radioactivity (CPM bound) determined in a Packard TopCount.</div><div class="NLM_p"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm100541c/production/images/medium/jm-2010-00541c_0011.gif" alt="" id="fx1" /></img></div><div class="NLM_p last">Dose-inhibition profiles for each compound were characterized by fitting the data to a four-parameter equation using an Excel based fitting program as previously described by Mosser et al.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> The apparent inhibition constant (<b><i>K</i></b><sub><b>I</b></sub>, <i>K</i><sub>I</sub> = 10<sup>â<b>p<i>K</i></b></sup><sub><b>I</b></sub>), the maximum inhibition at the low plateau relative to â100% inhibition controlâ (<b><i>I</i><sub>max</sub></b>; e.g. 1 â¥ same as this control), the minimum inhibition at the high plateau relative to the â0% inhibition controlâ (<b><i>I</i><sub>min</sub></b>, e.g. 0 â¥ same as the no drug control) and the Hill slope (<b><i>n</i>H</b>) are determined by a weighted nonlinear least-squares fitting of the raw experimental observations (CPM Bound) as a function of dose ([Drug]) according to the equation below:<span class="NLM_disp-formula" id="eq1"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm100541c/production/images/jm-2010-00541c_m001.gif" alt="" /></img><span class="labelSpan">(1)</span></span>The median signal of the â0% inhibition controlsâ (TB) and the median signal of the â100% inhibition controlsâ (NSB) are constants in eq <a class="ref internalNav" href="#eq1" aria-label="1">1</a> that are determined from the controls located in columns 1 and 12 of each assay plate. The concentration of radioligand in eq <a class="ref internalNav" href="#eq1" aria-label="1">1</a> ([Radiolabel]) is calculated for each run based on the ligand specific radioactivity and the measured CPM of an aliquot of the assay solution. The apparent dissociation constant of the radioligand for its receptor (<i>K</i><sub>D</sub>) in eq <a class="ref internalNav" href="#eq1" aria-label="1">1</a>, and the receptor concentration (<i>B</i><sub>max</sub>) is determined by a hot saturation experiment.</div></div><div id="sec3_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14"> FLIPR Assay</h4><div class="NLM_p last">For intracellular calcium measurements, Chinese hamster ovary (CHO) cells expressing the Ile408-Val variant of the orexin 1 receptor or the human orexin 2 receptor, were grown in Iscoveâs modified DMEM containing 2 mM <span class="smallcaps smallerCapital">l</span>-glutamine, 0.5 g/mL G418, 1% hypoxanthine-thymidine supplement, 100 U/mL penicillin, 100 ug/mL streptomycin, and 10% heat-inactivated fetal calf serum. The cells were seeded at 20000 cells/well into Becton-Dickinson black 384-well clear bottom sterile plates coated with poly-<span class="smallcaps smallerCapital">d</span>-lysine. All reagents were from GIBCO-Invitrogen Corp. The seeded plates were incubated overnight at 37 Â°C and 6% CO<sub>2</sub>. Ala-6,12 human orexin-A as the agonist was prepared as a 0.5 mM stock solution in 1% bovine serum albumin (BSA) and diluted in assay buffer (HBSS containing 20 mM HEPES and 2.5 mM probenecid, pH 7.4) for use in the assay at a final concentration of 0.3â2 nM. Test compounds were prepared as 10 mM stock solution in DMSO, then diluted and pipetted in 384-well plates, first in DMSO, then assay buffer. On the day of the assay, cells were washed three times with 100 Î¼L assay buffer and then incubated for 60 min (37 Â°C, 6% CO<sub>2</sub>) in 60 Î¼L of assay buffer containing 1 Î¼M Fluo-4AM ester, 0.02% pluronic acid, and 1% BSA. The dye loading solution was then aspirated and cells washed three times with 100 Î¼L of assay buffer. Then 30 Î¼L of that same buffer is left in each well. Within the fluorescent imaging plate reader (Molecular Devices), test compounds were added to the plate in a volume of 15 Î¼L, incubated for 5 min, and finally 15 Î¼L of agonist was added. Fluorescence was measured for each well at 1 s intervals for 1 min and at 6 s intervals for 4 min, and the height of each fluorescence peak was compared to the height of the fluorescence peak induced by 0.3â2 nM Ala-6,12 orexin-A with buffer in place of antagonist. For each antagonist, the IC<sub>50</sub> value (the concentration of compound needed to inhibit 50% of the agonist response) was determined.</div></div><div id="sec3_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> Rat Sleep Assay</h4><div class="NLM_p">Adult male SpragueâDawley rats (450â600 g; Taconic Farms, Germantown, NY) were subcutaneously implanted with telemetric physiologic monitors (model F50-EEE or 4ET SI; Data Sciences International, Arden Hills, MN) that were used to simultaneously record both the electrocorticogram (ECoG) and electromyogram (EMG) activities of the rat. For placement of the 4ET SI, animals were anesthetized with isoflurane and electrodes for recording ECoG signals and EMG signals were placed. Position of the wires are based on the following coordinates. Channel 1 wire. From Lambda AP +2, ML +2 â2. Channel 2 wires From BREGMA AP +1.5 ML +3.2 (hole 1) AP â10.5 (hole2). Channel 3 wires From BREGMA AP â3.0 ML +1.5, â3.5. EMG lead placement was in neck muscle. An incision was made â¼3â5 cm in length midline on the dorsal thorax to form a pocket on the left and right side of midline, and the telemetry module was placed with a saddlebag placement method. The animals were given a single dose of antibiotic (gentomycin, 5.8 mg/kg) and an analgesic (buprenorphine, 0.1 mL) within 3 h following surgery. The animals were allowed to recover from surgery for at least two weeks prior to recording. Throughout these experiments, animals were housed individually in plastic cages (19 in. Ã 10<sup>1</sup>/<sub>2</sub> in. Ã 8 in.; Lab Products, Seaford, DE) and were provided water and food ad libitum. Lights were on a 12 h light: 12 h dark cycle with lights off at 4:00 a.m. and on at 4:00 p.m. ECoG and EMG signals were collected simultaneously from all animals using Dataquest ART software system (Data Sciences International, Arden Hills, MN), digitally sampled at 500 Hz, and stored on a PC for off-line analysis.</div><div class="NLM_p last">The hydrochloride salt of compound <b>10</b> (458 mg) was dissolved in 70.2 mL of a 20% aqueous solution of TPGS (obtained from Eastman Chemical Company) and administered by oral gavage at 10 mpk of the free-base equivalent to four rats, 5 h into their active period (09:00 or ZT 17:00). For <b>3</b>, the free-base (1.27 g) was suspended in 70.2 mL of a 20% aqueous solution of TPGS and dosed as above. Recordings were started just prior to compound administration and were collected for 23 h. The experiments were based on a standard crossover design with two animals receiving compound for one week and the complementary group receiving vehicle, followed by a week of reversed administration. All animals were exposed to two days administration of orally gavaged vehicle prior to initiation of experimental drug administration to allow for habituation. For baseline sleep measurements, continuous recordings were collected for two days to get average sleep behaviors for each animal over contiguous days prior to drug and vehicle administration. During the drug administration studies, recordings were collected each day prior to, during, and following drug administration. Recordings were begun prior to compound administration so that the exact time of administration was recorded within the raw data file as artifactual noise which was caused by removing the implanted transmitter from the receptive field of the receiver during administration. This information allowed a direct measure of drug/vehicle administration time during offline analysis and was not included in the data analysis. Following the completion of data collection, all data were scored with automated sleep stage analysis software, Somnologica (Embla, Broomfield, CO). Assignment of sleep stages was made in general accord with those described by J. M. Montiâs group.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> Sleep/wake stages were assigned based upon a combination of level of movement within the field of the radio frequency receiver over which individually housed rats were caged, EMG activity, and ECoG frequencies over 10 s epochs. Active wake was assigned to the epoch when movement of the animal was detected over the receiver or when there was an active EMG signal over the epoch and the ECoG frequencies consisted of low-voltage high frequency activity. An epoch was scored as light sleep when there was no movement activity, the EMG was moderately activ,e and the ECoG consisted of either theta or theta activity mixed with less than 50% of the epoch showing delta activity. Delta sleep was scored when there was no gross movement, reduced EMG activity, and the ECoG consisted of more than 50% delta wave activity (i.e., 0.5 to 4 Hz). Rapid eye movement (REM) sleep was scored when there was no movement or EMG activity and the ECoG consisted of primarily theta activity. Results of staging were grouped into 30 min periods following drug administration and the number of entries into each stage and the duration of minutes spent in each stage were calculated. The results for all four animals were averaged by treatment, or vehicle, over seven administration nights and the results were statistically compared based upon a mixed ANOVA analysis.</div></div><div id="sec3_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> Bioactivation Assay</h4><div class="NLM_p">Human liver microsomes (pooled, BD Gentest) were preincubated at 1 mg/mL protein in 100 mM potassium phosphate buffer (pH 7.4) with 10 Î¼M test compound, 1 mM MgCl<sub>2</sub>, 1 mM EDTA, 5 mM glutathione, and 1 mM NADPH for 60 min at 37 Â°C. The reactions were terminated with 25% acetonitrile containing 0.15 Î¼M labetalol (internal standard). The samples were vortex-mixed and centrifuged at 14000 rpm for 10 min. The supernatant from each sample was transferred to an HPLC vial for HRMS analysis.</div><div class="NLM_p last">UPLC-high resolution mass spectrometry (HRMS) was used to identify the GSH-derived adducts. The system consisted of a Waters Acquity sample manager and two Waters Acquity UPLC pumps. HRMS was performed using a Waters Q-TOF Xevo mass spectrometer. Separation was achieved using a Phenomenex Synergi 2.5 Î¼m MAX-RP 100 Ã column (50 mm Ã 2 mm) heated to 60 Â°C. The mobile phase consisted of water with 0.1% formic acid (solvent A) and acetonitrile with 0.1% formic acid (solvent B) at a flow rate of 0.5 mL/min. The gradient began with 5% solvent B for the first minute, followed by a linear increase to 15% solvent B over the next 0.5 min. Solvent B was then increased to 50% over the next 11.5 min followed by a further increase to 90% over 2 min. The column was then washed with 95% solvent B for 1.5 min. At the end of each run, the column was re-equilibrated for 5 min at the initial conditions. Mass spectral analyses were carried out using electrospray ionization in positive ion mode. The ESI capillary voltage was set at 1.5 kV, and the source and desolvation temperatures were set at 100 and 600 Â°C, respectively. The mass scan range was 150 to 1000 amu with 0.25 s/scan. The lock mass of 588.8691 amu was used with a frequency of one scan per 5 scans. The relative amount of GSH adducts formed with each test compound was estimated using peak area ratios. The areas obtained from the mass spectral peaks associated with GSH-derived adducts were divided by the area of the internal standard, labetalol.</div></div><div id="sec3_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> Ex Vivo Occupancy Assay</h4><div class="NLM_p last">Transgenic rats expressing human OX<sub>2</sub>R were dosed intravenously by infusion over a 30 min period or orally with <b>3</b> at doses of 0.1â2.0 mg/kg in 25% hydroxypropyl-Î²-cyclodextrin and then sacrificed. Samples of brain were quickly removed and frozen for use in the ex vivo occupancy assay, while a second set of tissue samples, a plasma sample, and CSF were frozen for LCMS determination of drug levels. For the ex vivo assay, approximately 60 mg of cord or brain was homogenized in 67 volumes of ice-cold assay buffer (20 mM HEPES, 120 mM NaCl, 5 mM KCl, pH7.4) and centrifuged at 21000<i>g</i> for 1 min. The pellets were resuspended in ice-cold buffer at a concentration of 10 mg tissue/mL and 100 Î¼L aliquots were rapidly distributed to tubes with 0.5 mL rof oom temperature buffer containing 200 pM compound <b>A</b>. At 2, 4, 6, 8, 10, 12, and 15 min following membrane addition, incubations were terminated by filtration of three tubes over glass fiber filters. A parallel set of incubations performed in the presence of 1 Î¼M of an unlabeled, potent DORA (OX<sub>2</sub>R <i>K</i><sub>i</sub> = 1.0 nM) was used to determine nonspecific radioligand binding at each time point. Radioactivity on the filters was determined by liquid scintillation counting and compound <b>A</b> rates of association were determined by linear regression. Receptor occupancy in a drug treated animal is calculated as: % occupancy = (1 â (slope<sub>drug</sub>/slope<sub>vehicle</sub>)) Ã 100. The concentrations of drug required to achieve 90% receptor occupancy were derived by nonlinear curve fitting using Prism software.</div></div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18">B Chemistry</h3><div class="NLM_p">All solvents used were commercially available âanhydrousâ grade, and reagents were utilized without purification unless otherwise noted. Nonaqueous reactions were carried out in oven- or heat gun-dried glassware under a nitrogen atmosphere. Magnetic stirring was used to agitate the reactions and they were monitored for completion by either TLC (silica gel 60, Merck KGaA) or LC/MS. A SmithCreator microwave from Personal Chemistry was used for microwave heating, and a CombiFlash system utilizing RediSep cartridges by Teledyne Isco was utilized for silica gel chromatography with fraction collection at 254 nm. Reverse phase HPLC purification was carried out on a Waters HPLC (XBridge Prep C-18 5 Î¼M 19 mm Ã 150 mm column) utilizing a gradient of 0.1% TFA in water/acetonitrile with sample collection triggered by photodiode array detection. The reported yields are for isolated compounds of â¥95% purity, unless otherwise noted, and were not extensively optimized. Purity analysis was carried out by HPLC with a Waters 2690 separations module equipped with a YMC Pro 50 mm Ã 3 mm I.D. C-18 column interfaced with a Waters Micromass ZMD spectrometer utilizing a gradient of 0.05% TFA in water/acetonitrile with UV detection at 215 and 254 nm. <sup>1</sup>H and <sup>13</sup>C NMR spectra were recorded on a Varian INOVA 400, 500, or 600 MHz spectrometer, and all chemical shifts are referenced to an internal standard of tetramethylsilane or the CDCl<sub>3</sub> solvent peak, respectively. High resolving power accurate mass measurement electrospray (ES) and atmospheric pressure chemical ionization (APCI) mass spectral data were acquired by use of a Bruker Daltonics 7T Fourier transform ion cyclotron resonance mass spectrometer (FT-ICR MS). Optical rotations were determined at 23 Â°C on a Perkin-Elmer 241 spectrometer in the solvents and at the concentrations specified.</div><div class="NLM_p">As we have recently described, 1,4-disubstituted diazepane orexin receptor antagonists exhibit unusual conformations in solution and exist in multiple conformations as a result of hindered rotations that are slow on the NMR time-scale.<a onclick="showRef(event, 'cit25a'); return false;" href="javascript:void(0);" class="ref cit25a">(25a)</a> In the case of compound <b>4</b>, we attributed the four conformations to <i>cis</i>â<i>trans</i> amide isomerization and hindered rotation about the exocyclic CâN bond between the core and the quinazoline. In a similar vein, the proton spectra of compounds <b>3</b> and <b>7</b>â<b>13</b> consist of broad, overlapping multiplets precluding a detailed coupling constant analysis, and we feel that pictorial reproductions of the NMR spectra are more informative for comparative purposes; thus, NMR resonances of final compounds will not be listed in numerical format. Instead, we include reproductions of the <sup>1</sup>H and <sup>13</sup>C NMR spectra at 25 Â°C of all final compounds in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>, as well as the synthetic procedures for preparation of <b>8</b>â<b>13</b>. For compound <b>3</b> only, <sup>1</sup>H and <sup>13</sup>C chemical shifts assigned from the analysis of COSY, HSQC, and HMBC spectra will be presented herein.</div><div id="sec3_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> [(7<i>R</i>)-4-(5-Chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2<i>H</i>-1,2,3-triazol-2-yl)phenyl]methanone (<b>3</b>)</h4><div class="NLM_p">To a solution of <b>7</b> (29.5 g, 68.3 mmol) in 300 mL of EtOAc and 200 mL of MeOH under nitrogen was added 2.4 g of 20% Pd(OH)<sub>2</sub> on carbon. The reaction was stirred for 48 h at room temperature under a balloon of H<sub>2</sub>, then filtered through a pad of celite with the aid of additional MeOH and concentrated to provide 21.0 g (100%) of the secondary amine as a white foam. This material was dissolved in 250 mL of DMF, and to the solution was added triethylamine (29.3 mL, 210 mmol) and 2,5-dichloro-1,3-benzoxazole<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> (13.2 g, 70.1 mmol). After stirring for 2 h at 75 Â°C, the reaction was partitioned between EtOAc and saturated aqueous NaHCO<sub>3</sub>, the layers were separated, and the organic layer was washed with water, brine, dried over MgSO<sub>4</sub>, filtered, and concentrated by rotary evaporation. The residue was purified by column chromatography with a gradient of 0â100% EtOAc in hexanes to provide a colorless foam. This material was stirred in a solution of 150 mL of EtOAc and 300 mL of hexanes overnight, filtered through a BÃ¼chner funnel, and the solids were collected to provide 29.1 g (92% from <b>7</b>) of <b>3</b> as a white solid. HRMS calcd for C<sub>23</sub>H<sub>23</sub>ClN<sub>6</sub>O<sub>2</sub> (M + H): 451.1644; found 451.1631. [Î±]<sub>D</sub> = â24.8 (<i>c</i> = 1.0, chloroform).</div><div class="NLM_p">Compound <b>3</b> exists as a mixture of four rotameric components in chemical exchange in DMSO-<i>d</i><sub>6</sub> at room temperature (48:24:18:10). <sup>1</sup>H and <sup>13</sup>C chemical shifts of the two most populated rotamers were assigned from the analysis of COSY, HSQC, and HMBC spectra acquired on a sample dissolved in DMSO-<i>d</i><sub>6</sub> at 25 Â°C. See the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> for reproductions of the <sup>1</sup>H and <sup>13</sup>C NMR spectra at 25 Â°C in CDCl<sub>3</sub>.</div><div class="NLM_p">Rotamer 1: (48% of total) <sup>1</sup>H NMR (599.458 MHz, DMSO-<i>d</i><sub>6</sub>, 25 Â°C) Î´ 7.90 (2H), 7.82 (1H), 7.44 (2H), 7.35 (1H), 7.32 (1H), 7.04 (1H), 4.23 (1H), 4.06 (1H), 3.98 (1H), 3.77 (1H), 3.62 (1H), 3.53 (1H), 3.32 (1H), 2.41 (3H), 2.04 (1H), 1.64 (1H), 1.15 (3H). <sup>13</sup>C NMR (150.742 MHz, DMSO-<i>d</i><sub>6</sub>, 25 Â°C) Î´ 167.9, 162.9, 147.4, 147.1, 144.9, 137.9, 135.7, 133.4, 130.3, 128.0, 127.7, 122.1, 119.6, 114.9, 109.6 51.6, 46.3, 43.0, 39.8, 34.8, 20.2, 18.9.</div><div class="NLM_p last">Rotamer 2: (24% of total) <sup>1</sup>H NMR (599.458 MHz, DMSO-<i>d</i><sub>6</sub>, 25 Â°C). 8.04 (2H), 7.79 (1H), 7.42 (1H), 7.38 (1H), 7.31 (1H), 7.24 (1H), 7.02 (1H), 4.64 (1H), 4.25 (1H), 4.00 (1H), 3.94 (1H), 3.73 (1H), 3.58 (1H), 3.22 (1H), 2.34 (3H), 2.20 (1H), 1.77 (1H) 1.13 (3H). <sup>13</sup>C NMR (150.742 MHz, DMSO-<i>d</i><sub>6</sub>, 25 Â°C) Î´ 168.3, 162.6, 147.3, 147.1, 144.7, 138.2, 135.8, 133.0, 130.2, 128.1, 127.9, 121.9, 119, 114.9, 109.6, 47.7, 46.5, 44.4, 38.4, 32.7, 20.1, 16.1.</div></div><div id="sec3_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> <i>tert</i>-Butyl {2-[(3-Oxobutyl)amino]ethyl}carbamate, Carbobenzyloxy-Protected (<b>5</b>)</h4><div class="NLM_p last">To a solution of <i>tert</i>-butyl <i>N</i>-(2-aminoethyl)carbamate (39.4 mL, 250 mmol) in 500 mL of Et<sub>2</sub>O was added methyl vinyl ketone (20.5 mL, 250 mmol) dropwise. After stirring 18 h, the reaction was cooled to 0 Â°C and triethylamine (45.2 mL, 325 mmol) was added, followed by dropwise addition of benzyl chloroformate (39.2 mL, 250 mmol). The reaction was allowed to warm slowly to room temperature and then stirred 48 h before being partitioned between EtOAc and 10% aqueous citric acid in a separatory funnel. After separation, the aqueous layer was extracted again with EtOAc, the combined organic layers were washed with saturated aqueous NaHCO<sub>3</sub>, then brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated by rotary evaporation to provide 71.3 g of crude <b>5</b> as pale yellowishâbrown oil that was carried into the next step without further purification.</div></div><div id="sec3_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> 1-Benzyl 4-<i>tert</i>-Butyl 5-Methyl-1,4-diazepane-1,4-dicarboxylate (<b>6</b>)</h4><div class="NLM_p last">HCl gas was bubbled through a solution of 71.3 g crude <b>6</b> in 500 mL of EtOAc until the reaction was warm to the touch, the flask was capped, and stirred for 2 h at room temperature. The volatiles were removed by rotary evaporation, the residue was dissolved in 1 M HCl and washed twice with Et<sub>2</sub>O. The aqueous layer was carefully basified with NaOH and extracted three times with 2:1 CHCl<sub>3</sub>/EtOH. The combined organic phases were washed with a minimum amount of brine and concentrated by rotary evaporation. The residue was dissolved in CH<sub>2</sub>Cl<sub>2</sub>, filtered, and concentrated to provide 32.9 g of a brown oil. This material was dissolved in 400 mL of CH<sub>2</sub>Cl<sub>2</sub> and treated with 10 mL of acetic acid. After stirring 2 h at room temperature, sodium triacetoxyborohydride (39.6 g, 187 mmol) was added and the reaction was stirred 48 h at room temperature. Most of the solvent was removed by rotary evaporation, and the residue was dumped into saturated aqueous NaHCO<sub>3</sub> and extracted three times with 2:1 CHCl<sub>3</sub>/EtOH. The combined organic phases were washed with a minimum amount of brine and concentrated by rotary evaporation. The residue was dissolved in CH<sub>2</sub>Cl<sub>2</sub>, filtered, and concentrated to provide 32.3 g of a brown oil. This material was dissolved in 200 mL of CH<sub>2</sub>Cl<sub>2</sub> and treated with triethylamine (26.3 g, 260 mmol) and Boc<sub>2</sub>O (34.1 g, 156 mmol). After stirring overnight at room temperature, the reaction was diluted with additional CH<sub>2</sub>Cl<sub>2</sub> and washed sequentially with 10% aqueous citric acid, saturated aqueous NaHCO<sub>3</sub>, water, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated by rotary evaporation. The residue was purified by column chromatography with a gradient of 0 to 30% EtOAc in hexanes to provide 33.1 g (38% from methyl vinyl ketone) of <b>6</b> as a colorless oil. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) Î´ 7.4â7.3 (m, 5H), 5.1 (s, 2H), 4.25 (m, 0.5H), 4.0â3.6 (m, 4H), 3.3â2.9 (m, 3.5H), 2.1 (m, 1H), 2.55 (s, 9H), 1.1 (d, <i>J</i> = 6.6 Hz, 3H) ppm. LRMS = 249.1 (M + H â Boc).</div></div><div id="sec3_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> 1-Benzyl 4-<i>tert</i>-Butyl (5<i>R</i>)-5-Methyl-1,4-diazepane-1,4-dicarboxylate [<b>(<i>R</i>)</b>-<b>6</b>]</h4><div class="NLM_p last">Resolution of the enatiomers of <b>6</b> was carried out chromatographically using a Chiralpak AD 10 cm Ã 50 cm column with 60% EtOH in hexanes (containing 0.1% diethylamine as a modifier) at 175 mL/min. Resolution of 17.4 g of <b>6</b> in three equal injections provided 8.2 g (47%, 95% of theoretical) of <b>(<i>R</i>)</b>-<b>6</b> as the first eluting enatiomer. Analytical HPLC analysis carried out on a 46 mm Ã 250 mm Chiralpak AD column with the same eluent as above at a flow rate of 1 mL/min indicated that <b>(<i>R</i>)</b>-<b>6</b> was of >98% ee. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) Î´ 7.4â7.3 (m, 5H), 5.1 (s, 2H), 4.25 (m, 0.5H), 4.0â3.6 (m, 4H), 3.3â2.9 (m, 3.5H), 2.1 (m, 1H), 2.55 (s, 9H), 1.1 (d, <i>J</i> = 6.6 Hz, 3H) ppm. LRMS = 249.1 (M + H â Boc). [Î±]<sub>D</sub> = â24.3 (<i>c</i> = 1.0, chloroform).</div></div><div id="sec3_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> 2-(2<i>H</i>-1,2,3-Triazol-2-yl)-5-methylbenzoic Acid</h4><div class="NLM_p last">A solution of 2-iodo-5-methylbenzoic acid (4.0 g, 15.3 mmol) in DMF (10 mL) was treated with 1,2,3-triazole (2.1 g, 30.5 mmol), Cs<sub>2</sub>CO<sub>3</sub> (9.95 g, 30.5 mmol), CuI (0.145 g, 0.76 mmol), and <i>trans</i>-<i>N</i>,<i>N</i>â²-dimethylcyclohexane-1,2-diamine (0.43 g, 3.05 mmol). The mixture was heated at 120 Â°C for 10 min in a microwave reactor. The reaction was cooled to room temperature, diluted with water, and washed with EtOAc. The aqueous phase was acidified with 1N HCl and extracted with EtOAc. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated by rotary evaporation. The residue was purified by silica gel chromatography (0â10% MeOH in DCM with 0.1% AcOH) to provide the desired regioisomer as a white solid (1.93 g, 62%) followed by the undesired <i>N</i>1-isomer. Data for 2-(2<i>H</i>-1,2,3-triazol-2-yl)-5-methylbenzoic acid: <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 12.98 (bs, 1H), 8.04 (s, 2H), 7.72â7.45 (m, 3H), 2.41 (s, 3H) ppm. HRMS-ESI <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>10</sub>H<sub>10</sub>N<sub>3</sub>O<sub>2</sub>, 204.0768; found, 204.0769.</div></div><div id="sec3_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> Benzyl (5<i>R</i>)-5-Methyl-4-[5-methyl-2-(2<i>H</i>-1,2,3-triazol-2-yl)benzoyl]-1,4-diazepane-1-carboxylate (<b>7</b>)</h4><div class="NLM_p last">HCl gas was bubbled through a solution of 27 g (77 mmol) of <b>(<i>R</i>)</b>-<b>6</b> in 500 mL of EtOAc until the reaction reached approximately 50 Â°C, and the flask was capped and stirred for 15 min at room temperature. HCl gas was again bubbled through the solution, and the flask was capped and stirred 30 min at room temperature. The volatiles were removed by rotary evaporation to provide 22.3 g of a pale-yellow gum. This material was dissolved in 300 mL of DMF and treated with 2-(2<i>H</i>-1,2,3-triazol-2-yl)-5-methylbenzoic acid (15.9 g, 78 mmol), EDC (22.5 g, 118 mmol), 1-hydroxy-7-azabenzotriazole (12.8 g, 94 mmol), and <i>N</i>-methylmorpholine (43.1 mL, 392 mmol). After stirring at room temperature overnight, the reaction was partitioned between EtOAc and saturated aqueous NaHCO<sub>3</sub>, the layers were separated, and the organic layer was washed with water, brine, dried over MgSO<sub>4</sub>, filtered, and concentrated by rotary evaporation. The residue was purified by column chromatography with a gradient of 0â100% EtOAc in hexanes to provide 29.5 g [87% from <b>(<i>R</i>)</b>-<b>6</b>] of <b>7</b> as a colorless gum. LRMS = 434.5 (M + H). [Î±]<sub>D</sub> = â34.4 (<i>c</i> = 1.0, chloroform). See the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> for a reproduction of the <sup>1</sup>H NMR spectrum at 25 Â°C in CDCl<sub>3</sub>.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i26"><a href="/doi/suppl/10.1021/jm100541c">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73584" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73584" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Experimental procedures for compounds <b>8</b>â<b>13</b>, as well as reproductions of the <sup>1</sup>H and <sup>13</sup>C NMR spectra for key compounds. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm100541c/suppl_file/jm100541c_si_001.pdf">jm100541c_si_001.pdf (250.6 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm100541c" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20703" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20703" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher D. Cox</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry</span>;Â 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#e88b809a819bb78b8790a8858d9a8b83c68b8785"><span class="__cf_email__" data-cfemail="caa9a2b8a3b995a9a5b28aa7afb8a9a1e4a9a5a7">[emailÂ protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael J. Breslin</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David B. Whitman</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John D. Schreier</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Georgia B. McGaughey</span> - <span class="hlFld-Affiliation affiliation">Chemistry Modeling and Informatics</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael J. Bogusky</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anthony J. Roecker</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Swati P. Mercer</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rodney A. Bednar</span> - <span class="hlFld-Affiliation affiliation">In Vitro Sciences</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wei Lemaire</span> - <span class="hlFld-Affiliation affiliation">In Vitro Sciences</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joseph G. Bruno</span> - <span class="hlFld-Affiliation affiliation">In Vitro Sciences</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Duane R. Reiss</span> - <span class="hlFld-Affiliation affiliation">Depression and Circadian Disorders</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">C. Meacham Harrell</span> - <span class="hlFld-Affiliation affiliation">Depression and Circadian Disorders</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kathy L. Murphy</span> - <span class="hlFld-Affiliation affiliation">Depression and Circadian Disorders</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Susan L. Garson</span> - <span class="hlFld-Affiliation affiliation">Depression and Circadian Disorders</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Scott M. Doran</span> - <span class="hlFld-Affiliation affiliation">Depression and Circadian Disorders</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thomayant Prueksaritanont</span> - <span class="hlFld-Affiliation affiliation">Drug Metabolism</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wayne B. Anderson</span> - <span class="hlFld-Affiliation affiliation">Drug Metabolism</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cuyue Tang</span> - <span class="hlFld-Affiliation affiliation">Drug Metabolism</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shane Roller</span> - <span class="hlFld-Affiliation affiliation">Drug Metabolism</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tamara D. Cabalu</span> - <span class="hlFld-Affiliation affiliation">Drug Metabolism</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Donghui Cui</span> - <span class="hlFld-Affiliation affiliation">Drug Metabolism</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">George D. Hartman</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Steven D. Young</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ken S. Koblan</span> - <span class="hlFld-Affiliation affiliation">Depression and Circadian Disorders</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher J. Winrow</span> - <span class="hlFld-Affiliation affiliation">Depression and Circadian Disorders</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John J. Renger</span> - <span class="hlFld-Affiliation affiliation">Depression and Circadian Disorders</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul J. Coleman</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i25">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25368" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25368" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Dr. Chuck Ross and Joan Murphy for HRMS analysis, Kim Michel for animal dosing, and Kristi Hoffman, Ken Anderson, and Mary Beth Young for pharmacokinetic analysis.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i27">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47238" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47238" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 46 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Passarella, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duong, M.-T.</span><span> </span><span class="NLM_article-title">Diagnosis and treatment of insomnia</span> <span class="citation_source-journal">Am. J. Health-Syst. Pharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">927</span><span class="NLM_x">â</span> <span class="NLM_lpage">934</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm100541c&amp;key=10.2146%2Fajhp060640" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm100541c&amp;key=18463341" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm100541c&amp;key=1%3ACAS%3A528%3ADC%252BD1cXntVSqtrk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2008&pages=927-934&author=S.+Passarellaauthor=M.-T.+Duong&title=Diagnosis+and+treatment+of+insomnia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Diagnosis and treatment of insomnia</span></div><div class="casAuthors">Passarella, Stacy; Duong, Minh-Tri</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Health-System Pharmacy</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">927-934</span>CODEN:
                <span class="NLM_cas:coden">AHSPEK</span>;
        ISSN:<span class="NLM_cas:issn">1079-2082</span>.
    
            (<span class="NLM_cas:orgname">American Society of Health-System Pharmacists</span>)
        </div><div class="casAbstract">A review.  The diagnostic criteria and treatment of insomnia are reviewed.  Insomnia is most often described as a subjective complaint of poor sleep quality or quantity despite adequate time for sleep, resulting in daytime fatigue, irritability, and decreased concn.  Insomnia is classified as idiopathic or comorbid.  Comorbid insomnias are assocd. with psychiatric disorders, medical disorders, substance abuse, and specific sleep disorders.  Idiopathic insomnia is essentially a diagnosis of exclusion.  A wide array of terminol. exists for defining the duration of insomnia symptoms, which may add to the confusion regarding insomnia classification.  Acute insomnia refers to sleep problems lasting from one night to a few weeks, whereas chronic insomnia refers to sleep problems lasting at least three nights weekly for at least one month.  Diagnostic tools for identifying insomnia are multifactorial.  Nonpharmacol. interventions for insomnia include sleep-hygiene education, stimulus-control therapy, relaxation therapy, and sleep-restriction therapy.  The most effective pharmacol. therapies for insomnia are benzodiazepines, benzodiazepine-receptor agonists, melatonin-receptor agonists, and antidepressants.  Choice of a specific agent should be based on patient-specific factors, including age, proposed length of treatment, primary sleep complaint, history of drug or alc. abuse, and cost.  Conclusion. Many treatment options are available for patients with insomnia.  Behavioral therapies should be initiated as first-line treatment in most patients.  For patients who require the addn. of pharmacol. therapy, the drugs with the most evidence for benefit include benzodiazepines, benzodiazepine-receptor agonists, melatonin-receptor agonists, and antidepressants.  Selection of a specific agent must take into account numerous patient-specific factors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKGWBnBjBX9rVg90H21EOLACvtfcHk0lgRy-w6hlzj9A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXntVSqtrk%253D&md5=6dfd55fb9f72928de4717753da85e39c</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.2146%2Fajhp060640&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2146%252Fajhp060640%26sid%3Dliteratum%253Aachs%26aulast%3DPassarella%26aufirst%3DS.%26aulast%3DDuong%26aufirst%3DM.-T.%26atitle%3DDiagnosis%2520and%2520treatment%2520of%2520insomnia%26jtitle%3DAm.%2520J.%2520Health-Syst.%2520Pharm.%26date%3D2008%26volume%3D65%26spage%3D927%26epage%3D934" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Daley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morin, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LeBlanc, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">GrÃ©goire, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baillargeon, L.</span><span> </span><span class="NLM_article-title">Insomnia and its relationship to health-care utilization, work absenteeism, productivity and accidents</span> <span class="citation_source-journal">Sleep Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">427</span><span class="NLM_x">â</span> <span class="NLM_lpage">438</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm100541c&amp;key=10.1016%2Fj.sleep.2008.04.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm100541c&amp;key=18753000" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm100541c&amp;key=1%3ACAS%3A280%3ADC%252BD1MzhsVWgtw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=427-438&author=M.+Daleyauthor=C.+M.+Morinauthor=M.+LeBlancauthor=J.+P.+Gr%C3%A9goireauthor=J.+Savardauthor=L.+Baillargeon&title=Insomnia+and+its+relationship+to+health-care+utilization%2C+work+absenteeism%2C+productivity+and+accidents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Insomnia and its relationship to health-care utilization, work absenteeism, productivity and accidents</span></div><div class="casAuthors">Daley M; Morin C M; LeBlanc M; Gregoire J P; Savard J; Baillargeon L</div><div class="citationInfo"><span class="NLM_cas:title">Sleep medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">427-38</span>
        ISSN:<span class="NLM_cas:issn">1389-9457</span>.
    </div><div class="casAbstract">BACKGROUND AND PURPOSE:  To document and provide a micro analysis of the relationship between insomnia and health problems, health-care use, absenteeism, productivity and accidents.  PARTICIPANTS AND METHODS:  A population-based sample of 953 French-speaking adults from Quebec, Canada.  Participants were categorized as having insomnia syndrome (SYND) or insomnia symptoms (SYMPT) or as good sleepers (GS).  They completed questionnaires on sleep, health, use of health-care services and products, accidents, work absences and reduced work productivity.  Data were also obtained from the Quebec-government-administered health insurance board on selected variables (e.g., consultations with health-care professionals, diagnoses).  RESULTS:  There were significantly more individuals in the SYND group relative to the GS group reporting at least one chronic health problem (83% vs. 53%; OR: 2.78) and who had consulted a health-care professional in the past year (81% vs. 60%; OR: 2.8).  There were also higher proportions of individuals in the SYND group than in the GS group who had used prescription medications (57% vs. 30.7%; OR: 2.8), most notably to treat insomnia, mood and anxiety disorders, or who had used over-the-counter products (75.6% vs. 62.0%; OR: 1.8) and alcohol as a sleep aid (17.8% vs. 3.9%; OR: 4.6).  In terms of daytime function, 25.0% of the SYND had been absent from work relative to 17.1% of GS (OR: 1.7), 40.6% reported having experienced reduced productivity compared to 12.3% of GS (OR: 4.8) and non-motor-vehicle accidents occurred at higher rates in the SYND group (12.5% vs. 6.4% for GS; OR: 2.4).  No differences were found for hospitalisations or motor-vehicle accidents.  Most of the associations remained significant even after controlling for psychiatric comorbidity.  Rates for the SYMPT group were situated between SYND and GS on all major dependent variables.  Furthermore, insomnia and fatigue were perceived as contributing significantly to accidents, absences and decreased work productivity, regardless of insomnia status.  CONCLUSIONS:  This study indicates that insomnia is associated with significant morbidity in terms of health problems and health-care utilization, work absenteeism and reduced productivity, and risk of non-motor-vehicle accidents.  Future studies should evaluate whether treating insomnia can reverse this morbidity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSMQKeKDjgufH6HPRus0rAafW6udTcc2eb5NgBmSlm0lrntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MzhsVWgtw%253D%253D&md5=28609005d76f88135a3739f1dd7d7fb5</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.sleep.2008.04.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.sleep.2008.04.005%26sid%3Dliteratum%253Aachs%26aulast%3DDaley%26aufirst%3DM.%26aulast%3DMorin%26aufirst%3DC.%2BM.%26aulast%3DLeBlanc%26aufirst%3DM.%26aulast%3DGr%25C3%25A9goire%26aufirst%3DJ.%2BP.%26aulast%3DSavard%26aufirst%3DJ.%26aulast%3DBaillargeon%26aufirst%3DL.%26atitle%3DInsomnia%2520and%2520its%2520relationship%2520to%2520health-care%2520utilization%252C%2520work%2520absenteeism%252C%2520productivity%2520and%2520accidents%26jtitle%3DSleep%2520Med.%26date%3D2009%26volume%3D10%26spage%3D427%26epage%3D438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Sullivan, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guilleminault, C.</span><span> </span><span class="NLM_article-title">Emerging drugs for insomnia: new frontiers for old and new targets</span> <span class="citation_source-journal">Expert Opin. Emerging Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">411</span><span class="NLM_x">â</span> <span class="NLM_lpage">422</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Fjm100541c&amp;key=10.1517%2F14728210903171948" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=8&amp;doi=10.1021%2Fjm100541c&amp;key=19708818" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Fjm100541c&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVCgurbF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2009&pages=411-422&author=S.+S.+Sullivanauthor=C.+Guilleminault&title=Emerging+drugs+for+insomnia%3A+new+frontiers+for+old+and+new+targets"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging drugs for insomnia: new frontiers for old and novel targets</span></div><div class="casAuthors">Sullivan, Shannon S.; Guilleminault, Christian</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Emerging Drugs</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">411-422</span>CODEN:
                <span class="NLM_cas:coden">EOEDA3</span>;
        ISSN:<span class="NLM_cas:issn">1472-8214</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Insomnia is the most prevalent sleep disorder, with up to 50% of the US adult population reporting symptoms of insomnia on a weekly basis and â¼ 12% with insomnia disorder.  Comorbid conditions such as depression and anxiety are frequent.  Insomnia is more common with older age, female gender and socioeconomic status.  Traditionally, therapy has focused on GABAA receptor agonists, and off-label antidepressant and antihistamine use.  With increased understanding of complex neural networks involved in sleep and wake, hypnotics are being developed to target a broader variety of receptors with increasing selectivity.  This review summarizes promising compds. in Phase II and III trials with evidence supporting efficacy for treatment of insomnia.  5-HT2A and 5-HT2C antagonists, melatonergic (MT1/MT2) agonists, orexin receptor (OX1/OX2) antagonists, as well as GABAA receptor agonists are reviewed and summarized.  Data are collected from PubMed and Pharmaprojects database searches, company websites, recent scientific meeting presentations and abstrs.  A variety of drugs targeting several pathways, including GABAA agonism, MT1/MT2 agonism, 5-HT2A antagonism, OX1/OX2 antagonism and others, are in Phase II and III trials.  More work should be done to understand the impact of these drugs in certain populations and in the context of comorbid conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKfbmX3Dwh4LVg90H21EOLACvtfcHk0ljNaisD3CcTJw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVCgurbF&md5=33f28e611296310e8d3623290e20d7b3</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1517%2F14728210903171948&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728210903171948%26sid%3Dliteratum%253Aachs%26aulast%3DSullivan%26aufirst%3DS.%2BS.%26aulast%3DGuilleminault%26aufirst%3DC.%26atitle%3DEmerging%2520drugs%2520for%2520insomnia%253A%2520new%2520frontiers%2520for%2520old%2520and%2520new%2520targets%26jtitle%3DExpert%2520Opin.%2520Emerging%2520Drugs%26date%3D2009%26volume%3D14%26spage%3D411%26epage%3D422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Renger, J. J.</span><span> </span><span class="NLM_article-title">Overview of experimental and conventional pharmacological approaches in the treatment of sleep and wake disorders</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">937</span><span class="NLM_x">â</span> <span class="NLM_lpage">953</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Fjm100541c&amp;key=10.2174%2F156802608784936755" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Fjm100541c&amp;key=18673164" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Fjm100541c&amp;key=1%3ACAS%3A528%3ADC%252BD1cXps1OhtLw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=937-953&author=J.+J.+Renger&title=Overview+of+experimental+and+conventional+pharmacological+approaches+in+the+treatment+of+sleep+and+wake+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">Overview of experimental and conventional pharmacological approaches in the treatment of sleep and wake disorders</span></div><div class="casAuthors">Renger, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">937-953</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The fundamental purpose of sleep remains one of the most compelling questions yet to be answered in the area of neuroscience, if not all of biol.  A pervasive behavior among members of the animal kingdom, the functional necessity of engaging regularly in sleep is best demonstrated by showing that failing to do so leads to a broad repertoire of pathol. outcomes including cognitive, immunol., hormonal, and metabolic outcomes, among others.  Indeed, an abs. requirement for sleep has been shown in studies that have demonstrated that continuous total deprivation of sleep for as short a period as 15 days is generally lethal in some species.  The most common clin. sleep disorder, insomnia, is both a principal disease (primary insomnia) as well as a co-morbidity of a large no. of other ostensibly unrelated diseases including chronic pain, attention deficit hyperactivity disorder, and depression.  From a treatment perspective, restoring normal healthy sleep delivers subsequent benefits in waking cognitive function and mood with the potential for beneficial therapeutic impact on daily functioning across multiple diseases for which restorative healthy sleep is compromised.  Our remarkable escalation in understanding the anatomy and physiol. of sleep/wake control mechanisms provides new opportunities to modify the neurobiol. of sleep and wake-related behaviors in novel and exciting ways.  In parallel, expansion of sleep research into novel interfaces between sleep-wake biol. and disease states is revealing addnl. extensive implications of lost sleep.  Current investigational and conventional pharmacol. approaches for the treatment of sleep and wake disorders are discussed based on their mechanism of action within the CNS and their effect on sleep and wake.  This review of recent sleep biol. and sleep pharmacol. peers into the future of sleep therapeutics to highlight both mechanistic safety and functional outcomes as key for differentiating and establishing success for the next generation of arousal modifying therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6GNzViXvCXbVg90H21EOLACvtfcHk0ljNaisD3CcTJw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXps1OhtLw%253D&md5=0f24539a5d8032bde88186f6df1a44a6</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.2174%2F156802608784936755&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802608784936755%26sid%3Dliteratum%253Aachs%26aulast%3DRenger%26aufirst%3DJ.%2BJ.%26atitle%3DOverview%2520of%2520experimental%2520and%2520conventional%2520pharmacological%2520approaches%2520in%2520the%2520treatment%2520of%2520sleep%2520and%2520wake%2520disorders%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2008%26volume%3D8%26spage%3D937%26epage%3D953" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Wafford, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebert, B.</span><span> </span><span class="NLM_article-title">Emerging anti-insomnia drugs: tackling sleeplessness and the quality of wake time</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">530</span><span class="NLM_x">â</span> <span class="NLM_lpage">540</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=530-540&author=K.+A.+Waffordauthor=B.+Ebert&title=Emerging+anti-insomnia+drugs%3A+tackling+sleeplessness+and+the+quality+of+wake+time"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWafford%26aufirst%3DK.%2BA.%26aulast%3DEbert%26aufirst%3DB.%26atitle%3DEmerging%2520anti-insomnia%2520drugs%253A%2520tackling%2520sleeplessness%2520and%2520the%2520quality%2520of%2520wake%2520time%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2008%26volume%3D7%26spage%3D530%26epage%3D540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span> </span><span class="NLM_article-title">FDA Requests Label Change for All Sleep Disorder Drug Products</span>. FDA News Release P07045, <span class="NLM_month">March</span><span class="NLM_day">14</span>,<span class="NLM_x"> </span><span class="NLM_year">2007</span><span class="NLM_x">; </span><a href="http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2007/ucm108868.htm" class="extLink">http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2007/ucm108868.htm</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=FDA+Requests+Label+Change+for+All+Sleep+Disorder+Drug+Products.+FDA+News+Release+P07045%2C+March14%2C+2007%3B+http%3A%2F%2Fwww.fda.gov%2FNewsEvents%2FNewsroom%2FPressAnnouncements%2F2007%2Fucm108868.htm."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26atitle%3DFDA%2520Requests%2520Label%2520Change%2520for%2520All%2520Sleep%2520Disorder%2520Drug%2520Products%26jtitle%3DFDA%2520News%2520Release%2520P07045%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Palomer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prinep, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guglietta, A.</span><span> </span><span class="NLM_article-title">Recent advances in the treatment of insomnia</span> <span class="citation_source-journal">Annu. Rep. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">63</span><span class="NLM_x">â</span> <span class="NLM_lpage">80</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2007&pages=63-80&author=A.+Palomerauthor=M.+Prinepauthor=A.+Guglietta&title=Recent+advances+in+the+treatment+of+insomnia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPalomer%26aufirst%3DA.%26aulast%3DPrinep%26aufirst%3DM.%26aulast%3DGuglietta%26aufirst%3DA.%26atitle%3DRecent%2520advances%2520in%2520the%2520treatment%2520of%2520insomnia%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2007%26volume%3D42%26spage%3D63%26epage%3D80" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Borja, N. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniel, K. L.</span><span> </span><span class="NLM_article-title">Ramelteon for the treatment of insomnia</span> <span class="citation_source-journal">Clin. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">1540</span><span class="NLM_x">â</span> <span class="NLM_lpage">1555</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Fjm100541c&amp;key=10.1016%2Fj.clinthera.2006.10.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=8&amp;doi=10.1021%2Fjm100541c&amp;key=17157111" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Fjm100541c&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlartrzJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2006&pages=1540-1555&author=N.+L.+Borjaauthor=K.+L.+Daniel&title=Ramelteon+for+the+treatment+of+insomnia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7a</span><div class="casTitle"><span class="NLM_cas:atitle">Ramelteon for the treatment of insomnia</span></div><div class="casAuthors">Borja, Nancy L.; Daniel, Karen L.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1540-1555</span>CODEN:
                <span class="NLM_cas:coden">CLTHDG</span>;
        ISSN:<span class="NLM_cas:issn">0149-2918</span>.
    
            (<span class="NLM_cas:orgname">Excerpta Medica, Inc.</span>)
        </div><div class="casAbstract">A review.  Background: Insomnia is a common sleep disorder with a significant potential for deleterious effects on activities of daily living, productivity, and overall quality of life.  Ramelteon, a highly selective agonist for melatonin subtypes 1 and 2 receptors, is a hypnotic agent approved by the US Food and Drug Administration (FDA) for the treatment of insomnia characterized by difficulty falling asleep.  Objective: This article reviews the pharmacokinetic properties, efficacy, and tolerability of ramelteon in the treatment of insomnia characterized by difficulty falling asleep.  Methods: Relevant articles were identified through searches of MEDLINE (1966 to July 2006), International Pharmaceutical Abstrs. (Jan. 1970 to July 2006), EMBASE Drugs and Pharmacol. (1980 to third quarter 2006), and Current Contents/Clin. Medicine (2005 wk 32 to 2006 wk 31).  Search terms included ramelteon, TAK-375, melatonin agonist, melatonin receptor agonist, insomnia, and sleep disorders/drug therapy (MeSH).  Results: A literature search revealed 12 randomized, controlled clin. trials that examd. the efficacy or tolerability of ramelteon.  In addn., 17 studies were reviewed for pharmacol. and pharmacokinetic data.  The refs. of the clin. trials and recent review articles were examd. to ensure the comprehensiveness of the literature search.  In 2 trials of patients with primary insomnia, patients treated with ramelteon 4 to 32 mg had significant redns. in latency to persistent sleep (LPS) compared with placebo (P < 0.001).  Addnl., improvements in total sleep time (TST) were obsd. (P < 0.001), although increases in TST were noted only on nights 1-2 of the second study.  Similarly, improvement in sleep efficiency was reported only on nights 1-2 of the second trial (P < 0.001).  In elderly patients with primary insomnia, significant redns. in subjective LPS were obsd. with ramelteon 4 and 8 mg (P = 0.008); however, av. subjective LPS was >70 min.  Mean reported TST was significantly increased in the 4-mg group (P = 0.004).  A second study in elderly patients found decreases in LPS with ramelteon 4 mg (P < 0.001) and 8 mg (P < 0.01), as well as significant increases in TST (P < 0.05 and P < 0.01, resp.).  Sleep efficiency improved for patients treated with 4 mg (P < 0.05) and 8 mg (P < 0.01).  Overall, the mean decrease in LPS reported in trials of ramelteon ranged from 10 to 19 min, and the mean increase in TST was 8 to 22 min.  The most common adverse events obsd. with ramelteon included headache (7%), dizziness (5%), somnolence (5%), fatigue (4%), and nausea (3%).  No evidence of cognitive impairment, rebound insomnia, withdrawal effects, or abuse potential was noted.  Conclusions: Based on this review, ramelteon, the first FDA-approved melatonin receptor agonist, represents a pharmacol. option for the treatment of insomnia characterized by difficulty falling asleep.  In patients with insomnia, treatment with ramelteon was generally well tolerated and resulted in modest but statistically significant decreases in LPS.  In the absence of published trials comparing ramelteon with other sedative-hypnotic agents, it is not yet possible to det. its efficacy relative to other therapeutic options for insomnia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqH8KOdHeFwbLVg90H21EOLACvtfcHk0livQMnz4aPJJg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlartrzJ&md5=6c4c07814164db950f6de7c7d593972e</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1016%2Fj.clinthera.2006.10.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.clinthera.2006.10.016%26sid%3Dliteratum%253Aachs%26aulast%3DBorja%26aufirst%3DN.%2BL.%26aulast%3DDaniel%26aufirst%3DK.%2BL.%26atitle%3DRamelteon%2520for%2520the%2520treatment%2520of%2520insomnia%26jtitle%3DClin.%2520Ther.%26date%3D2006%26volume%3D28%26spage%3D1540%26epage%3D1555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Sateia, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirby-Long, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, J. L.</span><span> </span><span class="NLM_article-title">Efficacy and clinical safety of ramelteon: an evidence-based review</span> <span class="citation_source-journal">Sleep Med. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">319</span><span class="NLM_x">â</span> <span class="NLM_lpage">332</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=16&amp;doi=10.1021%2Fjm100541c&amp;key=10.1016%2Fj.smrv.2007.12.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=8&amp;doi=10.1021%2Fjm100541c&amp;key=18603221" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=32&amp;doi=10.1021%2Fjm100541c&amp;key=1%3ACAS%3A280%3ADC%252BD1cvjsVektA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2008&pages=319-332&author=M.+J.+Sateiaauthor=P.+Kirby-Longauthor=J.+L.+Taylor&title=Efficacy+and+clinical+safety+of+ramelteon%3A+an+evidence-based+review"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7bR"><div class="casContent"><span class="casTitleNuber">7b</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy and clinical safety of ramelteon: an evidence-based review</span></div><div class="casAuthors">Sateia Michael J; Kirby-Long Paula; Taylor Jennifer L</div><div class="citationInfo"><span class="NLM_cas:title">Sleep medicine reviews</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">319-32</span>
        ISSN:<span class="NLM_cas:issn">1087-0792</span>.
    </div><div class="casAbstract">Ramelteon is a novel hypnotic compound that is FDA-approved for the treatment of sleep-onset difficulty.  It is a melatonin 1/2 receptor agonist with rapid absorption, extensive first-pass metabolism and an elimination half-life of just over 1h.  Clinical efficacy data indicate moderate efficacy in reduction of sleep latency in adults of all ages with chronic insomnia, with estimated effect sizes roughly comparable to other standard hypnotic agents.  Objective studies show minimal increases in total sleep time and no significant impact on wake after sleep-onset or sleep-stage distribution.  Subjective reports demonstrate comparable, if slightly smaller, improvements.  The recommended dosage is 8mg but studies suggest a flat response across dosage ranges from 4 to 32mg.  Safety data indicate no evidence of clinically significant next-day performance effects and a reasonably low side effect profile.  Animal studies, and a single human study suggest low abuse potential.  Single-blind run-out from clinical trials have demonstrated no evidence of rebound insomnia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTao5mkhqwFD6Nc3HjJRoFAfW6udTcc2ebvpXaY8drCHbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1cvjsVektA%253D%253D&md5=7b94aef4c310eef9be12a54af296c001</span></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1016%2Fj.smrv.2007.12.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.smrv.2007.12.005%26sid%3Dliteratum%253Aachs%26aulast%3DSateia%26aufirst%3DM.%2BJ.%26aulast%3DKirby-Long%26aufirst%3DP.%26aulast%3DTaylor%26aufirst%3DJ.%2BL.%26atitle%3DEfficacy%2520and%2520clinical%2520safety%2520of%2520ramelteon%253A%2520an%2520evidence-based%2520review%26jtitle%3DSleep%2520Med.%2520Rev.%26date%3D2008%26volume%3D12%26spage%3D319%26epage%3D332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><div class="note"><p class="first last">For a compilation of investigations carried out to identify the orexin system and define its physiological roles, see:</p></div> <span class="citation_source-book">Hypocretins: Integrators of Physiological Functions</span>; <span class="NLM_contrib-group">de Lecea, L.; Sutcliffe, J. G.</span>, Eds.; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=L.+de+Lecea&author=J.+G.+Sutcliffe&title=Hypocretins%3A+Integrators+of+Physiological+Functions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DHypocretins%253A%2520Integrators%2520of%2520Physiological%2520Functions%26aulast%3Dde%2BLecea%26aufirst%3DL.%26pub%3DSpringer%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">De Lecea, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kilduff, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peyron, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, X.-B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foye, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danielson, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukuhara, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Battenberg, E. L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gautvik, V. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartlett, F. S.,  II</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frankel, W. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Den Pol, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bloom, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gautvik, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutcliffe, J. G.</span><span> </span><span class="NLM_article-title">The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">322</span><span class="NLM_x">â</span> <span class="NLM_lpage">327</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=16&amp;doi=10.1021%2Fjm100541c&amp;key=10.1073%2Fpnas.95.1.322" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=8&amp;doi=10.1021%2Fjm100541c&amp;key=9419374" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=32&amp;doi=10.1021%2Fjm100541c&amp;key=1%3ACAS%3A528%3ADyaK1cXjtl2hsw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=322-327&author=L.+De+Leceaauthor=T.+S.+Kilduffauthor=C.+Peyronauthor=X.-B.+Gaoauthor=P.+E.+Foyeauthor=P.+E.+Danielsonauthor=C.+Fukuharaauthor=E.+L.+F.+Battenbergauthor=V.+T.+Gautvikauthor=F.+S.+Bartlettauthor=W.+N.+Frankelauthor=A.+N.+Van+Den+Polauthor=F.+E.+Bloomauthor=K.+M.+Gautvikauthor=J.+G.+Sutcliffe&title=The+hypocretins%3A+hypothalamus-specific+peptides+with+neuroexcitatory+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9aR"><div class="casContent"><span class="casTitleNuber">9a</span><div class="casTitle"><span class="NLM_cas:atitle">The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity</span></div><div class="casAuthors">De Lecea, L.; Kilduff, T. S.; Peyron, C.; Gao, X. -B.; Foye, P. E.; Danielson, P. E.; Fukuhara, C.; Battenberg, E. L. F.; Gautvik, V. T.; Bartlett, F. S., II; Frankel, W. N.; Van Den Pol, A. N.; Bloom, F. E.; Gautvik, K. M.; Sutcliffe, J. G.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">322-327</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">We describe a hypothalamus-specific mRNA that encodes preprohypocretin, the putative precursor of a pair of peptides that share substantial amino acid identities with the gut hormone secretin.  The hypocretin (Hcrt) protein products are restricted to neuronal cell bodies of the dorsal and lateral hypothalamic areas.  The fibers of these neurons are widespread throughout the posterior hypothalamus and project to multiple targets in other areas, including brainstem and thalamus.  Hcrt immunoreactivity is assocd. with large granular vesicles at synapses.  One of the Hcrt peptides was excitatory when applied to cultured, synaptically coupled hypothalamic neurons, but not hippocampal neurons.  These observations suggest that the hypocretins function within the CNS as neurotransmitters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAEQa5lFLKr7Vg90H21EOLACvtfcHk0licER1KvfipvA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjtl2hsw%253D%253D&md5=52bde93a7933953f02930a6f57a0f1b1</span></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1073%2Fpnas.95.1.322&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.95.1.322%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BLecea%26aufirst%3DL.%26aulast%3DKilduff%26aufirst%3DT.%2BS.%26aulast%3DPeyron%26aufirst%3DC.%26aulast%3DGao%26aufirst%3DX.-B.%26aulast%3DFoye%26aufirst%3DP.%2BE.%26aulast%3DDanielson%26aufirst%3DP.%2BE.%26aulast%3DFukuhara%26aufirst%3DC.%26aulast%3DBattenberg%26aufirst%3DE.%2BL.%2BF.%26aulast%3DGautvik%26aufirst%3DV.%2BT.%26aulast%3DBartlett%26aufirst%3DF.%2BS.%26aulast%3DFrankel%26aufirst%3DW.%2BN.%26aulast%3DVan%2BDen%2BPol%26aufirst%3DA.%2BN.%26aulast%3DBloom%26aufirst%3DF.%2BE.%26aulast%3DGautvik%26aufirst%3DK.%2BM.%26aulast%3DSutcliffe%26aufirst%3DJ.%2BG.%26atitle%3DThe%2520hypocretins%253A%2520hypothalamus-specific%2520peptides%2520with%2520neuroexcitatory%2520activity%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1998%26volume%3D95%26spage%3D322%26epage%3D327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Sakurai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amemiya, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishii, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuzaki, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chemelli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozlowski, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arch, J. R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckingham, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haynes, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carr, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Annan, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNulty, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terrett, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elshourbagy, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergsma, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanagisawa, M.</span><span> </span><span class="NLM_article-title">Orexins and orexin receptors: A family of hypothalamic neuropeptides and G-protein receptors that regulate feeding behavior</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">573</span><span class="NLM_x">â</span> <span class="NLM_lpage">585</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=1998&pages=573-585&author=T.+Sakuraiauthor=A.+Amemiyaauthor=M.+Ishiiauthor=I.+Matsuzakiauthor=R.+Chemelliauthor=H.+Tanakaauthor=S.+C.+Williamsauthor=J.+A.+Richardsonauthor=G.+P.+Kozlowskiauthor=S.+Wilsonauthor=J.+R.+S.+Archauthor=R.+E.+Buckinghamauthor=A.+C.+Haynesauthor=S.+A.+Carrauthor=R.+S.+Annanauthor=D.+E.+McNultyauthor=W.+Liuauthor=J.+A.+Terrettauthor=N.+A.+Elshourbagyauthor=D.+J.+Bergsmaauthor=M.+Yanagisawa&title=Orexins+and+orexin+receptors%3A+A+family+of+hypothalamic+neuropeptides+and+G-protein+receptors+that+regulate+feeding+behavior"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSakurai%26aufirst%3DT.%26aulast%3DAmemiya%26aufirst%3DA.%26aulast%3DIshii%26aufirst%3DM.%26aulast%3DMatsuzaki%26aufirst%3DI.%26aulast%3DChemelli%26aufirst%3DR.%26aulast%3DTanaka%26aufirst%3DH.%26aulast%3DWilliams%26aufirst%3DS.%2BC.%26aulast%3DRichardson%26aufirst%3DJ.%2BA.%26aulast%3DKozlowski%26aufirst%3DG.%2BP.%26aulast%3DWilson%26aufirst%3DS.%26aulast%3DArch%26aufirst%3DJ.%2BR.%2BS.%26aulast%3DBuckingham%26aufirst%3DR.%2BE.%26aulast%3DHaynes%26aufirst%3DA.%2BC.%26aulast%3DCarr%26aufirst%3DS.%2BA.%26aulast%3DAnnan%26aufirst%3DR.%2BS.%26aulast%3DMcNulty%26aufirst%3DD.%2BE.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DTerrett%26aufirst%3DJ.%2BA.%26aulast%3DElshourbagy%26aufirst%3DN.%2BA.%26aulast%3DBergsma%26aufirst%3DD.%2BJ.%26aulast%3DYanagisawa%26aufirst%3DM.%26atitle%3DOrexins%2520and%2520orexin%2520receptors%253A%2520A%2520family%2520of%2520hypothalamic%2520neuropeptides%2520and%2520G-protein%2520receptors%2520that%2520regulate%2520feeding%2520behavior%26jtitle%3DCell%26date%3D1998%26volume%3D92%26spage%3D573%26epage%3D585" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Chemelli, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willie, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinton, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elmquist, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scammell, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kisanuki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitch, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakazato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammer, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saper, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanagisawa, M.</span><span> </span><span class="NLM_article-title">Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">437</span><span class="NLM_x">â</span> <span class="NLM_lpage">451</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=16&amp;doi=10.1021%2Fjm100541c&amp;key=10.1016%2FS0092-8674%2800%2981973-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=8&amp;doi=10.1021%2Fjm100541c&amp;key=10481909" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=32&amp;doi=10.1021%2Fjm100541c&amp;key=1%3ACAS%3A528%3ADyaK1MXlslWmsbo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=1999&pages=437-451&author=R.+M.+Chemelliauthor=J.+T.+Willieauthor=C.+M.+Sintonauthor=J.+K.+Elmquistauthor=T.+Scammellauthor=C.+Leeauthor=J.+A.+Richardsonauthor=S.+C.+Williamsauthor=Y.+Xiongauthor=Y.+Kisanukiauthor=T.+E.+Fitchauthor=M.+Nakazatoauthor=R.+E.+Hammerauthor=C.+B.+Saperauthor=M.+Yanagisawa&title=Narcolepsy+in+orexin+knockout+mice%3A+molecular+genetics+of+sleep+regulation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10aR"><div class="casContent"><span class="casTitleNuber">10a</span><div class="casTitle"><span class="NLM_cas:atitle">Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation</span></div><div class="casAuthors">Chemelli, Richard M.; Willie, Jon T.; Sinton, Christopher M.; Elmquist, Joel K.; Scammell, Thomas; Lee, Charlotte; Richardson, James A.; Williams, S. Clay; Xiong, Yumei; Kisanuki, Yaz; Fitch, Thomas E.; Nakazato, Masamitsu; Hammer, Robert E.; Saper, Clifford B.; Yanagisawa, Masashi</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">437-451</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Neurons contg. the neuropeptide orexin (hypocretin) are located exclusively in the lateral hypothalamus and send axons to numerous regions throughout the central nervous system, including the major nuclei implicated in sleep regulation.  Here, we report that, by behavioral and electroencephalog. criteria, orexin knockout mice exhibit a phenotype strikingly similar to human narcolepsy patients, as well as canarc-1 mutant dogs, the only known monogenic model of narcolepsy.  Moreover, modafinil, an anti-narcoleptic drug with ill-defined mechanisms of action, activates orexin-contg. neurons.  We propose that orexin regulates sleep/wakefulness states, and that orexin knockout mice are a model of human narcolepsy, a disorder characterized primarily by rapid eye movement (REM) sleep dysregulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomTMUcvI3kgbVg90H21EOLACvtfcHk0lh54JEZxhMJTw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlslWmsbo%253D&md5=71290ef78fe300cfe3c61b4f3fcf7e6f</span></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2981973-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252981973-X%26sid%3Dliteratum%253Aachs%26aulast%3DChemelli%26aufirst%3DR.%2BM.%26aulast%3DWillie%26aufirst%3DJ.%2BT.%26aulast%3DSinton%26aufirst%3DC.%2BM.%26aulast%3DElmquist%26aufirst%3DJ.%2BK.%26aulast%3DScammell%26aufirst%3DT.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DRichardson%26aufirst%3DJ.%2BA.%26aulast%3DWilliams%26aufirst%3DS.%2BC.%26aulast%3DXiong%26aufirst%3DY.%26aulast%3DKisanuki%26aufirst%3DY.%26aulast%3DFitch%26aufirst%3DT.%2BE.%26aulast%3DNakazato%26aufirst%3DM.%26aulast%3DHammer%26aufirst%3DR.%2BE.%26aulast%3DSaper%26aufirst%3DC.%2BB.%26aulast%3DYanagisawa%26aufirst%3DM.%26atitle%3DNarcolepsy%2520in%2520orexin%2520knockout%2520mice%253A%2520molecular%2520genetics%2520of%2520sleep%2520regulation%26jtitle%3DCell%26date%3D1999%26volume%3D98%26spage%3D437%26epage%3D451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Willie, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chemelli, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinton, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokita, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kisanuki, Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcus, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elmquist, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohlmeier, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammer, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanagisawa, M.</span><span> </span><span class="NLM_article-title">Distinct narcolepsy syndromes in orexin receptor 2 and orexin null mice: molecular genetic dissection of non-REM and REM sleep regulatory processes</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">715</span><span class="NLM_x">â</span> <span class="NLM_lpage">730</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2003&pages=715-730&author=J.+T.+Willieauthor=R.+M.+Chemelliauthor=C.+M.+Sintonauthor=S.+Tokitaauthor=S.+C.+Williamsauthor=Y.+Y.+Kisanukiauthor=J.+N.+Marcusauthor=C.+Leeauthor=J.+K.+Elmquistauthor=K.+A.+Kohlmeierauthor=C.+S.+Leonardauthor=J.+A.+Richardsonauthor=R.+E.+Hammerauthor=M.+Yanagisawa&title=Distinct+narcolepsy+syndromes+in+orexin+receptor+2+and+orexin+null+mice%3A+molecular+genetic+dissection+of+non-REM+and+REM+sleep+regulatory+processes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWillie%26aufirst%3DJ.%2BT.%26aulast%3DChemelli%26aufirst%3DR.%2BM.%26aulast%3DSinton%26aufirst%3DC.%2BM.%26aulast%3DTokita%26aufirst%3DS.%26aulast%3DWilliams%26aufirst%3DS.%2BC.%26aulast%3DKisanuki%26aufirst%3DY.%2BY.%26aulast%3DMarcus%26aufirst%3DJ.%2BN.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DElmquist%26aufirst%3DJ.%2BK.%26aulast%3DKohlmeier%26aufirst%3DK.%2BA.%26aulast%3DLeonard%26aufirst%3DC.%2BS.%26aulast%3DRichardson%26aufirst%3DJ.%2BA.%26aulast%3DHammer%26aufirst%3DR.%2BE.%26aulast%3DYanagisawa%26aufirst%3DM.%26atitle%3DDistinct%2520narcolepsy%2520syndromes%2520in%2520orexin%2520receptor%25202%2520and%2520orexin%2520null%2520mice%253A%2520molecular%2520genetic%2520dissection%2520of%2520non-REM%2520and%2520REM%2520sleep%2520regulatory%2520processes%26jtitle%3DNeuron%26date%3D2003%26volume%3D38%26spage%3D715%26epage%3D730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Lin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faraco, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadotani, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Jong, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishino, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mignot, E.</span><span> </span><span class="NLM_article-title">The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin receptor 2 gene</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">365</span><span class="NLM_x">â</span> <span class="NLM_lpage">376</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=1999&pages=365-376&author=L.+Linauthor=F.+Faracoauthor=R.+Liauthor=H.+Kadotaniauthor=W.+Rogersauthor=X.+Linauthor=X.+Qiuauthor=P.+J.+de+Jongauthor=S.+Nishinoauthor=E.+Mignot&title=The+sleep+disorder+canine+narcolepsy+is+caused+by+a+mutation+in+the+hypocretin+receptor+2+gene"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DL.%26aulast%3DFaraco%26aufirst%3DF.%26aulast%3DLi%26aufirst%3DR.%26aulast%3DKadotani%26aufirst%3DH.%26aulast%3DRogers%26aufirst%3DW.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DQiu%26aufirst%3DX.%26aulast%3Dde%2BJong%26aufirst%3DP.%2BJ.%26aulast%3DNishino%26aufirst%3DS.%26aulast%3DMignot%26aufirst%3DE.%26atitle%3DThe%2520sleep%2520disorder%2520canine%2520narcolepsy%2520is%2520caused%2520by%2520a%2520mutation%2520in%2520the%2520hypocretin%2520receptor%25202%2520gene%26jtitle%3DCell%26date%3D1999%26volume%3D98%26spage%3D365%26epage%3D376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Thannickal, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, R. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nienhuis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramanathan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gulyani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aldrich, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cornford, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegel, J. M.</span><span> </span><span class="NLM_article-title">Reduced number of hypocretin neurons in human narcolepsy</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">469</span><span class="NLM_x">â</span> <span class="NLM_lpage">474</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2000&pages=469-474&author=T.+C.+Thannickalauthor=R.+Y.+Mooreauthor=R.+Nienhuisauthor=L.+Ramanathanauthor=S.+Gulyaniauthor=M.+Aldrichauthor=M.+Cornfordauthor=J.+M.+Siegel&title=Reduced+number+of+hypocretin+neurons+in+human+narcolepsy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DThannickal%26aufirst%3DT.%2BC.%26aulast%3DMoore%26aufirst%3DR.%2BY.%26aulast%3DNienhuis%26aufirst%3DR.%26aulast%3DRamanathan%26aufirst%3DL.%26aulast%3DGulyani%26aufirst%3DS.%26aulast%3DAldrich%26aufirst%3DM.%26aulast%3DCornford%26aufirst%3DM.%26aulast%3DSiegel%26aufirst%3DJ.%2BM.%26atitle%3DReduced%2520number%2520of%2520hypocretin%2520neurons%2520in%2520human%2520narcolepsy%26jtitle%3DNeuron%26date%3D2000%26volume%3D27%26spage%3D469%26epage%3D474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Crocker, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espana, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papadopoulon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saper, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faraco, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakurai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mignot, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scammell, T. E.</span><span> </span><span class="NLM_article-title">Concomitant loss of dynorphin, Narp and orexin in narcolepsy</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">1184</span><span class="NLM_x">â</span> <span class="NLM_lpage">1188</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=1184-1188&author=A.+Crockerauthor=R.+A.+Espanaauthor=M.+Papadopoulonauthor=C.+B.+Saperauthor=J.+Faracoauthor=T.+Sakuraiauthor=M.+Hondaauthor=E.+Mignotauthor=T.+E.+Scammell&title=Concomitant+loss+of+dynorphin%2C+Narp+and+orexin+in+narcolepsy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCrocker%26aufirst%3DA.%26aulast%3DEspana%26aufirst%3DR.%2BA.%26aulast%3DPapadopoulon%26aufirst%3DM.%26aulast%3DSaper%26aufirst%3DC.%2BB.%26aulast%3DFaraco%26aufirst%3DJ.%26aulast%3DSakurai%26aufirst%3DT.%26aulast%3DHonda%26aufirst%3DM.%26aulast%3DMignot%26aufirst%3DE.%26aulast%3DScammell%26aufirst%3DT.%2BE.%26atitle%3DConcomitant%2520loss%2520of%2520dynorphin%252C%2520Narp%2520and%2520orexin%2520in%2520narcolepsy%26jtitle%3DNeurology%26date%3D2005%26volume%3D65%26spage%3D1184%26epage%3D1188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Blouin, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thannickal, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Worley, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baraban, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reti, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegel, J. M.</span><span> </span><span class="NLM_article-title">Narp immunostaining of human hypocretin (orexin) neurons: loss in narcolepsy</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">1189</span><span class="NLM_x">â</span> <span class="NLM_lpage">1192</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=1189-1192&author=A.+M.+Blouinauthor=T.+E.+Thannickalauthor=P.+F.+Worleyauthor=J.+M.+Barabanauthor=I.+M.+Retiauthor=J.+M.+Siegel&title=Narp+immunostaining+of+human+hypocretin+%28orexin%29+neurons%3A+loss+in+narcolepsy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBlouin%26aufirst%3DA.%2BM.%26aulast%3DThannickal%26aufirst%3DT.%2BE.%26aulast%3DWorley%26aufirst%3DP.%2BF.%26aulast%3DBaraban%26aufirst%3DJ.%2BM.%26aulast%3DReti%26aufirst%3DI.%2BM.%26aulast%3DSiegel%26aufirst%3DJ.%2BM.%26atitle%3DNarp%2520immunostaining%2520of%2520human%2520hypocretin%2520%2528orexin%2529%2520neurons%253A%2520loss%2520in%2520narcolepsy%26jtitle%3DNeurology%26date%3D2005%26volume%3D65%26spage%3D1189%26epage%3D1192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Akanmu, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honda, K.</span><span> </span><span class="NLM_article-title">Selective stimulation of orexin receptor type 2 promotes wakefulness in freely behaving rats</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">1048</span><span class="NLM_x">, </span> <span class="NLM_fpage">138</span><span class="NLM_x">â</span> <span class="NLM_lpage">145</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm100541c&amp;key=10.1016%2Fj.brainres.2005.04.064" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm100541c&amp;key=15919057" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm100541c&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlt1Grtr8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1048&publication_year=2005&pages=138-145&author=M.+A.+Akanmuauthor=K.+Honda&title=Selective+stimulation+of+orexin+receptor+type+2+promotes+wakefulness+in+freely+behaving+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Selective stimulation of orexin receptor type 2 promotes wakefulness in freely behaving rats</span></div><div class="casAuthors">Akanmu, Moses A.; Honda, Kazuki</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">1048</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">138-145</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Orexins A and B are a pair of neuropeptides implicated in the regulation of feeding and arousal behavior mediated through two orexin receptors type 1 and type 2.  The authors have detd. the arousal effects of newly developed selective orexin receptor type 2 agonist, [Ala11]orexin-B, on the sleep-wake cycle in rats.  The effects of third ventricle intracerebroventricular (ICV) infusion of the novel orexin receptor type 2 selective agonist, [Ala11]orexin-B, on the sleep-wake cycle were investigated.  ICV infusion of [Ala11]orexin-B (1, 10 and 40 nmol) during the light period (11:00-16:00) dose-dependently resulted in a significant increase in wake duration by 46.9% (n = 5, P < 0.05), 159.2% (n = 4, P < 0.01) and 163.6% (n = 7, P < 0.01), resp., and a significant decrease in rapid eye movement (REM) (P < 0.01) and non-REM sleep (P < 0.01) for all doses.  In contrast, ICV infusion of orexin B at the same doses (1, 10 and 40 nmol) caused a 16.6% (n = 6, non-significant), 99.8% (n = 6, P < 0.05) and 72.0% (n = 4, P < 0.05) increase in wakefulness, resp.  Moreover, orexin-A, which exerts its effects through orexin receptor type 1 and orexin receptor type 2 with similar potency, resulted in a significant increase in wakefulness duration by 17.1% (n = 6, P < 0.05), 184.0% (n = 6, P < 0.01) and 228.6% (n = 6, P < 0.01) at doses of 0.1, 1 and 10 nmol, resp.  Further, the enhancement of wakefulness was accompanied by a marked redn. in REM and non-REM sleep.  These findings suggest that orexin receptor type 2 plays an important role in the modulation of sleep-wake state and behavioral responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxWQ0WqME6H7Vg90H21EOLACvtfcHk0lhHbCscPvZlPg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlt1Grtr8%253D&md5=60ca1e78ee562eda40d65110a8b6ae7f</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.brainres.2005.04.064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainres.2005.04.064%26sid%3Dliteratum%253Aachs%26aulast%3DAkanmu%26aufirst%3DM.%2BA.%26aulast%3DHonda%26aufirst%3DK.%26atitle%3DSelective%2520stimulation%2520of%2520orexin%2520receptor%2520type%25202%2520promotes%2520wakefulness%2520in%2520freely%2520behaving%2520rats%26jtitle%3DBrain%2520Res.%26date%3D2005%26volume%3D1048%26spage%3D138%26epage%3D145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Selbach, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eriksson, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haas, H. L.</span><span> </span><span class="NLM_article-title">Drugs to interfere with orexins (hypocretins)</span> <span class="citation_source-journal">Drug News Perspect.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">669</span><span class="NLM_x">â</span> <span class="NLM_lpage">681</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=16&amp;doi=10.1021%2Fjm100541c&amp;key=10.1358%2Fdnp.2003.16.10.829298" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=8&amp;doi=10.1021%2Fjm100541c&amp;key=14747847" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=32&amp;doi=10.1021%2Fjm100541c&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhvFSgu7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2003&pages=669-681&author=O.+Selbachauthor=K.+S.+Erikssonauthor=H.+L.+Haas&title=Drugs+to+interfere+with+orexins+%28hypocretins%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15aR"><div class="casContent"><span class="casTitleNuber">15a</span><div class="casTitle"><span class="NLM_cas:atitle">Drugs to interfere with orexins (hypocretins)</span></div><div class="casAuthors">Selbach, Oliver; Eriksson, Krister S.; Haas, Helmut L.</div><div class="citationInfo"><span class="NLM_cas:title">Drug News & Perspectives</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">669-681</span>CODEN:
                <span class="NLM_cas:coden">DNPEED</span>;
        ISSN:<span class="NLM_cas:issn">0214-0934</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review.  Orexins (hypocretins) are bioactive peptides linking arousal, appetite and neuroendocrine-autonomic control.  Dysfunction of the orexin system is assocd. with narcolepsy-cataplexy.  Here, we review drugs interfering with orexins directly such as novel selective orexin receptor agonists and antagonists, as well as drugs interfering with orexins indirectly such as those used for the treatment of narcolepsy-cataplexy, and pharmacol. targets within the complex network of endogenous neurohumoral signals integrated and relayed by the orexin system.  These include amines, acetylcholine, purines, GABA and glutamate, as well as nutritional-metabolic, circadian-photic, immunol. and neuroendocrine-peptidergic influences.  Basic and clin. evaluation of drugs interfering with the orexin system will lead to a better understanding of the mol. prerequisites that control behavioral state, stress responses, energy homeostasis and survival, and yield therapeutic advances for the treatment of narcolepsy and other disorders of sleep, eating, mood and memory.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7vwj0sQ1p6bVg90H21EOLACvtfcHk0lihWC-2ftNQjw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhvFSgu7w%253D&md5=da662939c3c8c1bad326510e52649598</span></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=10.1358%2Fdnp.2003.16.10.829298&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdnp.2003.16.10.829298%26sid%3Dliteratum%253Aachs%26aulast%3DSelbach%26aufirst%3DO.%26aulast%3DEriksson%26aufirst%3DK.%2BS.%26aulast%3DHaas%26aufirst%3DH.%2BL.%26atitle%3DDrugs%2520to%2520interfere%2520with%2520orexins%2520%2528hypocretins%2529%26jtitle%3DDrug%2520News%2520Perspect.%26date%3D2003%26volume%3D16%26spage%3D669%26epage%3D681" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit15b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Baumann, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bassetti, C. L.</span><span> </span><span class="NLM_article-title">Hypocretins (orexins): clinical impact of the discovery of a neurotransmitter</span> <span class="citation_source-journal">Sleep Med. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">253</span><span class="NLM_x">â</span> <span class="NLM_lpage">268</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=16&amp;doi=10.1021%2Fjm100541c&amp;key=10.1016%2Fj.smrv.2005.01.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=8&amp;doi=10.1021%2Fjm100541c&amp;key=15979356" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=32&amp;doi=10.1021%2Fjm100541c&amp;key=1%3ACAS%3A280%3ADC%252BD2MzotVSruw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2005&pages=253-268&author=C.+R.+Baumannauthor=C.+L.+Bassetti&title=Hypocretins+%28orexins%29%3A+clinical+impact+of+the+discovery+of+a+neurotransmitter"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15bR"><div class="casContent"><span class="casTitleNuber">15b</span><div class="casTitle"><span class="NLM_cas:atitle">Hypocretins (orexins): clinical impact of the discovery of a neurotransmitter</span></div><div class="casAuthors">Baumann Christian R; Bassetti Claudio L</div><div class="citationInfo"><span class="NLM_cas:title">Sleep medicine reviews</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">253-68</span>
        ISSN:<span class="NLM_cas:issn">1087-0792</span>.
    </div><div class="casAbstract">Hypothalamic excitatory hypocretin (orexin) neurons have been discovered in 1998 and found to have widespread projections to basal forebrain, monoaminergic and cholinergic brainstem, and spinal cord regions.  The hypocretin system is influenced both neuronally (e.g. suprachiasmatic nucleus, GABAergic, cholinergic and aminergic brainstem nuclei) as well as metabolically (e.g. glucose, ghrelin, and leptin).  Physiologically the hypocretin system has been implicated in the regulation of behaviours that are associated with wakefulness, locomotion, and feeding.  A role in REM sleep, neuroendocrine, autonomic and metabolic functions has also been suggested.  Pathophysiologically a deficient hypocretin neurotransmission has been found in human narcolepsy and (engineered) animal models of the disorder.  Different mechanisms are involved including (1) degeneration of hypocretin neurons (mice), (2) hypocretin ligand deficiency (humans, mice, dogs), (3) hypocretin receptor deficiency (mice, dogs).  Reports of low hypocretin-1 cerebrospinal fluid levels in neurologic conditions (e.g.  Guillain-Barre syndrome, traumatic brain injury, hypothalamic lesions) with and without sleep-wake disturbances and, on the other hand, observations of normal levels in about 11% of narcoleptics raise questions about the exact nature and pathophysiological base of the link between hypocretin deficiency and clinical manifestations in human narcolepsy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT-P4vpnwYkeCXXDYhVZBdlfW6udTcc2ealWLJTO0UJ-7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2MzotVSruw%253D%253D&md5=4f27a144a729314c352eb0c2c9dde489</span></div><a href="/servlet/linkout?suffix=cit15b&amp;dbid=16384&amp;doi=10.1016%2Fj.smrv.2005.01.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.smrv.2005.01.005%26sid%3Dliteratum%253Aachs%26aulast%3DBaumann%26aufirst%3DC.%2BR.%26aulast%3DBassetti%26aufirst%3DC.%2BL.%26atitle%3DHypocretins%2520%2528orexins%2529%253A%2520clinical%2520impact%2520of%2520the%2520discovery%2520of%2520a%2520neurotransmitter%26jtitle%3DSleep%2520Med.%2520Rev.%26date%3D2005%26volume%3D9%26spage%3D253%26epage%3D268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit15c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Boss, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brisbare-Roch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenck, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aissaoui, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koberstein, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sifferlen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weller, T.</span><span> </span><span class="NLM_article-title">Orexin receptor antagonism: A new principle in neuroscience</span> <span class="citation_source-journal">Chemia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">974</span><span class="NLM_x">â</span> <span class="NLM_lpage">979</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15c&amp;dbid=32&amp;doi=10.1021%2Fjm100541c&amp;key=1%3ACAS%3A528%3ADC%252BD1MXntlWmtg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2008&pages=974-979&author=C.+Bossauthor=C.+Brisbare-Rochauthor=F.+Jenckauthor=H.+Aissaouiauthor=R.+Kobersteinauthor=T.+Sifferlenauthor=T.+Weller&title=Orexin+receptor+antagonism%3A+A+new+principle+in+neuroscience"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15cR"><div class="casContent"><span class="casTitleNuber">15c</span><div class="casTitle"><span class="NLM_cas:atitle">Orexin receptor antagonism: a new principle in neuroscience</span></div><div class="casAuthors">Boss, Christoph; Brisbare-Roch, Catherine; Jenck, Francois; Aissaoui, Hamed; Koberstein, Ralf; Sifferlen, Thierry; Weller, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Chimia</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">974-979</span>CODEN:
                <span class="NLM_cas:coden">CHIMAD</span>;
        ISSN:<span class="NLM_cas:issn">0009-4293</span>.
    
            (<span class="NLM_cas:orgname">Swiss Chemical Society</span>)
        </div><div class="casAbstract">A review.  Orexins are hypothalamic neuropeptides interacting with G-protein coupled receptors in the brain.  They play a role in the regulation of sleep-wake cycles in mammals, as suggested by the deficits in orexinergic function that are assocd. with rodent, canine and human narcolepsy.  Selective or dual orexin1-receptor and/or orexin2-receptor antagonists or agonists that cross the blood-brain-barrier (BBB) may be of therapeutic interest for disorders of disturbed arousal and alertness.  This article summarizes recent research to identify and characterize orexin receptor antagonists and their therapeutic potential for normalizing sleep in insomnia patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6167zZnUiA7Vg90H21EOLACvtfcHk0lh_nOm02ZU-5Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXntlWmtg%253D%253D&md5=984cbca7fe1adf3bb42f6c42be966bd4</span></div><a href="/servlet/linkout?suffix=cit15c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBoss%26aufirst%3DC.%26aulast%3DBrisbare-Roch%26aufirst%3DC.%26aulast%3DJenck%26aufirst%3DF.%26aulast%3DAissaoui%26aufirst%3DH.%26aulast%3DKoberstein%26aufirst%3DR.%26aulast%3DSifferlen%26aufirst%3DT.%26aulast%3DWeller%26aufirst%3DT.%26atitle%3DOrexin%2520receptor%2520antagonism%253A%2520A%2520new%2520principle%2520in%2520neuroscience%26jtitle%3DChemia%26date%3D2008%26volume%3D62%26spage%3D974%26epage%3D979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit15d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Boss, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brisbare-Roch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenck, F.</span><span> </span><span class="NLM_article-title">Biomedical application of orexin/hypocretin receptor ligands in neuroscience</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">891</span><span class="NLM_x">â</span> <span class="NLM_lpage">903</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm801296d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15d&amp;dbid=32&amp;doi=10.1021%2Fjm100541c&amp;key=1%3ACAS%3A528%3ADC%252BD1MXptlOqsg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=891-903&author=C.+Bossauthor=C.+Brisbare-Rochauthor=F.+Jenck&title=Biomedical+application+of+orexin%2Fhypocretin+receptor+ligands+in+neuroscience"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15dR"><div class="casContent"><span class="casTitleNuber">15d</span><div class="casTitle"><span class="NLM_cas:atitle">Biomedical Application of Orexin/Hypocretin Receptor Ligands in Neuroscience</span></div><div class="casAuthors">Boss, Christoph; Brisbare-Roch, Catherine; Jenck, Francois</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">891-903</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Orexin/hypocretin neuropeptides (orexin-A or hypocretin1 and orexin-B or hypocretin2) are peptides discovered and published in 1998 as the outcome of methodical deorphanization programs focusing on brain orphan G-protein-coupled receptors (GPCR).  Orexins/hypocretins bind to two receptors (orexin1/OX1 or HCRT1 and orexin2/OX2 or HCRT2 receptors) and are proteolytically derived from a single precursor peptide in a discrete population of neurons of the perifornical area of the lateral hypothalamus.  OX1 receptors have preferential affinity for orexin-A, whereas OX2 receptors do not discriminate between both neuropeptides in vitro.  OX1 or OX2 activation produces intracellular Ca2+ increases via functional coupling involving a Gq or Go mechanism of transduction.  This ultimately results in slow membrane depolarization and in neuronal activation found to involve different ionic conductance in various brain regions in the rat, such as potassium conductance in the locus coeruleus or calcium current in the tuberomammilary nucleus.  Manipulation of the orexin system using brain-penetrant orexin receptor antagonists or inverse agonists will probably prove therapeutically useful in the treatment of those medical and psychiatric conditions assocd. with disturbed vigilance.  Orexin circuitry may indeed be disturbed under states such as sleep loss, night or shift work, jet lag, or even aging.  A major advantage of brain-penetrant receptor ligands over engineered genetic modifications is their transient mode of action, allowing recovery to natural orexin function.  This property is of major pharmacol. interest for scientific and therapeutic innovation in this field.  Hopefully, many novel orexin receptor ligands of second or third generation will emerge from the current medicinal chem. programs and will further contribute to the understanding of the physiol. and pathophysiol. roles of endogenous orexins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgwJlDWhwQVLVg90H21EOLACvtfcHk0lh_nOm02ZU-5Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXptlOqsg%253D%253D&md5=1b5af413b125e5cf5e7f5735253598ef</span></div><a href="/servlet/linkout?suffix=cit15d&amp;dbid=16384&amp;doi=10.1021%2Fjm801296d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801296d%26sid%3Dliteratum%253Aachs%26aulast%3DBoss%26aufirst%3DC.%26aulast%3DBrisbare-Roch%26aufirst%3DC.%26aulast%3DJenck%26aufirst%3DF.%26atitle%3DBiomedical%2520application%2520of%2520orexin%252Fhypocretin%2520receptor%2520ligands%2520in%2520neuroscience%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D891%26epage%3D903" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">McAtee, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutton, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudolph, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aluisio, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phoung, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dvorak, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovenberg, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carruthers, N. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, T. K.</span><span> </span><span class="NLM_article-title">Novel substituted 4-phenyl-[1,3]dioxanes: potent and selective orexin 2 (OX<sub>2</sub>R) antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">4225</span><span class="NLM_x">â</span> <span class="NLM_lpage">4229</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=4225-4229&author=L.+C.+McAteeauthor=S.+W.+Suttonauthor=D.+A.+Rudolphauthor=X.+Liauthor=L.+E.+Aluisioauthor=V.+K.+Phoungauthor=C.+A.+Dvorakauthor=T.+W.+Lovenbergauthor=N.+I.+Carruthersauthor=T.+K.+Jones&title=Novel+substituted+4-phenyl-%5B1%2C3%5Ddioxanes%3A+potent+and+selective+orexin+2+%28OX2R%29+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcAtee%26aufirst%3DL.%2BC.%26aulast%3DSutton%26aufirst%3DS.%2BW.%26aulast%3DRudolph%26aufirst%3DD.%2BA.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DAluisio%26aufirst%3DL.%2BE.%26aulast%3DPhoung%26aufirst%3DV.%2BK.%26aulast%3DDvorak%26aufirst%3DC.%2BA.%26aulast%3DLovenberg%26aufirst%3DT.%2BW.%26aulast%3DCarruthers%26aufirst%3DN.%2BI.%26aulast%3DJones%26aufirst%3DT.%2BK.%26atitle%3DNovel%2520substituted%25204-phenyl-%255B1%252C3%255Ddioxanes%253A%2520potent%2520and%2520selective%2520orexin%25202%2520%2528OX2R%2529%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D4225%26epage%3D4229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Bingham, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deehan, M. R.</span><span> </span><span class="NLM_article-title">Eating, sleeping and rewarding: orexin receptors and their antagonists</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">551</span><span class="NLM_x">â</span> <span class="NLM_lpage">559</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2006&pages=551-559&author=M.+J.+Binghamauthor=J.+Caiauthor=M.+R.+Deehan&title=Eating%2C+sleeping+and+rewarding%3A+orexin+receptors+and+their+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBingham%26aufirst%3DM.%2BJ.%26aulast%3DCai%26aufirst%3DJ.%26aulast%3DDeehan%26aufirst%3DM.%2BR.%26atitle%3DEating%252C%2520sleeping%2520and%2520rewarding%253A%2520orexin%2520receptors%2520and%2520their%2520antagonists%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2006%26volume%3D9%26spage%3D551%26epage%3D559" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Cai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooke, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherborne, B. S.</span><span> </span><span class="NLM_article-title">Antagonists of the orexin receptors</span> <span class="citation_source-journal">Expert Opin. Ther. Patents</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">631</span><span class="NLM_x">â</span> <span class="NLM_lpage">646</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16c&amp;dbid=16&amp;doi=10.1021%2Fjm100541c&amp;key=10.1517%2F13543776.16.5.631" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16c&amp;dbid=32&amp;doi=10.1021%2Fjm100541c&amp;key=1%3ACAS%3A528%3ADC%252BD28Xkt12gsrY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=631-646&author=J.+Caiauthor=F.+E.+Cookeauthor=B.+S.+Sherborne&title=Antagonists+of+the+orexin+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16cR"><div class="casContent"><span class="casTitleNuber">16c</span><div class="casTitle"><span class="NLM_cas:atitle">Antagonists of the orexin receptors</span></div><div class="casAuthors">Cai, Jiaqiang; Cooke, Fiona E.; Sherborne, Bradley S.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">631-646</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Orexin-A and orexin-B are neuropeptides that are produced by neurons in the lateral hypothalamus.  These neuropeptides bind and activate two closely related G-protein-coupled receptors, orexin-1 and orexin-2, and are involved in a variety of biol. functions, including feeding, sleep-wake cycle, regulation of gastric acid secretion and reward seeking.  Orexin-1 receptor agonists are shown to have antinociceptive activity, while orexin-1 receptor antagonists reverse both orexin-A and fasting-induced food intake.  Mutant and non-functional orexin-2 receptor is linked to canine and some cases of human narcolepsy.  Orexin-A was undetectable in the cerebrospinal fluid of 32 out of 38 narcoleptic patients, but readily detected in normal control individuals.  These findings indicate that orexin receptor antagonists could be useful for the treatment of obesity, diabetes and sleep disorders.  This review covers patent literature published during the period 1999-2005 on orexin-1 and orexin-2 receptor antagonists, together with some recent literature covering orexin receptor agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8vbKokvyHK7Vg90H21EOLACvtfcHk0ljhT62wmj-19Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xkt12gsrY%253D&md5=ae3360c8df3b2ac6b9e8b6476bc77f6c</span></div><a href="/servlet/linkout?suffix=cit16c&amp;dbid=16384&amp;doi=10.1517%2F13543776.16.5.631&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.16.5.631%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DJ.%26aulast%3DCooke%26aufirst%3DF.%2BE.%26aulast%3DSherborne%26aufirst%3DB.%2BS.%26atitle%3DAntagonists%2520of%2520the%2520orexin%2520receptors%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Patents%26date%3D2006%26volume%3D16%26spage%3D631%26epage%3D646" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Roecker, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, P. J.</span><span> </span><span class="NLM_article-title">Orexin receptor antagonists: Medicinal chemistry and therapeutic potential</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">977</span><span class="NLM_x">â</span> <span class="NLM_lpage">987</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16d&amp;dbid=16&amp;doi=10.1021%2Fjm100541c&amp;key=10.2174%2F156802608784936746" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16d&amp;dbid=8&amp;doi=10.1021%2Fjm100541c&amp;key=18673167" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16d&amp;dbid=32&amp;doi=10.1021%2Fjm100541c&amp;key=1%3ACAS%3A528%3ADC%252BD1cXps1OhtLs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=977-987&author=A.+J.+Roeckerauthor=P.+J.+Coleman&title=Orexin+receptor+antagonists%3A+Medicinal+chemistry+and+therapeutic+potential"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16dR"><div class="casContent"><span class="casTitleNuber">16d</span><div class="casTitle"><span class="NLM_cas:atitle">Orexin receptor antagonists: medicinal chemistry and therapeutic potential</span></div><div class="casAuthors">Roecker, Anthony J.; Coleman, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">977-987</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Actelion Pharmaceuticals achieved clin. proof-of-concept for the treatment of insomnia in 2007 with the release of Phase II data on Almorexant, a potent dual (OX1R/OX2R) orexin receptor antagonist.  GlaxoSmithKline also released clin. efficacy data on an orexin receptor antagonist in 2007 for the treatment of insomnia.  With these exciting findings, the search for orexin (or hypocretin) receptor antagonists for the treatment of sleep and neurol. disorders has recently increased in intensity in the pharmaceutical industry.  This review will focus on the medicinal chem. of orexin antagonists and the potential therapeutic value of this therapy for the treatment of insomnia.  Receptor subtype selectivity will also be described to highlight the tools currently available to delineate receptor-specific pharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdIppLgKDUZbVg90H21EOLACvtfcHk0ljhT62wmj-19Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXps1OhtLs%253D&md5=9e2d3aeb8221c75e2a95232cffdfbf20</span></div><a href="/servlet/linkout?suffix=cit16d&amp;dbid=16384&amp;doi=10.2174%2F156802608784936746&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802608784936746%26sid%3Dliteratum%253Aachs%26aulast%3DRoecker%26aufirst%3DA.%2BJ.%26aulast%3DColeman%26aufirst%3DP.%2BJ.%26atitle%3DOrexin%2520receptor%2520antagonists%253A%2520Medicinal%2520chemistry%2520and%2520therapeutic%2520potential%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2008%26volume%3D8%26spage%3D977%26epage%3D987" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Bergman, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roecker, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercer, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bednar, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiss, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ransom, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrell, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettibone, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemaire, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Preuksaritanont, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winrow, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renger, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koblan, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, P. J.</span><span> </span><span class="NLM_article-title">Proline bis-amides as potent dual orexin receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1425</span><span class="NLM_x">â</span> <span class="NLM_lpage">1430</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=1425-1430&author=J.+M.+Bergmanauthor=A.+J.+Roeckerauthor=S.+P.+Mercerauthor=R.+A.+Bednarauthor=D.+R.+Reissauthor=R.+W.+Ransomauthor=C.+M.+Harrellauthor=D.+J.+Pettiboneauthor=W.+Lemaireauthor=K.+L.+Murphyauthor=C.+Liauthor=T.+Preuksaritanontauthor=C.+J.+Winrowauthor=J.+J.+Rengerauthor=K.+S.+Koblanauthor=G.+D.+Hartmanauthor=P.+J.+Coleman&title=Proline+bis-amides+as+potent+dual+orexin+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBergman%26aufirst%3DJ.%2BM.%26aulast%3DRoecker%26aufirst%3DA.%2BJ.%26aulast%3DMercer%26aufirst%3DS.%2BP.%26aulast%3DBednar%26aufirst%3DR.%2BA.%26aulast%3DReiss%26aufirst%3DD.%2BR.%26aulast%3DRansom%26aufirst%3DR.%2BW.%26aulast%3DHarrell%26aufirst%3DC.%2BM.%26aulast%3DPettibone%26aufirst%3DD.%2BJ.%26aulast%3DLemaire%26aufirst%3DW.%26aulast%3DMurphy%26aufirst%3DK.%2BL.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DPreuksaritanont%26aufirst%3DT.%26aulast%3DWinrow%26aufirst%3DC.%2BJ.%26aulast%3DRenger%26aufirst%3DJ.%2BJ.%26aulast%3DKoblan%26aufirst%3DK.%2BS.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DColeman%26aufirst%3DP.%2BJ.%26atitle%3DProline%2520bis-amides%2520as%2520potent%2520dual%2520orexin%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D1425%26epage%3D1430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Cole, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stroke, I. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, L.-Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hussain, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simhadri, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brescia, M.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waksmunski, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strohl, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tellew, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saunders, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Appell, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henderson, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, M. L.</span><span> </span><span class="NLM_article-title">Synthesis of (3,4-dimethoxyphenoxy)alkylamino acetamides as orexin-2 receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">5420</span><span class="NLM_x">â</span> <span class="NLM_lpage">5423</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=5420-5423&author=A.+G.+Coleauthor=I.+L.+Strokeauthor=L.-Q.+Qinauthor=Z.+Hussainauthor=S.+Simhadriauthor=M.-R.+Bresciaauthor=F.+S.+Waksmunskiauthor=B.+Strohlauthor=J.+E.+Tellewauthor=J.+P.+Williamsauthor=J.+Saundersauthor=K.+C.+Appellauthor=I.+Hendersonauthor=M.+L.+Webb&title=Synthesis+of+%283%2C4-dimethoxyphenoxy%29alkylamino+acetamides+as+orexin-2+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCole%26aufirst%3DA.%2BG.%26aulast%3DStroke%26aufirst%3DI.%2BL.%26aulast%3DQin%26aufirst%3DL.-Q.%26aulast%3DHussain%26aufirst%3DZ.%26aulast%3DSimhadri%26aufirst%3DS.%26aulast%3DBrescia%26aufirst%3DM.-R.%26aulast%3DWaksmunski%26aufirst%3DF.%2BS.%26aulast%3DStrohl%26aufirst%3DB.%26aulast%3DTellew%26aufirst%3DJ.%2BE.%26aulast%3DWilliams%26aufirst%3DJ.%2BP.%26aulast%3DSaunders%26aufirst%3DJ.%26aulast%3DAppell%26aufirst%3DK.%2BC.%26aulast%3DHenderson%26aufirst%3DI.%26aulast%3DWebb%26aufirst%3DM.%2BL.%26atitle%3DSynthesis%2520of%2520%25283%252C4-dimethoxyphenoxy%2529alkylamino%2520acetamides%2520as%2520orexin-2%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D5420%26epage%3D5423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Aissaoui, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koberstain, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zumbrunn, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatfield, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brisbane-Roch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenck, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boss, C.</span><span> </span><span class="NLM_article-title"><i>N</i>-Glycine-sulfonamides as potent dual orexin 1/orexin 2 receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">5729</span><span class="NLM_x">â</span> <span class="NLM_lpage">5733</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=5729-5733&author=H.+Aissaouiauthor=R.+Koberstainauthor=C.+Zumbrunnauthor=J.+Gatfieldauthor=C.+Brisbane-Rochauthor=F.+Jenckauthor=A.+Treiberauthor=C.+Boss&title=N-Glycine-sulfonamides+as+potent+dual+orexin+1%2Forexin+2+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16g&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAissaoui%26aufirst%3DH.%26aulast%3DKoberstain%26aufirst%3DR.%26aulast%3DZumbrunn%26aufirst%3DC.%26aulast%3DGatfield%26aufirst%3DJ.%26aulast%3DBrisbane-Roch%26aufirst%3DC.%26aulast%3DJenck%26aufirst%3DF.%26aulast%3DTreiber%26aufirst%3DA.%26aulast%3DBoss%26aufirst%3DC.%26atitle%3DN-Glycine-sulfonamides%2520as%2520potent%2520dual%2520orexin%25201%252Forexin%25202%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D5729%26epage%3D5733" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Sifferlen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boss, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cottreel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koberstain, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gude, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aissaoui, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weller, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatfield, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brisbane-Roch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenck, F.</span><span> </span><span class="NLM_article-title">Novel pyrazolo-tetrahydropyridines as potent orexin receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1539</span><span class="NLM_x">â</span> <span class="NLM_lpage">1542</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=1539-1542&author=T.+Sifferlenauthor=C.+Bossauthor=E.+Cottreelauthor=R.+Koberstainauthor=M.+Gudeauthor=H.+Aissaouiauthor=T.+Wellerauthor=J.+Gatfieldauthor=C.+Brisbane-Rochauthor=F.+Jenck&title=Novel+pyrazolo-tetrahydropyridines+as+potent+orexin+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16h&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSifferlen%26aufirst%3DT.%26aulast%3DBoss%26aufirst%3DC.%26aulast%3DCottreel%26aufirst%3DE.%26aulast%3DKoberstain%26aufirst%3DR.%26aulast%3DGude%26aufirst%3DM.%26aulast%3DAissaoui%26aufirst%3DH.%26aulast%3DWeller%26aufirst%3DT.%26aulast%3DGatfield%26aufirst%3DJ.%26aulast%3DBrisbane-Roch%26aufirst%3DC.%26aulast%3DJenck%26aufirst%3DF.%26atitle%3DNovel%2520pyrazolo-tetrahydropyridines%2520as%2520potent%2520orexin%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D1539%26epage%3D1542" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16i"><span><span class="NLM_label">(i) </span><span class="NLM_contrib-group">Coleman, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renger, J. J.</span><span> </span><span class="NLM_article-title">Orexin receptor antagonists: a review of promising compounds patented since 2006</span> <span class="citation_source-journal">Expert Opin. Ther. Patents</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">307</span><span class="NLM_x">â</span> <span class="NLM_lpage">324</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16i&amp;dbid=16&amp;doi=10.1021%2Fjm100541c&amp;key=10.1517%2F13543770903567085" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16i&amp;dbid=32&amp;doi=10.1021%2Fjm100541c&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisValurw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=307-324&author=P.+J.+Colemanauthor=J.+J.+Renger&title=Orexin+receptor+antagonists%3A+a+review+of+promising+compounds+patented+since+2006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16iR"><div class="casContent"><span class="casTitleNuber">16i</span><div class="casTitle"><span class="NLM_cas:atitle">Orexin receptor antagonists: a review of promising compounds patented since 2006</span></div><div class="casAuthors">Coleman, Paul J.; Renger, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">307-324</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: The orexin neuropeptide system plays a central role in maintaining arousal and wakefulness.  It has been demonstrated that small mol. antagonists to the orexin receptors promote sleep in preclin. species and in patients with insomnia.  This review provides a summary of published patent applications claiming novel orexin antagonists from 2006 to mid-2009, covering both selective and dual orexin receptor antagonists.  Readers will gain an overview of orexin biol. focusing on genetic and pharmacol. validation of this target for treating sleep disorders.  Addnl., this review discusses the importance of receptor subtype selectivity and the potential role of subtype selective and dual orexin antagonists in treating psychiatric illnesses beyond insomnia.  This review identifies companies that are significant contributors to the patent literature claiming novel orexin receptor antagonists.  The study of the orexin system has emerged as one of the key new fields of investigation in neuroscience.  The demonstration of clin. proof-of-concept for the treatment of primary insomnia by Actelion in early 2007 has spurred significant interest in this field and competition has markedly increased since 2006.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7s9_Nt_Xc1bVg90H21EOLACvtfcHk0limqqEAhCnfTA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisValurw%253D&md5=0a0b10abb4e21347a2293124d6529fb6</span></div><a href="/servlet/linkout?suffix=cit16i&amp;dbid=16384&amp;doi=10.1517%2F13543770903567085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543770903567085%26sid%3Dliteratum%253Aachs%26aulast%3DColeman%26aufirst%3DP.%2BJ.%26aulast%3DRenger%26aufirst%3DJ.%2BJ.%26atitle%3DOrexin%2520receptor%2520antagonists%253A%2520a%2520review%2520of%2520promising%2520compounds%2520patented%2520since%25202006%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Patents%26date%3D2010%26volume%3D20%26spage%3D307%26epage%3D324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Dugovic, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shelton, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aluisio, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraser, I. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutton, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonaventure, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yun, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dvorak, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carruthers, N. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovenberg, T. W.</span><span> </span><span class="NLM_article-title">Blockade of orexin-1 receptors attenuates orexin-2 receptor antagonism-induced sleep promotion in rat</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">330</span><span class="NLM_x">, </span> <span class="NLM_fpage">141</span><span class="NLM_x">â</span> <span class="NLM_lpage">152</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm100541c&amp;key=10.1124%2Fjpet.109.152009" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=330&publication_year=2009&pages=141-152&author=C.+Dugovicauthor=J.+E.+Sheltonauthor=L.+E.+Aluisioauthor=I.+C.+Fraserauthor=X.+Jiangauthor=S.+W.+Suttonauthor=P.+Bonaventureauthor=S.+Yunauthor=X.+Liauthor=B.+Lordauthor=C.+A.+Dvorakauthor=N.+I.+Carruthersauthor=T.+W.+Lovenberg&title=Blockade+of+orexin-1+receptors+attenuates+orexin-2+receptor+antagonism-induced+sleep+promotion+in+rat"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1124%2Fjpet.109.152009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.109.152009%26sid%3Dliteratum%253Aachs%26aulast%3DDugovic%26aufirst%3DC.%26aulast%3DShelton%26aufirst%3DJ.%2BE.%26aulast%3DAluisio%26aufirst%3DL.%2BE.%26aulast%3DFraser%26aufirst%3DI.%2BC.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DSutton%26aufirst%3DS.%2BW.%26aulast%3DBonaventure%26aufirst%3DP.%26aulast%3DYun%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLord%26aufirst%3DB.%26aulast%3DDvorak%26aufirst%3DC.%2BA.%26aulast%3DCarruthers%26aufirst%3DN.%2BI.%26aulast%3DLovenberg%26aufirst%3DT.%2BW.%26atitle%3DBlockade%2520of%2520orexin-1%2520receptors%2520attenuates%2520orexin-2%2520receptor%2520antagonism-induced%2520sleep%2520promotion%2520in%2520rat%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2009%26volume%3D330%26spage%3D141%26epage%3D152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Owen, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">CasteÃ±er, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">BolÃ³s, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estivill, C.</span><span> </span><span class="NLM_article-title">Almorexant</span> <span class="citation_source-journal">Drugs Future</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">5</span><span class="NLM_x">â</span> <span class="NLM_lpage">10</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm100541c&amp;key=10.1358%2Fdof.2009.034.01.1324392" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm100541c&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlvVWhuro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2009&pages=5-10&author=R.+T.+Owenauthor=R.+Caste%C3%B1erauthor=J.+Bol%C3%B3sauthor=C.+Estivill&title=Almorexant"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Almorexant: dual orexin OX1/OX2 antagonist treatment of sleep disorders</span></div><div class="casAuthors">Owen, R. T.; Castaner, R.; Bolos, J.; Estivill, C.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs of the Future</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">5-10</span>CODEN:
                <span class="NLM_cas:coden">DRFUD4</span>;
        ISSN:<span class="NLM_cas:issn">0377-8282</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review.  Almorexant is a novel, selective, orally active dual orexin OX1 and OX2 receptor antagonist.  It is rapidly absorbed and distributed and shows no tendency to accumulate with repeated dosing.  Preclin. studies in rats and dogs have demonstrated a sleep-promoting effect which resembles physiol. sleep; this could be quickly reversed upon sensorimotor stimulation and yet allow resumption of sleep upon its cessation.  Almorexant's sleep-promoting effects were confirmed in volunteers and patients with primary insomnia.  It dose-dependently increased sleep efficiency and decreased sleep latency and wake time after sleep onset.  The compd. was well tolerated, with no significant effects on next-day motor performance, memory or reaction time.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopXHdSyxFfF7Vg90H21EOLACvtfcHk0lhEZSxFcWjArA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlvVWhuro%253D&md5=61c1f2630f572fbf818dc3c8a299144e</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1358%2Fdof.2009.034.01.1324392&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdof.2009.034.01.1324392%26sid%3Dliteratum%253Aachs%26aulast%3DOwen%26aufirst%3DR.%2BT.%26aulast%3DCaste%25C3%25B1er%26aufirst%3DR.%26aulast%3DBol%25C3%25B3s%26aufirst%3DJ.%26aulast%3DEstivill%26aufirst%3DC.%26atitle%3DAlmorexant%26jtitle%3DDrugs%2520Future%26date%3D2009%26volume%3D34%26spage%3D5%26epage%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Brisbare-Roch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dingemanse, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koberstein, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoever, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aissaoui, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flores, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nayler, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Gerven, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Haas, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weller, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischli, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clozel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenck, F.</span><span> </span><span class="NLM_article-title">Promotion of sleep by targeting the orexin system in rats, dogs and humans</span> <span class="citation_source-journal">Nature Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">150</span><span class="NLM_x">â</span> <span class="NLM_lpage">155</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=150-155&author=C.+Brisbare-Rochauthor=J.+Dingemanseauthor=R.+Kobersteinauthor=P.+Hoeverauthor=H.+Aissaouiauthor=S.+Floresauthor=C.+Muellerauthor=O.+Naylerauthor=J.+van+Gervenauthor=S.+L.+de+Haasauthor=P.+Hessauthor=C.+Qiuauthor=S.+Buchmannauthor=M.+Scherzauthor=T.+Wellerauthor=W.+Fischliauthor=M.+Clozelauthor=F.+Jenck&title=Promotion+of+sleep+by+targeting+the+orexin+system+in+rats%2C+dogs+and+humans"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrisbare-Roch%26aufirst%3DC.%26aulast%3DDingemanse%26aufirst%3DJ.%26aulast%3DKoberstein%26aufirst%3DR.%26aulast%3DHoever%26aufirst%3DP.%26aulast%3DAissaoui%26aufirst%3DH.%26aulast%3DFlores%26aufirst%3DS.%26aulast%3DMueller%26aufirst%3DC.%26aulast%3DNayler%26aufirst%3DO.%26aulast%3Dvan%2BGerven%26aufirst%3DJ.%26aulast%3Dde%2BHaas%26aufirst%3DS.%2BL.%26aulast%3DHess%26aufirst%3DP.%26aulast%3DQiu%26aufirst%3DC.%26aulast%3DBuchmann%26aufirst%3DS.%26aulast%3DScherz%26aufirst%3DM.%26aulast%3DWeller%26aufirst%3DT.%26aulast%3DFischli%26aufirst%3DW.%26aulast%3DClozel%26aufirst%3DM.%26aulast%3DJenck%26aufirst%3DF.%26atitle%3DPromotion%2520of%2520sleep%2520by%2520targeting%2520the%2520orexin%2520system%2520in%2520rats%252C%2520dogs%2520and%2520humans%26jtitle%3DNature%2520Med.%26date%3D2007%26volume%3D13%26spage%3D150%26epage%3D155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span> </span><span class="NLM_article-title">New Data On Orexin Receptor Antagonist Almorexant Shows Therapeutic Potential To Restore Normal Physiological Sleep In Insomnia Patients</span>. Medical News Today<span class="NLM_month">Sep</span><span class="NLM_day">04</span>,<span class="NLM_x"> </span><span class="NLM_year">2007</span><span class="NLM_x">; </span><a href="http://www.medicalnewstoday.com/articles/81354.php" class="extLink">http://www.medicalnewstoday.com/articles/81354.php</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=New+Data+On+Orexin+Receptor+Antagonist+Almorexant+Shows+Therapeutic+Potential+To+Restore+Normal+Physiological+Sleep+In+Insomnia+Patients.+Medical+News+TodaySep04%2C+2007%3B+http%3A%2F%2Fwww.medicalnewstoday.com%2Farticles%2F81354.php."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26atitle%3DNew%2520Data%2520On%2520Orexin%2520Receptor%2520Antagonist%2520Almorexant%2520Shows%2520Therapeutic%2520Potential%2520To%2520Restore%2520Normal%2520Physiological%2520Sleep%2520In%2520Insomnia%2520Patients%26jtitle%3DMedical%2520News%2520Today%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="note"><p class="first last">Following the observation of preclinical toxicity, GSK entered into a deal with Actelion to jointly develop and market Almorexant, see: <a href="http://www.bioworld.com/servlet/com.accumedia.web.Dispatcher?next=bioWorldHeadlines_article&amp;forceid=48183" class="extLink">http://www.bioworld.com/servlet/com.accumedia.web.Dispatcher?next=bioWorldHeadlines_article&forceid=48183</a></p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span> </span><span class="NLM_article-title">Merck 2008 Annual Business BriefingâFinal</span>. Goliath Business News<span class="NLM_month">Dec</span><span class="NLM_day">9</span>,<span class="NLM_x"> </span><span class="NLM_year">2008</span><span class="NLM_x">; </span><a href="http://goliath.ecnext.com/coms2/gi_0199-9773483/Merck-2008-Annual-Business-Briefing.html" class="extLink">http://goliath.ecnext.com/coms2/gi_0199-9773483/Merck-2008-Annual-Business-Briefing.html</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Merck+2008+Annual+Business+Briefing%E2%80%94Final.+Goliath+Business+NewsDec9%2C+2008%3B+http%3A%2F%2Fgoliath.ecnext.com%2Fcoms2%2Fgi_0199-9773483%2FMerck-2008-Annual-Business-Briefing.html."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26atitle%3DMerck%25202008%2520Annual%2520Business%2520Briefing%25E2%2580%2594Final%26jtitle%3DGoliath%2520Business%2520News%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span> </span><span class="NLM_article-title">A Long Term Safety Study of MK4305 in Patients With Primary Insomnia</span>ClinicalTrials.gov<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">; </span><a href="http://clinicaltrials.gov/ct2/show/NCT01021813" class="extLink">http://clinicaltrials.gov/ct2/show/NCT01021813</a></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=A+Long+Term+Safety+Study+of+MK4305+in+Patients+With+Primary+InsomniaClinicalTrials.gov+2009%3B+http%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT01021813"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26atitle%3DA%2520Long%2520Term%2520Safety%2520Study%2520of%2520MK4305%2520in%2520Patients%2520With%2520Primary%2520Insomnia%26jtitle%3DClinicalTrials.gov%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Whitman, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breslin, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brashear, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreier, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogusky, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bednar, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemaire, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruno, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiss, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrell, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraus, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garson, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doran, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prueksaritanont, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winrow, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koblan, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renger, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, P. J.</span><span> </span><span class="NLM_article-title">Discovery of a potent, CNS-penetrant orexin receptor antagonist based on an <i>N,N</i>-disubstituted-1,4-diazepane scaffold that promotes sleep in rats</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1069</span><span class="NLM_x">â</span> <span class="NLM_lpage">1074</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=1069-1074&author=D.+B.+Whitmanauthor=C.+D.+Coxauthor=M.+J.+Breslinauthor=K.+M.+Brashearauthor=J.+D.+Schreierauthor=M.+J.+Boguskyauthor=R.+A.+Bednarauthor=W.+Lemaireauthor=J.+G.+Brunoauthor=G.+D.+Hartmanauthor=D.+R.+Reissauthor=C.+M.+Harrellauthor=R.+L.+Krausauthor=Y.+Liauthor=S.+L.+Garsonauthor=S.+M.+Doranauthor=T.+Prueksaritanontauthor=C.+Liauthor=C.+J.+Winrowauthor=K.+S.+Koblanauthor=J.+J.+Rengerauthor=P.+J.+Coleman&title=Discovery+of+a+potent%2C+CNS-penetrant+orexin+receptor+antagonist+based+on+an+N%2CN-disubstituted-1%2C4-diazepane+scaffold+that+promotes+sleep+in+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWhitman%26aufirst%3DD.%2BB.%26aulast%3DCox%26aufirst%3DC.%2BD.%26aulast%3DBreslin%26aufirst%3DM.%2BJ.%26aulast%3DBrashear%26aufirst%3DK.%2BM.%26aulast%3DSchreier%26aufirst%3DJ.%2BD.%26aulast%3DBogusky%26aufirst%3DM.%2BJ.%26aulast%3DBednar%26aufirst%3DR.%2BA.%26aulast%3DLemaire%26aufirst%3DW.%26aulast%3DBruno%26aufirst%3DJ.%2BG.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DReiss%26aufirst%3DD.%2BR.%26aulast%3DHarrell%26aufirst%3DC.%2BM.%26aulast%3DKraus%26aufirst%3DR.%2BL.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DGarson%26aufirst%3DS.%2BL.%26aulast%3DDoran%26aufirst%3DS.%2BM.%26aulast%3DPrueksaritanont%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DWinrow%26aufirst%3DC.%2BJ.%26aulast%3DKoblan%26aufirst%3DK.%2BS.%26aulast%3DRenger%26aufirst%3DJ.%2BJ.%26aulast%3DColeman%26aufirst%3DP.%2BJ.%26atitle%3DDiscovery%2520of%2520a%2520potent%252C%2520CNS-penetrant%2520orexin%2520receptor%2520antagonist%2520based%2520on%2520an%2520N%252CN-disubstituted-1%252C4-diazepane%2520scaffold%2520that%2520promotes%2520sleep%2520in%2520rats%26jtitle%3DChemMedChem%26date%3D2009%26volume%3D4%26spage%3D1069%26epage%3D1074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="note"><p class="first last">Further investigations by NMR spectroscopy, X-ray crystallography and molecular modeling revealed that <b>4</b> exists both in the solid state and solution in an unusual horseshoe- or U-shaped conformation characterized by a Ï-stacking interaction between the quinazoline and phenyl rings.</p></div><div class="NLM_citation" id="cit25a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Cox, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGaughey, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogusky, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitman, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ball, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winrow, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renger, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, P. J.</span><span> </span><span class="NLM_article-title">Conformational analysis of <i>N,N</i>-disubstituted-1,4-diazepane orexin receptor antagonists and implications for receptor binding</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">2997</span><span class="NLM_x">â</span> <span class="NLM_lpage">3001</span><div class="note"><p class="first last">We recently reported that bridged diazepane analogues, whose design and synthesis was inspired by the low energy conformation of <b>4</b>, are also potent DORAs that promote sleep in rats, see:</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=2997-3001&author=C.+D.+Coxauthor=G.+B.+McGaugheyauthor=M.+J.+Boguskyauthor=D.+B.+Whitmanauthor=R.+G.+Ballauthor=C.+J.+Winrowauthor=J.+J.+Rengerauthor=P.+J.+Coleman&title=Conformational+analysis+of+N%2CN-disubstituted-1%2C4-diazepane+orexin+receptor+antagonists+and+implications+for+receptor+binding"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCox%26aufirst%3DC.%2BD.%26aulast%3DMcGaughey%26aufirst%3DG.%2BB.%26aulast%3DBogusky%26aufirst%3DM.%2BJ.%26aulast%3DWhitman%26aufirst%3DD.%2BB.%26aulast%3DBall%26aufirst%3DR.%2BG.%26aulast%3DWinrow%26aufirst%3DC.%2BJ.%26aulast%3DRenger%26aufirst%3DJ.%2BJ.%26aulast%3DColeman%26aufirst%3DP.%2BJ.%26atitle%3DConformational%2520analysis%2520of%2520N%252CN-disubstituted-1%252C4-diazepane%2520orexin%2520receptor%2520antagonists%2520and%2520implications%2520for%2520receptor%2520binding%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D2997%26epage%3D3001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit25b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Coleman, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreier, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGaughey, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogusky, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ball, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrell, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiss, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prueksaritanont, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winrow, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renger, J. J.</span><span> </span><span class="NLM_article-title">Design and synthesis of conformationally constrained <i>N</i>,<i>N</i>-disubstituted-1,4-diazepanes as potent orexin receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2311</span><span class="NLM_x">â</span> <span class="NLM_lpage">2315</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=2311-2315&author=P.+J.+Colemanauthor=J.+D.+Schreierauthor=G.+B.+McGaugheyauthor=M.+J.+Boguskyauthor=C.+D.+Coxauthor=G.+D.+Hartmanauthor=R.+G.+Ballauthor=C.+M.+Harrellauthor=D.+R.+Reissauthor=T.+Prueksaritanontauthor=C.+J.+Winrowauthor=J.+J.+Renger&title=Design+and+synthesis+of+conformationally+constrained+N%2CN-disubstituted-1%2C4-diazepanes+as+potent+orexin+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DColeman%26aufirst%3DP.%2BJ.%26aulast%3DSchreier%26aufirst%3DJ.%2BD.%26aulast%3DMcGaughey%26aufirst%3DG.%2BB.%26aulast%3DBogusky%26aufirst%3DM.%2BJ.%26aulast%3DCox%26aufirst%3DC.%2BD.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DBall%26aufirst%3DR.%2BG.%26aulast%3DHarrell%26aufirst%3DC.%2BM.%26aulast%3DReiss%26aufirst%3DD.%2BR.%26aulast%3DPrueksaritanont%26aufirst%3DT.%26aulast%3DWinrow%26aufirst%3DC.%2BJ.%26aulast%3DRenger%26aufirst%3DJ.%2BJ.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520conformationally%2520constrained%2520N%252CN-disubstituted-1%252C4-diazepanes%2520as%2520potent%2520orexin%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D2311%26epage%3D2315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit25c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Coleman, P. J.; Schreier, J. D.; Roecker, A. J.; Mercer, S. P.; McGaughey, G. B.; Cox, C. D; Hartman, G. D.; Harrell, C. M.; Reiss, D. R.; Garson, S. L.; Anderson, W. B.; Prueksaritanont, T.; Winrow, C. J.; Renger, J. J.</span><span> </span><span class="NLM_article-title">Discovery of 3,9-diazabicyclo[4.2.1]nonanes as potent orexin receptor antagonists with sleep-promoting activity in the rat</span>.  <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span>DOI: <span class="refDoi">Â DOI: 10.1016/j.bmcl.2010.05.047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25c&amp;dbid=16&amp;doi=10.1021%2Fjm100541c&amp;key=10.1016%2Fj.bmcl.2010.05.047" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=P.+J.+Coleman&author=J.+D.+Schreier&author=A.+J.+Roecker&author=S.+P.+Mercer&author=G.+B.+McGaughey&author=C.+D+Cox&author=G.+D.+Hartman&author=C.+M.+Harrell&author=D.+R.+Reiss&author=S.+L.+Garson&author=W.+B.+Anderson&author=T.+Prueksaritanont&author=C.+J.+Winrow&author=J.+J.+Renger&title=Discovery+of+3%2C9-diazabicyclo%5B4.2.1%5Dnonanes+as+potent+orexin+receptor+antagonists+with+sleep-promoting+activity+in+the+rat&doi=10.1016%2Fj.bmcl.2010.05.047"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25c&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.05.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.05.047%26sid%3Dliteratum%253Aachs%26aulast%3DColeman%26aufirst%3DP.%2BJ.%26atitle%3DDiscovery%2520of%25203%252C9-diazabicyclo%255B4.2.1%255Dnonanes%2520as%2520potent%2520orexin%2520receptor%2520antagonists%2520with%2520sleep-promoting%2520activity%2520in%2520the%2520rat%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26doi%3D10.1016%2Fj.bmcl.2010.05.047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="note"><p class="first last">Other vehicles studied included 0.5% aqueous methylcellulose, 10% Tween 80 in water, and 0.1 M citric acid.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="note"><p class="first last">The position of oxidation is not known. For simplicity in visualization, oxidation at the 7-position of the core is shown.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><div class="note"><p class="first last">A large number of the cores made during this effort are described in</p></div><span class="NLM_contrib-group">Coleman, P. J.; Cox, C. D.; Roecker, A. J.</span><span> </span><span class="NLM_article-title">Discovery of Dual Orexin Receptor Antagonists (DORAs) for the Treatment of Insomnia</span>.  <span class="citation_source-journal">Curr. Top. Med. Chem.</span> in press.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=A+large+number+of+the+cores+made+during+this+effort+are+described+inColeman%2C+P.+J.%3B+Cox%2C+C.+D.%3B+Roecker%2C+A.+J.+Discovery+of+Dual+Orexin+Receptor+Antagonists+%28DORAs%29+for+the+Treatment+of+Insomnia.+Curr.+Top.+Med.+Chem.+in+press."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DColeman%26aufirst%3DP.%2BJ.%26atitle%3DDiscovery%2520of%2520Dual%2520Orexin%2520Receptor%2520Antagonists%2520%2528DORAs%2529%2520for%2520the%2520Treatment%2520of%2520Insomnia%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="note"><p class="first last">Dog pharmacokinetic âcassettesâ where utilized wherein 5â6 test compounds plus a standard were dosed IV in DMSO, with the goal being to identify compounds with reduced IV clearance. Promising analogues were then repeated as both IV and PO singles. In general, the data obtained in cassette format was reproduced well in the IV singles. Though some exceptions were noted, this strategy led to a number of diazepanes with improved bioavailability.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Poppelsdorf, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myerly, R. C.</span><span> </span><span class="NLM_article-title">A novel synthesis of homopiperazine and its monomethyl derivatives</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1961</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">131</span><span class="NLM_x">â</span> <span class="NLM_lpage">134</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo01060a031" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1961&pages=131-134&author=F.+Poppelsdorfauthor=R.+C.+Myerly&title=A+novel+synthesis+of+homopiperazine+and+its+monomethyl+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30a&amp;dbid=16384&amp;doi=10.1021%2Fjo01060a031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01060a031%26sid%3Dliteratum%253Aachs%26aulast%3DPoppelsdorf%26aufirst%3DF.%26aulast%3DMyerly%26aufirst%3DR.%2BC.%26atitle%3DA%2520novel%2520synthesis%2520of%2520homopiperazine%2520and%2520its%2520monomethyl%2520derivatives%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1961%26volume%3D26%26spage%3D131%26epage%3D134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit30b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Benalil, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carboni, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaultier, M.</span><span> </span><span class="NLM_article-title">Synthesis of 2,3,6,7-tetrahydro- and 2,3,4,5,6,7-hexahydro-1<i>H</i>-1,4-diazepines via a tandem Michael-type addition-intramolecular aza-Wittig sequence</span> <span class="citation_source-journal">J. Chem. Soc., Perkin Trans 1</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_fpage">1061</span><span class="NLM_x">â</span> <span class="NLM_lpage">1064</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1993&pages=1061-1064&author=A.+Benalilauthor=A.+Guerinauthor=B.+Carboniauthor=M.+Vaultier&title=Synthesis+of+2%2C3%2C6%2C7-tetrahydro-+and+2%2C3%2C4%2C5%2C6%2C7-hexahydro-1H-1%2C4-diazepines+via+a+tandem+Michael-type+addition-intramolecular+aza-Wittig+sequence"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBenalil%26aufirst%3DA.%26aulast%3DGuerin%26aufirst%3DA.%26aulast%3DCarboni%26aufirst%3DB.%26aulast%3DVaultier%26aufirst%3DM.%26atitle%3DSynthesis%2520of%25202%252C3%252C6%252C7-tetrahydro-%2520and%25202%252C3%252C4%252C5%252C6%252C7-hexahydro-1H-1%252C4-diazepines%2520via%2520a%2520tandem%2520Michael-type%2520addition-intramolecular%2520aza-Wittig%2520sequence%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Perkin%2520Trans%25201%26date%3D1993%26spage%3D1061%26epage%3D1064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit30c"><span><span class="NLM_label">(c) </span><div class="note"><p class="first last">Subsequent to our work reported herein, an efficient synthesis of the mono-protected 5-methyldiazepane core was reported, see:</p></div><span class="NLM_contrib-group">Wlodarczyk, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilleron, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Millet, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houssin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">HÃ©nichart, J.-P.</span><span> </span><span class="NLM_article-title">Synthesis of 1,4-diazepin-5-ones under microwave irradiation and their reduction products</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">2583</span><span class="NLM_x">â</span> <span class="NLM_lpage">2586</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2007&pages=2583-2586&author=N.+Wlodarczykauthor=P.+Gilleronauthor=R.+Milletauthor=R.+Houssinauthor=J.-P.+H%C3%A9nichart&title=Synthesis+of+1%2C4-diazepin-5-ones+under+microwave+irradiation+and+their+reduction+products"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWlodarczyk%26aufirst%3DN.%26aulast%3DGilleron%26aufirst%3DP.%26aulast%3DMillet%26aufirst%3DR.%26aulast%3DHoussin%26aufirst%3DR.%26aulast%3DH%25C3%25A9nichart%26aufirst%3DJ.-P.%26atitle%3DSynthesis%2520of%25201%252C4-diazepin-5-ones%2520under%2520microwave%2520irradiation%2520and%2520their%2520reduction%2520products%26jtitle%3DTetrahedron%2520Lett.%26date%3D2007%26volume%3D48%26spage%3D2583%26epage%3D2586" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Leonard, J.; Lygo, B.; Procter, G.</span> <span class="citation_source-book">Advanced Practical Organic Chemistry</span>; <span class="NLM_publisher-name">Blackie</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">1995</span><span class="NLM_x">; </span>p  <span class="NLM_fpage">6</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1995&pages=6&author=J.+Leonard&author=B.+Lygo&author=G.+Procter&title=Advanced+Practical+Organic+Chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DLeonard%26aufirst%3DJ.%26btitle%3DAdvanced%2520Practical%2520Organic%2520Chemistry%26pub%3DBlackie%26date%3D1995%26spage%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="note"><p class="first last">For instance, the (<i>S</i>)-antipode of compound <b>9</b> has OX<sub>1</sub>R <i>K</i><sub>i</sub> = 54 nM and OX<sub>2</sub>R <i>K</i><sub>i</sub> = 8.5 nM, corresponding to 8- and 18-fold losses in potency, respectively, relative to the (<i>R</i>)-antipode. We have confirmed the stereochemistry in the active series is (<i>R</i>) by both X-ray crystallography using anomalous dispersion, as well as an asymmetric synthesis starting from the chiral pool.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="note"><p class="first last">In general, installation of the tolyl methyl group on the benzamide increases potency on both receptors, but has a greater effect on OX<sub>1</sub>R potency.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><div class="note"><p class="first last">We have found that a vehicle of 20% TPGS in water to be an excellent vehicle for improving exposure of BCS class II molecules such as the diazepanes described herein and is also highly compatible with our sleep studies. For a study of the effects that TPGS has on oral absorption, see:</p></div><span class="NLM_contrib-group">Varma, M. V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panchagnula, R.</span><span> </span><span class="NLM_article-title">Enhanced oral paclitaxel absorption with vitamin E-TPGS: effect on solubility and permeability in vitro, in situ and in vivo</span> <span class="citation_source-journal">Eur. J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">445</span><span class="NLM_x">â</span> <span class="NLM_lpage">453</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm100541c&amp;key=10.1016%2Fj.ejps.2005.04.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm100541c&amp;key=15890503" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm100541c&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlsVCltbg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=445-453&author=M.+V.+S.+Varmaauthor=R.+Panchagnula&title=Enhanced+oral+paclitaxel+absorption+with+vitamin+E-TPGS%3A+effect+on+solubility+and+permeability+in+vitro%2C+in+situ+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Enhanced oral paclitaxel absorption with vitamin E-TPGS: Effect on solubility and permeability in vitro, in situ and in vivo</span></div><div class="casAuthors">Varma, Manthena V. S.; Panchagnula, Ramesh</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">4-5</span>),
    <span class="NLM_cas:pages">445-453</span>CODEN:
                <span class="NLM_cas:coden">EPSCED</span>;
        ISSN:<span class="NLM_cas:issn">0928-0987</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Soly. and permeability being important determinants of oral drug absorption, this study was aimed to investigate the effect of Î±-tocopheryl polyethylene glycol 1000 succinate (TPGS) on the soly. and intestinal permeability of paclitaxel in vitro, in situ and in vivo, to est. the absorption enhancement ability of TPGS.  Aq. soly. of paclitaxel is significantly enhanced by TPGS, where a linear increase was demonstrated above a TPGS concn. of 0.1 mg/mL.  Paclitaxel demonstrated asym. transport across rat ileum with significantly greater (26-fold) basolateral-to-apical (B-A) permeability than that in apical-to-basolateral (A-B) direction.  Presence of P-glycoprotein (P-gp) inhibitor, verapamil (200 Î¼M), diminished asym. transport of paclitaxel suggesting the role of P-gp-mediated efflux.  TPGS showed a concn.-dependent increase in A-B permeability and decreased B-A permeability.  The max. efflux inhibition activity was found at a min. TPGS concn. of 0.1 mg/mL, however, further increase in TPGS concn. resulted in decreased A-B permeability with no change in B-A permeability.  Thus, the max. paclitaxel permeability attained with 0.1 mg/mL TPGS was attributed to the interplay between TPGS concn. dependent P-gp inhibition activity and micelle formation.  In situ permeability studies in rats also demonstrated the role of efflux in limiting permeability of paclitaxel and inhibitory efficiency of TPGS.  The plasma concn. of [14C]paclitaxel following oral administration (25 mg/kg) was significantly increased by coadministration of TPGS at a dose of 50 mg/kg in rats.  Bioavailability is enhanced about 4.2- and 6.3-fold when [14C]paclitaxel was administrated with verapamil (25 mg/kg) and TPGS, resp., as compared to [14C]paclitaxel administered alone.  The effect of verapamil on oral bioavailability of [14C]paclitaxel was limited relative to the TPGS, consistent with the in vitro soly. and permeability enhancement ability of TPGS.  In conclusion, the current data suggests that the coadministration of TPGS may improve the bioavailability of BCS class II-IV drugs with low soly. and/or less permeable as a result of significant P-gp-mediated efflux.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwAg2sRFu08rVg90H21EOLACvtfcHk0lgk6tgAIenzhA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlsVCltbg%253D&md5=b4cd1a878214885498a601b65ffd57f2</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.ejps.2005.04.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejps.2005.04.003%26sid%3Dliteratum%253Aachs%26aulast%3DVarma%26aufirst%3DM.%2BV.%2BS.%26aulast%3DPanchagnula%26aufirst%3DR.%26atitle%3DEnhanced%2520oral%2520paclitaxel%2520absorption%2520with%2520vitamin%2520E-TPGS%253A%2520effect%2520on%2520solubility%2520and%2520permeability%2520in%2520vitro%252C%2520in%2520situ%2520and%2520in%2520vivo%26jtitle%3DEur.%2520J.%2520Pharm.%2520Sci.%26date%3D2005%26volume%3D25%26spage%3D445%26epage%3D453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="note"><p class="first last">Brain, plasma, and CSF concentrations were measured following a 30 min continuous IV infusion of <b>10</b> at 0.25, 0.75, and 1.5 mg/kg in 25% hydroxypropyl-Î²-cyclodextrin.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Evans, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watt, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicoll-Griffith, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baillie, T. A.</span><span> </span><span class="NLM_article-title">Drugâprotein adducts: an industry perspective on minimizing the potential for drug bioactivation in drug discovery and development</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">â</span> <span class="NLM_lpage">16</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx034170b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2004&pages=3-16&author=D.+C.+Evansauthor=A.+P.+Wattauthor=D.+A.+Nicoll-Griffithauthor=T.+A.+Baillie&title=Drug%E2%88%92protein+adducts%3A+an+industry+perspective+on+minimizing+the+potential+for+drug+bioactivation+in+drug+discovery+and+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36a&amp;dbid=16384&amp;doi=10.1021%2Ftx034170b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx034170b%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DD.%2BC.%26aulast%3DWatt%26aufirst%3DA.%2BP.%26aulast%3DNicoll-Griffith%26aufirst%3DD.%2BA.%26aulast%3DBaillie%26aufirst%3DT.%2BA.%26atitle%3DDrug%25E2%2588%2592protein%2520adducts%253A%2520an%2520industry%2520perspective%2520on%2520minimizing%2520the%2520potential%2520for%2520drug%2520bioactivation%2520in%2520drug%2520discovery%2520and%2520development%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2004%26volume%3D17%26spage%3D3%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit36b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kumar, S.; Baillie, T. A.</span><span> </span><span class="NLM_article-title">Minimizing metabolic activation in drug discovery</span> in  <span class="citation_source-book">Handbook of Drug Metabolism</span>, <span class="NLM_edition">2nd</span> ed.; <span class="NLM_contrib-group">Pearson, P. G.; Wienkers, L. C.</span>, Eds.; <span class="NLM_publisher-name">Informa Healthcare</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">; </span>Chapter 23.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=S.+Kumar&author=T.+A.+Baillieauthor=P.+G.+Pearson&author=L.+C.+Wienkers&title=Handbook+of+Drug+Metabolism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DS.%26atitle%3DMinimizing%2520metabolic%2520activation%2520in%2520drug%2520discovery%26btitle%3DHandbook%2520of%2520Drug%2520Metabolism%26aulast%3DPearson%26aufirst%3DP.%2BG.%26pub%3DInforma%2520Healthcare%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="note"><p class="first last">See the <a class="ref internalNav" href="#sec3" aria-label="Experimental Section">Experimental Section</a> for details.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="note"><p class="first last">GSH-adducts were identified that had a mass spectral signal corresponding to loss of the fluorine atom, suggesting the fluoroquinazoline as a site of bioactivation. The GSH-adduct/IS ratio of compound <b>4</b> is 5.0, suggesting that the nonfluorinated quinazoline also likely undergoes bioactivation and subsequent trapping with GSH.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="note"><p class="first last">As with diazepane DORA <b>4</b>, solution NMR studies of <b>3</b> indicate a very complex situation with several low energy conformations in equilibrium. Studies are underway to characterize the low energy conformations of <b>3</b> and how they fit with our proposed bioactive conformation model.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="note"><p class="first last">Brain, plasma, and CSF concentrations were measured following a 30 min continuous IV infusion of <b>3</b> at 0.25, 0.75, and 1.5, and 2.0 mg/kg in 25% hydroxypropyl-Î²-cyclodextrin. Brain/plasma ratios ranged from 0.6â1.2 and the CSF/plasma ratios ranged from 0.007â0.017. When dosed at 10 mg/kg PO in 20% TPGS, at 1 h post dose the brain/plasma ratio was 0.7 and the CSF/plasma ratio was 0.007.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><div class="note"><p class="first last">A manuscript in preparation will describe the pharmacology of <b>3</b> in more detail, including analysis of its dose-dependent effects on sleep in rats, dogs, and monkeys.</p></div><span class="NLM_contrib-group">Winrow, C. J.</span> unpublished results.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=A+manuscript+in+preparation+will+describe+the+pharmacology+of+3+in+more+detail%2C+including+analysis+of+its+dose-dependent+effects+on+sleep+in+rats%2C+dogs%2C+and+monkeys.Winrow%2C+C.+J.+unpublished+results."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DWinrow%26aufirst%3DC.%2BJ." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="note"><p class="first last">The identities of <b>14</b>â<b>16</b> were confirmed by independent synthesis.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Kunapuli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ransom, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettibone, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerby, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimwood, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuck, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodder, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inglese, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strulovici, B.</span><span> </span><span class="NLM_article-title">Development of an intact cell reporter gene Î²-lactamase assay for G-protein coupled receptors for high-throughput screening</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">314</span><span class="NLM_x">, </span> <span class="NLM_fpage">16</span><span class="NLM_x">â</span> <span class="NLM_lpage">29</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=314&publication_year=2003&pages=16-29&author=P.+Kunapuliauthor=R.+Ransomauthor=K.+L.+Murphyauthor=D.+J.+Pettiboneauthor=J.+Kerbyauthor=S.+Grimwoodauthor=P.+Zuckauthor=P.+Hodderauthor=R.+Lacsonauthor=I.+Hoffmanauthor=J.+Ingleseauthor=B.+Strulovici&title=Development+of+an+intact+cell+reporter+gene+%CE%B2-lactamase+assay+for+G-protein+coupled+receptors+for+high-throughput+screening"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKunapuli%26aufirst%3DP.%26aulast%3DRansom%26aufirst%3DR.%26aulast%3DMurphy%26aufirst%3DK.%2BL.%26aulast%3DPettibone%26aufirst%3DD.%2BJ.%26aulast%3DKerby%26aufirst%3DJ.%26aulast%3DGrimwood%26aufirst%3DS.%26aulast%3DZuck%26aufirst%3DP.%26aulast%3DHodder%26aufirst%3DP.%26aulast%3DLacson%26aufirst%3DR.%26aulast%3DHoffman%26aufirst%3DI.%26aulast%3DInglese%26aufirst%3DJ.%26aulast%3DStrulovici%26aufirst%3DB.%26atitle%3DDevelopment%2520of%2520an%2520intact%2520cell%2520reporter%2520gene%2520%25CE%25B2-lactamase%2520assay%2520for%2520G-protein%2520coupled%2520receptors%2520for%2520high-throughput%2520screening%26jtitle%3DAnal.%2520Biochem.%26date%3D2003%26volume%3D314%26spage%3D16%26epage%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Mosser, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanley, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaul, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bednar, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koblan, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bednar, R. A.</span><span> </span><span class="NLM_article-title">Automation of in vitro dose-inhibition assays using the Tecan Genesis and an integrated software package to support the drug discovery process</span> <span class="citation_source-journal">J. Assoc. Lab. Autom.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">54</span><span class="NLM_x">â</span> <span class="NLM_lpage">62</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm100541c&amp;key=10.1016%2FS1535-5535%2804%2900281-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm100541c&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnsVSlsr8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2003&pages=54-62&author=S.+D.+Mosserauthor=L.+Stanleyauthor=S.+L.+Gaulauthor=B.+Bednarauthor=K.+S.+Koblanauthor=R.+A.+Bednar&title=Automation+of+in+vitro+dose-inhibition+assays+using+the+Tecan+Genesis+and+an+integrated+software+package+to+support+the+drug+discovery+process"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Automation of in vitro dose-inhibition assays utilizing the Tecan Genesis and an integrated software package to support the drug discovery process</span></div><div class="casAuthors">Mosser, Scott D.; Gaul, Stanley L.; Bednar, Bohumil; Koblan, Kenneth S.; Bednar, Rodney A.</div><div class="citationInfo"><span class="NLM_cas:title">JALA</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">54-63</span>CODEN:
                <span class="NLM_cas:coden">JALLFO</span>;
        ISSN:<span class="NLM_cas:issn">1535-5535</span>.
    
            (<span class="NLM_cas:orgname">Association for Laboratory Automation</span>)
        </div><div class="casAbstract">The authors have automated in vitro dose-inhibition assays to evaluate newly synthesized chem. entities and to rapidly produce and disseminate the results with minimal personnel.  A variety of assay methods were automated using the Tecan Genesis Workstation to produce ten-point titrn. curves and generate reproducible KI values.  The authors' integrated software package provides the unique ability to simultaneously inventory and schedule compds. into various in vitro assays.  A worklist generator, in combination with a Gemini script automatically makes variable pre-dilns. of compds., retrieves incubation plates from the Carousel using the RoMa Arm, performs serial dilns. of compds. within the final 96 well incubation plate using disposable tips, and adds essential assay reagents.  The authors' "Expert System for Data Anal." automatically retrieves data from a reader (e.g., TopCount, FLIPR or VIPR), analyzes the data based on a set of rules, and provides value added reports.  An overview of the basic workflow and the integrated software for support of the drug discovery process is described.  The ability of the Tecan Robot to produce dose-inhibition profiles is illustrated and validated by using a radioligand binding assay and a DMSO solubilized fluorescein dye method.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVyPEo0myW4LVg90H21EOLACvtfcHk0lg4XKQPJ_Tmxw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnsVSlsr8%253D&md5=f4a8e1caed4109a299f2566224829ea2</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2FS1535-5535%2804%2900281-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1535-5535%252804%252900281-3%26sid%3Dliteratum%253Aachs%26aulast%3DMosser%26aufirst%3DS.%2BD.%26aulast%3DStanley%26aufirst%3DL.%26aulast%3DGaul%26aufirst%3DS.%2BL.%26aulast%3DBednar%26aufirst%3DB.%26aulast%3DKoblan%26aufirst%3DK.%2BS.%26aulast%3DBednar%26aufirst%3DR.%2BA.%26atitle%3DAutomation%2520of%2520in%2520vitro%2520dose-inhibition%2520assays%2520using%2520the%2520Tecan%2520Genesis%2520and%2520an%2520integrated%2520software%2520package%2520to%2520support%2520the%2520drug%2520discovery%2520process%26jtitle%3DJ.%2520Assoc.%2520Lab.%2520Autom.%26date%3D2003%26volume%3D8%26spage%3D54%26epage%3D62" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Alvarino, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monti, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jantos, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monti, D.</span><span> </span><span class="NLM_article-title">Effect of SX-3228, a selective ligand for the BZ1 receptor, on sleep and waking during the lightâdark cycle in the rat</span> <span class="citation_source-journal">Braz. J. Med. Biol. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">1007</span><span class="NLM_x">â</span> <span class="NLM_lpage">1014</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45a&amp;dbid=16&amp;doi=10.1021%2Fjm100541c&amp;key=10.1590%2FS0100-879X1999000800011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45a&amp;dbid=8&amp;doi=10.1021%2Fjm100541c&amp;key=10454763" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45a&amp;dbid=32&amp;doi=10.1021%2Fjm100541c&amp;key=1%3ACAS%3A528%3ADyaK1MXmtFGhtbo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1999&pages=1007-1014&author=F.+Alvarinoauthor=J.+M.+Montiauthor=H.+Jantosauthor=D.+Monti&title=Effect+of+SX-3228%2C+a+selective+ligand+for+the+BZ1+receptor%2C+on+sleep+and+waking+during+the+light%E2%88%92dark+cycle+in+the+rat"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45aR"><div class="casContent"><span class="casTitleNuber">45a</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of SX-3228, a selective ligand for the BZ1 receptor, on sleep and waking during the light-dark cycle in the rat</span></div><div class="casAuthors">Alvarino, F.; Monti, J. M.; Jantos, H.; Monti, D.</div><div class="citationInfo"><span class="NLM_cas:title">Brazilian Journal of Medical and Biological Research</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1007-1014</span>CODEN:
                <span class="NLM_cas:coden">BJMRDK</span>;
        ISSN:<span class="NLM_cas:issn">0100-879X</span>.
    
            (<span class="NLM_cas:orgname">Associacao Brasileira de Divulgacao Cientifica</span>)
        </div><div class="casAbstract">The effects of the benzodiazepine1 (BZ1) receptor agonist SX-3228 were studied in rats (N = 12) implanted for chronic sleep procedures.  Administration of 0.5, 1.0 and 2.5 mg/kg SX-3228, s.c., to rats 1 h after the beginning of the light phase of the light-dark cycle induced a significant redn. of rapid-eye-movement sleep (REMS) during the third recording hour.  Moreover, slow wave sleep (SWS) was increased during the fourth recording hour after the two largest doses of the compd.  Administration of 0.5, 1.0 and 2.5 mg/kg SX-3228 one hour after the beginning of the dark period of the light-dark cycle caused a significant and maintained (6-h recording period) redn. of waking (W), whereas SWS and light sleep (LS) were increased.  REMS values tended to increase during the entire recording period; however, the increase was statistically significant only for the 1.0 mg/kg dose during the first recording hour.  In addn., a significant and dose-related increase of power d. in the delta and the theta regions was found during nonREM sleep (LS and SWS) in the dark period.  Our results indicate that SX-3228 is a potent hypnotic when given to the rat during the dark period of the light-dark cycle.  Moreover, the sleep induced by SX-3228 during the dark phase closely resembles the physiol. sleep of the rat.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq317lLOTXW1rVg90H21EOLACvtfcHk0liBwx7LKe-rLg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmtFGhtbo%253D&md5=5db1329b791c2d421ffbe718294c66b6</span></div><a href="/servlet/linkout?suffix=cit45a&amp;dbid=16384&amp;doi=10.1590%2FS0100-879X1999000800011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1590%252FS0100-879X1999000800011%26sid%3Dliteratum%253Aachs%26aulast%3DAlvarino%26aufirst%3DF.%26aulast%3DMonti%26aufirst%3DJ.%2BM.%26aulast%3DJantos%26aufirst%3DH.%26aulast%3DMonti%26aufirst%3DD.%26atitle%3DEffect%2520of%2520SX-3228%252C%2520a%2520selective%2520ligand%2520for%2520the%2520BZ1%2520receptor%252C%2520on%2520sleep%2520and%2520waking%2520during%2520the%2520light%25E2%2588%2592dark%2520cycle%2520in%2520the%2520rat%26jtitle%3DBraz.%2520J.%2520Med.%2520Biol.%2520Res.%26date%3D1999%26volume%3D32%26spage%3D1007%26epage%3D1014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit45b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Monti, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jantos, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monti, D.</span><span> </span><span class="NLM_article-title">Increase in waking and reduction of NREM and REM sleep after nitric oxide synthase inhibition: prevention with GABAA or adenosine A1 receptor agonists</span> <span class="citation_source-journal">Behav. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">123</span><span class="NLM_x">, </span> <span class="NLM_fpage">23</span><span class="NLM_x">â</span> <span class="NLM_lpage">35</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2001&pages=23-35&author=J.+M.+Montiauthor=H.+Jantosauthor=D.+Monti&title=Increase+in+waking+and+reduction+of+NREM+and+REM+sleep+after+nitric+oxide+synthase+inhibition%3A+prevention+with+GABAA+or+adenosine+A1+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMonti%26aufirst%3DJ.%2BM.%26aulast%3DJantos%26aufirst%3DH.%26aulast%3DMonti%26aufirst%3DD.%26atitle%3DIncrease%2520in%2520waking%2520and%2520reduction%2520of%2520NREM%2520and%2520REM%2520sleep%2520after%2520nitric%2520oxide%2520synthase%2520inhibition%253A%2520prevention%2520with%2520GABAA%2520or%2520adenosine%2520A1%2520receptor%2520agonists%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D2001%26volume%3D123%26spage%3D23%26epage%3D35" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Lazer, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miao, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, H.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorcek, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spero, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pal, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behnke, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watrous, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Homon, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guindon, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farina, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, J.</span><span> </span><span class="NLM_article-title">Benzoxazolamines and benzothiazolamines: Potent, enantioselective inhibitors of leukotriene biosynthesis with a novel mechanism of action</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">913</span><span class="NLM_x">â</span> <span class="NLM_lpage">923</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00033a008" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=913-923&author=E.+S.+Lazerauthor=C.+K.+Miaoauthor=H.-C.+Wongauthor=R.+Sorcekauthor=D.+M.+Speroauthor=A.+Gilmanauthor=K.+Palauthor=M.+Behnkeauthor=A.+G.+Grahamauthor=J.+M.+Watrousauthor=C.+A.+Homonauthor=J.+Nagelauthor=A.+Shahauthor=Y.+Guindonauthor=P.+R.+Farinaauthor=J.+Adams&title=Benzoxazolamines+and+benzothiazolamines%3A+Potent%2C+enantioselective+inhibitors+of+leukotriene+biosynthesis+with+a+novel+mechanism+of+action"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fjm00033a008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00033a008%26sid%3Dliteratum%253Aachs%26aulast%3DLazer%26aufirst%3DE.%2BS.%26aulast%3DMiao%26aufirst%3DC.%2BK.%26aulast%3DWong%26aufirst%3DH.-C.%26aulast%3DSorcek%26aufirst%3DR.%26aulast%3DSpero%26aufirst%3DD.%2BM.%26aulast%3DGilman%26aufirst%3DA.%26aulast%3DPal%26aufirst%3DK.%26aulast%3DBehnke%26aufirst%3DM.%26aulast%3DGraham%26aufirst%3DA.%2BG.%26aulast%3DWatrous%26aufirst%3DJ.%2BM.%26aulast%3DHomon%26aufirst%3DC.%2BA.%26aulast%3DNagel%26aufirst%3DJ.%26aulast%3DShah%26aufirst%3DA.%26aulast%3DGuindon%26aufirst%3DY.%26aulast%3DFarina%26aufirst%3DP.%2BR.%26aulast%3DAdams%26aufirst%3DJ.%26atitle%3DBenzoxazolamines%2520and%2520benzothiazolamines%253A%2520Potent%252C%2520enantioselective%2520inhibitors%2520of%2520leukotriene%2520biosynthesis%2520with%2520a%2520novel%2520mechanism%2520of%2520action%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26spage%3D913%26epage%3D923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3a','cit3b'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7a','cit7b'],'ref8':['cit8'],'ref9':['cit9a','cit9b'],'ref10':['cit10a'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13a','cit13b','cit13c'],'ref14':['cit14'],'ref15':['cit15a','cit15b','cit15c','cit15d'],'ref16':['cit16a','cit16b','cit16c','cit16d','cit16e','cit16f','cit16g','cit16h','cit16i'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':[],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25a','cit25b','cit25c'],'ref26':[],'ref27':[],'ref28':['cit28'],'ref29':[],'ref30':['cit30a','cit30b','cit30c'],'ref31':['cit31'],'ref32':[],'ref33':[],'ref34':['cit34'],'ref35':[],'ref36':['cit36a','cit36b'],'ref37':[],'ref38':[],'ref39':[],'ref40':[],'ref41':['cit41'],'ref42':[],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45a','cit45b'],'ref46':['cit46']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 236 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Fang-Fang Feng, Jun-Kuan Li, Xuan-Yu Liu, Fa-Guang Zhang, Chi Wai Cheung, <span class="NLM_string-name hlFld-ContribAuthor">Jun-An Ma</span>. </span><span class="cited-content_cbyCitation_article-title">General Synthesis of Tri-Carbo-Substituted N2-Aryl-1,2,3-triazoles via Cu-Catalyzed Annulation of Azirines with Aryldiazonium Salts. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>85 </em>
                                    (16)
                                     , 10872-10883. <a href="https://doi.org/10.1021/acs.joc.0c01433" title="DOI URL">https://doi.org/10.1021/acs.joc.0c01433</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.0c01433&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.0c01433%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DGeneral%252BSynthesis%252Bof%252BTri-Carbo-Substituted%252BN2-Aryl-1%25252C2%25252C3-triazoles%252Bvia%252BCu-Catalyzed%252BAnnulation%252Bof%252BAzirines%252Bwith%252BAryldiazonium%252BSalts%26aulast%3DFeng%26aufirst%3DFang-Fang%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D17062020%26date%3D03082020%26date%3D21072020%26volume%3D85%26issue%3D16%26spage%3D10872%26epage%3D10883" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Zefei Xu, Peiyuan Yao, Xiang Sheng, Jinlong Li, Jianjiong Li, Shanshan Yu, Jinhui Feng, Qiaqing Wu, <span class="NLM_string-name hlFld-ContribAuthor">Dunming Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Biocatalytic Access to 1,4-Diazepanes via Imine Reductase-Catalyzed Intramolecular Asymmetric Reductive Amination. </span><span class="cited-content_cbyCitation_journal-name">ACS Catalysis</span><span> <strong>2020,</strong> <em>10 </em>
                                    (15)
                                     , 8780-8787. <a href="https://doi.org/10.1021/acscatal.0c02400" title="DOI URL">https://doi.org/10.1021/acscatal.0c02400</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscatal.0c02400&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscatal.0c02400%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Catalysis%26atitle%3DBiocatalytic%252BAccess%252Bto%252B1%25252C4-Diazepanes%252Bvia%252BImine%252BReductase-Catalyzed%252BIntramolecular%252BAsymmetric%252BReductive%252BAmination%26aulast%3DXu%26aufirst%3DZefei%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D31052020%26date%3D12072020%26date%3D24072020%26date%3D13072020%26volume%3D10%26issue%3D15%26spage%3D8780%26epage%3D8787" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Gunasekaran Balamurugan, Rengan Ramesh, <span class="NLM_string-name hlFld-ContribAuthor">Jan Grzegorz Malecki</span>. </span><span class="cited-content_cbyCitation_article-title">Nickel(II)âNÎNÎO Pincer Type Complex-Catalyzed N-alkylation of Amines with Alcohols via the Hydrogen Autotransfer Reaction. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>85 </em>
                                    (11)
                                     , 7125-7135. <a href="https://doi.org/10.1021/acs.joc.0c00530" title="DOI URL">https://doi.org/10.1021/acs.joc.0c00530</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.0c00530&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.0c00530%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DNickel%252528II%252529%2525E2%252580%252593N%2525CE%25259BN%2525CE%25259BO%252BPincer%252BType%252BComplex-Catalyzed%252BN-alkylation%252Bof%252BAmines%252Bwith%252BAlcohols%252Bvia%252Bthe%252BHydrogen%252BAutotransfer%252BReaction%26aulast%3DBalamurugan%26aufirst%3DGunasekaran%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D28022020%26date%3D19052020%26date%3D08052020%26volume%3D85%26issue%3D11%26spage%3D7125%26epage%3D7135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Mathieu Rappas, Ammar A. E. Ali, Kirstie A. Bennett, Jason D. Brown, Sarah J. Bucknell, Miles Congreve, Robert M. Cooke, Gabriella Cseke, Chris de Graaf, Andrew S. DorÃ©, James C. Errey, Ali Jazayeri, Fiona H. Marshall, Jonathan S. Mason, Richard Mould, Jayesh C. Patel, Benjamin G. Tehan, Malcolm Weir, <span class="NLM_string-name hlFld-ContribAuthor">John A. Christopher</span>. </span><span class="cited-content_cbyCitation_article-title">Comparison of Orexin 1 and Orexin 2 Ligand Binding Modes Using X-ray Crystallography and Computational Analysis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (4)
                                     , 1528-1543. <a href="https://doi.org/10.1021/acs.jmedchem.9b01787" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01787</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01787&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01787%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DComparison%252Bof%252BOrexin%252B1%252Band%252BOrexin%252B2%252BLigand%252BBinding%252BModes%252BUsing%252BX-ray%252BCrystallography%252Band%252BComputational%252BAnalysis%26aulast%3DRappas%26aufirst%3DMathieu%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D28102019%26date%3D19012020%26date%3D20122019%26volume%3D63%26issue%3D4%26spage%3D1528%26epage%3D1543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jason M. Uslaner, William J. Herring, <span class="NLM_string-name hlFld-ContribAuthor">Paul J. Coleman</span>. </span><span class="cited-content_cbyCitation_article-title">The Discovery of Suvorexant: Lessons Learned That Can Be Applied to Other CNS Drug Development Efforts. </span><span class="cited-content_cbyCitation_journal-name">ACS Pharmacology & Translational Science</span><span> <strong>2020,</strong> <em>3 </em>
                                    (1)
                                     , 161-168. <a href="https://doi.org/10.1021/acsptsci.9b00110" title="DOI URL">https://doi.org/10.1021/acsptsci.9b00110</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsptsci.9b00110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsptsci.9b00110%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Pharmacology%2520%2526%2520Translational%2520Science%26atitle%3DThe%252BDiscovery%252Bof%252BSuvorexant%25253A%252BLessons%252BLearned%252BThat%252BCan%252BBe%252BApplied%252Bto%252BOther%252BCNS%252BDrug%252BDevelopment%252BEfforts%26aulast%3DUslaner%26aufirst%3DJason%2BM.%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D03122019%26date%3D28012020%26volume%3D3%26issue%3D1%26spage%3D161%26epage%3D168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Oleg I. Afanasyev, Ekaterina Kuchuk, Dmitry L. Usanov, <span class="NLM_string-name hlFld-ContribAuthor">Denis Chusov</span>. </span><span class="cited-content_cbyCitation_article-title">Reductive Amination in the Synthesis of Pharmaceuticals. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2019,</strong> <em>119 </em>
                                    (23)
                                     , 11857-11911. <a href="https://doi.org/10.1021/acs.chemrev.9b00383" title="DOI URL">https://doi.org/10.1021/acs.chemrev.9b00383</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.9b00383&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.9b00383%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DReductive%252BAmination%252Bin%252Bthe%252BSynthesis%252Bof%252BPharmaceuticals%26aulast%3DAfanasyev%26aufirst%3DOleg%2BI.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D17062019%26date%3D21102019%26volume%3D119%26issue%3D23%26spage%3D11857%26epage%3D11911" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Pengli Bao, Huilan Yue, Na Meng, Xiaohui Zhao, Jiangsheng Li, <span class="NLM_string-name hlFld-ContribAuthor">Wei Wei</span>. </span><span class="cited-content_cbyCitation_article-title">Copper-Catalyzed Three-Component Reaction of Alkynes, TMSN3, and Ethers: Regiocontrollable Synthesis of N1- and N2-Oxyalkylated 1,2,3-Triazoles. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2019,</strong> <em>21 </em>
                                    (18)
                                     , 7218-7222. <a href="https://doi.org/10.1021/acs.orglett.9b02295" title="DOI URL">https://doi.org/10.1021/acs.orglett.9b02295</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.9b02295&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.9b02295%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DCopper-Catalyzed%252BThree-Component%252BReaction%252Bof%252BAlkynes%25252C%252BTMSN3%25252C%252Band%252BEthers%25253A%252BRegiocontrollable%252BSynthesis%252Bof%252BN1-%252Band%252BN2-Oxyalkylated%252B1%25252C2%25252C3-Triazoles%26aulast%3DBao%26aufirst%3DPengli%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D03072019%26date%3D04092019%26volume%3D21%26issue%3D18%26spage%3D7218%26epage%3D7222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Dingyuan Yan, Heming Jiang, Wenxue Sun, Wei Wei, Jing Zhao, Xinhao Zhang, <span class="NLM_string-name hlFld-ContribAuthor">Yun-Dong Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Benzofurans and Benzoxazoles through a [3,3]-Sigmatropic Rearrangement: OâNHAc as a Multitasking Functional Group. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2019,</strong> <em>23 </em>
                                    (8)
                                     , 1646-1653. <a href="https://doi.org/10.1021/acs.oprd.9b00002" title="DOI URL">https://doi.org/10.1021/acs.oprd.9b00002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.oprd.9b00002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.oprd.9b00002%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DSynthesis%252Bof%252BBenzofurans%252Band%252BBenzoxazoles%252Bthrough%252Ba%252B%25255B3%25252C3%25255D-Sigmatropic%252BRearrangement%25253A%252BO%2525E2%252580%252593NHAc%252Bas%252Ba%252BMultitasking%252BFunctional%252BGroup%26aulast%3DYan%26aufirst%3DDingyuan%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D01012019%26date%3D20032019%26volume%3D23%26issue%3D8%26spage%3D1646%26epage%3D1653" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Sahar Roshandel, Maiko J. Lunn, Golam Rasul, Daniel Sylvinson Muthiah Ravinson, Suresh C. Suri, <span class="NLM_string-name hlFld-ContribAuthor">G. K. Surya Prakash</span>. </span><span class="cited-content_cbyCitation_article-title">Catalyst-Free Regioselective N2 Arylation of 1,2,3-Triazoles Using Diaryl Iodonium Salts. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2019,</strong> <em>21 </em>
                                    (16)
                                     , 6255-6258. <a href="https://doi.org/10.1021/acs.orglett.9b02140" title="DOI URL">https://doi.org/10.1021/acs.orglett.9b02140</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.9b02140&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.9b02140%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DCatalyst-Free%252BRegioselective%252BN2%252BArylation%252Bof%252B1%25252C2%25252C3-Triazoles%252BUsing%252BDiaryl%252BIodonium%252BSalts%26aulast%3DRoshandel%26aufirst%3DSahar%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D20062019%26date%3D06082019%26volume%3D21%26issue%3D16%26spage%3D6255%26epage%3D6258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Mookda Pattarawarapan, Dolnapa Yamano, Nitaya Wiriya, <span class="NLM_string-name hlFld-ContribAuthor">Wong Phakhodee</span>. </span><span class="cited-content_cbyCitation_article-title">Metal-Free Synthesis of 2-N,N-Dialkylaminobenzoxazoles Using Tertiary Amines as the Nitrogen Source. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>84 </em>
                                    (10)
                                     , 6516-6523. <a href="https://doi.org/10.1021/acs.joc.9b00797" title="DOI URL">https://doi.org/10.1021/acs.joc.9b00797</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.9b00797&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.9b00797%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DMetal-Free%252BSynthesis%252Bof%252B2-N%25252CN-Dialkylaminobenzoxazoles%252BUsing%252BTertiary%252BAmines%252Bas%252Bthe%252BNitrogen%252BSource%26aulast%3DPattarawarapan%26aufirst%3DMookda%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D21032019%26date%3D01052019%26date%3D24042019%26volume%3D84%26issue%3D10%26spage%3D6516%26epage%3D6523" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Lasse Karhu, Aniket Magarkar, Alex Bunker, <span class="NLM_string-name hlFld-ContribAuthor">Henri Xhaard</span>. </span><span class="cited-content_cbyCitation_article-title">Determinants of Orexin Receptor Binding and ActivationâA Molecular Dynamics Study. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Physical Chemistry B</span><span> <strong>2019,</strong> <em>123 </em>
                                    (12)
                                     , 2609-2622. <a href="https://doi.org/10.1021/acs.jpcb.8b10220" title="DOI URL">https://doi.org/10.1021/acs.jpcb.8b10220</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jpcb.8b10220&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jpcb.8b10220%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Physical%2520Chemistry%2520B%26atitle%3DDeterminants%252Bof%252BOrexin%252BReceptor%252BBinding%252Band%252BActivation%2525E2%252580%252594A%252BMolecular%252BDynamics%252BStudy%26aulast%3DKarhu%26aufirst%3DLasse%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D2019%26date%3D19102018%26date%3D18022019%26date%3D18032019%26date%3D20022019%26volume%3D123%26issue%3D12%26spage%3D2609%26epage%3D2622" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Russell
T. Smith, Xiaheng Zhang, Juan A. RincÃ³n, Javier Agejas, Carlos Mateos, Mario Barberis, Susana GarcÃ­a-Cerrada, Oscar de Frutos, <span class="NLM_string-name hlFld-ContribAuthor">David W. C. MacMillan</span>. </span><span class="cited-content_cbyCitation_article-title">Metallaphotoredox-Catalyzed Cross-Electrophile Csp3âCsp3 Coupling of Aliphatic Bromides. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2018,</strong> <em>140 </em>
                                    (50)
                                     , 17433-17438. <a href="https://doi.org/10.1021/jacs.8b12025" title="DOI URL">https://doi.org/10.1021/jacs.8b12025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.8b12025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.8b12025%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DMetallaphotoredox-Catalyzed%252BCross-Electrophile%252BCsp3%2525E2%252580%252593Csp3%252BCoupling%252Bof%252BAliphatic%252BBromides%26aulast%3DSmith%26aufirst%3DRussell%2BT.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D08112018%26date%3D10122018%26date%3D05122018%26volume%3D140%26issue%3D50%26spage%3D17433%26epage%3D17438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Hong-Xia Wang, Tian-Qi Wei, Pei Xu, Shun-Yi Wang, <span class="NLM_string-name hlFld-ContribAuthor">Shun-Jun Ji</span>. </span><span class="cited-content_cbyCitation_article-title">I2/TBHP-Mediated Oxidative Coupling of Amino-Based Bisnucleophiles and Isocyanides: Access to 2-Aminobenzoxazinones, 2-Aminobenzoxazines, and 2-Aminoquinazolines under Metal-Free Conditions. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2018,</strong> <em>83 </em>
                                    (21)
                                     , 13491-13497. <a href="https://doi.org/10.1021/acs.joc.8b02395" title="DOI URL">https://doi.org/10.1021/acs.joc.8b02395</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.8b02395&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.8b02395%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DI2%25252FTBHP-Mediated%252BOxidative%252BCoupling%252Bof%252BAmino-Based%252BBisnucleophiles%252Band%252BIsocyanides%25253A%252BAccess%252Bto%252B2-Aminobenzoxazinones%25252C%252B2-Aminobenzoxazines%25252C%252Band%252B2-Aminoquinazolines%252Bunder%252BMetal-Free%252BConditions%26aulast%3DWang%26aufirst%3DHong-Xia%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D16092018%26date%3D19102018%26date%3D11102018%26volume%3D83%26issue%3D21%26spage%3D13491%26epage%3D13497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eakkaphon  Rattanangkool</span>, <span class="hlFld-ContribAuthor ">Mongkol  Sukwattanasinitt</span>, and <span class="hlFld-ContribAuthor ">Sumrit  Wacharasindhu</span>  . </span><span class="cited-content_cbyCitation_article-title">Organocatalytic Visible Light Enabled SNAr of Heterocyclic Thiols: A Metal-Free Approach to 2-Aminobenzoxazoles and 4-Aminoquinazolines. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2017,</strong> <em>82 </em>
                                    (24)
                                     , 13256-13262. <a href="https://doi.org/10.1021/acs.joc.7b02357" title="DOI URL">https://doi.org/10.1021/acs.joc.7b02357</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.7b02357&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.7b02357%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DOrganocatalytic%252BVisible%252BLight%252BEnabled%252BSNAr%252Bof%252BHeterocyclic%252BThiols%25253A%252BA%252BMetal-Free%252BApproach%252Bto%252B2-Aminobenzoxazoles%252Band%252B4-Aminoquinazolines%26aulast%3DRattanangkool%26aufirst%3DEakkaphon%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D18092017%26date%3D28112017%26date%3D15122017%26date%3D14112017%26volume%3D82%26issue%3D24%26spage%3D13256%26epage%3D13262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hiroshi  Nagase</span>, <span class="hlFld-ContribAuthor ">Naoshi  Yamamoto</span>, <span class="hlFld-ContribAuthor ">Masahiro  Yata</span>, <span class="hlFld-ContribAuthor ">Sayaka  Ohrui</span>, <span class="hlFld-ContribAuthor ">Takahiro  Okada</span>, <span class="hlFld-ContribAuthor ">Tsuyoshi  Saitoh</span>, <span class="hlFld-ContribAuthor ">Noriki  Kutsumura</span>, <span class="hlFld-ContribAuthor ">Yasuyuki  Nagumo</span>, <span class="hlFld-ContribAuthor ">Yoko  Irukayama-Tomobe</span>, <span class="hlFld-ContribAuthor ">Yukiko  Ishikawa</span>, <span class="hlFld-ContribAuthor ">Yasuhiro  Ogawa</span>, <span class="hlFld-ContribAuthor ">Shigeto  Hirayama</span>, <span class="hlFld-ContribAuthor ">Daisuke  Kuroda</span>, <span class="hlFld-ContribAuthor ">Yurie  Watanabe</span>, <span class="hlFld-ContribAuthor ">Hiroaki  Gouda</span>, and <span class="hlFld-ContribAuthor ">Masashi  Yanagisawa</span>  . </span><span class="cited-content_cbyCitation_article-title">Design and Synthesis of Potent and Highly Selective Orexin 1 Receptor Antagonists with a Morphinan Skeleton and Their Pharmacologies. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (3)
                                     , 1018-1040. <a href="https://doi.org/10.1021/acs.jmedchem.6b01418" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01418</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01418&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01418%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252BSynthesis%252Bof%252BPotent%252Band%252BHighly%252BSelective%252BOrexin%252B1%252BReceptor%252BAntagonists%252Bwith%252Ba%252BMorphinan%252BSkeleton%252Band%252BTheir%252BPharmacologies%26aulast%3DNagase%26aufirst%3DHiroshi%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D23092016%26date%3D18012017%26date%3D09022017%26date%3D04012017%26volume%3D60%26issue%3D3%26spage%3D1018%26epage%3D1040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Roy P.  Lester</span>, <span class="hlFld-ContribAuthor ">Travis  Bham</span>, <span class="hlFld-ContribAuthor ">Thomas W.  Bousfield</span>, <span class="hlFld-ContribAuthor ">William  Lewis</span>, and <span class="hlFld-ContribAuthor ">Jason E.  Camp</span>  . </span><span class="cited-content_cbyCitation_article-title">Exploring the Reactivity of 2-Trichloromethylbenzoxazoles for Access to Substituted Benzoxazoles. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2016,</strong> <em>81 </em>
                                    (24)
                                     , 12472-12477. <a href="https://doi.org/10.1021/acs.joc.6b02315" title="DOI URL">https://doi.org/10.1021/acs.joc.6b02315</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.6b02315&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.6b02315%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DExploring%252Bthe%252BReactivity%252Bof%252B2-Trichloromethylbenzoxazoles%252Bfor%252BAccess%252Bto%252BSubstituted%252BBenzoxazoles%26aulast%3DLester%26aufirst%3DRoy%2BP.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D21092016%26date%3D06122016%26date%3D16122016%26volume%3D81%26issue%3D24%26spage%3D12472%26epage%3D12477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tanaji T.  Talele</span>  . </span><span class="cited-content_cbyCitation_article-title">The âCyclopropyl Fragmentâ is a Versatile Player that Frequently Appears in Preclinical/Clinical Drug Molecules. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (19)
                                     , 8712-8756. <a href="https://doi.org/10.1021/acs.jmedchem.6b00472" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00472</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00472&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00472%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252B%2525E2%252580%25259CCyclopropyl%252BFragment%2525E2%252580%25259D%252Bis%252Ba%252BVersatile%252BPlayer%252Bthat%252BFrequently%252BAppears%252Bin%252BPreclinical%25252FClinical%252BDrug%252BMolecules%26aulast%3DTalele%26aufirst%3DTanaji%2BT.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D30032016%26date%3D30062016%26date%3D13102016%26date%3D14062016%26volume%3D59%26issue%3D19%26spage%3D8712%26epage%3D8756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ainoleena  Turku</span>, <span class="hlFld-ContribAuthor ">Alexandre  Borrel</span>, <span class="hlFld-ContribAuthor ">Teppo O.  Leino</span>, <span class="hlFld-ContribAuthor ">Lasse  Karhu</span>, <span class="hlFld-ContribAuthor ">Jyrki P.  Kukkonen</span>, and <span class="hlFld-ContribAuthor ">Henri  Xhaard</span>  . </span><span class="cited-content_cbyCitation_article-title">Pharmacophore Model To Discover OX1 and OX2 Orexin Receptor Ligands. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (18)
                                     , 8263-8275. <a href="https://doi.org/10.1021/acs.jmedchem.6b00333" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00333</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00333&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00333%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPharmacophore%252BModel%252BTo%252BDiscover%252BOX1%252Band%252BOX2%252BOrexin%252BReceptor%252BLigands%26aulast%3DTurku%26aufirst%3DAinoleena%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D03032016%26date%3D08092016%26date%3D22092016%26date%3D22082016%26volume%3D59%26issue%3D18%26spage%3D8263%26epage%3D8275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Li-Li  Zhu</span>, <span class="hlFld-ContribAuthor ">Xiao-Qi  Xu</span>, <span class="hlFld-ContribAuthor ">Jin-Wei  Shi</span>, <span class="hlFld-ContribAuthor ">Bai-Ling  Chen</span>, and <span class="hlFld-ContribAuthor ">Zili  Chen</span>  . </span><span class="cited-content_cbyCitation_article-title">N2-Selective Iodofunctionalization of Olefins with NH-1,2,3-Triazoles to provide N2-Alkyl-Substituted 1,2,3-Triazoles. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2016,</strong> <em>81 </em>
                                    (9)
                                     , 3568-3575. <a href="https://doi.org/10.1021/acs.joc.6b00185" title="DOI URL">https://doi.org/10.1021/acs.joc.6b00185</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.6b00185&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.6b00185%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DN2-Selective%252BIodofunctionalization%252Bof%252BOlefins%252Bwith%252BNH-1%25252C2%25252C3-Triazoles%252Bto%252Bprovide%252BN2-Alkyl-Substituted%252B1%25252C2%25252C3-Triazoles%26aulast%3DZhu%26aufirst%3DLi-Li%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D31012016%26date%3D08042016%26date%3D06052016%26date%3D31032016%26volume%3D81%26issue%3D9%26spage%3D3568%26epage%3D3575" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anthony J.  Roecker</span>, <span class="hlFld-ContribAuthor ">Christopher D.  Cox</span>, and <span class="hlFld-ContribAuthor ">Paul J.  Coleman</span>  . </span><span class="cited-content_cbyCitation_article-title">Orexin Receptor Antagonists: New Therapeutic Agents for the Treatment of Insomnia. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (2)
                                     , 504-530. <a href="https://doi.org/10.1021/acs.jmedchem.5b00832" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00832</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00832&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b00832%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOrexin%252BReceptor%252BAntagonists%25253A%252BNew%252BTherapeutic%252BAgents%252Bfor%252Bthe%252BTreatment%252Bof%252BInsomnia%26aulast%3DRoecker%26aufirst%3DAnthony%2BJ.%26date%3D2016%26date%3D2015%26date%3D2015%26date%3D30052015%26date%3D15092015%26date%3D28012016%26date%3D28082015%26volume%3D59%26issue%3D2%26spage%3D504%26epage%3D530" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor "> Debra J.    Wallace </span><span class="hlFld-ContribAuthor "> Ian    Mangion </span><span class="hlFld-ContribAuthor "> Paul    Coleman </span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and Chemical Development of Suvorexant - A Dual Orexin Antagonist for Sleep Disorder. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 1-36. <a href="https://doi.org/10.1021/bk-2016-1239.ch001" title="DOI URL">https://doi.org/10.1021/bk-2016-1239.ch001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/bk-2016-1239.ch001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fbk-2016-1239.ch001%26sid%3Dliteratum%253Aachs%26atitle%3DDiscovery%252Band%252BChemical%252BDevelopment%252Bof%252BSuvorexant%252B-%252BA%252BDual%252BOrexin%252BAntagonist%252Bfor%252BSleep%252BDisorder%26aulast%3DWallace%26aufirst%3DDebra%2BJ.%26date%3D2016%26date%3D2016%26spage%3D1%26epage%3D36%26atitle%3DComprehensive%252BAccounts%252Bof%252BPharmaceutical%252BResearch%252Band%252BDevelopment%25253A%252BFrom%252BDiscovery%252Bto%252BLate-Stage%252BProcess%252BDevelopment%252BVolume%252B1%26aulast%3DAbdel-Magid%26aufirst%3DAhmed%2BF.%26date%3D2016%26date%3D2016%26volume%3D1239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Takashi  Nagahara</span>, <span class="hlFld-ContribAuthor ">Tsuyoshi  Saitoh</span>, <span class="hlFld-ContribAuthor ">Noriki  Kutsumura</span>, <span class="hlFld-ContribAuthor ">Yoko  Irukayama-Tomobe</span>, <span class="hlFld-ContribAuthor ">Yasuhiro  Ogawa</span>, <span class="hlFld-ContribAuthor ">Daisuke  Kuroda</span>, <span class="hlFld-ContribAuthor ">Hiroaki  Gouda</span>, <span class="hlFld-ContribAuthor ">Hidetoshi  Kumagai</span>, <span class="hlFld-ContribAuthor ">Hideaki  Fujii</span>, <span class="hlFld-ContribAuthor ">Masashi  Yanagisawa</span>, and <span class="hlFld-ContribAuthor ">Hiroshi  Nagase</span>  . </span><span class="cited-content_cbyCitation_article-title">Design and Synthesis of Non-Peptide, Selective Orexin Receptor 2 Agonists. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (20)
                                     , 7931-7937. <a href="https://doi.org/10.1021/acs.jmedchem.5b00988" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00988</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00988&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b00988%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252BSynthesis%252Bof%252BNon-Peptide%25252C%252BSelective%252BOrexin%252BReceptor%252B2%252BAgonists%26aulast%3DNagahara%26aufirst%3DTakashi%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D25062015%26date%3D26082015%26date%3D22102015%26date%3D12082015%26volume%3D58%26issue%3D20%26spage%3D7931%26epage%3D7937" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael A.  Letavic</span>, <span class="hlFld-ContribAuthor ">Pascal  Bonaventure</span>, <span class="hlFld-ContribAuthor ">Nicholas I.  Carruthers</span>, <span class="hlFld-ContribAuthor ">Christine  Dugovic</span>, <span class="hlFld-ContribAuthor ">Tatiana  Koudriakova</span>, <span class="hlFld-ContribAuthor ">Brian  Lord</span>, <span class="hlFld-ContribAuthor ">Timothy W.  Lovenberg</span>, <span class="hlFld-ContribAuthor ">Kiev S.  Ly</span>, <span class="hlFld-ContribAuthor ">Neelakandha S.  Mani</span>, <span class="hlFld-ContribAuthor ">Diane  Nepomuceno</span>, <span class="hlFld-ContribAuthor ">Daniel J.  Pippel</span>, <span class="hlFld-ContribAuthor ">Michele  Rizzolio</span>, <span class="hlFld-ContribAuthor ">Jonathan E.  Shelton</span>, <span class="hlFld-ContribAuthor ">Chandra R.  Shah</span>, <span class="hlFld-ContribAuthor ">Brock T.  Shireman</span>, <span class="hlFld-ContribAuthor ">Lana K.  Young</span>, and <span class="hlFld-ContribAuthor ">Sujin  Yun</span>  . </span><span class="cited-content_cbyCitation_article-title">Novel Octahydropyrrolo[3,4-c]pyrroles Are Selective Orexin-2 Antagonists: SAR Leading to a Clinical Candidate. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (14)
                                     , 5620-5636. <a href="https://doi.org/10.1021/acs.jmedchem.5b00742" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00742</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00742&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b00742%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BOctahydropyrrolo%25255B3%25252C4-c%25255Dpyrroles%252BAre%252BSelective%252BOrexin-2%252BAntagonists%25253A%252BSAR%252BLeading%252Bto%252Ba%252BClinical%252BCandidate%26aulast%3DLetavic%26aufirst%3DMichael%2BA.%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D14052015%26date%3D08072015%26date%3D23072015%26date%3D18062015%26volume%3D58%26issue%3D14%26spage%3D5620%26epage%3D5636" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu  Yoshida</span>, <span class="hlFld-ContribAuthor ">Yoshimitsu  Naoe</span>, <span class="hlFld-ContribAuthor ">Taro  Terauchi</span>, <span class="hlFld-ContribAuthor ">Fumihiro  Ozaki</span>, <span class="hlFld-ContribAuthor ">Takashi  Doko</span>, <span class="hlFld-ContribAuthor ">Ayumi  Takemura</span>, <span class="hlFld-ContribAuthor ">Toshiaki  Tanaka</span>, <span class="hlFld-ContribAuthor ">Keiichi  Sorimachi</span>, <span class="hlFld-ContribAuthor ">Carsten T.  Beuckmann</span>, <span class="hlFld-ContribAuthor ">Michiyuki  Suzuki</span>, <span class="hlFld-ContribAuthor ">Takashi  Ueno</span>, <span class="hlFld-ContribAuthor ">Shunsuke  Ozaki</span>, and <span class="hlFld-ContribAuthor ">Masahiro  Yonaga</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of (1R,2S)-2-{[(2,4-Dimethylpyrimidin-5-yl)oxy]methyl}-2-(3-fluorophenyl)-N-(5-fluoropyridin-2-yl)cyclopropanecarboxamide (E2006): A Potent and Efficacious Oral Orexin Receptor Antagonist. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (11)
                                     , 4648-4664. <a href="https://doi.org/10.1021/acs.jmedchem.5b00217" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00217</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00217&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b00217%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B%2525281R%25252C2S%252529-2-%25257B%25255B%2525282%25252C4-Dimethylpyrimidin-5-yl%252529oxy%25255Dmethyl%25257D-2-%2525283-fluorophenyl%252529-N-%2525285-fluoropyridin-2-yl%252529cyclopropanecarboxamide%252B%252528E2006%252529%25253A%252BA%252BPotent%252Band%252BEfficacious%252BOral%252BOrexin%252BReceptor%252BAntagonist%26aulast%3DYoshida%26aufirst%3DYu%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D06022015%26date%3D22052015%26date%3D11062015%26date%3D08052015%26volume%3D58%26issue%3D11%26spage%3D4648%26epage%3D4664" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ananya  Srivastava</span>, <span class="hlFld-ContribAuthor ">Leena  Aggarwal</span>, and <span class="hlFld-ContribAuthor ">Nidhi  Jain</span>  . </span><span class="cited-content_cbyCitation_article-title">One-Pot Sequential Alkynylation and Cycloaddition: Regioselective Construction and Biological Evaluation of Novel BenzoxazoleâTriazole Derivatives. </span><span class="cited-content_cbyCitation_journal-name">ACS Combinatorial Science</span><span> <strong>2015,</strong> <em>17 </em>
                                    (1)
                                     , 39-48. <a href="https://doi.org/10.1021/co500135z" title="DOI URL">https://doi.org/10.1021/co500135z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/co500135z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fco500135z%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Combinatorial%2520Science%26atitle%3DOne-Pot%252BSequential%252BAlkynylation%252Band%252BCycloaddition%25253A%252BRegioselective%252BConstruction%252Band%252BBiological%252BEvaluation%252Bof%252BNovel%252BBenzoxazole%2525E2%252580%252593Triazole%252BDerivatives%26aulast%3DSrivastava%26aufirst%3DAnanya%26date%3D2015%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D28082014%26date%3D10112014%26date%3D02122014%26date%3D12012015%26date%3D14112014%26volume%3D17%26issue%3D1%26spage%3D39%26epage%3D48" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John Y. L.  Chung</span>, <span class="hlFld-ContribAuthor ">Yong-Li  Zhong</span>, <span class="hlFld-ContribAuthor ">Kevin M.  Maloney</span>, <span class="hlFld-ContribAuthor ">Robert A.  Reamer</span>, <span class="hlFld-ContribAuthor ">Jeffrey C.  Moore</span>, <span class="hlFld-ContribAuthor ">Hallena  Strotman</span>, <span class="hlFld-ContribAuthor ">Alexei  Kalinin</span>, <span class="hlFld-ContribAuthor ">Ronnie  Feng</span>, <span class="hlFld-ContribAuthor ">Neil A.  Strotman</span>, <span class="hlFld-ContribAuthor ">Bangping  Xiang</span>, and <span class="hlFld-ContribAuthor ">Nobuyoshi  Yasuda</span>  . </span><span class="cited-content_cbyCitation_article-title">Unusual Pyrimidine Participation: Efficient Stereoselective Synthesis of Potent Dual Orexin Receptor Antagonist MK-6096. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2014,</strong> <em>16 </em>
                                    (22)
                                     , 5890-5893. <a href="https://doi.org/10.1021/ol5028249" title="DOI URL">https://doi.org/10.1021/ol5028249</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ol5028249&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fol5028249%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DUnusual%252BPyrimidine%252BParticipation%25253A%252BEfficient%252BStereoselective%252BSynthesis%252Bof%252BPotent%252BDual%252BOrexin%252BReceptor%252BAntagonist%252BMK-6096%26aulast%3DChung%26aufirst%3DJohn%2BY.%2BL.%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D29092014%26date%3D03112014%26date%3D21112014%26volume%3D16%26issue%3D22%26spage%3D5890%26epage%3D5893" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexander  Heifetz</span>, <span class="hlFld-ContribAuthor ">Oliver  Barker</span>, <span class="hlFld-ContribAuthor ">G. Benjamin  Morris</span>, <span class="hlFld-ContribAuthor ">Richard J.  Law</span>, <span class="hlFld-ContribAuthor ">Mark  Slack</span>, and <span class="hlFld-ContribAuthor ">Philip C.  Biggin</span>  . </span><span class="cited-content_cbyCitation_article-title">Toward an Understanding of Agonist Binding to Human Orexin-1 and Orexin-2 Receptors with G-Protein-Coupled Receptor Modeling and Site-Directed Mutagenesis. </span><span class="cited-content_cbyCitation_journal-name">Biochemistry</span><span> <strong>2013,</strong> <em>52 </em>
                                    (46)
                                     , 8246-8260. <a href="https://doi.org/10.1021/bi401119m" title="DOI URL">https://doi.org/10.1021/bi401119m</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/bi401119m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fbi401119m%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemistry%26atitle%3DToward%252Ban%252BUnderstanding%252Bof%252BAgonist%252BBinding%252Bto%252BHuman%252BOrexin-1%252Band%252BOrexin-2%252BReceptors%252Bwith%252BG-Protein-Coupled%252BReceptor%252BModeling%252Band%252BSite-Directed%252BMutagenesis%26aulast%3DHeifetz%26aufirst%3DAlexander%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D16082013%26date%3D21102013%26date%3D08112013%26date%3D19112013%26date%3D21102013%26volume%3D52%26issue%3D46%26spage%3D8246%26epage%3D8260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Claudia  Betschart</span>, <span class="hlFld-ContribAuthor ">Samuel  Hintermann</span>, <span class="hlFld-ContribAuthor ">Dirk  Behnke</span>, <span class="hlFld-ContribAuthor ">Simona  Cotesta</span>, <span class="hlFld-ContribAuthor ">Markus  Fendt</span>, <span class="hlFld-ContribAuthor ">Christine E.  Gee</span>, <span class="hlFld-ContribAuthor ">Laura H.  Jacobson</span>, <span class="hlFld-ContribAuthor ">Grit  Laue</span>, <span class="hlFld-ContribAuthor ">Silvio  Ofner</span>, <span class="hlFld-ContribAuthor ">Vinod  Chaudhari</span>, <span class="hlFld-ContribAuthor ">Sangamesh  Badiger</span>, <span class="hlFld-ContribAuthor ">Chetan  Pandit</span>, <span class="hlFld-ContribAuthor ">Juergen  Wagner</span>, and <span class="hlFld-ContribAuthor ">Daniel  Hoyer</span>  . </span><span class="cited-content_cbyCitation_article-title">Identification of a Novel Series of Orexin Receptor Antagonists with a Distinct Effect on Sleep Architecture for the Treatment of Insomnia. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (19)
                                     , 7590-7607. <a href="https://doi.org/10.1021/jm4007627" title="DOI URL">https://doi.org/10.1021/jm4007627</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm4007627&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm4007627%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252Ba%252BNovel%252BSeries%252Bof%252BOrexin%252BReceptor%252BAntagonists%252Bwith%252Ba%252BDistinct%252BEffect%252Bon%252BSleep%252BArchitecture%252Bfor%252Bthe%252BTreatment%252Bof%252BInsomnia%26aulast%3DBetschart%26aufirst%3DClaudia%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D22052013%26date%3D18092013%26date%3D10102013%26date%3D21082013%26volume%3D56%26issue%3D19%26spage%3D7590%26epage%3D7607" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bifu  Liu</span>, <span class="hlFld-ContribAuthor ">Meizhou  Yin</span>, <span class="hlFld-ContribAuthor ">Hanling  Gao</span>, <span class="hlFld-ContribAuthor ">Wanqing  Wu</span>, and <span class="hlFld-ContribAuthor ">Huanfeng  Jiang</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis of 2-Aminobenzoxazoles and 3-Aminobenzoxazines via Palladium-Catalyzed Aerobic Oxidation of o-Aminophenols with Isocyanides. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2013,</strong> <em>78 </em>
                                    (7)
                                     , 3009-3020. <a href="https://doi.org/10.1021/jo400002f" title="DOI URL">https://doi.org/10.1021/jo400002f</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jo400002f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjo400002f%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252B2-Aminobenzoxazoles%252Band%252B3-Aminobenzoxazines%252Bvia%252BPalladium-Catalyzed%252BAerobic%252BOxidation%252Bof%252Bo-Aminophenols%252Bwith%252BIsocyanides%26aulast%3DLiu%26aufirst%3DBifu%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D01012013%26date%3D15032013%26date%3D05042013%26date%3D11032013%26volume%3D78%26issue%3D7%26spage%3D3009%26epage%3D3020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">MÃ©lina  Girardin</span>, <span class="hlFld-ContribAuthor ">StÃ©phane G.  Ouellet</span>, <span class="hlFld-ContribAuthor ">Danny  Gauvreau</span>, <span class="hlFld-ContribAuthor ">Jeffrey C.  Moore</span>, <span class="hlFld-ContribAuthor ">Greg  Hughes</span>, <span class="hlFld-ContribAuthor ">Paul N.  Devine</span>, <span class="hlFld-ContribAuthor ">Paul D.  OâShea</span>, and <span class="hlFld-ContribAuthor ">Louis-Charles  Campeau</span>  . </span><span class="cited-content_cbyCitation_article-title">Convergent Kilogram-Scale Synthesis of Dual Orexin Receptor Antagonist. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2013,</strong> <em>17 </em>
                                    (1)
                                     , 61-68. <a href="https://doi.org/10.1021/op3002678" title="DOI URL">https://doi.org/10.1021/op3002678</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/op3002678&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fop3002678%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DConvergent%252BKilogram-Scale%252BSynthesis%252Bof%252BDual%252BOrexin%252BReceptor%252BAntagonist%26aulast%3DGirardin%26aufirst%3DM%25C3%25A9lina%26date%3D2013%26date%3D2012%26date%3D2012%26date%3D23092012%26date%3D13122012%26date%3D18012013%26date%3D30112012%26volume%3D17%26issue%3D1%26spage%3D61%26epage%3D68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Corey R.  Hopkins</span>  . </span><span class="cited-content_cbyCitation_article-title">ACS Chemical Neuroscience Molecule Spotlight on Suvorexant. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2012,</strong> <em>3 </em>
                                    (9)
                                     , 647-648. <a href="https://doi.org/10.1021/cn300086a" title="DOI URL">https://doi.org/10.1021/cn300086a</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cn300086a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcn300086a%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DACS%252BChemical%252BNeuroscience%252BMolecule%252BSpotlight%252Bon%252BSuvorexant%26aulast%3DHopkins%26aufirst%3DCorey%2BR.%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D09072012%26date%3D09072012%26date%3D19092012%26volume%3D3%26issue%3D9%26spage%3D647%26epage%3D648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ian K.  Mangion</span>, <span class="hlFld-ContribAuthor ">Benjamin D.  Sherry</span>, <span class="hlFld-ContribAuthor ">Jingjun  Yin</span>, and <span class="hlFld-ContribAuthor ">Fred J.  Fleitz</span>  . </span><span class="cited-content_cbyCitation_article-title">Enantioselective Synthesis of a Dual Orexin Receptor Antagonist. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2012,</strong> <em>14 </em>
                                    (13)
                                     , 3458-3461. <a href="https://doi.org/10.1021/ol3014123" title="DOI URL">https://doi.org/10.1021/ol3014123</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ol3014123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fol3014123%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DEnantioselective%252BSynthesis%252Bof%252Ba%252BDual%252BOrexin%252BReceptor%252BAntagonist%26aulast%3DMangion%26aufirst%3DIan%2BK.%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D22052012%26date%3D22062012%26date%3D06072012%26volume%3D14%26issue%3D13%26spage%3D3458%26epage%3D3461" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Murali Mohan  Guru</span> and <span class="hlFld-ContribAuthor ">Tharmalingam  Punniyamurthy</span>  . </span><span class="cited-content_cbyCitation_article-title">Copper(II)-Catalyzed Aerobic Oxidative Synthesis of Substituted 1,2,3- and 1,2,4-Triazoles from Bisarylhydrazones via CâH Functionalization/CâC/NâN/CâN Bonds Formation. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2012,</strong> <em>77 </em>
                                    (11)
                                     , 5063-5073. <a href="https://doi.org/10.1021/jo300592t" title="DOI URL">https://doi.org/10.1021/jo300592t</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jo300592t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjo300592t%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DCopper%252528II%252529-Catalyzed%252BAerobic%252BOxidative%252BSynthesis%252Bof%252BSubstituted%252B1%25252C2%25252C3-%252Band%252B1%25252C2%25252C4-Triazoles%252Bfrom%252BBisarylhydrazones%252Bvia%252BC%2525E2%252580%252593H%252BFunctionalization%25252FC%2525E2%252580%252593C%25252FN%2525E2%252580%252593N%25252FC%2525E2%252580%252593N%252BBonds%252BFormation%26aulast%3DGuru%26aufirst%3DMurali%2BMohan%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D21032012%26date%3D11052012%26date%3D01062012%26date%3D09052012%26volume%3D77%26issue%3D11%26spage%3D5063%26epage%3D5073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Neil A.  Strotman</span>, <span class="hlFld-ContribAuthor ">Carl A.  Baxter</span>, <span class="hlFld-ContribAuthor ">Karel M. J.  Brands</span>, <span class="hlFld-ContribAuthor ">Ed  Cleator</span>, <span class="hlFld-ContribAuthor ">Shane W.  Krska</span>, <span class="hlFld-ContribAuthor ">Robert A.  Reamer</span>, <span class="hlFld-ContribAuthor ">Debra J.  Wallace</span>, and <span class="hlFld-ContribAuthor ">Timothy J.  Wright</span>  . </span><span class="cited-content_cbyCitation_article-title">Reaction Development and Mechanistic Study of a Ruthenium Catalyzed Intramolecular Asymmetric Reductive Amination en Route to the Dual Orexin Inhibitor Suvorexant (MK-4305). </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2011,</strong> <em>133 </em>
                                    (21)
                                     , 8362-8371. <a href="https://doi.org/10.1021/ja202358f" title="DOI URL">https://doi.org/10.1021/ja202358f</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ja202358f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fja202358f%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DReaction%252BDevelopment%252Band%252BMechanistic%252BStudy%252Bof%252Ba%252BRuthenium%252BCatalyzed%252BIntramolecular%252BAsymmetric%252BReductive%252BAmination%252Ben%252BRoute%252Bto%252Bthe%252BDual%252BOrexin%252BInhibitor%252BSuvorexant%252B%252528MK-4305%252529%26aulast%3DStrotman%26aufirst%3DNeil%2BA.%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D15032011%26date%3D11052011%26date%3D01062011%26date%3D02052011%26volume%3D133%26issue%3D21%26spage%3D8362%26epage%3D8371" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Carl A.  Baxter</span>, <span class="hlFld-ContribAuthor ">Ed  Cleator</span>, <span class="hlFld-ContribAuthor ">Karel M. J.  Brands</span>, <span class="hlFld-ContribAuthor ">John S.  Edwards</span>, <span class="hlFld-ContribAuthor ">Robert A.  Reamer</span>, <span class="hlFld-ContribAuthor ">Faye J.  Sheen</span>, <span class="hlFld-ContribAuthor ">Gavin W.  Stewart</span>, <span class="hlFld-ContribAuthor ">Neil A.  Strotman</span>, and <span class="hlFld-ContribAuthor ">Debra J.  Wallace</span>  . </span><span class="cited-content_cbyCitation_article-title">The First Large-Scale Synthesis of MK-4305: A Dual Orexin Receptor Antagonist for the Treatment of Sleep Disorder. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2011,</strong> <em>15 </em>
                                    (2)
                                     , 367-375. <a href="https://doi.org/10.1021/op1002853" title="DOI URL">https://doi.org/10.1021/op1002853</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/op1002853&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fop1002853%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DThe%252BFirst%252BLarge-Scale%252BSynthesis%252Bof%252BMK-4305%25253A%252BA%252BDual%252BOrexin%252BReceptor%252BAntagonist%252Bfor%252Bthe%252BTreatment%252Bof%252BSleep%252BDisorder%26aulast%3DBaxter%26aufirst%3DCarl%2BA.%26date%3D2011%26date%3D2011%26date%3D2010%26date%3D25102010%26date%3D04032011%26date%3D18032011%26volume%3D15%26issue%3D2%26spage%3D367%26epage%3D375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christopher L.  Cioffi</span>, <span class="hlFld-ContribAuthor ">John J.  Lansing</span>, and <span class="hlFld-ContribAuthor ">Hamza  YÃ¼ksel</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 2-Aminobenzoxazoles Using Tetramethyl Orthocarbonate or 1,1-Dichlorodiphenoxymethane. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2010,</strong> <em>75 </em>
                                    (22)
                                     , 7942-7945. <a href="https://doi.org/10.1021/jo1017052" title="DOI URL">https://doi.org/10.1021/jo1017052</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jo1017052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjo1017052%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252B2-Aminobenzoxazoles%252BUsing%252BTetramethyl%252BOrthocarbonate%252Bor%252B1%25252C1-Dichlorodiphenoxymethane%26aulast%3DCioffi%26aufirst%3DChristopher%2BL.%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D30082010%26date%3D25102010%26date%3D19112010%26volume%3D75%26issue%3D22%26spage%3D7942%26epage%3D7945" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rosa Maria  Vitale</span>, <span class="hlFld-ContribAuthor ">Fabio Arturo  Iannotti</span>, <span class="hlFld-ContribAuthor ">Aniello  Schiano Moriello</span>, <span class="hlFld-ContribAuthor ">Lea  Tunisi</span>, <span class="hlFld-ContribAuthor ">Fabiana  Piscitelli</span>, <span class="hlFld-ContribAuthor ">Ranjev  Savopoulos</span>, <span class="hlFld-ContribAuthor ">Luigia  Cristino</span>, <span class="hlFld-ContribAuthor ">Luciano  De Petrocellis</span>, <span class="hlFld-ContribAuthor ">Pietro  Amodeo</span>, <span class="hlFld-ContribAuthor ">Roy  Gray</span>, <span class="hlFld-ContribAuthor ">Vincenzo  Di Marzo</span>. </span><span class="cited-content_cbyCitation_article-title">Identification and Characterization of Cannabidiol as an OX1R Antagonist by Computational and In Vitro Functional Validation. </span><span class="cited-content_cbyCitation_journal-name">Biomolecules</span><span> <strong>2021,</strong> <em>11 </em>
                                    (8)
                                     , 1134. <a href="https://doi.org/10.3390/biom11081134" title="DOI URL">https://doi.org/10.3390/biom11081134</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biom11081134&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiom11081134%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomolecules%26atitle%3DIdentification%252Band%252BCharacterization%252Bof%252BCannabidiol%252Bas%252Ban%252BOX1R%252BAntagonist%252Bby%252BComputational%252Band%252BIn%252BVitro%252BFunctional%252BValidation%26aulast%3DVitale%26aufirst%3DRosa%2BMaria%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D8%26spage%3D1134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jacqueline B.  Mehr</span>, <span class="hlFld-ContribAuthor ">Deborah  Mitchison</span>, <span class="hlFld-ContribAuthor ">Hannah E.  Bowrey</span>, <span class="hlFld-ContribAuthor ">Morgan H.  James</span>. </span><span class="cited-content_cbyCitation_article-title">Sleep dysregulation in binge eating disorder and âfood addictionâ: the orexin (hypocretin) system as a potential neurobiological link. </span><span class="cited-content_cbyCitation_journal-name">Neuropsychopharmacology</span><span> <strong>2021,</strong> <em>1411 </em><a href="https://doi.org/10.1038/s41386-021-01052-z" title="DOI URL">https://doi.org/10.1038/s41386-021-01052-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41386-021-01052-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41386-021-01052-z%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropsychopharmacology%26atitle%3DSleep%252Bdysregulation%252Bin%252Bbinge%252Beating%252Bdisorder%252Band%252B%2525E2%252580%25259Cfood%252Baddiction%2525E2%252580%25259D%25253A%252Bthe%252Borexin%252B%252528hypocretin%252529%252Bsystem%252Bas%252Ba%252Bpotential%252Bneurobiological%252Blink%26aulast%3DMehr%26aufirst%3DJacqueline%2BB.%26date%3D2021%26date%3D2021%26volume%3D1411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hannah B.  Elam</span>, <span class="hlFld-ContribAuthor ">Stephanie M.  Perez</span>, <span class="hlFld-ContribAuthor ">Jennifer J.  Donegan</span>, <span class="hlFld-ContribAuthor ">Daniel J.  Lodge</span>. </span><span class="cited-content_cbyCitation_article-title">Orexin receptor antagonists reverse aberrant dopamine neuron activity and related behaviors in a rodent model of stress-induced psychosis. </span><span class="cited-content_cbyCitation_journal-name">Translational Psychiatry</span><span> <strong>2021,</strong> <em>11 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41398-021-01235-8" title="DOI URL">https://doi.org/10.1038/s41398-021-01235-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41398-021-01235-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41398-021-01235-8%26sid%3Dliteratum%253Aachs%26jtitle%3DTranslational%2520Psychiatry%26atitle%3DOrexin%252Breceptor%252Bantagonists%252Breverse%252Baberrant%252Bdopamine%252Bneuron%252Bactivity%252Band%252Brelated%252Bbehaviors%252Bin%252Ba%252Brodent%252Bmodel%252Bof%252Bstress-induced%252Bpsychosis%26aulast%3DElam%26aufirst%3DHannah%2BB.%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xunlei  Lv</span>, <span class="hlFld-ContribAuthor ">Jing  Pan</span>, <span class="hlFld-ContribAuthor ">Weiyuan  Liu</span>, <span class="hlFld-ContribAuthor ">Xue  Meng</span>, <span class="hlFld-ContribAuthor ">Liang  Chen</span>, <span class="hlFld-ContribAuthor ">Ting  Zhou</span>, <span class="hlFld-ContribAuthor ">Kuaile  Lin</span>, <span class="hlFld-ContribAuthor ">Deyong  Ye</span>, <span class="hlFld-ContribAuthor ">Weicheng  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Identification, synthesis and strategy for minimization of potential impurities in the synthesis of suvorexant. </span><span class="cited-content_cbyCitation_journal-name">Synthetic Communications</span><span> <strong>2021,</strong> <em> </em>, 1-12. <a href="https://doi.org/10.1080/00397911.2021.1930055" title="DOI URL">https://doi.org/10.1080/00397911.2021.1930055</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/00397911.2021.1930055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F00397911.2021.1930055%26sid%3Dliteratum%253Aachs%26jtitle%3DSynthetic%2520Communications%26atitle%3DIdentification%25252C%252Bsynthesis%252Band%252Bstrategy%252Bfor%252Bminimization%252Bof%252Bpotential%252Bimpurities%252Bin%252Bthe%252Bsynthesis%252Bof%252Bsuvorexant%26aulast%3DLv%26aufirst%3DXunlei%26date%3D2021%26date%3D2021%26spage%3D1%26epage%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jeffrey L.  Barr</span>, <span class="hlFld-ContribAuthor ">Pingwei  Zhao</span>, <span class="hlFld-ContribAuthor ">G. Cristina  Brailoiu</span>, <span class="hlFld-ContribAuthor ">Eugen  Brailoiu</span>. </span><span class="cited-content_cbyCitation_article-title">Choline-Sigma-1R as an Additional Mechanism for Potentiation of Orexin by Cocaine. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2021,</strong> <em>22 </em>
                                    (10)
                                     , 5160. <a href="https://doi.org/10.3390/ijms22105160" title="DOI URL">https://doi.org/10.3390/ijms22105160</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms22105160&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms22105160%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DCholine-Sigma-1R%252Bas%252Ban%252BAdditional%252BMechanism%252Bfor%252BPotentiation%252Bof%252BOrexin%252Bby%252BCocaine%26aulast%3DBarr%26aufirst%3DJeffrey%2BL.%26date%3D2021%26date%3D2021%26volume%3D22%26issue%3D10%26spage%3D5160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xumu  Zhang</span>, <span class="hlFld-ContribAuthor ">PanâLin  Shao</span>. </span><span class="cited-content_cbyCitation_article-title">Industrial Applications of Asymmetric (Transfer) Hydrogenation. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 175-219. <a href="https://doi.org/10.1002/9783527822294.ch6" title="DOI URL">https://doi.org/10.1002/9783527822294.ch6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527822294.ch6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527822294.ch6%26sid%3Dliteratum%253Aachs%26atitle%3DIndustrial%252BApplications%252Bof%252BAsymmetric%252B%252528Transfer%252529%252BHydrogenation%26aulast%3DZhang%26aufirst%3DXumu%26date%3D2021%26date%3D2021%26spage%3D175%26epage%3D219%26pub%3DWiley%26atitle%3DAsymmetric%252BHydrogenation%252Band%252BTransfer%252BHydrogenation%26aulast%3DRatovelomanana%25E2%2580%2590Vidal%26aufirst%3DVirginie%26date%3D2021%26date%3D2021%26volume%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David P.  Rotella</span>. </span><span class="cited-content_cbyCitation_article-title">Drug Discovery in Erectile Dysfunction and Sleep Disorders. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 1-19. <a href="https://doi.org/10.1002/0471266949.bmc200.pub2" title="DOI URL">https://doi.org/10.1002/0471266949.bmc200.pub2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471266949.bmc200.pub2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471266949.bmc200.pub2%26sid%3Dliteratum%253Aachs%26atitle%3DDrug%252BDiscovery%252Bin%252BErectile%252BDysfunction%252Band%252BSleep%252BDisorders%26aulast%3DRotella%26aufirst%3DDavid%2BP.%26date%3D2021%26date%3D2021%26spage%3D1%26epage%3D19%26pub%3DWiley%26atitle%3DBurger%252527s%252BMedicinal%252BChemistry%252Band%252BDrug%252BDiscovery%26aulast%3DAbraham%26aufirst%3DDonald%2BJ.%26date%3D2003%26date%3D2003%26volume%3D56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tanay  Ghoshal</span>, <span class="hlFld-ContribAuthor ">Tarun M.  Patel</span>, <span class="hlFld-ContribAuthor ">Sharadsrikar  Kotturi</span>. </span><span class="cited-content_cbyCitation_article-title">A facile electrochemical synthesis of suvorexant. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2021,</strong> <em>70 </em>, 153014. <a href="https://doi.org/10.1016/j.tetlet.2021.153014" title="DOI URL">https://doi.org/10.1016/j.tetlet.2021.153014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2021.153014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2021.153014%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DA%252Bfacile%252Belectrochemical%252Bsynthesis%252Bof%252Bsuvorexant%26aulast%3DGhoshal%26aufirst%3DTanay%26date%3D2021%26volume%3D70%26spage%3D153014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mahesh K  Kaushik</span>, <span class="hlFld-ContribAuthor ">Kosuke  Aritake</span>, <span class="hlFld-ContribAuthor ">Yoan  Cherasse</span>, <span class="hlFld-ContribAuthor ">Aya  Imanishi</span>, <span class="hlFld-ContribAuthor ">Takashi  Kanbayashi</span>, <span class="hlFld-ContribAuthor ">Yoshihiro  Urade</span>, <span class="hlFld-ContribAuthor ">Masashi  Yanagisawa</span>. </span><span class="cited-content_cbyCitation_article-title">Induction of narcolepsy-like symptoms by orexin receptor antagonists in mice. </span><span class="cited-content_cbyCitation_journal-name">Sleep</span><span> <strong>2021,</strong> <em>98 </em><a href="https://doi.org/10.1093/sleep/zsab043" title="DOI URL">https://doi.org/10.1093/sleep/zsab043</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/sleep/zsab043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fsleep%2Fzsab043%26sid%3Dliteratum%253Aachs%26jtitle%3DSleep%26atitle%3DInduction%252Bof%252Bnarcolepsy-like%252Bsymptoms%252Bby%252Borexin%252Breceptor%252Bantagonists%252Bin%252Bmice%26aulast%3DKaushik%26aufirst%3DMahesh%2BK%26date%3D2021%26date%3D2021%26volume%3D98" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Benjamin E.  Blass</span>. </span><span class="cited-content_cbyCitation_article-title">Translational medicine and biomarkers. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 523-560. <a href="https://doi.org/10.1016/B978-0-12-817214-8.00011-7" title="DOI URL">https://doi.org/10.1016/B978-0-12-817214-8.00011-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-817214-8.00011-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-817214-8.00011-7%26sid%3Dliteratum%253Aachs%26atitle%3DTranslational%252Bmedicine%252Band%252Bbiomarkers%26aulast%3DBlass%26aufirst%3DBenjamin%2BE.%26date%3D2021%26spage%3D523%26epage%3D560%26pub%3DElsevier%26atitle%3DBasic%252BPrinciples%252Bof%252BDrug%252BDiscovery%252Band%252BDevelopment%26date%3D2021%26volume%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Han  Luo</span>, <span class="hlFld-ContribAuthor ">Zongyuan  Tang</span>, <span class="hlFld-ContribAuthor ">Tao  Wang</span>, <span class="hlFld-ContribAuthor ">Yi  Tian</span>, <span class="hlFld-ContribAuthor ">Yuan  Zhang</span>, <span class="hlFld-ContribAuthor ">You  Li</span>, <span class="hlFld-ContribAuthor ">Shanshan  Li</span>, <span class="hlFld-ContribAuthor ">Yiliang  Gong</span>, <span class="hlFld-ContribAuthor ">Baosheng  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Regioselective
              N
              1
              - and
              N
              2
              -heterocycloalkylation of
              N
              1
              -sulfonyl-1,2,3-triazoles. </span><span class="cited-content_cbyCitation_journal-name">Organic Chemistry Frontiers</span><span> <strong>2020,</strong> <em>7 </em>
                                    (22)
                                     , 3727-3733. <a href="https://doi.org/10.1039/D0QO01111H" title="DOI URL">https://doi.org/10.1039/D0QO01111H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0QO01111H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0QO01111H%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Chemistry%2520Frontiers%26atitle%3DRegioselective%252BN%252B1%252B-%252Band%252BN%252B2%252B-heterocycloalkylation%252Bof%252BN%252B1%252B-sulfonyl-1%25252C2%25252C3-triazoles%26aulast%3DLuo%26aufirst%3DHan%26date%3D2020%26date%3D2020%26volume%3D7%26issue%3D22%26spage%3D3727%26epage%3D3733" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Clemens  Muehlan</span>, <span class="hlFld-ContribAuthor ">Cedric  Vaillant</span>, <span class="hlFld-ContribAuthor ">Isabelle  Zenklusen</span>, <span class="hlFld-ContribAuthor ">Stephan  Kraehenbuehl</span>, <span class="hlFld-ContribAuthor ">Jasper  Dingemanse</span>. </span><span class="cited-content_cbyCitation_article-title">Clinical pharmacology, efficacy, and safety of orexin receptor antagonists for the treatment of insomnia disorders. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Metabolism & Toxicology</span><span> <strong>2020,</strong> <em>16 </em>
                                    (11)
                                     , 1063-1078. <a href="https://doi.org/10.1080/17425255.2020.1817380" title="DOI URL">https://doi.org/10.1080/17425255.2020.1817380</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17425255.2020.1817380&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17425255.2020.1817380%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Metabolism%2520%2526%2520Toxicology%26atitle%3DClinical%252Bpharmacology%25252C%252Befficacy%25252C%252Band%252Bsafety%252Bof%252Borexin%252Breceptor%252Bantagonists%252Bfor%252Bthe%252Btreatment%252Bof%252Binsomnia%252Bdisorders%26aulast%3DMuehlan%26aufirst%3DClemens%26date%3D2020%26date%3D2020%26volume%3D16%26issue%3D11%26spage%3D1063%26epage%3D1078" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jinli  Zhang</span>, <span class="hlFld-ContribAuthor ">Ling  Chen</span>, <span class="hlFld-ContribAuthor ">Yibo  Dong</span>, <span class="hlFld-ContribAuthor ">Jinchen  Yang</span>, <span class="hlFld-ContribAuthor ">Yangjie  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">A Cu
              2
              O/TBAB-promoted approach to synthesize heteroaromatic 2-amines
              via
              one-pot cyclization of aryl isothiocyanates with
              ortho
              -substituted amines in water. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2020,</strong> <em>18 </em>
                                    (37)
                                     , 7425-7430. <a href="https://doi.org/10.1039/D0OB01431A" title="DOI URL">https://doi.org/10.1039/D0OB01431A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0OB01431A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0OB01431A%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DA%252BCu%252B2%252BO%25252FTBAB-promoted%252Bapproach%252Bto%252Bsynthesize%252Bheteroaromatic%252B2-amines%252Bvia%252Bone-pot%252Bcyclization%252Bof%252Baryl%252Bisothiocyanates%252Bwith%252Bortho%252B-substituted%252Bamines%252Bin%252Bwater%26aulast%3DZhang%26aufirst%3DJinli%26date%3D2020%26date%3D2020%26volume%3D18%26issue%3D37%26spage%3D7425%26epage%3D7430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bin  Guo</span>, <span class="hlFld-ContribAuthor ">Jingya  Xiu</span>, <span class="hlFld-ContribAuthor ">Yi  Shen</span>, <span class="hlFld-ContribAuthor ">Qingeng  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological activity evaluation of azacycloheptane sulfonamide derivatives as potential orexin receptor antagonists. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2020,</strong> <em>10 </em>
                                    (51)
                                     , 30683-30691. <a href="https://doi.org/10.1039/D0RA05068G" title="DOI URL">https://doi.org/10.1039/D0RA05068G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0RA05068G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0RA05068G%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DSynthesis%252Band%252Bbiological%252Bactivity%252Bevaluation%252Bof%252Bazacycloheptane%252Bsulfonamide%252Bderivatives%252Bas%252Bpotential%252Borexin%252Breceptor%252Bantagonists%26aulast%3DGuo%26aufirst%3DBin%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D51%26spage%3D30683%26epage%3D30691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aya  Futamura</span>, <span class="hlFld-ContribAuthor ">Ryo  Suzuki</span>, <span class="hlFld-ContribAuthor ">Yunoshin  Tamura</span>, <span class="hlFld-ContribAuthor ">Hiroshi  Kawamoto</span>, <span class="hlFld-ContribAuthor ">Mari  Ohmichi</span>, <span class="hlFld-ContribAuthor ">Noriko  Hino</span>, <span class="hlFld-ContribAuthor ">Yuichi  Tokumaru</span>, <span class="hlFld-ContribAuthor ">Sora  Kirinuki</span>, <span class="hlFld-ContribAuthor ">Tetsuaki  Hiyoshi</span>, <span class="hlFld-ContribAuthor ">Takeshi  Aoki</span>, <span class="hlFld-ContribAuthor ">Daiji  Kambe</span>, <span class="hlFld-ContribAuthor ">Dai  Nozawa</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of ORN0829, a potent dual orexin 1/2 receptor antagonist for the treatment of insomnia. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2020,</strong> <em>28 </em>
                                    (13)
                                     , 115489. <a href="https://doi.org/10.1016/j.bmc.2020.115489" title="DOI URL">https://doi.org/10.1016/j.bmc.2020.115489</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2020.115489&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2020.115489%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BORN0829%25252C%252Ba%252Bpotent%252Bdual%252Borexin%252B1%25252F2%252Breceptor%252Bantagonist%252Bfor%252Bthe%252Btreatment%252Bof%252Binsomnia%26aulast%3DFutamura%26aufirst%3DAya%26date%3D2020%26volume%3D28%26issue%3D13%26spage%3D115489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Britni  Skillman</span>, <span class="hlFld-ContribAuthor ">Sarah  Kerrigan</span>. </span><span class="cited-content_cbyCitation_article-title">CYP450-Mediated metabolism of suvorexant and investigation of metabolites in forensic case specimens. </span><span class="cited-content_cbyCitation_journal-name">Forensic Science International</span><span> <strong>2020,</strong> <em>312 </em>, 110307. <a href="https://doi.org/10.1016/j.forsciint.2020.110307" title="DOI URL">https://doi.org/10.1016/j.forsciint.2020.110307</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.forsciint.2020.110307&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.forsciint.2020.110307%26sid%3Dliteratum%253Aachs%26jtitle%3DForensic%2520Science%2520International%26atitle%3DCYP450-Mediated%252Bmetabolism%252Bof%252Bsuvorexant%252Band%252Binvestigation%252Bof%252Bmetabolites%252Bin%252Bforensic%252Bcase%252Bspecimens%26aulast%3DSkillman%26aufirst%3DBritni%26date%3D2020%26volume%3D312%26spage%3D110307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fang  Zhou</span>, <span class="hlFld-ContribAuthor ">Xu-Dong  Yan</span>, <span class="hlFld-ContribAuthor ">Chun  Wang</span>, <span class="hlFld-ContribAuthor ">Ye-Xin  He</span>, <span class="hlFld-ContribAuthor ">Yi-Ying  Li</span>, <span class="hlFld-ContribAuthor ">Jun  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhao-Jun  Wang</span>, <span class="hlFld-ContribAuthor ">Hong-Yan  Cai</span>, <span class="hlFld-ContribAuthor ">Jin-Shun  Qi</span>, <span class="hlFld-ContribAuthor ">Mei-Na  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Suvorexant ameliorates cognitive impairments and pathology in APP/PS1 transgenic mice. </span><span class="cited-content_cbyCitation_journal-name">Neurobiology of Aging</span><span> <strong>2020,</strong> <em>91 </em>, 66-75. <a href="https://doi.org/10.1016/j.neurobiolaging.2020.02.020" title="DOI URL">https://doi.org/10.1016/j.neurobiolaging.2020.02.020</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neurobiolaging.2020.02.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neurobiolaging.2020.02.020%26sid%3Dliteratum%253Aachs%26jtitle%3DNeurobiology%2520of%2520Aging%26atitle%3DSuvorexant%252Bameliorates%252Bcognitive%252Bimpairments%252Band%252Bpathology%252Bin%252BAPP%25252FPS1%252Btransgenic%252Bmice%26aulast%3DZhou%26aufirst%3DFang%26date%3D2020%26volume%3D91%26spage%3D66%26epage%3D75" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">. </span><span class="cited-content_cbyCitation_article-title">Drug Targets. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 1-96. <a href="https://doi.org/10.1002/9781119607311.ch1" title="DOI URL">https://doi.org/10.1002/9781119607311.ch1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781119607311.ch1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781119607311.ch1%26sid%3Dliteratum%253Aachs%26atitle%3DDrug%252BTargets%26date%3D2020%26date%3D2020%26spage%3D1%26epage%3D96%26pub%3DWiley%26atitle%3DMedicinal%252BChemistry%252Bfor%252BPractitioners%26aulast%3DLi%26aufirst%3DJie%2BJack%26date%3D2020%26date%3D2020%26volume%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shi-Bin  Li</span>, <span class="hlFld-ContribAuthor ">Luis  de Lecea</span>. </span><span class="cited-content_cbyCitation_article-title">The hypocretin (orexin) system: from a neural circuitry perspective. </span><span class="cited-content_cbyCitation_journal-name">Neuropharmacology</span><span> <strong>2020,</strong> <em>167 </em>, 107993. <a href="https://doi.org/10.1016/j.neuropharm.2020.107993" title="DOI URL">https://doi.org/10.1016/j.neuropharm.2020.107993</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuropharm.2020.107993&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuropharm.2020.107993%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropharmacology%26atitle%3DThe%252Bhypocretin%252B%252528orexin%252529%252Bsystem%25253A%252Bfrom%252Ba%252Bneural%252Bcircuitry%252Bperspective%26aulast%3DLi%26aufirst%3DShi-Bin%26date%3D2020%26volume%3D167%26spage%3D107993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Britni  Skillman</span>, <span class="hlFld-ContribAuthor ">Sarah  Kerrigan</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of Suvorexant in Blood Using LCâMS-MS: Important Considerations for Matrix Effects and Quantitative Interferences in Targeted Assays. </span><span class="cited-content_cbyCitation_journal-name">Journal of Analytical Toxicology</span><span> <strong>2020,</strong> <em>44 </em>
                                    (3)
                                     , 245-255. <a href="https://doi.org/10.1093/jat/bkz083" title="DOI URL">https://doi.org/10.1093/jat/bkz083</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/jat/bkz083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fjat%2Fbkz083%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Analytical%2520Toxicology%26atitle%3DIdentification%252Bof%252BSuvorexant%252Bin%252BBlood%252BUsing%252BLC%2525E2%252580%252593MS-MS%25253A%252BImportant%252BConsiderations%252Bfor%252BMatrix%252BEffects%252Band%252BQuantitative%252BInterferences%252Bin%252BTargeted%252BAssays%26aulast%3DSkillman%26aufirst%3DBritni%26date%3D2020%26date%3D2019%26volume%3D44%26issue%3D3%26spage%3D245%26epage%3D255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Morgan H.  James</span>, <span class="hlFld-ContribAuthor ">Jennifer E.  Fragale</span>, <span class="hlFld-ContribAuthor ">R. Nisha  Aurora</span>, <span class="hlFld-ContribAuthor ">Nina A.  Cooperman</span>, <span class="hlFld-ContribAuthor ">Daniel D.  Langleben</span>, <span class="hlFld-ContribAuthor ">Gary  Aston-Jones</span>. </span><span class="cited-content_cbyCitation_article-title">Repurposing the dual orexin receptor antagonist suvorexant for the treatment of opioid use disorder: why sleep on this any longer?. </span><span class="cited-content_cbyCitation_journal-name">Neuropsychopharmacology</span><span> <strong>2020,</strong> <em>45 </em>
                                    (5)
                                     , 717-719. <a href="https://doi.org/10.1038/s41386-020-0619-x" title="DOI URL">https://doi.org/10.1038/s41386-020-0619-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41386-020-0619-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41386-020-0619-x%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropsychopharmacology%26atitle%3DRepurposing%252Bthe%252Bdual%252Borexin%252Breceptor%252Bantagonist%252Bsuvorexant%252Bfor%252Bthe%252Btreatment%252Bof%252Bopioid%252Buse%252Bdisorder%25253A%252Bwhy%252Bsleep%252Bon%252Bthis%252Bany%252Blonger%25253F%26aulast%3DJames%26aufirst%3DMorgan%2BH.%26date%3D2020%26date%3D2020%26volume%3D45%26issue%3D5%26spage%3D717%26epage%3D719" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lauren  Lesiak</span>, <span class="hlFld-ContribAuthor ">Xinqi  Zhou</span>, <span class="hlFld-ContribAuthor ">Yuan  Fang</span>, <span class="hlFld-ContribAuthor ">Jia  Zhao</span>, <span class="hlFld-ContribAuthor ">Jon R.  Beck</span>, <span class="hlFld-ContribAuthor ">Cliff I.  Stains</span>. </span><span class="cited-content_cbyCitation_article-title">Imaging GPCR internalization using near-infrared Nebraska red-based reagents. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2020,</strong> <em>18 </em>
                                    (13)
                                     , 2459-2467. <a href="https://doi.org/10.1039/D0OB00043D" title="DOI URL">https://doi.org/10.1039/D0OB00043D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0OB00043D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0OB00043D%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DImaging%252BGPCR%252Binternalization%252Busing%252Bnear-infrared%252BNebraska%252Bred-based%252Breagents%26aulast%3DLesiak%26aufirst%3DLauren%26date%3D2020%26date%3D2020%26volume%3D18%26issue%3D13%26spage%3D2459%26epage%3D2467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christine  Brotschi</span>, <span class="hlFld-ContribAuthor ">Martin H.  Bolli</span>, <span class="hlFld-ContribAuthor ">John  Gatfield</span>, <span class="hlFld-ContribAuthor ">Bibia  Heidmann</span>, <span class="hlFld-ContribAuthor ">Francois  Jenck</span>, <span class="hlFld-ContribAuthor ">Catherine  Roch</span>, <span class="hlFld-ContribAuthor ">Thierry  Sifferlen</span>, <span class="hlFld-ContribAuthor ">Alexander  Treiber</span>, <span class="hlFld-ContribAuthor ">Jodi T.  Williams</span>, <span class="hlFld-ContribAuthor ">Christoph  Boss</span>. </span><span class="cited-content_cbyCitation_article-title">From Oxadiazole to Triazole Analogues: Optimization toward a Dual Orexin Receptor Antagonist with Improved inâvivo Efficacy in Dogs. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2020,</strong> <em>15 </em>
                                    (5)
                                     , 430-448. <a href="https://doi.org/10.1002/cmdc.201900618" title="DOI URL">https://doi.org/10.1002/cmdc.201900618</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201900618&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201900618%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DFrom%252BOxadiazole%252Bto%252BTriazole%252BAnalogues%25253A%252BOptimization%252Btoward%252Ba%252BDual%252BOrexin%252BReceptor%252BAntagonist%252Bwith%252BImproved%252Bin%2525E2%252580%252585vivo%252BEfficacy%252Bin%252BDogs%26aulast%3DBrotschi%26aufirst%3DChristine%26date%3D2020%26date%3D2020%26volume%3D15%26issue%3D5%26spage%3D430%26epage%3D448" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">W. Joseph  Herring</span>, <span class="hlFld-ContribAuthor ">Paulette  Ceesay</span>, <span class="hlFld-ContribAuthor ">Ellen  Snyder</span>, <span class="hlFld-ContribAuthor ">Donald  Bliwise</span>, <span class="hlFld-ContribAuthor ">Kerry  Budd</span>, <span class="hlFld-ContribAuthor ">Jill  Hutzelmann</span>, <span class="hlFld-ContribAuthor ">Joanne  Stevens</span>, <span class="hlFld-ContribAuthor ">Christopher  Lines</span>, <span class="hlFld-ContribAuthor ">David  Michelson</span>. </span><span class="cited-content_cbyCitation_article-title">Polysomnographic assessment of suvorexant in patients with probable Alzheimer's disease dementia and insomnia: a randomized trial. </span><span class="cited-content_cbyCitation_journal-name">Alzheimer's & Dementia</span><span> <strong>2020,</strong> <em>16 </em>
                                    (3)
                                     , 541-551. <a href="https://doi.org/10.1002/alz.12035" title="DOI URL">https://doi.org/10.1002/alz.12035</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/alz.12035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Falz.12035%26sid%3Dliteratum%253Aachs%26jtitle%3DAlzheimer%2527s%2520%2526%2520Dementia%26atitle%3DPolysomnographic%252Bassessment%252Bof%252Bsuvorexant%252Bin%252Bpatients%252Bwith%252Bprobable%252BAlzheimer%252527s%252Bdisease%252Bdementia%252Band%252Binsomnia%25253A%252Ba%252Brandomized%252Btrial%26aulast%3DHerring%26aufirst%3DW.%2BJoseph%26date%3D2020%26date%3D2020%26volume%3D16%26issue%3D3%26spage%3D541%26epage%3D551" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Steven J.  Simmons</span>, <span class="hlFld-ContribAuthor ">Taylor A.  Gentile</span>. </span><span class="cited-content_cbyCitation_article-title">Cocaine abuse and midbrain circuits: Functional anatomy of hypocretin/orexin transmission and therapeutic prospect. </span><span class="cited-content_cbyCitation_journal-name">Brain Research</span><span> <strong>2020,</strong> <em>1731 </em>, 146164. <a href="https://doi.org/10.1016/j.brainres.2019.02.026" title="DOI URL">https://doi.org/10.1016/j.brainres.2019.02.026</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.brainres.2019.02.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.brainres.2019.02.026%26sid%3Dliteratum%253Aachs%26jtitle%3DBrain%2520Research%26atitle%3DCocaine%252Babuse%252Band%252Bmidbrain%252Bcircuits%25253A%252BFunctional%252Banatomy%252Bof%252Bhypocretin%25252Forexin%252Btransmission%252Band%252Btherapeutic%252Bprospect%26aulast%3DSimmons%26aufirst%3DSteven%2BJ.%26date%3D2020%26volume%3D1731%26spage%3D146164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cheng-yi  Chen</span>, <span class="hlFld-ContribAuthor ">Xiaowei  Lu</span>, <span class="hlFld-ContribAuthor ">Mareike C.  Holland</span>, <span class="hlFld-ContribAuthor ">Shichang  Lv</span>, <span class="hlFld-ContribAuthor ">Xuebao  Ji</span>, <span class="hlFld-ContribAuthor ">Wei  Liu</span>, <span class="hlFld-ContribAuthor ">Jie  Liu</span>, <span class="hlFld-ContribAuthor ">Dominique  Depre</span>, <span class="hlFld-ContribAuthor ">Pieter  Westerduin</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 2-Substituted 1,2,3-Triazoles via an Intramolecular
              N
              -
              N
              Bond Formation. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>2020 </em>
                                    (5)
                                     , 548-551. <a href="https://doi.org/10.1002/ejoc.201901519" title="DOI URL">https://doi.org/10.1002/ejoc.201901519</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201901519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201901519%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252B2-Substituted%252B1%25252C2%25252C3-Triazoles%252Bvia%252Ban%252BIntramolecular%252BN%252B-%252BN%252BBond%252BFormation%26aulast%3DChen%26aufirst%3DCheng-yi%26date%3D2020%26date%3D2019%26volume%3D2020%26issue%3D5%26spage%3D548%26epage%3D551" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel  Hoyer</span>, <span class="hlFld-ContribAuthor ">Andrew  Allen</span>, <span class="hlFld-ContribAuthor ">Laura H.  Jacobson</span>. </span><span class="cited-content_cbyCitation_article-title">Hypnotics with novel modes of action. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Clinical Pharmacology</span><span> <strong>2020,</strong> <em>86 </em>
                                    (2)
                                     , 244-249. <a href="https://doi.org/10.1111/bcp.14180" title="DOI URL">https://doi.org/10.1111/bcp.14180</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/bcp.14180&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fbcp.14180%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Clinical%2520Pharmacology%26atitle%3DHypnotics%252Bwith%252Bnovel%252Bmodes%252Bof%252Baction%26aulast%3DHoyer%26aufirst%3DDaniel%26date%3D2020%26date%3D2020%26volume%3D86%26issue%3D2%26spage%3D244%26epage%3D249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nabil A.  Nimer</span>, <span class="hlFld-ContribAuthor ">Najlaa S.  Ismael</span>, <span class="hlFld-ContribAuthor ">Ruwaida W.  Abdo</span>, <span class="hlFld-ContribAuthor ">Sura Y.  Taha Alkhammas</span>, <span class="hlFld-ContribAuthor ">Qutaiba A.  Alkhames Aga</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacology of Neuropeptides: Substance P, Vasoactive Intestinal Peptides, Neuropeptide Y, Calcitonin Peptides and Their Receptors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 503-551. <a href="https://doi.org/10.1007/978-981-15-3556-7_15" title="DOI URL">https://doi.org/10.1007/978-981-15-3556-7_15</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-981-15-3556-7_15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-981-15-3556-7_15%26sid%3Dliteratum%253Aachs%26atitle%3DPharmacology%252Bof%252BNeuropeptides%25253A%252BSubstance%252BP%25252C%252BVasoactive%252BIntestinal%252BPeptides%25252C%252BNeuropeptide%252BY%25252C%252BCalcitonin%252BPeptides%252Band%252BTheir%252BReceptors%26aulast%3DNimer%26aufirst%3DNabil%2BA.%26date%3D2020%26date%3D2020%26spage%3D503%26epage%3D551%26pub%3DSpringer%2520Singapore%26atitle%3DFrontiers%252Bin%252BPharmacology%252Bof%252BNeurotransmitters%26aulast%3DKumar%26aufirst%3DPuneet%26date%3D2020%26volume%3D106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jaehoon  Seol</span>, <span class="hlFld-ContribAuthor ">Yuya  Fujii</span>, <span class="hlFld-ContribAuthor ">Insung  Park</span>, <span class="hlFld-ContribAuthor ">Yoko  Suzuki</span>, <span class="hlFld-ContribAuthor ">Fusae  Kawana</span>, <span class="hlFld-ContribAuthor ">Katsuhiko  Yajima</span>, <span class="hlFld-ContribAuthor ">Shoji  Fukusumi</span>, <span class="hlFld-ContribAuthor ">Tomohiro  Okura</span>, <span class="hlFld-ContribAuthor ">Makoto  Satoh</span>, <span class="hlFld-ContribAuthor ">Kumpei  Tokuyama</span>, <span class="hlFld-ContribAuthor ">Toshio  Kokubo</span>, <span class="hlFld-ContribAuthor ">Masashi  Yanagisawa</span>. </span><span class="cited-content_cbyCitation_article-title">Distinct effects of orexin receptor antagonist and GABA
              A
              agonist on sleep and physical/cognitive functions after forced awakening. </span><span class="cited-content_cbyCitation_journal-name">Proceedings of the National Academy of Sciences</span><span> <strong>2019,</strong> <em>116 </em>
                                    (48)
                                     , 24353-24358. <a href="https://doi.org/10.1073/pnas.1907354116" title="DOI URL">https://doi.org/10.1073/pnas.1907354116</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1073/pnas.1907354116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1073%2Fpnas.1907354116%26sid%3Dliteratum%253Aachs%26jtitle%3DProceedings%2520of%2520the%2520National%2520Academy%2520of%2520Sciences%26atitle%3DDistinct%252Beffects%252Bof%252Borexin%252Breceptor%252Bantagonist%252Band%252BGABA%252BA%252Bagonist%252Bon%252Bsleep%252Band%252Bphysical%25252Fcognitive%252Bfunctions%252Bafter%252Bforced%252Bawakening%26aulast%3DSeol%26aufirst%3DJaehoon%26date%3D2019%26date%3D2019%26volume%3D116%26issue%3D48%26spage%3D24353%26epage%3D24358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chuanle  Zhu</span>, <span class="hlFld-ContribAuthor ">Hao  Zeng</span>, <span class="hlFld-ContribAuthor ">Fulin  Chen</span>, <span class="hlFld-ContribAuthor ">Chi  Liu</span>, <span class="hlFld-ContribAuthor ">Huanfeng  Jiang</span>. </span><span class="cited-content_cbyCitation_article-title">CopperâCatalyzed Cyclization of Aryl Amines and Aryldiazonium Salts under Air: Access to
              N
              â2âArylâNaphthotriazoles. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2019,</strong> <em>361 </em>
                                    (22)
                                     , 5149-5159. <a href="https://doi.org/10.1002/adsc.201900981" title="DOI URL">https://doi.org/10.1002/adsc.201900981</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.201900981&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.201900981%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DCopper%2525E2%252580%252590Catalyzed%252BCyclization%252Bof%252BAryl%252BAmines%252Band%252BAryldiazonium%252BSalts%252Bunder%252BAir%25253A%252BAccess%252Bto%252BN%252B%2525E2%252580%2525902%2525E2%252580%252590Aryl%2525E2%252580%252590Naphthotriazoles%26aulast%3DZhu%26aufirst%3DChuanle%26date%3D2019%26date%3D2019%26volume%3D361%26issue%3D22%26spage%3D5149%26epage%3D5159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alain  Couvineau</span>, <span class="hlFld-ContribAuthor ">Thierry  Voisin</span>, <span class="hlFld-ContribAuthor ">Pascal  Nicole</span>, <span class="hlFld-ContribAuthor ">ValÃ©rie  Gratio</span>, <span class="hlFld-ContribAuthor ">Catalina  Abad</span>, <span class="hlFld-ContribAuthor ">Yossan-Var  Tan</span>. </span><span class="cited-content_cbyCitation_article-title">Orexins as Novel Therapeutic Targets in Inflammatory and Neurodegenerative Diseases. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Endocrinology</span><span> <strong>2019,</strong> <em>10 </em><a href="https://doi.org/10.3389/fendo.2019.00709" title="DOI URL">https://doi.org/10.3389/fendo.2019.00709</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fendo.2019.00709&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffendo.2019.00709%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Endocrinology%26atitle%3DOrexins%252Bas%252BNovel%252BTherapeutic%252BTargets%252Bin%252BInflammatory%252Band%252BNeurodegenerative%252BDiseases%26aulast%3DCouvineau%26aufirst%3DAlain%26date%3D2019%26date%3D2019%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nayyef  Aljaar</span>, <span class="hlFld-ContribAuthor ">Raghuram  Gujjarappa</span>, <span class="hlFld-ContribAuthor ">Mahmoud  AlâRefai</span>, <span class="hlFld-ContribAuthor ">Majed  Shtaiwi</span>, <span class="hlFld-ContribAuthor ">Chandi C.  Malakar</span>. </span><span class="cited-content_cbyCitation_article-title">Overview on Recent Approaches towards Synthesis of 2âKetoâannulated Oxazole Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Journal of Heterocyclic Chemistry</span><span> <strong>2019,</strong> <em>56 </em>
                                    (10)
                                     , 2730-2743. <a href="https://doi.org/10.1002/jhet.3673" title="DOI URL">https://doi.org/10.1002/jhet.3673</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jhet.3673&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjhet.3673%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Heterocyclic%2520Chemistry%26atitle%3DOverview%252Bon%252BRecent%252BApproaches%252Btowards%252BSynthesis%252Bof%252B2%2525E2%252580%252590Keto%2525E2%252580%252590annulated%252BOxazole%252BDerivatives%26aulast%3DAljaar%26aufirst%3DNayyef%26date%3D2019%26date%3D2019%26volume%3D56%26issue%3D10%26spage%3D2730%26epage%3D2743" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christine  Brotschi</span>, <span class="hlFld-ContribAuthor ">Catherine  Roch</span>, <span class="hlFld-ContribAuthor ">John  Gatfield</span>, <span class="hlFld-ContribAuthor ">Alexander  Treiber</span>, <span class="hlFld-ContribAuthor ">Jodi T.  Williams</span>, <span class="hlFld-ContribAuthor ">Thierry  Sifferlen</span>, <span class="hlFld-ContribAuthor ">Bibia  Heidmann</span>, <span class="hlFld-ContribAuthor ">Francois  Jenck</span>, <span class="hlFld-ContribAuthor ">Martin H.  Bolli</span>, <span class="hlFld-ContribAuthor ">Christoph  Boss</span>. </span><span class="cited-content_cbyCitation_article-title">Oxadiazole Derivatives as Dual Orexin Receptor Antagonists: Synthesis, StructureâActivity Relationships, and SleepâPromoting Properties in Rats. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2019,</strong> <em>14 </em>
                                    (13)
                                     , 1257-1270. <a href="https://doi.org/10.1002/cmdc.201900242" title="DOI URL">https://doi.org/10.1002/cmdc.201900242</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201900242&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201900242%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DOxadiazole%252BDerivatives%252Bas%252BDual%252BOrexin%252BReceptor%252BAntagonists%25253A%252BSynthesis%25252C%252BStructure%2525E2%252580%252593Activity%252BRelationships%25252C%252Band%252BSleep%2525E2%252580%252590Promoting%252BProperties%252Bin%252BRats%26aulast%3DBrotschi%26aufirst%3DChristine%26date%3D2019%26date%3D2019%26volume%3D14%26issue%3D13%26spage%3D1257%26epage%3D1270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aisha S.  Shariq</span>, <span class="hlFld-ContribAuthor ">Joshua D.  Rosenblat</span>, <span class="hlFld-ContribAuthor ">Asem  Alageel</span>, <span class="hlFld-ContribAuthor ">Rodrigo B.  Mansur</span>, <span class="hlFld-ContribAuthor ">Carola  Rong</span>, <span class="hlFld-ContribAuthor ">Roger C.  Ho</span>, <span class="hlFld-ContribAuthor ">Renee-Marie  Ragguett</span>, <span class="hlFld-ContribAuthor ">Zihang  Pan</span>, <span class="hlFld-ContribAuthor ">Elisa  Brietzke</span>, <span class="hlFld-ContribAuthor ">Roger S.  McIntyre</span>. </span><span class="cited-content_cbyCitation_article-title">Evaluating the role of orexins in the pathophysiology and treatment of depression: A comprehensive review. </span><span class="cited-content_cbyCitation_journal-name">Progress in Neuro-Psychopharmacology and Biological Psychiatry</span><span> <strong>2019,</strong> <em>92 </em>, 1-7. <a href="https://doi.org/10.1016/j.pnpbp.2018.12.008" title="DOI URL">https://doi.org/10.1016/j.pnpbp.2018.12.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pnpbp.2018.12.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pnpbp.2018.12.008%26sid%3Dliteratum%253Aachs%26jtitle%3DProgress%2520in%2520Neuro-Psychopharmacology%2520and%2520Biological%2520Psychiatry%26atitle%3DEvaluating%252Bthe%252Brole%252Bof%252Borexins%252Bin%252Bthe%252Bpathophysiology%252Band%252Btreatment%252Bof%252Bdepression%25253A%252BA%252Bcomprehensive%252Breview%26aulast%3DShariq%26aufirst%3DAisha%2BS.%26date%3D2019%26volume%3D92%26spage%3D1%26epage%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sangback  Lee</span>, <span class="hlFld-ContribAuthor ">Yunmi  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">Copper-Catalyzed Electrophilic Amination of Benzoxazoles via Magnesation. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>2019 </em>
                                    (19)
                                     , 3045-3050. <a href="https://doi.org/10.1002/ejoc.201900335" title="DOI URL">https://doi.org/10.1002/ejoc.201900335</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201900335&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201900335%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DCopper-Catalyzed%252BElectrophilic%252BAmination%252Bof%252BBenzoxazoles%252Bvia%252BMagnesation%26aulast%3DLee%26aufirst%3DSangback%26date%3D2019%26date%3D2019%26volume%3D2019%26issue%3D19%26spage%3D3045%26epage%3D3050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Naoshi  Yamamoto</span>, <span class="hlFld-ContribAuthor ">Sayaka  Ohrui</span>, <span class="hlFld-ContribAuthor ">Takahiro  Okada</span>, <span class="hlFld-ContribAuthor ">Tsuyoshi  Saitoh</span>, <span class="hlFld-ContribAuthor ">Noriki  Kutsumura</span>, <span class="hlFld-ContribAuthor ">Yasuyuki  Nagumo</span>, <span class="hlFld-ContribAuthor ">Yoko  Irukayama-Tomobe</span>, <span class="hlFld-ContribAuthor ">Yasuhiro  Ogawa</span>, <span class="hlFld-ContribAuthor ">Yukiko  Ishikawa</span>, <span class="hlFld-ContribAuthor ">Yurie  Watanabe</span>, <span class="hlFld-ContribAuthor ">Daichi  Hayakawa</span>, <span class="hlFld-ContribAuthor ">Hiroaki  Gouda</span>, <span class="hlFld-ContribAuthor ">Masashi  Yanagisawa</span>, <span class="hlFld-ContribAuthor ">Hiroshi  Nagase</span>. </span><span class="cited-content_cbyCitation_article-title">Essential structure of orexin 1 receptor antagonist YNT-707, part III: Role of the 14-hydroxy and the 3-methoxy groups in antagonistic activity toward the orexin 1 receptor in YNT-707 derivatives lacking the 4,5-epoxy ring. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2019,</strong> <em>27 </em>
                                    (8)
                                     , 1747-1758. <a href="https://doi.org/10.1016/j.bmc.2019.03.010" title="DOI URL">https://doi.org/10.1016/j.bmc.2019.03.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2019.03.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2019.03.010%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DEssential%252Bstructure%252Bof%252Borexin%252B1%252Breceptor%252Bantagonist%252BYNT-707%25252C%252Bpart%252BIII%25253A%252BRole%252Bof%252Bthe%252B14-hydroxy%252Band%252Bthe%252B3-methoxy%252Bgroups%252Bin%252Bantagonistic%252Bactivity%252Btoward%252Bthe%252Borexin%252B1%252Breceptor%252Bin%252BYNT-707%252Bderivatives%252Blacking%252Bthe%252B4%25252C5-epoxy%252Bring%26aulast%3DYamamoto%26aufirst%3DNaoshi%26date%3D2019%26volume%3D27%26issue%3D8%26spage%3D1747%26epage%3D1758" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Manuel  Sanchez-Alavez</span>, <span class="hlFld-ContribAuthor ">Jessica  Benedict</span>, <span class="hlFld-ContribAuthor ">Derek N  Wills</span>, <span class="hlFld-ContribAuthor ">Cindy L  Ehlers</span>. </span><span class="cited-content_cbyCitation_article-title">Effect of suvorexant on event-related oscillations and EEG sleep in rats exposed to chronic intermittent ethanol vapor and protracted withdrawal. </span><span class="cited-content_cbyCitation_journal-name">Sleep</span><span> <strong>2019,</strong> <em>42 </em>
                                    (4)
                                     <a href="https://doi.org/10.1093/sleep/zsz020" title="DOI URL">https://doi.org/10.1093/sleep/zsz020</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/sleep/zsz020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fsleep%2Fzsz020%26sid%3Dliteratum%253Aachs%26jtitle%3DSleep%26atitle%3DEffect%252Bof%252Bsuvorexant%252Bon%252Bevent-related%252Boscillations%252Band%252BEEG%252Bsleep%252Bin%252Brats%252Bexposed%252Bto%252Bchronic%252Bintermittent%252Bethanol%252Bvapor%252Band%252Bprotracted%252Bwithdrawal%26aulast%3DSanchez-Alavez%26aufirst%3DManuel%26date%3D2019%26date%3D2019%26volume%3D42%26issue%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">W. Joseph  Herring</span>, <span class="hlFld-ContribAuthor ">Thomas  Roth</span>, <span class="hlFld-ContribAuthor ">Andrew D.  Krystal</span>, <span class="hlFld-ContribAuthor ">David  Michelson</span>. </span><span class="cited-content_cbyCitation_article-title">Orexin receptor antagonists for the treatment of insomnia and potential treatment of other neuropsychiatric indications. </span><span class="cited-content_cbyCitation_journal-name">Journal of Sleep Research</span><span> <strong>2019,</strong> <em>28 </em>
                                    (2)
                                     <a href="https://doi.org/10.1111/jsr.12782" title="DOI URL">https://doi.org/10.1111/jsr.12782</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/jsr.12782&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fjsr.12782%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Sleep%2520Research%26atitle%3DOrexin%252Breceptor%252Bantagonists%252Bfor%252Bthe%252Btreatment%252Bof%252Binsomnia%252Band%252Bpotential%252Btreatment%252Bof%252Bother%252Bneuropsychiatric%252Bindications%26aulast%3DHerring%26aufirst%3DW.%2BJoseph%26date%3D2019%26date%3D2018%26volume%3D28%26issue%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrea  Lawson</span>, <span class="hlFld-ContribAuthor ">Roohie  Parmar</span>, <span class="hlFld-ContribAuthor ">Eileen P.  Sloan</span>. </span><span class="cited-content_cbyCitation_article-title">Sleep Disorders. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 341-376. <a href="https://doi.org/10.1007/978-3-319-92919-4_21" title="DOI URL">https://doi.org/10.1007/978-3-319-92919-4_21</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-319-92919-4_21&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-319-92919-4_21%26sid%3Dliteratum%253Aachs%26atitle%3DSleep%252BDisorders%26aulast%3DLawson%26aufirst%3DAndrea%26date%3D2019%26date%3D2019%26spage%3D341%26epage%3D376%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DPerinatal%252BPsychopharmacology%26aulast%3DUguz%26aufirst%3DFaruk%26date%3D2019%26volume%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">RODRIGO OCTÃVIO M.A. DE  SOUZA</span>, <span class="hlFld-ContribAuthor ">LEANDRO S. DE MARIZ E  MIRANDA</span>. </span><span class="cited-content_cbyCitation_article-title">Strategies Towards the Synthesis of N2-Substituted 1,2,3-Triazoles. </span><span class="cited-content_cbyCitation_journal-name">Anais da Academia Brasileira de CiÃªncias</span><span> <strong>2019,</strong> <em>91 </em>
                                    (suppl 1)
                                     <a href="https://doi.org/10.1590/0001-3765201820180751" title="DOI URL">https://doi.org/10.1590/0001-3765201820180751</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1590/0001-3765201820180751&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1590%2F0001-3765201820180751%26sid%3Dliteratum%253Aachs%26jtitle%3DAnais%2520da%2520Academia%2520Brasileira%2520de%2520Ci%25C3%25AAncias%26atitle%3DStrategies%252BTowards%252Bthe%252BSynthesis%252Bof%252BN2-Substituted%252B1%25252C2%25252C3-Triazoles%26aulast%3DSOUZA%26aufirst%3DRODRIGO%2BOCT%25C3%2581VIO%2BM.A.%2BDE%26date%3D2019%26date%3D2019%26volume%3D91%26issue%3Dsuppl%25201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Diego P  Sangi</span>, <span class="hlFld-ContribAuthor ">Yuri G  Meira</span>, <span class="hlFld-ContribAuthor ">NatÃ¡lia M  Moreira</span>, <span class="hlFld-ContribAuthor ">Thais A  Lopes</span>, <span class="hlFld-ContribAuthor ">Mathias P  Leite</span>, <span class="hlFld-ContribAuthor ">Milton E  PereiraâFlores</span>, <span class="hlFld-ContribAuthor ">Elson S  Alvarenga</span>. </span><span class="cited-content_cbyCitation_article-title">Benzoxazoles as novel herbicidal agents. </span><span class="cited-content_cbyCitation_journal-name">Pest Management Science</span><span> <strong>2019,</strong> <em>75 </em>
                                    (1)
                                     , 262-269. <a href="https://doi.org/10.1002/ps.5111" title="DOI URL">https://doi.org/10.1002/ps.5111</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ps.5111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fps.5111%26sid%3Dliteratum%253Aachs%26jtitle%3DPest%2520Management%2520Science%26atitle%3DBenzoxazoles%252Bas%252Bnovel%252Bherbicidal%252Bagents%26aulast%3DSangi%26aufirst%3DDiego%2BP%26date%3D2019%26date%3D2018%26volume%3D75%26issue%3D1%26spage%3D262%26epage%3D269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mustafa  Korkutata</span>, <span class="hlFld-ContribAuthor ">Tsuyoshi  Saitoh</span>, <span class="hlFld-ContribAuthor ">Yoan  Cherasse</span>, <span class="hlFld-ContribAuthor ">Shuji  Ioka</span>, <span class="hlFld-ContribAuthor ">Feng  Duo</span>, <span class="hlFld-ContribAuthor ">Rujie  Qin</span>, <span class="hlFld-ContribAuthor ">Nobuyuki  Murakoshi</span>, <span class="hlFld-ContribAuthor ">Shinya  Fujii</span>, <span class="hlFld-ContribAuthor ">Xuzhao  Zhou</span>, <span class="hlFld-ContribAuthor ">Fumihiro  Sugiyama</span>, <span class="hlFld-ContribAuthor ">Jiang-Fan  Chen</span>, <span class="hlFld-ContribAuthor ">Hidetoshi  Kumagai</span>, <span class="hlFld-ContribAuthor ">Hiroshi  Nagase</span>, <span class="hlFld-ContribAuthor ">Michael  Lazarus</span>. </span><span class="cited-content_cbyCitation_article-title">Enhancing endogenous adenosine A2A receptor signaling induces slow-wave sleep without affecting body temperature and cardiovascular function. </span><span class="cited-content_cbyCitation_journal-name">Neuropharmacology</span><span> <strong>2019,</strong> <em>144 </em>, 122-132. <a href="https://doi.org/10.1016/j.neuropharm.2018.10.022" title="DOI URL">https://doi.org/10.1016/j.neuropharm.2018.10.022</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuropharm.2018.10.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuropharm.2018.10.022%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropharmacology%26atitle%3DEnhancing%252Bendogenous%252Badenosine%252BA2A%252Breceptor%252Bsignaling%252Binduces%252Bslow-wave%252Bsleep%252Bwithout%252Baffecting%252Bbody%252Btemperature%252Band%252Bcardiovascular%252Bfunction%26aulast%3DKorkutata%26aufirst%3DMustafa%26date%3D2019%26volume%3D144%26spage%3D122%26epage%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shaoyi  Sun</span>, <span class="hlFld-ContribAuthor ">Jianmin  Fu</span>. </span><span class="cited-content_cbyCitation_article-title">Methyl-containing pharmaceuticals: Methylation in drug design. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>28 </em>
                                    (20)
                                     , 3283-3289. <a href="https://doi.org/10.1016/j.bmcl.2018.09.016" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.09.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.09.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.09.016%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DMethyl-containing%252Bpharmaceuticals%25253A%252BMethylation%252Bin%252Bdrug%252Bdesign%26aulast%3DSun%26aufirst%3DShaoyi%26date%3D2018%26volume%3D28%26issue%3D20%26spage%3D3283%26epage%3D3289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alain  Couvineau</span>, <span class="hlFld-ContribAuthor ">StÃ©phanie  Dayot</span>, <span class="hlFld-ContribAuthor ">Pascal  Nicole</span>, <span class="hlFld-ContribAuthor ">ValÃ©rie  Gratio</span>, <span class="hlFld-ContribAuthor ">Vinciane  Rebours</span>, <span class="hlFld-ContribAuthor ">Anne  Couvelard</span>, <span class="hlFld-ContribAuthor ">Thierry  Voisin</span>. </span><span class="cited-content_cbyCitation_article-title">The Anti-tumoral Properties of Orexin/Hypocretin Hypothalamic Neuropeptides: An Unexpected Therapeutic Role. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Endocrinology</span><span> <strong>2018,</strong> <em>9 </em><a href="https://doi.org/10.3389/fendo.2018.00573" title="DOI URL">https://doi.org/10.3389/fendo.2018.00573</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fendo.2018.00573&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffendo.2018.00573%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Endocrinology%26atitle%3DThe%252BAnti-tumoral%252BProperties%252Bof%252BOrexin%25252FHypocretin%252BHypothalamic%252BNeuropeptides%25253A%252BAn%252BUnexpected%252BTherapeutic%252BRole%26aulast%3DCouvineau%26aufirst%3DAlain%26date%3D2018%26date%3D2018%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Youai  Qiu</span>, <span class="hlFld-ContribAuthor ">Julia  Struwe</span>, <span class="hlFld-ContribAuthor ">Tjark H.  Meyer</span>, <span class="hlFld-ContribAuthor ">JoÃ£o C. A.  Oliveira</span>, <span class="hlFld-ContribAuthor ">Lutz  Ackermann</span>. </span><span class="cited-content_cbyCitation_article-title">Catalyst- and Reagent-Free Electrochemical Azole CâH Amination. </span><span class="cited-content_cbyCitation_journal-name">Chemistry - A European Journal</span><span> <strong>2018,</strong> <em>24 </em>
                                    (49)
                                     , 12784-12789. <a href="https://doi.org/10.1002/chem.201802832" title="DOI URL">https://doi.org/10.1002/chem.201802832</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.201802832&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.201802832%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520-%2520A%2520European%2520Journal%26atitle%3DCatalyst-%252Band%252BReagent-Free%252BElectrochemical%252BAzole%252BC%2525E2%252588%252592H%252BAmination%26aulast%3DQiu%26aufirst%3DYouai%26date%3D2018%26date%3D2018%26volume%3D24%26issue%3D49%26spage%3D12784%26epage%3D12789" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Britni  Skillman</span>, <span class="hlFld-ContribAuthor ">Sarah  Kerrigan</span>. </span><span class="cited-content_cbyCitation_article-title">Quantification of suvorexant in blood using liquid chromatography-quadrupole/time of flight (LC-Q/TOF) mass spectrometry. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chromatography B</span><span> <strong>2018,</strong> <em>1091 </em>, 87-95. <a href="https://doi.org/10.1016/j.jchromb.2018.05.006" title="DOI URL">https://doi.org/10.1016/j.jchromb.2018.05.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jchromb.2018.05.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jchromb.2018.05.006%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chromatography%2520B%26atitle%3DQuantification%252Bof%252Bsuvorexant%252Bin%252Bblood%252Busing%252Bliquid%252Bchromatography-quadrupole%25252Ftime%252Bof%252Bflight%252B%252528LC-Q%25252FTOF%252529%252Bmass%252Bspectrometry%26aulast%3DSkillman%26aufirst%3DBritni%26date%3D2018%26volume%3D1091%26spage%3D87%26epage%3D95" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qifeng  Bai</span>, <span class="hlFld-ContribAuthor ">Horacio  PÃ©rez-SÃ¡nchez</span>, <span class="hlFld-ContribAuthor ">Zhuoyu  Shi</span>, <span class="hlFld-ContribAuthor ">Lanlan  Li</span>, <span class="hlFld-ContribAuthor ">Danfeng  Shi</span>, <span class="hlFld-ContribAuthor ">Huanxiang  Liu</span>, <span class="hlFld-ContribAuthor ">Xiaojun  Yao</span>. </span><span class="cited-content_cbyCitation_article-title">Computational studies on horseshoe shape pocket of human orexin receptor type 2 and boat conformation of suvorexant by molecular dynamics simulations. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2018,</strong> <em>92 </em>
                                    (1)
                                     , 1221-1231. <a href="https://doi.org/10.1111/cbdd.13181" title="DOI URL">https://doi.org/10.1111/cbdd.13181</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.13181&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.13181%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DComputational%252Bstudies%252Bon%252Bhorseshoe%252Bshape%252Bpocket%252Bof%252Bhuman%252Borexin%252Breceptor%252Btype%252B2%252Band%252Bboat%252Bconformation%252Bof%252Bsuvorexant%252Bby%252Bmolecular%252Bdynamics%252Bsimulations%26aulast%3DBai%26aufirst%3DQifeng%26date%3D2018%26date%3D2018%26volume%3D92%26issue%3D1%26spage%3D1221%26epage%3D1231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sheng-Chun  Chen</span>, <span class="hlFld-ContribAuthor ">Nan  Li</span>, <span class="hlFld-ContribAuthor ">Feng  Tian</span>, <span class="hlFld-ContribAuthor ">Nan-Nan  Chai</span>, <span class="hlFld-ContribAuthor ">Ming-Yang  He</span>, <span class="hlFld-ContribAuthor ">Qun  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Mild direct amination of benzoxazoles using interpenetrating Cobalt(II)-based metal-organic framework as an efficient heterogeneous catalyst. </span><span class="cited-content_cbyCitation_journal-name">Molecular Catalysis</span><span> <strong>2018,</strong> <em>450 </em>, 104-111. <a href="https://doi.org/10.1016/j.mcat.2018.03.011" title="DOI URL">https://doi.org/10.1016/j.mcat.2018.03.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.mcat.2018.03.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.mcat.2018.03.011%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Catalysis%26atitle%3DMild%252Bdirect%252Bamination%252Bof%252Bbenzoxazoles%252Busing%252Binterpenetrating%252BCobalt%252528II%252529-based%252Bmetal-organic%252Bframework%252Bas%252Ban%252Befficient%252Bheterogeneous%252Bcatalyst%26aulast%3DChen%26aufirst%3DSheng-Chun%26date%3D2018%26volume%3D450%26spage%3D104%26epage%3D111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tobias  Atkin</span>, <span class="hlFld-ContribAuthor ">Stefano  Comai</span>, <span class="hlFld-ContribAuthor ">Gabriella  Gobbi</span>, . </span><span class="cited-content_cbyCitation_article-title">Drugs for Insomnia beyond Benzodiazepines: Pharmacology, Clinical Applications, and Discovery. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Reviews</span><span> <strong>2018,</strong> <em>70 </em>
                                    (2)
                                     , 197-245. <a href="https://doi.org/10.1124/pr.117.014381" title="DOI URL">https://doi.org/10.1124/pr.117.014381</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/pr.117.014381&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fpr.117.014381%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Reviews%26atitle%3DDrugs%252Bfor%252BInsomnia%252Bbeyond%252BBenzodiazepines%25253A%252BPharmacology%25252C%252BClinical%252BApplications%25252C%252Band%252BDiscovery%26aulast%3DAtkin%26aufirst%3DTobias%26date%3D2018%26date%3D2018%26volume%3D70%26issue%3D2%26spage%3D197%26epage%3D245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pratip Kumar  Dutta</span>, <span class="hlFld-ContribAuthor ">Subhabrata  Sen</span>, <span class="hlFld-ContribAuthor ">Debasree  Saha</span>, <span class="hlFld-ContribAuthor ">Basabbijayi  Dhar</span>. </span><span class="cited-content_cbyCitation_article-title">Solid Supported Nano Structured Cu-Catalyst for Solvent/Ligand Free C
              2
              Amination of Azoles. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2018,</strong> <em>2018 </em>
                                    (5)
                                     , 657-665. <a href="https://doi.org/10.1002/ejoc.201701669" title="DOI URL">https://doi.org/10.1002/ejoc.201701669</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201701669&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201701669%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSolid%252BSupported%252BNano%252BStructured%252BCu-Catalyst%252Bfor%252BSolvent%25252FLigand%252BFree%252BC%252B2%252BAmination%252Bof%252BAzoles%26aulast%3DDutta%26aufirst%3DPratip%2BKumar%26date%3D2018%26date%3D2018%26volume%3D2018%26issue%3D5%26spage%3D657%26epage%3D665" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sayaka  Ohrui</span>, <span class="hlFld-ContribAuthor ">Naoshi  Yamamoto</span>, <span class="hlFld-ContribAuthor ">Tsuyoshi  Saitoh</span>, <span class="hlFld-ContribAuthor ">Noriki  Kutsumura</span>, <span class="hlFld-ContribAuthor ">Yasuyuki  Nagumo</span>, <span class="hlFld-ContribAuthor ">Yoko  Irukayama-Tomobe</span>, <span class="hlFld-ContribAuthor ">Yasuhiro  Ogawa</span>, <span class="hlFld-ContribAuthor ">Yukiko  Ishikawa</span>, <span class="hlFld-ContribAuthor ">Yurie  Watanabe</span>, <span class="hlFld-ContribAuthor ">Daichi  Hayakawa</span>, <span class="hlFld-ContribAuthor ">Hiroaki  Gouda</span>, <span class="hlFld-ContribAuthor ">Masashi  Yanagisawa</span>, <span class="hlFld-ContribAuthor ">Hiroshi  Nagase</span>. </span><span class="cited-content_cbyCitation_article-title">Essential structure of orexin 1 receptor antagonist YNT-707, Part II: Drastic effect of the 14-hydroxy group on the orexin 1 receptor antagonistic activity. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>28 </em>
                                    (4)
                                     , 774-777. <a href="https://doi.org/10.1016/j.bmcl.2017.12.069" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.12.069</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.12.069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.12.069%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DEssential%252Bstructure%252Bof%252Borexin%252B1%252Breceptor%252Bantagonist%252BYNT-707%25252C%252BPart%252BII%25253A%252BDrastic%252Beffect%252Bof%252Bthe%252B14-hydroxy%252Bgroup%252Bon%252Bthe%252Borexin%252B1%252Breceptor%252Bantagonistic%252Bactivity%26aulast%3DOhrui%26aufirst%3DSayaka%26date%3D2018%26volume%3D28%26issue%3D4%26spage%3D774%26epage%3D777" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amanpreet  Kaur</span>, <span class="hlFld-ContribAuthor ">Ranjana  Prakash</span>, <span class="hlFld-ContribAuthor ">Satyendra Kumar  Pandey</span>. </span><span class="cited-content_cbyCitation_article-title">An Asymmetric Synthesis of ((3
              R
              ,6
              R
              )-6-Methylpiperidine-3-yl)methanol; A Piperidine Core Unit of Potent Dual Orexin Receptor Antagonist MK-6096. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2018,</strong> <em>3 </em>
                                    (1)
                                     , 105-107. <a href="https://doi.org/10.1002/slct.201702732" title="DOI URL">https://doi.org/10.1002/slct.201702732</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.201702732&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.201702732%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DAn%252BAsymmetric%252BSynthesis%252Bof%252B%252528%2525283%252BR%252B%25252C6%252BR%252B%252529-6-Methylpiperidine-3-yl%252529methanol%25253B%252BA%252BPiperidine%252BCore%252BUnit%252Bof%252BPotent%252BDual%252BOrexin%252BReceptor%252BAntagonist%252BMK-6096%26aulast%3DKaur%26aufirst%3DAmanpreet%26date%3D2018%26date%3D2018%26volume%3D3%26issue%3D1%26spage%3D105%26epage%3D107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ryoji  Suno</span>, <span class="hlFld-ContribAuthor ">Kanako Terakado  Kimura</span>, <span class="hlFld-ContribAuthor ">Takanori  Nakane</span>, <span class="hlFld-ContribAuthor ">Keitaro  Yamashita</span>, <span class="hlFld-ContribAuthor ">Junmei  Wang</span>, <span class="hlFld-ContribAuthor ">Takaaki  Fujiwara</span>, <span class="hlFld-ContribAuthor ">Yasuaki  Yamanaka</span>, <span class="hlFld-ContribAuthor ">Dohyun  Im</span>, <span class="hlFld-ContribAuthor ">Shoichiro  Horita</span>, <span class="hlFld-ContribAuthor ">Hirokazu  Tsujimoto</span>, <span class="hlFld-ContribAuthor ">Maki S.  Tawaramoto</span>, <span class="hlFld-ContribAuthor ">Takatsugu  Hirokawa</span>, <span class="hlFld-ContribAuthor ">Eriko  Nango</span>, <span class="hlFld-ContribAuthor ">Kensuke  Tono</span>, <span class="hlFld-ContribAuthor ">Takashi  Kameshima</span>, <span class="hlFld-ContribAuthor ">Takaki  Hatsui</span>, <span class="hlFld-ContribAuthor ">Yasumasa  Joti</span>, <span class="hlFld-ContribAuthor ">Makina  Yabashi</span>, <span class="hlFld-ContribAuthor ">Keiko  Shimamoto</span>, <span class="hlFld-ContribAuthor ">Masaki  Yamamoto</span>, <span class="hlFld-ContribAuthor ">Daniel M.  Rosenbaum</span>, <span class="hlFld-ContribAuthor ">So  Iwata</span>, <span class="hlFld-ContribAuthor ">Tatsuro  Shimamura</span>, <span class="hlFld-ContribAuthor ">Takuya  Kobayashi</span>. </span><span class="cited-content_cbyCitation_article-title">Crystal Structures of Human Orexin 2 Receptor Bound to the Subtype-Selective Antagonist EMPA. </span><span class="cited-content_cbyCitation_journal-name">Structure</span><span> <strong>2018,</strong> <em>26 </em>
                                    (1)
                                     , 7-19.e5. <a href="https://doi.org/10.1016/j.str.2017.11.005" title="DOI URL">https://doi.org/10.1016/j.str.2017.11.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.str.2017.11.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.str.2017.11.005%26sid%3Dliteratum%253Aachs%26jtitle%3DStructure%26atitle%3DCrystal%252BStructures%252Bof%252BHuman%252BOrexin%252B2%252BReceptor%252BBound%252Bto%252Bthe%252BSubtype-Selective%252BAntagonist%252BEMPA%26aulast%3DSuno%26aufirst%3DRyoji%26date%3D2018%26volume%3D26%26issue%3D1%26spage%3D7%26epage%3D19.e5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chuanle  Zhu</span>, <span class="hlFld-ContribAuthor ">Hao  Zeng</span>, <span class="hlFld-ContribAuthor ">Fulin  Chen</span>, <span class="hlFld-ContribAuthor ">Chi  Liu</span>, <span class="hlFld-ContribAuthor ">Rui  Zhu</span>, <span class="hlFld-ContribAuthor ">Wanqing  Wu</span>, <span class="hlFld-ContribAuthor ">Huanfeng  Jiang</span>. </span><span class="cited-content_cbyCitation_article-title">Copper-catalyzed coupling of oxime acetates and aryldiazonium salts: an azide-free strategy toward
              N
              -2-aryl-1,2,3-triazoles. </span><span class="cited-content_cbyCitation_journal-name">Organic Chemistry Frontiers</span><span> <strong>2018,</strong> <em>5 </em>
                                    (4)
                                     , 571-576. <a href="https://doi.org/10.1039/C7QO00874K" title="DOI URL">https://doi.org/10.1039/C7QO00874K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7QO00874K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7QO00874K%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Chemistry%2520Frontiers%26atitle%3DCopper-catalyzed%252Bcoupling%252Bof%252Boxime%252Bacetates%252Band%252Baryldiazonium%252Bsalts%25253A%252Ban%252Bazide-free%252Bstrategy%252Btoward%252BN%252B-2-aryl-1%25252C2%25252C3-triazoles%26aulast%3DZhu%26aufirst%3DChuanle%26date%3D2018%26date%3D2018%26volume%3D5%26issue%3D4%26spage%3D571%26epage%3D576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rui  Sang</span>, <span class="hlFld-ContribAuthor ">Yang  Zheng</span>, <span class="hlFld-ContribAuthor ">Hailong  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiaohua  Wu</span>, <span class="hlFld-ContribAuthor ">Qiantao  Wang</span>, <span class="hlFld-ContribAuthor ">Li  Hai</span>, <span class="hlFld-ContribAuthor ">Yong  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Palladium-catalyzed direct CâH ethoxycarbonylation of 2-aryl-1,2,3-triazoles and efficient synthesis of suvorexant. </span><span class="cited-content_cbyCitation_journal-name">Organic Chemistry Frontiers</span><span> <strong>2018,</strong> <em>5 </em>
                                    (4)
                                     , 648-652. <a href="https://doi.org/10.1039/C7QO00945C" title="DOI URL">https://doi.org/10.1039/C7QO00945C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7QO00945C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7QO00945C%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Chemistry%2520Frontiers%26atitle%3DPalladium-catalyzed%252Bdirect%252BC%2525E2%252580%252593H%252Bethoxycarbonylation%252Bof%252B2-aryl-1%25252C2%25252C3-triazoles%252Band%252Befficient%252Bsynthesis%252Bof%252Bsuvorexant%26aulast%3DSang%26aufirst%3DRui%26date%3D2018%26date%3D2018%26volume%3D5%26issue%3D4%26spage%3D648%26epage%3D652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Manickam  Bakthadoss</span>, <span class="hlFld-ContribAuthor ">Mohammad  Mushaf</span>. </span><span class="cited-content_cbyCitation_article-title">A distal vinyl shift (DVS) through quadruple domino reaction: synthesis of
              N
              -vinyl benzoheterocyclic scaffolds. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2018,</strong> <em>8 </em>
                                    (22)
                                     , 12152-12156. <a href="https://doi.org/10.1039/C8RA01478G" title="DOI URL">https://doi.org/10.1039/C8RA01478G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8RA01478G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8RA01478G%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DA%252Bdistal%252Bvinyl%252Bshift%252B%252528DVS%252529%252Bthrough%252Bquadruple%252Bdomino%252Breaction%25253A%252Bsynthesis%252Bof%252BN%252B-vinyl%252Bbenzoheterocyclic%252Bscaffolds%26aulast%3DBakthadoss%26aufirst%3DManickam%26date%3D2018%26date%3D2018%26volume%3D8%26issue%3D22%26spage%3D12152%26epage%3D12156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guoli  Luo</span>, <span class="hlFld-ContribAuthor ">Chenyang  Sun</span>, <span class="hlFld-ContribAuthor ">Yan  Li</span>, <span class="hlFld-ContribAuthor ">Xiaoxiao  Li</span>, <span class="hlFld-ContribAuthor ">Zhigang  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">N
              2
              -selective alkylation of NH-1,2,3-triazoles with vinyl ethers
              via
              gold catalysis. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2018,</strong> <em>8 </em>
                                    (49)
                                     , 27610-27615. <a href="https://doi.org/10.1039/C8RA04790A" title="DOI URL">https://doi.org/10.1039/C8RA04790A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8RA04790A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8RA04790A%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DN%252B2%252B-selective%252Balkylation%252Bof%252BNH-1%25252C2%25252C3-triazoles%252Bwith%252Bvinyl%252Bethers%252Bvia%252Bgold%252Bcatalysis%26aulast%3DLuo%26aufirst%3DGuoli%26date%3D2018%26date%3D2018%26volume%3D8%26issue%3D49%26spage%3D27610%26epage%3D27615" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vladimir  Svetnik</span>, <span class="hlFld-ContribAuthor ">Ellen S  Snyder</span>, <span class="hlFld-ContribAuthor ">Peining  Tao</span>, <span class="hlFld-ContribAuthor ">Thomas E  Scammell</span>, <span class="hlFld-ContribAuthor ">Thomas  Roth</span>, <span class="hlFld-ContribAuthor ">Christopher  Lines</span>, <span class="hlFld-ContribAuthor ">W Joseph  Herring</span>. </span><span class="cited-content_cbyCitation_article-title">Insight Into Reduction of Wakefulness by Suvorexant in Patients With Insomnia: Analysis of Wake Bouts. </span><span class="cited-content_cbyCitation_journal-name">Sleep</span><span> <strong>2018,</strong> <em>41 </em>
                                    (1)
                                     <a href="https://doi.org/10.1093/sleep/zsx178" title="DOI URL">https://doi.org/10.1093/sleep/zsx178</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/sleep/zsx178&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fsleep%2Fzsx178%26sid%3Dliteratum%253Aachs%26jtitle%3DSleep%26atitle%3DInsight%252BInto%252BReduction%252Bof%252BWakefulness%252Bby%252BSuvorexant%252Bin%252BPatients%252BWith%252BInsomnia%25253A%252BAnalysis%252Bof%252BWake%252BBouts%26aulast%3DSvetnik%26aufirst%3DVladimir%26date%3D2018%26date%3D2017%26volume%3D41%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">E. Z.  Yakupov</span>, <span class="hlFld-ContribAuthor ">D. V.  Artemieva</span>, <span class="hlFld-ContribAuthor ">Yu. V.  Troshina</span>. </span><span class="cited-content_cbyCitation_article-title">Multimodality of clinical effects of orexin. </span><span class="cited-content_cbyCitation_journal-name">Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova</span><span> <strong>2018,</strong> <em>118 </em>
                                    (12)
                                     , 114. <a href="https://doi.org/10.17116/jnevro2018118121114" title="DOI URL">https://doi.org/10.17116/jnevro2018118121114</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.17116/jnevro2018118121114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.17116%2Fjnevro2018118121114%26sid%3Dliteratum%253Aachs%26jtitle%3DZhurnal%2520nevrologii%2520i%2520psikhiatrii%2520im.%2520S.S.%2520Korsakova%26atitle%3DMultimodality%252Bof%252Bclinical%252Beffects%252Bof%252Borexin%26aulast%3DYakupov%26aufirst%3DE.%2BZ.%26date%3D2018%26volume%3D118%26issue%3D12%26spage%3D114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel  Hoyer</span>, <span class="hlFld-ContribAuthor ">Laura H.  Jacobson</span>. </span><span class="cited-content_cbyCitation_article-title">Orexin Receptor Antagonists. </span><span class="cited-content_cbyCitation_journal-name">Current Sleep Medicine Reports</span><span> <strong>2017,</strong> <em>3 </em>
                                    (4)
                                     , 342-353. <a href="https://doi.org/10.1007/s40675-017-0099-7" title="DOI URL">https://doi.org/10.1007/s40675-017-0099-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s40675-017-0099-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs40675-017-0099-7%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Sleep%2520Medicine%2520Reports%26atitle%3DOrexin%252BReceptor%252BAntagonists%26aulast%3DHoyer%26aufirst%3DDaniel%26date%3D2017%26date%3D2017%26volume%3D3%26issue%3D4%26spage%3D342%26epage%3D353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aya  Futamura</span>, <span class="hlFld-ContribAuthor ">Dai  Nozawa</span>, <span class="hlFld-ContribAuthor ">Yuko  Araki</span>, <span class="hlFld-ContribAuthor ">Yunoshin  Tamura</span>, <span class="hlFld-ContribAuthor ">Seiken  Tokura</span>, <span class="hlFld-ContribAuthor ">Hiroshi  Kawamoto</span>, <span class="hlFld-ContribAuthor ">Yuichi  Tokumaru</span>, <span class="hlFld-ContribAuthor ">Sora  Kakihara</span>, <span class="hlFld-ContribAuthor ">Takeshi  Aoki</span>, <span class="hlFld-ContribAuthor ">Norikazu  Ohtake</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of highly selective and potent orexin receptor 1 antagonists derived from a dual orexin receptor 1/2 antagonist based on the structural framework of pyrazoylethylbenzamide. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2017,</strong> <em>25 </em>
                                    (20)
                                     , 5203-5215. <a href="https://doi.org/10.1016/j.bmc.2017.07.051" title="DOI URL">https://doi.org/10.1016/j.bmc.2017.07.051</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2017.07.051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2017.07.051%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252Bhighly%252Bselective%252Band%252Bpotent%252Borexin%252Breceptor%252B1%252Bantagonists%252Bderived%252Bfrom%252Ba%252Bdual%252Borexin%252Breceptor%252B1%25252F2%252Bantagonist%252Bbased%252Bon%252Bthe%252Bstructural%252Bframework%252Bof%252Bpyrazoylethylbenzamide%26aulast%3DFutamura%26aufirst%3DAya%26date%3D2017%26volume%3D25%26issue%3D20%26spage%3D5203%26epage%3D5215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Young-Jin  Kang</span>, <span class="hlFld-ContribAuthor ">Guilian  Tian</span>, <span class="hlFld-ContribAuthor ">Afsheen  Bazrafkan</span>, <span class="hlFld-ContribAuthor ">Maryam H.  Farahabadi</span>, <span class="hlFld-ContribAuthor ">Matine  Azadian</span>, <span class="hlFld-ContribAuthor ">Hamidreza  Abbasi</span>, <span class="hlFld-ContribAuthor ">Brittany E.  Shamaoun</span>, <span class="hlFld-ContribAuthor ">Oswald  Steward</span>, <span class="hlFld-ContribAuthor ">Yama  Akbari</span>. </span><span class="cited-content_cbyCitation_article-title">Recovery from Coma Post-Cardiac Arrest Is Dependent on the Orexin Pathway. </span><span class="cited-content_cbyCitation_journal-name">Journal of Neurotrauma</span><span> <strong>2017,</strong> <em>34 </em>
                                    (19)
                                     , 2823-2832. <a href="https://doi.org/10.1089/neu.2016.4852" title="DOI URL">https://doi.org/10.1089/neu.2016.4852</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1089/neu.2016.4852&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1089%2Fneu.2016.4852%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Neurotrauma%26atitle%3DRecovery%252Bfrom%252BComa%252BPost-Cardiac%252BArrest%252BIs%252BDependent%252Bon%252Bthe%252BOrexin%252BPathway%26aulast%3DKang%26aufirst%3DYoung-Jin%26date%3D2017%26volume%3D34%26issue%3D19%26spage%3D2823%26epage%3D2832" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexander  Treiber</span>, <span class="hlFld-ContribAuthor ">Ruben  de Kanter</span>, <span class="hlFld-ContribAuthor ">Catherine  Roch</span>, <span class="hlFld-ContribAuthor ">John  Gatfield</span>, <span class="hlFld-ContribAuthor ">Christoph  Boss</span>, <span class="hlFld-ContribAuthor ">Markus  von Raumer</span>, <span class="hlFld-ContribAuthor ">Benno  Schindelholz</span>, <span class="hlFld-ContribAuthor ">Clemens  Muehlan</span>, <span class="hlFld-ContribAuthor ">Joop  van Gerven</span>, <span class="hlFld-ContribAuthor ">Francois  Jenck</span>. </span><span class="cited-content_cbyCitation_article-title">The Use of Physiology-Based Pharmacokinetic and Pharmacodynamic Modeling in the Discovery of the Dual Orexin Receptor Antagonist ACT-541468. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmacology and Experimental Therapeutics</span><span> <strong>2017,</strong> <em>362 </em>
                                    (3)
                                     , 489-503. <a href="https://doi.org/10.1124/jpet.117.241596" title="DOI URL">https://doi.org/10.1124/jpet.117.241596</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/jpet.117.241596&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fjpet.117.241596%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmacology%2520and%2520Experimental%2520Therapeutics%26atitle%3DThe%252BUse%252Bof%252BPhysiology-Based%252BPharmacokinetic%252Band%252BPharmacodynamic%252BModeling%252Bin%252Bthe%252BDiscovery%252Bof%252Bthe%252BDual%252BOrexin%252BReceptor%252BAntagonist%252BACT-541468%26aulast%3DTreiber%26aufirst%3DAlexander%26date%3D2017%26date%3D2017%26volume%3D362%26issue%3D3%26spage%3D489%26epage%3D503" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kai  Liu</span>, <span class="hlFld-ContribAuthor ">Juhyun  Kim</span>, <span class="hlFld-ContribAuthor ">Dong Won  Kim</span>, <span class="hlFld-ContribAuthor ">Yi Stephanie  Zhang</span>, <span class="hlFld-ContribAuthor ">Hechen  Bao</span>, <span class="hlFld-ContribAuthor ">Myrto  Denaxa</span>, <span class="hlFld-ContribAuthor ">Szu-Aun  Lim</span>, <span class="hlFld-ContribAuthor ">Eileen  Kim</span>, <span class="hlFld-ContribAuthor ">Chang  Liu</span>, <span class="hlFld-ContribAuthor ">Ian R.  Wickersham</span>, <span class="hlFld-ContribAuthor ">Vassilis  Pachnis</span>, <span class="hlFld-ContribAuthor ">Samer  Hattar</span>, <span class="hlFld-ContribAuthor ">Juan  Song</span>, <span class="hlFld-ContribAuthor ">Solange P.  Brown</span>, <span class="hlFld-ContribAuthor ">Seth  Blackshaw</span>. </span><span class="cited-content_cbyCitation_article-title">Lhx6-positive GABA-releasing neurons of the zona incerta promote sleep. </span><span class="cited-content_cbyCitation_journal-name">Nature</span><span> <strong>2017,</strong> <em>548 </em>
                                    (7669)
                                     , 582-587. <a href="https://doi.org/10.1038/nature23663" title="DOI URL">https://doi.org/10.1038/nature23663</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/nature23663&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fnature23663%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%26atitle%3DLhx6-positive%252BGABA-releasing%252Bneurons%252Bof%252Bthe%252Bzona%252Bincerta%252Bpromote%252Bsleep%26aulast%3DLiu%26aufirst%3DKai%26date%3D2017%26date%3D2017%26volume%3D548%26issue%3D7669%26spage%3D582%26epage%3D587" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div><a href="#" data-source="/pb/widgets/cited-by?doi=10.1021%2Fjm100541c&amp;widgetId=9cf770f4-a9a2-46e0-bd29-3da15bcf4ae0&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2010.53.issue-14%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Fjm100541c&amp;citedByCount=236&amp;pagesCount=3&amp;pageNumber=2" title="Load more citations" class="button_primary float-right cited-by__see-more mb-5"><i aria-hidden="âtrueâ" class="icon-angle-double-down"></i><span>Load more citations</span></a></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm100541c/production/images/medium/jm-2010-00541c_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm100541c/production/images/large/jm-2010-00541c_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100541c&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm100541c/production/images/medium/jm-2010-00541c_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm100541c/production/images/large/jm-2010-00541c_0013.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. DORAs studied to date in clinical trials.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm100541c/production/images/large/jm-2010-00541c_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100541c&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm100541c/production/images/medium/jm-2010-00541c_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm100541c/production/images/large/jm-2010-00541c_0014.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Previously reported diazepane-based DORA <b>4</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm100541c/production/images/large/jm-2010-00541c_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100541c&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm100541c/production/images/medium/jm-2010-00541c_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm100541c/production/images/large/jm-2010-00541c_0015.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Proposed Mechanism of Semicarbazide Trapping When <b>4</b> Is Incubated in Liver Microsomes Fortified with Semicarbazide</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm100541c/production/images/large/jm-2010-00541c_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100541c&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm100541c/production/images/medium/jm-2010-00541c_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm100541c/production/images/large/jm-2010-00541c_0001.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. General scaffold for examining mono- and disubstituted diazepane cores.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm100541c/production/images/large/jm-2010-00541c_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100541c&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm100541c/production/images/medium/jm-2010-00541c_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm100541c/production/images/large/jm-2010-00541c_0002.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Previously Reported Synthesis of the 7-Methyldiazepane Core<a onclick="showRef(event, 'cit30b'); return false;" href="javascript:void(0);" class="ref cit30b">(30b)</a><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm100541c/production/images/large/jm-2010-00541c_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100541c&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Et<sub>2</sub>O (70%); (b) PPh<sub>3</sub>, Et<sub>2</sub>O (72%); (c), LAH, Et<sub>2</sub>O (91%).</p></p></figure><figure data-id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm100541c/production/images/medium/jm-2010-00541c_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm100541c/production/images/large/jm-2010-00541c_0003.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of 7-Methyldiazepane DORA Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm100541c/production/images/large/jm-2010-00541c_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100541c&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Et<sub>2</sub>O, then TEA and benzyl chloroformate; (b) HCl<sub>(g)</sub>, EtOAc; (c) NaBH(OAc)<sub>3</sub>, HOAc, CH<sub>2</sub>Cl<sub>2</sub>; (d) Boc<sub>2</sub>O, TEA, CH<sub>2</sub>Cl<sub>2</sub> (38% for 4 steps); (e) Chiralpak AD, 60% EtOH in hexanes (0.1% DEA as modifier), first isomer to elute is the desired (<i>R</i>)-isomer; (f) HCl<sub>(g)</sub>, EtOAc; (g) 2-(2<i>H</i>-1,2,3-triazol-2-yl)-5-methylbenzoic acid, EDC, HOAT, NMM, DMF (87% for 2 steps); (h) H<sub>2</sub>, Pd(OH)<sub>2</sub>, MeOH/EtOAc; (i) 2-chloroquinazoline, K<sub>2</sub>CO<sub>3</sub>, DMF (75% for 2 steps).</p></p></figure><figure data-id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm100541c/production/images/medium/jm-2010-00541c_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm100541c/production/images/large/jm-2010-00541c_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Effects of a 10 mg/kg dose of <b>10</b> on rat sleep. The duration of time spent in active wake, light sleep, delta sleep, and REM sleep in vehicle (closed circles) vs drug (open circles) treated animals following a 10 mg/kg po dose of <b>10</b> in 20% TPGS administered at 09:00. The open area in the bar above the abscissa designates lights on and the filled area designates lights off. Values are mean Â± SEM. Vertical gray lines represent statistically significant differences from vehicle treatment as determined using mixed-model ANOVAs at each time point. Significance levels are indicated by length of tic marks (short <0.5, medium <0.01, long <0.001).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm100541c/production/images/large/jm-2010-00541c_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100541c&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm100541c/production/images/medium/jm-2010-00541c_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm100541c/production/images/large/jm-2010-00541c_0008.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effects of a 30 mg/kg dose of <b>3</b> on rat sleep. The duration of time spent in active wake, light sleep, delta sleep, and REM sleep in vehicle (closed circles) vs drug (open circles) treated animals following a 30 mg/kg po dose of <b>3</b> in 20% TPGS administered at 09:00. The open area in the bar above the abscissa designates lights on and the filled area designates lights off. Values are mean Â± SEM. Vertical gray lines represent statistically significant differences from vehicle treatment as determined using mixed-model ANOVAs at each time point. Significance levels are indicated by length of tic marks (short < 0.5, medium < 0.01, long < 0.001).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm100541c/production/images/large/jm-2010-00541c_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100541c&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm100541c/production/images/medium/jm-2010-00541c_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm100541c/production/images/large/jm-2010-00541c_0009.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Plot of occupancy versus dose for compound <b>3</b> in transgenic rats. Similar plots of occupancy versus concentration of <b>3</b> in plasma, brain, or CSF can be generated.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm100541c/production/images/large/jm-2010-00541c_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100541c&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch4" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm100541c/production/images/medium/jm-2010-00541c_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm100541c/production/images/large/jm-2010-00541c_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Oxidative Metabolites of <b>3</b> Identified from a BDC Rat Study</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-14/jm100541c/production/images/large/jm-2010-00541c_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100541c&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i27">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51587" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51587" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 46 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Passarella, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duong, M.-T.</span><span> </span><span class="NLM_article-title">Diagnosis and treatment of insomnia</span> <span class="citation_source-journal">Am. J. Health-Syst. Pharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">927</span><span class="NLM_x">â</span> <span class="NLM_lpage">934</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm100541c&amp;key=10.2146%2Fajhp060640" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm100541c&amp;key=18463341" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm100541c&amp;key=1%3ACAS%3A528%3ADC%252BD1cXntVSqtrk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2008&pages=927-934&author=S.+Passarellaauthor=M.-T.+Duong&title=Diagnosis+and+treatment+of+insomnia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Diagnosis and treatment of insomnia</span></div><div class="casAuthors">Passarella, Stacy; Duong, Minh-Tri</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Health-System Pharmacy</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">927-934</span>CODEN:
                <span class="NLM_cas:coden">AHSPEK</span>;
        ISSN:<span class="NLM_cas:issn">1079-2082</span>.
    
            (<span class="NLM_cas:orgname">American Society of Health-System Pharmacists</span>)
        </div><div class="casAbstract">A review.  The diagnostic criteria and treatment of insomnia are reviewed.  Insomnia is most often described as a subjective complaint of poor sleep quality or quantity despite adequate time for sleep, resulting in daytime fatigue, irritability, and decreased concn.  Insomnia is classified as idiopathic or comorbid.  Comorbid insomnias are assocd. with psychiatric disorders, medical disorders, substance abuse, and specific sleep disorders.  Idiopathic insomnia is essentially a diagnosis of exclusion.  A wide array of terminol. exists for defining the duration of insomnia symptoms, which may add to the confusion regarding insomnia classification.  Acute insomnia refers to sleep problems lasting from one night to a few weeks, whereas chronic insomnia refers to sleep problems lasting at least three nights weekly for at least one month.  Diagnostic tools for identifying insomnia are multifactorial.  Nonpharmacol. interventions for insomnia include sleep-hygiene education, stimulus-control therapy, relaxation therapy, and sleep-restriction therapy.  The most effective pharmacol. therapies for insomnia are benzodiazepines, benzodiazepine-receptor agonists, melatonin-receptor agonists, and antidepressants.  Choice of a specific agent should be based on patient-specific factors, including age, proposed length of treatment, primary sleep complaint, history of drug or alc. abuse, and cost.  Conclusion. Many treatment options are available for patients with insomnia.  Behavioral therapies should be initiated as first-line treatment in most patients.  For patients who require the addn. of pharmacol. therapy, the drugs with the most evidence for benefit include benzodiazepines, benzodiazepine-receptor agonists, melatonin-receptor agonists, and antidepressants.  Selection of a specific agent must take into account numerous patient-specific factors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKGWBnBjBX9rVg90H21EOLACvtfcHk0lhQ24rrEQB-mw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXntVSqtrk%253D&md5=6dfd55fb9f72928de4717753da85e39c</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.2146%2Fajhp060640&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2146%252Fajhp060640%26sid%3Dliteratum%253Aachs%26aulast%3DPassarella%26aufirst%3DS.%26aulast%3DDuong%26aufirst%3DM.-T.%26atitle%3DDiagnosis%2520and%2520treatment%2520of%2520insomnia%26jtitle%3DAm.%2520J.%2520Health-Syst.%2520Pharm.%26date%3D2008%26volume%3D65%26spage%3D927%26epage%3D934" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Daley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morin, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LeBlanc, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">GrÃ©goire, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baillargeon, L.</span><span> </span><span class="NLM_article-title">Insomnia and its relationship to health-care utilization, work absenteeism, productivity and accidents</span> <span class="citation_source-journal">Sleep Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">427</span><span class="NLM_x">â</span> <span class="NLM_lpage">438</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm100541c&amp;key=10.1016%2Fj.sleep.2008.04.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm100541c&amp;key=18753000" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm100541c&amp;key=1%3ACAS%3A280%3ADC%252BD1MzhsVWgtw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=427-438&author=M.+Daleyauthor=C.+M.+Morinauthor=M.+LeBlancauthor=J.+P.+Gr%C3%A9goireauthor=J.+Savardauthor=L.+Baillargeon&title=Insomnia+and+its+relationship+to+health-care+utilization%2C+work+absenteeism%2C+productivity+and+accidents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Insomnia and its relationship to health-care utilization, work absenteeism, productivity and accidents</span></div><div class="casAuthors">Daley M; Morin C M; LeBlanc M; Gregoire J P; Savard J; Baillargeon L</div><div class="citationInfo"><span class="NLM_cas:title">Sleep medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">427-38</span>
        ISSN:<span class="NLM_cas:issn">1389-9457</span>.
    </div><div class="casAbstract">BACKGROUND AND PURPOSE:  To document and provide a micro analysis of the relationship between insomnia and health problems, health-care use, absenteeism, productivity and accidents.  PARTICIPANTS AND METHODS:  A population-based sample of 953 French-speaking adults from Quebec, Canada.  Participants were categorized as having insomnia syndrome (SYND) or insomnia symptoms (SYMPT) or as good sleepers (GS).  They completed questionnaires on sleep, health, use of health-care services and products, accidents, work absences and reduced work productivity.  Data were also obtained from the Quebec-government-administered health insurance board on selected variables (e.g., consultations with health-care professionals, diagnoses).  RESULTS:  There were significantly more individuals in the SYND group relative to the GS group reporting at least one chronic health problem (83% vs. 53%; OR: 2.78) and who had consulted a health-care professional in the past year (81% vs. 60%; OR: 2.8).  There were also higher proportions of individuals in the SYND group than in the GS group who had used prescription medications (57% vs. 30.7%; OR: 2.8), most notably to treat insomnia, mood and anxiety disorders, or who had used over-the-counter products (75.6% vs. 62.0%; OR: 1.8) and alcohol as a sleep aid (17.8% vs. 3.9%; OR: 4.6).  In terms of daytime function, 25.0% of the SYND had been absent from work relative to 17.1% of GS (OR: 1.7), 40.6% reported having experienced reduced productivity compared to 12.3% of GS (OR: 4.8) and non-motor-vehicle accidents occurred at higher rates in the SYND group (12.5% vs. 6.4% for GS; OR: 2.4).  No differences were found for hospitalisations or motor-vehicle accidents.  Most of the associations remained significant even after controlling for psychiatric comorbidity.  Rates for the SYMPT group were situated between SYND and GS on all major dependent variables.  Furthermore, insomnia and fatigue were perceived as contributing significantly to accidents, absences and decreased work productivity, regardless of insomnia status.  CONCLUSIONS:  This study indicates that insomnia is associated with significant morbidity in terms of health problems and health-care utilization, work absenteeism and reduced productivity, and risk of non-motor-vehicle accidents.  Future studies should evaluate whether treating insomnia can reverse this morbidity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSMQKeKDjgufH6HPRus0rAafW6udTcc2eb2qldO8zEfCLntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MzhsVWgtw%253D%253D&md5=28609005d76f88135a3739f1dd7d7fb5</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.sleep.2008.04.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.sleep.2008.04.005%26sid%3Dliteratum%253Aachs%26aulast%3DDaley%26aufirst%3DM.%26aulast%3DMorin%26aufirst%3DC.%2BM.%26aulast%3DLeBlanc%26aufirst%3DM.%26aulast%3DGr%25C3%25A9goire%26aufirst%3DJ.%2BP.%26aulast%3DSavard%26aufirst%3DJ.%26aulast%3DBaillargeon%26aufirst%3DL.%26atitle%3DInsomnia%2520and%2520its%2520relationship%2520to%2520health-care%2520utilization%252C%2520work%2520absenteeism%252C%2520productivity%2520and%2520accidents%26jtitle%3DSleep%2520Med.%26date%3D2009%26volume%3D10%26spage%3D427%26epage%3D438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Sullivan, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guilleminault, C.</span><span> </span><span class="NLM_article-title">Emerging drugs for insomnia: new frontiers for old and new targets</span> <span class="citation_source-journal">Expert Opin. Emerging Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">411</span><span class="NLM_x">â</span> <span class="NLM_lpage">422</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Fjm100541c&amp;key=10.1517%2F14728210903171948" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=8&amp;doi=10.1021%2Fjm100541c&amp;key=19708818" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Fjm100541c&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVCgurbF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2009&pages=411-422&author=S.+S.+Sullivanauthor=C.+Guilleminault&title=Emerging+drugs+for+insomnia%3A+new+frontiers+for+old+and+new+targets"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging drugs for insomnia: new frontiers for old and novel targets</span></div><div class="casAuthors">Sullivan, Shannon S.; Guilleminault, Christian</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Emerging Drugs</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">411-422</span>CODEN:
                <span class="NLM_cas:coden">EOEDA3</span>;
        ISSN:<span class="NLM_cas:issn">1472-8214</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Insomnia is the most prevalent sleep disorder, with up to 50% of the US adult population reporting symptoms of insomnia on a weekly basis and â¼ 12% with insomnia disorder.  Comorbid conditions such as depression and anxiety are frequent.  Insomnia is more common with older age, female gender and socioeconomic status.  Traditionally, therapy has focused on GABAA receptor agonists, and off-label antidepressant and antihistamine use.  With increased understanding of complex neural networks involved in sleep and wake, hypnotics are being developed to target a broader variety of receptors with increasing selectivity.  This review summarizes promising compds. in Phase II and III trials with evidence supporting efficacy for treatment of insomnia.  5-HT2A and 5-HT2C antagonists, melatonergic (MT1/MT2) agonists, orexin receptor (OX1/OX2) antagonists, as well as GABAA receptor agonists are reviewed and summarized.  Data are collected from PubMed and Pharmaprojects database searches, company websites, recent scientific meeting presentations and abstrs.  A variety of drugs targeting several pathways, including GABAA agonism, MT1/MT2 agonism, 5-HT2A antagonism, OX1/OX2 antagonism and others, are in Phase II and III trials.  More work should be done to understand the impact of these drugs in certain populations and in the context of comorbid conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKfbmX3Dwh4LVg90H21EOLACvtfcHk0lh4LR6iMhd1ew"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVCgurbF&md5=33f28e611296310e8d3623290e20d7b3</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1517%2F14728210903171948&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728210903171948%26sid%3Dliteratum%253Aachs%26aulast%3DSullivan%26aufirst%3DS.%2BS.%26aulast%3DGuilleminault%26aufirst%3DC.%26atitle%3DEmerging%2520drugs%2520for%2520insomnia%253A%2520new%2520frontiers%2520for%2520old%2520and%2520new%2520targets%26jtitle%3DExpert%2520Opin.%2520Emerging%2520Drugs%26date%3D2009%26volume%3D14%26spage%3D411%26epage%3D422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Renger, J. J.</span><span> </span><span class="NLM_article-title">Overview of experimental and conventional pharmacological approaches in the treatment of sleep and wake disorders</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">937</span><span class="NLM_x">â</span> <span class="NLM_lpage">953</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Fjm100541c&amp;key=10.2174%2F156802608784936755" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Fjm100541c&amp;key=18673164" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Fjm100541c&amp;key=1%3ACAS%3A528%3ADC%252BD1cXps1OhtLw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=937-953&author=J.+J.+Renger&title=Overview+of+experimental+and+conventional+pharmacological+approaches+in+the+treatment+of+sleep+and+wake+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">Overview of experimental and conventional pharmacological approaches in the treatment of sleep and wake disorders</span></div><div class="casAuthors">Renger, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">937-953</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The fundamental purpose of sleep remains one of the most compelling questions yet to be answered in the area of neuroscience, if not all of biol.  A pervasive behavior among members of the animal kingdom, the functional necessity of engaging regularly in sleep is best demonstrated by showing that failing to do so leads to a broad repertoire of pathol. outcomes including cognitive, immunol., hormonal, and metabolic outcomes, among others.  Indeed, an abs. requirement for sleep has been shown in studies that have demonstrated that continuous total deprivation of sleep for as short a period as 15 days is generally lethal in some species.  The most common clin. sleep disorder, insomnia, is both a principal disease (primary insomnia) as well as a co-morbidity of a large no. of other ostensibly unrelated diseases including chronic pain, attention deficit hyperactivity disorder, and depression.  From a treatment perspective, restoring normal healthy sleep delivers subsequent benefits in waking cognitive function and mood with the potential for beneficial therapeutic impact on daily functioning across multiple diseases for which restorative healthy sleep is compromised.  Our remarkable escalation in understanding the anatomy and physiol. of sleep/wake control mechanisms provides new opportunities to modify the neurobiol. of sleep and wake-related behaviors in novel and exciting ways.  In parallel, expansion of sleep research into novel interfaces between sleep-wake biol. and disease states is revealing addnl. extensive implications of lost sleep.  Current investigational and conventional pharmacol. approaches for the treatment of sleep and wake disorders are discussed based on their mechanism of action within the CNS and their effect on sleep and wake.  This review of recent sleep biol. and sleep pharmacol. peers into the future of sleep therapeutics to highlight both mechanistic safety and functional outcomes as key for differentiating and establishing success for the next generation of arousal modifying therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6GNzViXvCXbVg90H21EOLACvtfcHk0lhlr5dXtcy-PA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXps1OhtLw%253D&md5=0f24539a5d8032bde88186f6df1a44a6</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.2174%2F156802608784936755&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802608784936755%26sid%3Dliteratum%253Aachs%26aulast%3DRenger%26aufirst%3DJ.%2BJ.%26atitle%3DOverview%2520of%2520experimental%2520and%2520conventional%2520pharmacological%2520approaches%2520in%2520the%2520treatment%2520of%2520sleep%2520and%2520wake%2520disorders%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2008%26volume%3D8%26spage%3D937%26epage%3D953" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Wafford, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebert, B.</span><span> </span><span class="NLM_article-title">Emerging anti-insomnia drugs: tackling sleeplessness and the quality of wake time</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">530</span><span class="NLM_x">â</span> <span class="NLM_lpage">540</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=530-540&author=K.+A.+Waffordauthor=B.+Ebert&title=Emerging+anti-insomnia+drugs%3A+tackling+sleeplessness+and+the+quality+of+wake+time"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWafford%26aufirst%3DK.%2BA.%26aulast%3DEbert%26aufirst%3DB.%26atitle%3DEmerging%2520anti-insomnia%2520drugs%253A%2520tackling%2520sleeplessness%2520and%2520the%2520quality%2520of%2520wake%2520time%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2008%26volume%3D7%26spage%3D530%26epage%3D540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span> </span><span class="NLM_article-title">FDA Requests Label Change for All Sleep Disorder Drug Products</span>. FDA News Release P07045, <span class="NLM_month">March</span><span class="NLM_day">14</span>,<span class="NLM_x"> </span><span class="NLM_year">2007</span><span class="NLM_x">; </span><a href="http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2007/ucm108868.htm" class="extLink">http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2007/ucm108868.htm</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=FDA+Requests+Label+Change+for+All+Sleep+Disorder+Drug+Products.+FDA+News+Release+P07045%2C+March14%2C+2007%3B+http%3A%2F%2Fwww.fda.gov%2FNewsEvents%2FNewsroom%2FPressAnnouncements%2F2007%2Fucm108868.htm."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26atitle%3DFDA%2520Requests%2520Label%2520Change%2520for%2520All%2520Sleep%2520Disorder%2520Drug%2520Products%26jtitle%3DFDA%2520News%2520Release%2520P07045%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Palomer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prinep, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guglietta, A.</span><span> </span><span class="NLM_article-title">Recent advances in the treatment of insomnia</span> <span class="citation_source-journal">Annu. Rep. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">63</span><span class="NLM_x">â</span> <span class="NLM_lpage">80</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2007&pages=63-80&author=A.+Palomerauthor=M.+Prinepauthor=A.+Guglietta&title=Recent+advances+in+the+treatment+of+insomnia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPalomer%26aufirst%3DA.%26aulast%3DPrinep%26aufirst%3DM.%26aulast%3DGuglietta%26aufirst%3DA.%26atitle%3DRecent%2520advances%2520in%2520the%2520treatment%2520of%2520insomnia%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2007%26volume%3D42%26spage%3D63%26epage%3D80" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Borja, N. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniel, K. L.</span><span> </span><span class="NLM_article-title">Ramelteon for the treatment of insomnia</span> <span class="citation_source-journal">Clin. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">1540</span><span class="NLM_x">â</span> <span class="NLM_lpage">1555</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Fjm100541c&amp;key=10.1016%2Fj.clinthera.2006.10.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=8&amp;doi=10.1021%2Fjm100541c&amp;key=17157111" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Fjm100541c&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlartrzJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2006&pages=1540-1555&author=N.+L.+Borjaauthor=K.+L.+Daniel&title=Ramelteon+for+the+treatment+of+insomnia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7a</span><div class="casTitle"><span class="NLM_cas:atitle">Ramelteon for the treatment of insomnia</span></div><div class="casAuthors">Borja, Nancy L.; Daniel, Karen L.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1540-1555</span>CODEN:
                <span class="NLM_cas:coden">CLTHDG</span>;
        ISSN:<span class="NLM_cas:issn">0149-2918</span>.
    
            (<span class="NLM_cas:orgname">Excerpta Medica, Inc.</span>)
        </div><div class="casAbstract">A review.  Background: Insomnia is a common sleep disorder with a significant potential for deleterious effects on activities of daily living, productivity, and overall quality of life.  Ramelteon, a highly selective agonist for melatonin subtypes 1 and 2 receptors, is a hypnotic agent approved by the US Food and Drug Administration (FDA) for the treatment of insomnia characterized by difficulty falling asleep.  Objective: This article reviews the pharmacokinetic properties, efficacy, and tolerability of ramelteon in the treatment of insomnia characterized by difficulty falling asleep.  Methods: Relevant articles were identified through searches of MEDLINE (1966 to July 2006), International Pharmaceutical Abstrs. (Jan. 1970 to July 2006), EMBASE Drugs and Pharmacol. (1980 to third quarter 2006), and Current Contents/Clin. Medicine (2005 wk 32 to 2006 wk 31).  Search terms included ramelteon, TAK-375, melatonin agonist, melatonin receptor agonist, insomnia, and sleep disorders/drug therapy (MeSH).  Results: A literature search revealed 12 randomized, controlled clin. trials that examd. the efficacy or tolerability of ramelteon.  In addn., 17 studies were reviewed for pharmacol. and pharmacokinetic data.  The refs. of the clin. trials and recent review articles were examd. to ensure the comprehensiveness of the literature search.  In 2 trials of patients with primary insomnia, patients treated with ramelteon 4 to 32 mg had significant redns. in latency to persistent sleep (LPS) compared with placebo (P < 0.001).  Addnl., improvements in total sleep time (TST) were obsd. (P < 0.001), although increases in TST were noted only on nights 1-2 of the second study.  Similarly, improvement in sleep efficiency was reported only on nights 1-2 of the second trial (P < 0.001).  In elderly patients with primary insomnia, significant redns. in subjective LPS were obsd. with ramelteon 4 and 8 mg (P = 0.008); however, av. subjective LPS was >70 min.  Mean reported TST was significantly increased in the 4-mg group (P = 0.004).  A second study in elderly patients found decreases in LPS with ramelteon 4 mg (P < 0.001) and 8 mg (P < 0.01), as well as significant increases in TST (P < 0.05 and P < 0.01, resp.).  Sleep efficiency improved for patients treated with 4 mg (P < 0.05) and 8 mg (P < 0.01).  Overall, the mean decrease in LPS reported in trials of ramelteon ranged from 10 to 19 min, and the mean increase in TST was 8 to 22 min.  The most common adverse events obsd. with ramelteon included headache (7%), dizziness (5%), somnolence (5%), fatigue (4%), and nausea (3%).  No evidence of cognitive impairment, rebound insomnia, withdrawal effects, or abuse potential was noted.  Conclusions: Based on this review, ramelteon, the first FDA-approved melatonin receptor agonist, represents a pharmacol. option for the treatment of insomnia characterized by difficulty falling asleep.  In patients with insomnia, treatment with ramelteon was generally well tolerated and resulted in modest but statistically significant decreases in LPS.  In the absence of published trials comparing ramelteon with other sedative-hypnotic agents, it is not yet possible to det. its efficacy relative to other therapeutic options for insomnia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqH8KOdHeFwbLVg90H21EOLACvtfcHk0lhlr5dXtcy-PA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlartrzJ&md5=6c4c07814164db950f6de7c7d593972e</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1016%2Fj.clinthera.2006.10.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.clinthera.2006.10.016%26sid%3Dliteratum%253Aachs%26aulast%3DBorja%26aufirst%3DN.%2BL.%26aulast%3DDaniel%26aufirst%3DK.%2BL.%26atitle%3DRamelteon%2520for%2520the%2520treatment%2520of%2520insomnia%26jtitle%3DClin.%2520Ther.%26date%3D2006%26volume%3D28%26spage%3D1540%26epage%3D1555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Sateia, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirby-Long, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, J. L.</span><span> </span><span class="NLM_article-title">Efficacy and clinical safety of ramelteon: an evidence-based review</span> <span class="citation_source-journal">Sleep Med. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">319</span><span class="NLM_x">â</span> <span class="NLM_lpage">332</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=16&amp;doi=10.1021%2Fjm100541c&amp;key=10.1016%2Fj.smrv.2007.12.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=8&amp;doi=10.1021%2Fjm100541c&amp;key=18603221" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=32&amp;doi=10.1021%2Fjm100541c&amp;key=1%3ACAS%3A280%3ADC%252BD1cvjsVektA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2008&pages=319-332&author=M.+J.+Sateiaauthor=P.+Kirby-Longauthor=J.+L.+Taylor&title=Efficacy+and+clinical+safety+of+ramelteon%3A+an+evidence-based+review"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7bR"><div class="casContent"><span class="casTitleNuber">7b</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy and clinical safety of ramelteon: an evidence-based review</span></div><div class="casAuthors">Sateia Michael J; Kirby-Long Paula; Taylor Jennifer L</div><div class="citationInfo"><span class="NLM_cas:title">Sleep medicine reviews</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">319-32</span>
        ISSN:<span class="NLM_cas:issn">1087-0792</span>.
    </div><div class="casAbstract">Ramelteon is a novel hypnotic compound that is FDA-approved for the treatment of sleep-onset difficulty.  It is a melatonin 1/2 receptor agonist with rapid absorption, extensive first-pass metabolism and an elimination half-life of just over 1h.  Clinical efficacy data indicate moderate efficacy in reduction of sleep latency in adults of all ages with chronic insomnia, with estimated effect sizes roughly comparable to other standard hypnotic agents.  Objective studies show minimal increases in total sleep time and no significant impact on wake after sleep-onset or sleep-stage distribution.  Subjective reports demonstrate comparable, if slightly smaller, improvements.  The recommended dosage is 8mg but studies suggest a flat response across dosage ranges from 4 to 32mg.  Safety data indicate no evidence of clinically significant next-day performance effects and a reasonably low side effect profile.  Animal studies, and a single human study suggest low abuse potential.  Single-blind run-out from clinical trials have demonstrated no evidence of rebound insomnia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTao5mkhqwFD6Nc3HjJRoFAfW6udTcc2eYFV8bhzqkKVbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1cvjsVektA%253D%253D&md5=7b94aef4c310eef9be12a54af296c001</span></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1016%2Fj.smrv.2007.12.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.smrv.2007.12.005%26sid%3Dliteratum%253Aachs%26aulast%3DSateia%26aufirst%3DM.%2BJ.%26aulast%3DKirby-Long%26aufirst%3DP.%26aulast%3DTaylor%26aufirst%3DJ.%2BL.%26atitle%3DEfficacy%2520and%2520clinical%2520safety%2520of%2520ramelteon%253A%2520an%2520evidence-based%2520review%26jtitle%3DSleep%2520Med.%2520Rev.%26date%3D2008%26volume%3D12%26spage%3D319%26epage%3D332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><div class="note"><p class="first last">For a compilation of investigations carried out to identify the orexin system and define its physiological roles, see:</p></div> <span class="citation_source-book">Hypocretins: Integrators of Physiological Functions</span>; <span class="NLM_contrib-group">de Lecea, L.; Sutcliffe, J. G.</span>, Eds.; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=L.+de+Lecea&author=J.+G.+Sutcliffe&title=Hypocretins%3A+Integrators+of+Physiological+Functions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DHypocretins%253A%2520Integrators%2520of%2520Physiological%2520Functions%26aulast%3Dde%2BLecea%26aufirst%3DL.%26pub%3DSpringer%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">De Lecea, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kilduff, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peyron, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, X.-B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foye, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danielson, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukuhara, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Battenberg, E. L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gautvik, V. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartlett, F. S.,  II</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frankel, W. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Den Pol, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bloom, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gautvik, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutcliffe, J. G.</span><span> </span><span class="NLM_article-title">The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">322</span><span class="NLM_x">â</span> <span class="NLM_lpage">327</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=16&amp;doi=10.1021%2Fjm100541c&amp;key=10.1073%2Fpnas.95.1.322" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=8&amp;doi=10.1021%2Fjm100541c&amp;key=9419374" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=32&amp;doi=10.1021%2Fjm100541c&amp;key=1%3ACAS%3A528%3ADyaK1cXjtl2hsw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=322-327&author=L.+De+Leceaauthor=T.+S.+Kilduffauthor=C.+Peyronauthor=X.-B.+Gaoauthor=P.+E.+Foyeauthor=P.+E.+Danielsonauthor=C.+Fukuharaauthor=E.+L.+F.+Battenbergauthor=V.+T.+Gautvikauthor=F.+S.+Bartlettauthor=W.+N.+Frankelauthor=A.+N.+Van+Den+Polauthor=F.+E.+Bloomauthor=K.+M.+Gautvikauthor=J.+G.+Sutcliffe&title=The+hypocretins%3A+hypothalamus-specific+peptides+with+neuroexcitatory+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9aR"><div class="casContent"><span class="casTitleNuber">9a</span><div class="casTitle"><span class="NLM_cas:atitle">The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity</span></div><div class="casAuthors">De Lecea, L.; Kilduff, T. S.; Peyron, C.; Gao, X. -B.; Foye, P. E.; Danielson, P. E.; Fukuhara, C.; Battenberg, E. L. F.; Gautvik, V. T.; Bartlett, F. S., II; Frankel, W. N.; Van Den Pol, A. N.; Bloom, F. E.; Gautvik, K. M.; Sutcliffe, J. G.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">322-327</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">We describe a hypothalamus-specific mRNA that encodes preprohypocretin, the putative precursor of a pair of peptides that share substantial amino acid identities with the gut hormone secretin.  The hypocretin (Hcrt) protein products are restricted to neuronal cell bodies of the dorsal and lateral hypothalamic areas.  The fibers of these neurons are widespread throughout the posterior hypothalamus and project to multiple targets in other areas, including brainstem and thalamus.  Hcrt immunoreactivity is assocd. with large granular vesicles at synapses.  One of the Hcrt peptides was excitatory when applied to cultured, synaptically coupled hypothalamic neurons, but not hippocampal neurons.  These observations suggest that the hypocretins function within the CNS as neurotransmitters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAEQa5lFLKr7Vg90H21EOLACvtfcHk0lg0VXrDux9sIQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjtl2hsw%253D%253D&md5=52bde93a7933953f02930a6f57a0f1b1</span></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1073%2Fpnas.95.1.322&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.95.1.322%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BLecea%26aufirst%3DL.%26aulast%3DKilduff%26aufirst%3DT.%2BS.%26aulast%3DPeyron%26aufirst%3DC.%26aulast%3DGao%26aufirst%3DX.-B.%26aulast%3DFoye%26aufirst%3DP.%2BE.%26aulast%3DDanielson%26aufirst%3DP.%2BE.%26aulast%3DFukuhara%26aufirst%3DC.%26aulast%3DBattenberg%26aufirst%3DE.%2BL.%2BF.%26aulast%3DGautvik%26aufirst%3DV.%2BT.%26aulast%3DBartlett%26aufirst%3DF.%2BS.%26aulast%3DFrankel%26aufirst%3DW.%2BN.%26aulast%3DVan%2BDen%2BPol%26aufirst%3DA.%2BN.%26aulast%3DBloom%26aufirst%3DF.%2BE.%26aulast%3DGautvik%26aufirst%3DK.%2BM.%26aulast%3DSutcliffe%26aufirst%3DJ.%2BG.%26atitle%3DThe%2520hypocretins%253A%2520hypothalamus-specific%2520peptides%2520with%2520neuroexcitatory%2520activity%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1998%26volume%3D95%26spage%3D322%26epage%3D327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Sakurai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amemiya, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishii, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuzaki, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chemelli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozlowski, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arch, J. R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckingham, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haynes, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carr, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Annan, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNulty, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terrett, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elshourbagy, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergsma, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanagisawa, M.</span><span> </span><span class="NLM_article-title">Orexins and orexin receptors: A family of hypothalamic neuropeptides and G-protein receptors that regulate feeding behavior</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">573</span><span class="NLM_x">â</span> <span class="NLM_lpage">585</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=1998&pages=573-585&author=T.+Sakuraiauthor=A.+Amemiyaauthor=M.+Ishiiauthor=I.+Matsuzakiauthor=R.+Chemelliauthor=H.+Tanakaauthor=S.+C.+Williamsauthor=J.+A.+Richardsonauthor=G.+P.+Kozlowskiauthor=S.+Wilsonauthor=J.+R.+S.+Archauthor=R.+E.+Buckinghamauthor=A.+C.+Haynesauthor=S.+A.+Carrauthor=R.+S.+Annanauthor=D.+E.+McNultyauthor=W.+Liuauthor=J.+A.+Terrettauthor=N.+A.+Elshourbagyauthor=D.+J.+Bergsmaauthor=M.+Yanagisawa&title=Orexins+and+orexin+receptors%3A+A+family+of+hypothalamic+neuropeptides+and+G-protein+receptors+that+regulate+feeding+behavior"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSakurai%26aufirst%3DT.%26aulast%3DAmemiya%26aufirst%3DA.%26aulast%3DIshii%26aufirst%3DM.%26aulast%3DMatsuzaki%26aufirst%3DI.%26aulast%3DChemelli%26aufirst%3DR.%26aulast%3DTanaka%26aufirst%3DH.%26aulast%3DWilliams%26aufirst%3DS.%2BC.%26aulast%3DRichardson%26aufirst%3DJ.%2BA.%26aulast%3DKozlowski%26aufirst%3DG.%2BP.%26aulast%3DWilson%26aufirst%3DS.%26aulast%3DArch%26aufirst%3DJ.%2BR.%2BS.%26aulast%3DBuckingham%26aufirst%3DR.%2BE.%26aulast%3DHaynes%26aufirst%3DA.%2BC.%26aulast%3DCarr%26aufirst%3DS.%2BA.%26aulast%3DAnnan%26aufirst%3DR.%2BS.%26aulast%3DMcNulty%26aufirst%3DD.%2BE.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DTerrett%26aufirst%3DJ.%2BA.%26aulast%3DElshourbagy%26aufirst%3DN.%2BA.%26aulast%3DBergsma%26aufirst%3DD.%2BJ.%26aulast%3DYanagisawa%26aufirst%3DM.%26atitle%3DOrexins%2520and%2520orexin%2520receptors%253A%2520A%2520family%2520of%2520hypothalamic%2520neuropeptides%2520and%2520G-protein%2520receptors%2520that%2520regulate%2520feeding%2520behavior%26jtitle%3DCell%26date%3D1998%26volume%3D92%26spage%3D573%26epage%3D585" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Chemelli, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willie, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinton, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elmquist, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scammell, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kisanuki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitch, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakazato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammer, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saper, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanagisawa, M.</span><span> </span><span class="NLM_article-title">Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">437</span><span class="NLM_x">â</span> <span class="NLM_lpage">451</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=16&amp;doi=10.1021%2Fjm100541c&amp;key=10.1016%2FS0092-8674%2800%2981973-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=8&amp;doi=10.1021%2Fjm100541c&amp;key=10481909" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=32&amp;doi=10.1021%2Fjm100541c&amp;key=1%3ACAS%3A528%3ADyaK1MXlslWmsbo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=1999&pages=437-451&author=R.+M.+Chemelliauthor=J.+T.+Willieauthor=C.+M.+Sintonauthor=J.+K.+Elmquistauthor=T.+Scammellauthor=C.+Leeauthor=J.+A.+Richardsonauthor=S.+C.+Williamsauthor=Y.+Xiongauthor=Y.+Kisanukiauthor=T.+E.+Fitchauthor=M.+Nakazatoauthor=R.+E.+Hammerauthor=C.+B.+Saperauthor=M.+Yanagisawa&title=Narcolepsy+in+orexin+knockout+mice%3A+molecular+genetics+of+sleep+regulation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10aR"><div class="casContent"><span class="casTitleNuber">10a</span><div class="casTitle"><span class="NLM_cas:atitle">Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation</span></div><div class="casAuthors">Chemelli, Richard M.; Willie, Jon T.; Sinton, Christopher M.; Elmquist, Joel K.; Scammell, Thomas; Lee, Charlotte; Richardson, James A.; Williams, S. Clay; Xiong, Yumei; Kisanuki, Yaz; Fitch, Thomas E.; Nakazato, Masamitsu; Hammer, Robert E.; Saper, Clifford B.; Yanagisawa, Masashi</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">437-451</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Neurons contg. the neuropeptide orexin (hypocretin) are located exclusively in the lateral hypothalamus and send axons to numerous regions throughout the central nervous system, including the major nuclei implicated in sleep regulation.  Here, we report that, by behavioral and electroencephalog. criteria, orexin knockout mice exhibit a phenotype strikingly similar to human narcolepsy patients, as well as canarc-1 mutant dogs, the only known monogenic model of narcolepsy.  Moreover, modafinil, an anti-narcoleptic drug with ill-defined mechanisms of action, activates orexin-contg. neurons.  We propose that orexin regulates sleep/wakefulness states, and that orexin knockout mice are a model of human narcolepsy, a disorder characterized primarily by rapid eye movement (REM) sleep dysregulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomTMUcvI3kgbVg90H21EOLACvtfcHk0ljKCJgCAtYl0Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlslWmsbo%253D&md5=71290ef78fe300cfe3c61b4f3fcf7e6f</span></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2981973-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252981973-X%26sid%3Dliteratum%253Aachs%26aulast%3DChemelli%26aufirst%3DR.%2BM.%26aulast%3DWillie%26aufirst%3DJ.%2BT.%26aulast%3DSinton%26aufirst%3DC.%2BM.%26aulast%3DElmquist%26aufirst%3DJ.%2BK.%26aulast%3DScammell%26aufirst%3DT.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DRichardson%26aufirst%3DJ.%2BA.%26aulast%3DWilliams%26aufirst%3DS.%2BC.%26aulast%3DXiong%26aufirst%3DY.%26aulast%3DKisanuki%26aufirst%3DY.%26aulast%3DFitch%26aufirst%3DT.%2BE.%26aulast%3DNakazato%26aufirst%3DM.%26aulast%3DHammer%26aufirst%3DR.%2BE.%26aulast%3DSaper%26aufirst%3DC.%2BB.%26aulast%3DYanagisawa%26aufirst%3DM.%26atitle%3DNarcolepsy%2520in%2520orexin%2520knockout%2520mice%253A%2520molecular%2520genetics%2520of%2520sleep%2520regulation%26jtitle%3DCell%26date%3D1999%26volume%3D98%26spage%3D437%26epage%3D451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Willie, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chemelli, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinton, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokita, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kisanuki, Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcus, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elmquist, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohlmeier, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammer, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanagisawa, M.</span><span> </span><span class="NLM_article-title">Distinct narcolepsy syndromes in orexin receptor 2 and orexin null mice: molecular genetic dissection of non-REM and REM sleep regulatory processes</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">715</span><span class="NLM_x">â</span> <span class="NLM_lpage">730</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2003&pages=715-730&author=J.+T.+Willieauthor=R.+M.+Chemelliauthor=C.+M.+Sintonauthor=S.+Tokitaauthor=S.+C.+Williamsauthor=Y.+Y.+Kisanukiauthor=J.+N.+Marcusauthor=C.+Leeauthor=J.+K.+Elmquistauthor=K.+A.+Kohlmeierauthor=C.+S.+Leonardauthor=J.+A.+Richardsonauthor=R.+E.+Hammerauthor=M.+Yanagisawa&title=Distinct+narcolepsy+syndromes+in+orexin+receptor+2+and+orexin+null+mice%3A+molecular+genetic+dissection+of+non-REM+and+REM+sleep+regulatory+processes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWillie%26aufirst%3DJ.%2BT.%26aulast%3DChemelli%26aufirst%3DR.%2BM.%26aulast%3DSinton%26aufirst%3DC.%2BM.%26aulast%3DTokita%26aufirst%3DS.%26aulast%3DWilliams%26aufirst%3DS.%2BC.%26aulast%3DKisanuki%26aufirst%3DY.%2BY.%26aulast%3DMarcus%26aufirst%3DJ.%2BN.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DElmquist%26aufirst%3DJ.%2BK.%26aulast%3DKohlmeier%26aufirst%3DK.%2BA.%26aulast%3DLeonard%26aufirst%3DC.%2BS.%26aulast%3DRichardson%26aufirst%3DJ.%2BA.%26aulast%3DHammer%26aufirst%3DR.%2BE.%26aulast%3DYanagisawa%26aufirst%3DM.%26atitle%3DDistinct%2520narcolepsy%2520syndromes%2520in%2520orexin%2520receptor%25202%2520and%2520orexin%2520null%2520mice%253A%2520molecular%2520genetic%2520dissection%2520of%2520non-REM%2520and%2520REM%2520sleep%2520regulatory%2520processes%26jtitle%3DNeuron%26date%3D2003%26volume%3D38%26spage%3D715%26epage%3D730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Lin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faraco, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadotani, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Jong, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishino, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mignot, E.</span><span> </span><span class="NLM_article-title">The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin receptor 2 gene</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">365</span><span class="NLM_x">â</span> <span class="NLM_lpage">376</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=1999&pages=365-376&author=L.+Linauthor=F.+Faracoauthor=R.+Liauthor=H.+Kadotaniauthor=W.+Rogersauthor=X.+Linauthor=X.+Qiuauthor=P.+J.+de+Jongauthor=S.+Nishinoauthor=E.+Mignot&title=The+sleep+disorder+canine+narcolepsy+is+caused+by+a+mutation+in+the+hypocretin+receptor+2+gene"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DL.%26aulast%3DFaraco%26aufirst%3DF.%26aulast%3DLi%26aufirst%3DR.%26aulast%3DKadotani%26aufirst%3DH.%26aulast%3DRogers%26aufirst%3DW.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DQiu%26aufirst%3DX.%26aulast%3Dde%2BJong%26aufirst%3DP.%2BJ.%26aulast%3DNishino%26aufirst%3DS.%26aulast%3DMignot%26aufirst%3DE.%26atitle%3DThe%2520sleep%2520disorder%2520canine%2520narcolepsy%2520is%2520caused%2520by%2520a%2520mutation%2520in%2520the%2520hypocretin%2520receptor%25202%2520gene%26jtitle%3DCell%26date%3D1999%26volume%3D98%26spage%3D365%26epage%3D376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Thannickal, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, R. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nienhuis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramanathan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gulyani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aldrich, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cornford, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegel, J. M.</span><span> </span><span class="NLM_article-title">Reduced number of hypocretin neurons in human narcolepsy</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">469</span><span class="NLM_x">â</span> <span class="NLM_lpage">474</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2000&pages=469-474&author=T.+C.+Thannickalauthor=R.+Y.+Mooreauthor=R.+Nienhuisauthor=L.+Ramanathanauthor=S.+Gulyaniauthor=M.+Aldrichauthor=M.+Cornfordauthor=J.+M.+Siegel&title=Reduced+number+of+hypocretin+neurons+in+human+narcolepsy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DThannickal%26aufirst%3DT.%2BC.%26aulast%3DMoore%26aufirst%3DR.%2BY.%26aulast%3DNienhuis%26aufirst%3DR.%26aulast%3DRamanathan%26aufirst%3DL.%26aulast%3DGulyani%26aufirst%3DS.%26aulast%3DAldrich%26aufirst%3DM.%26aulast%3DCornford%26aufirst%3DM.%26aulast%3DSiegel%26aufirst%3DJ.%2BM.%26atitle%3DReduced%2520number%2520of%2520hypocretin%2520neurons%2520in%2520human%2520narcolepsy%26jtitle%3DNeuron%26date%3D2000%26volume%3D27%26spage%3D469%26epage%3D474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Crocker, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espana, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papadopoulon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saper, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faraco, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakurai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mignot, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scammell, T. E.</span><span> </span><span class="NLM_article-title">Concomitant loss of dynorphin, Narp and orexin in narcolepsy</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">1184</span><span class="NLM_x">â</span> <span class="NLM_lpage">1188</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=1184-1188&author=A.+Crockerauthor=R.+A.+Espanaauthor=M.+Papadopoulonauthor=C.+B.+Saperauthor=J.+Faracoauthor=T.+Sakuraiauthor=M.+Hondaauthor=E.+Mignotauthor=T.+E.+Scammell&title=Concomitant+loss+of+dynorphin%2C+Narp+and+orexin+in+narcolepsy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCrocker%26aufirst%3DA.%26aulast%3DEspana%26aufirst%3DR.%2BA.%26aulast%3DPapadopoulon%26aufirst%3DM.%26aulast%3DSaper%26aufirst%3DC.%2BB.%26aulast%3DFaraco%26aufirst%3DJ.%26aulast%3DSakurai%26aufirst%3DT.%26aulast%3DHonda%26aufirst%3DM.%26aulast%3DMignot%26aufirst%3DE.%26aulast%3DScammell%26aufirst%3DT.%2BE.%26atitle%3DConcomitant%2520loss%2520of%2520dynorphin%252C%2520Narp%2520and%2520orexin%2520in%2520narcolepsy%26jtitle%3DNeurology%26date%3D2005%26volume%3D65%26spage%3D1184%26epage%3D1188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Blouin, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thannickal, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Worley, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baraban, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reti, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegel, J. M.</span><span> </span><span class="NLM_article-title">Narp immunostaining of human hypocretin (orexin) neurons: loss in narcolepsy</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">1189</span><span class="NLM_x">â</span> <span class="NLM_lpage">1192</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=1189-1192&author=A.+M.+Blouinauthor=T.+E.+Thannickalauthor=P.+F.+Worleyauthor=J.+M.+Barabanauthor=I.+M.+Retiauthor=J.+M.+Siegel&title=Narp+immunostaining+of+human+hypocretin+%28orexin%29+neurons%3A+loss+in+narcolepsy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBlouin%26aufirst%3DA.%2BM.%26aulast%3DThannickal%26aufirst%3DT.%2BE.%26aulast%3DWorley%26aufirst%3DP.%2BF.%26aulast%3DBaraban%26aufirst%3DJ.%2BM.%26aulast%3DReti%26aufirst%3DI.%2BM.%26aulast%3DSiegel%26aufirst%3DJ.%2BM.%26atitle%3DNarp%2520immunostaining%2520of%2520human%2520hypocretin%2520%2528orexin%2529%2520neurons%253A%2520loss%2520in%2520narcolepsy%26jtitle%3DNeurology%26date%3D2005%26volume%3D65%26spage%3D1189%26epage%3D1192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Akanmu, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honda, K.</span><span> </span><span class="NLM_article-title">Selective stimulation of orexin receptor type 2 promotes wakefulness in freely behaving rats</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">1048</span><span class="NLM_x">, </span> <span class="NLM_fpage">138</span><span class="NLM_x">â</span> <span class="NLM_lpage">145</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm100541c&amp;key=10.1016%2Fj.brainres.2005.04.064" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm100541c&amp;key=15919057" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm100541c&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlt1Grtr8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1048&publication_year=2005&pages=138-145&author=M.+A.+Akanmuauthor=K.+Honda&title=Selective+stimulation+of+orexin+receptor+type+2+promotes+wakefulness+in+freely+behaving+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Selective stimulation of orexin receptor type 2 promotes wakefulness in freely behaving rats</span></div><div class="casAuthors">Akanmu, Moses A.; Honda, Kazuki</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">1048</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">138-145</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Orexins A and B are a pair of neuropeptides implicated in the regulation of feeding and arousal behavior mediated through two orexin receptors type 1 and type 2.  The authors have detd. the arousal effects of newly developed selective orexin receptor type 2 agonist, [Ala11]orexin-B, on the sleep-wake cycle in rats.  The effects of third ventricle intracerebroventricular (ICV) infusion of the novel orexin receptor type 2 selective agonist, [Ala11]orexin-B, on the sleep-wake cycle were investigated.  ICV infusion of [Ala11]orexin-B (1, 10 and 40 nmol) during the light period (11:00-16:00) dose-dependently resulted in a significant increase in wake duration by 46.9% (n = 5, P < 0.05), 159.2% (n = 4, P < 0.01) and 163.6% (n = 7, P < 0.01), resp., and a significant decrease in rapid eye movement (REM) (P < 0.01) and non-REM sleep (P < 0.01) for all doses.  In contrast, ICV infusion of orexin B at the same doses (1, 10 and 40 nmol) caused a 16.6% (n = 6, non-significant), 99.8% (n = 6, P < 0.05) and 72.0% (n = 4, P < 0.05) increase in wakefulness, resp.  Moreover, orexin-A, which exerts its effects through orexin receptor type 1 and orexin receptor type 2 with similar potency, resulted in a significant increase in wakefulness duration by 17.1% (n = 6, P < 0.05), 184.0% (n = 6, P < 0.01) and 228.6% (n = 6, P < 0.01) at doses of 0.1, 1 and 10 nmol, resp.  Further, the enhancement of wakefulness was accompanied by a marked redn. in REM and non-REM sleep.  These findings suggest that orexin receptor type 2 plays an important role in the modulation of sleep-wake state and behavioral responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxWQ0WqME6H7Vg90H21EOLACvtfcHk0ljtprrtWDviNA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlt1Grtr8%253D&md5=60ca1e78ee562eda40d65110a8b6ae7f</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.brainres.2005.04.064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainres.2005.04.064%26sid%3Dliteratum%253Aachs%26aulast%3DAkanmu%26aufirst%3DM.%2BA.%26aulast%3DHonda%26aufirst%3DK.%26atitle%3DSelective%2520stimulation%2520of%2520orexin%2520receptor%2520type%25202%2520promotes%2520wakefulness%2520in%2520freely%2520behaving%2520rats%26jtitle%3DBrain%2520Res.%26date%3D2005%26volume%3D1048%26spage%3D138%26epage%3D145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Selbach, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eriksson, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haas, H. L.</span><span> </span><span class="NLM_article-title">Drugs to interfere with orexins (hypocretins)</span> <span class="citation_source-journal">Drug News Perspect.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">669</span><span class="NLM_x">â</span> <span class="NLM_lpage">681</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=16&amp;doi=10.1021%2Fjm100541c&amp;key=10.1358%2Fdnp.2003.16.10.829298" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=8&amp;doi=10.1021%2Fjm100541c&amp;key=14747847" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=32&amp;doi=10.1021%2Fjm100541c&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhvFSgu7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2003&pages=669-681&author=O.+Selbachauthor=K.+S.+Erikssonauthor=H.+L.+Haas&title=Drugs+to+interfere+with+orexins+%28hypocretins%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15aR"><div class="casContent"><span class="casTitleNuber">15a</span><div class="casTitle"><span class="NLM_cas:atitle">Drugs to interfere with orexins (hypocretins)</span></div><div class="casAuthors">Selbach, Oliver; Eriksson, Krister S.; Haas, Helmut L.</div><div class="citationInfo"><span class="NLM_cas:title">Drug News & Perspectives</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">669-681</span>CODEN:
                <span class="NLM_cas:coden">DNPEED</span>;
        ISSN:<span class="NLM_cas:issn">0214-0934</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review.  Orexins (hypocretins) are bioactive peptides linking arousal, appetite and neuroendocrine-autonomic control.  Dysfunction of the orexin system is assocd. with narcolepsy-cataplexy.  Here, we review drugs interfering with orexins directly such as novel selective orexin receptor agonists and antagonists, as well as drugs interfering with orexins indirectly such as those used for the treatment of narcolepsy-cataplexy, and pharmacol. targets within the complex network of endogenous neurohumoral signals integrated and relayed by the orexin system.  These include amines, acetylcholine, purines, GABA and glutamate, as well as nutritional-metabolic, circadian-photic, immunol. and neuroendocrine-peptidergic influences.  Basic and clin. evaluation of drugs interfering with the orexin system will lead to a better understanding of the mol. prerequisites that control behavioral state, stress responses, energy homeostasis and survival, and yield therapeutic advances for the treatment of narcolepsy and other disorders of sleep, eating, mood and memory.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7vwj0sQ1p6bVg90H21EOLACvtfcHk0ljtprrtWDviNA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhvFSgu7w%253D&md5=da662939c3c8c1bad326510e52649598</span></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=10.1358%2Fdnp.2003.16.10.829298&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdnp.2003.16.10.829298%26sid%3Dliteratum%253Aachs%26aulast%3DSelbach%26aufirst%3DO.%26aulast%3DEriksson%26aufirst%3DK.%2BS.%26aulast%3DHaas%26aufirst%3DH.%2BL.%26atitle%3DDrugs%2520to%2520interfere%2520with%2520orexins%2520%2528hypocretins%2529%26jtitle%3DDrug%2520News%2520Perspect.%26date%3D2003%26volume%3D16%26spage%3D669%26epage%3D681" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit15b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Baumann, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bassetti, C. L.</span><span> </span><span class="NLM_article-title">Hypocretins (orexins): clinical impact of the discovery of a neurotransmitter</span> <span class="citation_source-journal">Sleep Med. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">253</span><span class="NLM_x">â</span> <span class="NLM_lpage">268</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=16&amp;doi=10.1021%2Fjm100541c&amp;key=10.1016%2Fj.smrv.2005.01.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=8&amp;doi=10.1021%2Fjm100541c&amp;key=15979356" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=32&amp;doi=10.1021%2Fjm100541c&amp;key=1%3ACAS%3A280%3ADC%252BD2MzotVSruw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2005&pages=253-268&author=C.+R.+Baumannauthor=C.+L.+Bassetti&title=Hypocretins+%28orexins%29%3A+clinical+impact+of+the+discovery+of+a+neurotransmitter"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15bR"><div class="casContent"><span class="casTitleNuber">15b</span><div class="casTitle"><span class="NLM_cas:atitle">Hypocretins (orexins): clinical impact of the discovery of a neurotransmitter</span></div><div class="casAuthors">Baumann Christian R; Bassetti Claudio L</div><div class="citationInfo"><span class="NLM_cas:title">Sleep medicine reviews</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">253-68</span>
        ISSN:<span class="NLM_cas:issn">1087-0792</span>.
    </div><div class="casAbstract">Hypothalamic excitatory hypocretin (orexin) neurons have been discovered in 1998 and found to have widespread projections to basal forebrain, monoaminergic and cholinergic brainstem, and spinal cord regions.  The hypocretin system is influenced both neuronally (e.g. suprachiasmatic nucleus, GABAergic, cholinergic and aminergic brainstem nuclei) as well as metabolically (e.g. glucose, ghrelin, and leptin).  Physiologically the hypocretin system has been implicated in the regulation of behaviours that are associated with wakefulness, locomotion, and feeding.  A role in REM sleep, neuroendocrine, autonomic and metabolic functions has also been suggested.  Pathophysiologically a deficient hypocretin neurotransmission has been found in human narcolepsy and (engineered) animal models of the disorder.  Different mechanisms are involved including (1) degeneration of hypocretin neurons (mice), (2) hypocretin ligand deficiency (humans, mice, dogs), (3) hypocretin receptor deficiency (mice, dogs).  Reports of low hypocretin-1 cerebrospinal fluid levels in neurologic conditions (e.g.  Guillain-Barre syndrome, traumatic brain injury, hypothalamic lesions) with and without sleep-wake disturbances and, on the other hand, observations of normal levels in about 11% of narcoleptics raise questions about the exact nature and pathophysiological base of the link between hypocretin deficiency and clinical manifestations in human narcolepsy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT-P4vpnwYkeCXXDYhVZBdlfW6udTcc2eb0_uxu-7Z-SLntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2MzotVSruw%253D%253D&md5=4f27a144a729314c352eb0c2c9dde489</span></div><a href="/servlet/linkout?suffix=cit15b&amp;dbid=16384&amp;doi=10.1016%2Fj.smrv.2005.01.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.smrv.2005.01.005%26sid%3Dliteratum%253Aachs%26aulast%3DBaumann%26aufirst%3DC.%2BR.%26aulast%3DBassetti%26aufirst%3DC.%2BL.%26atitle%3DHypocretins%2520%2528orexins%2529%253A%2520clinical%2520impact%2520of%2520the%2520discovery%2520of%2520a%2520neurotransmitter%26jtitle%3DSleep%2520Med.%2520Rev.%26date%3D2005%26volume%3D9%26spage%3D253%26epage%3D268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit15c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Boss, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brisbare-Roch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenck, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aissaoui, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koberstein, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sifferlen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weller, T.</span><span> </span><span class="NLM_article-title">Orexin receptor antagonism: A new principle in neuroscience</span> <span class="citation_source-journal">Chemia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">974</span><span class="NLM_x">â</span> <span class="NLM_lpage">979</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15c&amp;dbid=32&amp;doi=10.1021%2Fjm100541c&amp;key=1%3ACAS%3A528%3ADC%252BD1MXntlWmtg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2008&pages=974-979&author=C.+Bossauthor=C.+Brisbare-Rochauthor=F.+Jenckauthor=H.+Aissaouiauthor=R.+Kobersteinauthor=T.+Sifferlenauthor=T.+Weller&title=Orexin+receptor+antagonism%3A+A+new+principle+in+neuroscience"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15cR"><div class="casContent"><span class="casTitleNuber">15c</span><div class="casTitle"><span class="NLM_cas:atitle">Orexin receptor antagonism: a new principle in neuroscience</span></div><div class="casAuthors">Boss, Christoph; Brisbare-Roch, Catherine; Jenck, Francois; Aissaoui, Hamed; Koberstein, Ralf; Sifferlen, Thierry; Weller, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Chimia</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">974-979</span>CODEN:
                <span class="NLM_cas:coden">CHIMAD</span>;
        ISSN:<span class="NLM_cas:issn">0009-4293</span>.
    
            (<span class="NLM_cas:orgname">Swiss Chemical Society</span>)
        </div><div class="casAbstract">A review.  Orexins are hypothalamic neuropeptides interacting with G-protein coupled receptors in the brain.  They play a role in the regulation of sleep-wake cycles in mammals, as suggested by the deficits in orexinergic function that are assocd. with rodent, canine and human narcolepsy.  Selective or dual orexin1-receptor and/or orexin2-receptor antagonists or agonists that cross the blood-brain-barrier (BBB) may be of therapeutic interest for disorders of disturbed arousal and alertness.  This article summarizes recent research to identify and characterize orexin receptor antagonists and their therapeutic potential for normalizing sleep in insomnia patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6167zZnUiA7Vg90H21EOLACvtfcHk0ljtprrtWDviNA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXntlWmtg%253D%253D&md5=984cbca7fe1adf3bb42f6c42be966bd4</span></div><a href="/servlet/linkout?suffix=cit15c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBoss%26aufirst%3DC.%26aulast%3DBrisbare-Roch%26aufirst%3DC.%26aulast%3DJenck%26aufirst%3DF.%26aulast%3DAissaoui%26aufirst%3DH.%26aulast%3DKoberstein%26aufirst%3DR.%26aulast%3DSifferlen%26aufirst%3DT.%26aulast%3DWeller%26aufirst%3DT.%26atitle%3DOrexin%2520receptor%2520antagonism%253A%2520A%2520new%2520principle%2520in%2520neuroscience%26jtitle%3DChemia%26date%3D2008%26volume%3D62%26spage%3D974%26epage%3D979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit15d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Boss, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brisbare-Roch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenck, F.</span><span> </span><span class="NLM_article-title">Biomedical application of orexin/hypocretin receptor ligands in neuroscience</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">891</span><span class="NLM_x">â</span> <span class="NLM_lpage">903</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm801296d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15d&amp;dbid=32&amp;doi=10.1021%2Fjm100541c&amp;key=1%3ACAS%3A528%3ADC%252BD1MXptlOqsg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=891-903&author=C.+Bossauthor=C.+Brisbare-Rochauthor=F.+Jenck&title=Biomedical+application+of+orexin%2Fhypocretin+receptor+ligands+in+neuroscience"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15dR"><div class="casContent"><span class="casTitleNuber">15d</span><div class="casTitle"><span class="NLM_cas:atitle">Biomedical Application of Orexin/Hypocretin Receptor Ligands in Neuroscience</span></div><div class="casAuthors">Boss, Christoph; Brisbare-Roch, Catherine; Jenck, Francois</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">891-903</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Orexin/hypocretin neuropeptides (orexin-A or hypocretin1 and orexin-B or hypocretin2) are peptides discovered and published in 1998 as the outcome of methodical deorphanization programs focusing on brain orphan G-protein-coupled receptors (GPCR).  Orexins/hypocretins bind to two receptors (orexin1/OX1 or HCRT1 and orexin2/OX2 or HCRT2 receptors) and are proteolytically derived from a single precursor peptide in a discrete population of neurons of the perifornical area of the lateral hypothalamus.  OX1 receptors have preferential affinity for orexin-A, whereas OX2 receptors do not discriminate between both neuropeptides in vitro.  OX1 or OX2 activation produces intracellular Ca2+ increases via functional coupling involving a Gq or Go mechanism of transduction.  This ultimately results in slow membrane depolarization and in neuronal activation found to involve different ionic conductance in various brain regions in the rat, such as potassium conductance in the locus coeruleus or calcium current in the tuberomammilary nucleus.  Manipulation of the orexin system using brain-penetrant orexin receptor antagonists or inverse agonists will probably prove therapeutically useful in the treatment of those medical and psychiatric conditions assocd. with disturbed vigilance.  Orexin circuitry may indeed be disturbed under states such as sleep loss, night or shift work, jet lag, or even aging.  A major advantage of brain-penetrant receptor ligands over engineered genetic modifications is their transient mode of action, allowing recovery to natural orexin function.  This property is of major pharmacol. interest for scientific and therapeutic innovation in this field.  Hopefully, many novel orexin receptor ligands of second or third generation will emerge from the current medicinal chem. programs and will further contribute to the understanding of the physiol. and pathophysiol. roles of endogenous orexins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgwJlDWhwQVLVg90H21EOLACvtfcHk0ljUrXLbRHgcrQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXptlOqsg%253D%253D&md5=1b5af413b125e5cf5e7f5735253598ef</span></div><a href="/servlet/linkout?suffix=cit15d&amp;dbid=16384&amp;doi=10.1021%2Fjm801296d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801296d%26sid%3Dliteratum%253Aachs%26aulast%3DBoss%26aufirst%3DC.%26aulast%3DBrisbare-Roch%26aufirst%3DC.%26aulast%3DJenck%26aufirst%3DF.%26atitle%3DBiomedical%2520application%2520of%2520orexin%252Fhypocretin%2520receptor%2520ligands%2520in%2520neuroscience%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D891%26epage%3D903" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">McAtee, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutton, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudolph, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aluisio, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phoung, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dvorak, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovenberg, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carruthers, N. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, T. K.</span><span> </span><span class="NLM_article-title">Novel substituted 4-phenyl-[1,3]dioxanes: potent and selective orexin 2 (OX<sub>2</sub>R) antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">4225</span><span class="NLM_x">â</span> <span class="NLM_lpage">4229</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=4225-4229&author=L.+C.+McAteeauthor=S.+W.+Suttonauthor=D.+A.+Rudolphauthor=X.+Liauthor=L.+E.+Aluisioauthor=V.+K.+Phoungauthor=C.+A.+Dvorakauthor=T.+W.+Lovenbergauthor=N.+I.+Carruthersauthor=T.+K.+Jones&title=Novel+substituted+4-phenyl-%5B1%2C3%5Ddioxanes%3A+potent+and+selective+orexin+2+%28OX2R%29+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcAtee%26aufirst%3DL.%2BC.%26aulast%3DSutton%26aufirst%3DS.%2BW.%26aulast%3DRudolph%26aufirst%3DD.%2BA.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DAluisio%26aufirst%3DL.%2BE.%26aulast%3DPhoung%26aufirst%3DV.%2BK.%26aulast%3DDvorak%26aufirst%3DC.%2BA.%26aulast%3DLovenberg%26aufirst%3DT.%2BW.%26aulast%3DCarruthers%26aufirst%3DN.%2BI.%26aulast%3DJones%26aufirst%3DT.%2BK.%26atitle%3DNovel%2520substituted%25204-phenyl-%255B1%252C3%255Ddioxanes%253A%2520potent%2520and%2520selective%2520orexin%25202%2520%2528OX2R%2529%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D4225%26epage%3D4229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Bingham, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deehan, M. R.</span><span> </span><span class="NLM_article-title">Eating, sleeping and rewarding: orexin receptors and their antagonists</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">551</span><span class="NLM_x">â</span> <span class="NLM_lpage">559</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2006&pages=551-559&author=M.+J.+Binghamauthor=J.+Caiauthor=M.+R.+Deehan&title=Eating%2C+sleeping+and+rewarding%3A+orexin+receptors+and+their+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBingham%26aufirst%3DM.%2BJ.%26aulast%3DCai%26aufirst%3DJ.%26aulast%3DDeehan%26aufirst%3DM.%2BR.%26atitle%3DEating%252C%2520sleeping%2520and%2520rewarding%253A%2520orexin%2520receptors%2520and%2520their%2520antagonists%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2006%26volume%3D9%26spage%3D551%26epage%3D559" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Cai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooke, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherborne, B. S.</span><span> </span><span class="NLM_article-title">Antagonists of the orexin receptors</span> <span class="citation_source-journal">Expert Opin. Ther. Patents</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">631</span><span class="NLM_x">â</span> <span class="NLM_lpage">646</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16c&amp;dbid=16&amp;doi=10.1021%2Fjm100541c&amp;key=10.1517%2F13543776.16.5.631" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16c&amp;dbid=32&amp;doi=10.1021%2Fjm100541c&amp;key=1%3ACAS%3A528%3ADC%252BD28Xkt12gsrY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=631-646&author=J.+Caiauthor=F.+E.+Cookeauthor=B.+S.+Sherborne&title=Antagonists+of+the+orexin+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16cR"><div class="casContent"><span class="casTitleNuber">16c</span><div class="casTitle"><span class="NLM_cas:atitle">Antagonists of the orexin receptors</span></div><div class="casAuthors">Cai, Jiaqiang; Cooke, Fiona E.; Sherborne, Bradley S.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">631-646</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Orexin-A and orexin-B are neuropeptides that are produced by neurons in the lateral hypothalamus.  These neuropeptides bind and activate two closely related G-protein-coupled receptors, orexin-1 and orexin-2, and are involved in a variety of biol. functions, including feeding, sleep-wake cycle, regulation of gastric acid secretion and reward seeking.  Orexin-1 receptor agonists are shown to have antinociceptive activity, while orexin-1 receptor antagonists reverse both orexin-A and fasting-induced food intake.  Mutant and non-functional orexin-2 receptor is linked to canine and some cases of human narcolepsy.  Orexin-A was undetectable in the cerebrospinal fluid of 32 out of 38 narcoleptic patients, but readily detected in normal control individuals.  These findings indicate that orexin receptor antagonists could be useful for the treatment of obesity, diabetes and sleep disorders.  This review covers patent literature published during the period 1999-2005 on orexin-1 and orexin-2 receptor antagonists, together with some recent literature covering orexin receptor agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8vbKokvyHK7Vg90H21EOLACvtfcHk0ljUrXLbRHgcrQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xkt12gsrY%253D&md5=ae3360c8df3b2ac6b9e8b6476bc77f6c</span></div><a href="/servlet/linkout?suffix=cit16c&amp;dbid=16384&amp;doi=10.1517%2F13543776.16.5.631&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.16.5.631%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DJ.%26aulast%3DCooke%26aufirst%3DF.%2BE.%26aulast%3DSherborne%26aufirst%3DB.%2BS.%26atitle%3DAntagonists%2520of%2520the%2520orexin%2520receptors%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Patents%26date%3D2006%26volume%3D16%26spage%3D631%26epage%3D646" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Roecker, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, P. J.</span><span> </span><span class="NLM_article-title">Orexin receptor antagonists: Medicinal chemistry and therapeutic potential</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">977</span><span class="NLM_x">â</span> <span class="NLM_lpage">987</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16d&amp;dbid=16&amp;doi=10.1021%2Fjm100541c&amp;key=10.2174%2F156802608784936746" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16d&amp;dbid=8&amp;doi=10.1021%2Fjm100541c&amp;key=18673167" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16d&amp;dbid=32&amp;doi=10.1021%2Fjm100541c&amp;key=1%3ACAS%3A528%3ADC%252BD1cXps1OhtLs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=977-987&author=A.+J.+Roeckerauthor=P.+J.+Coleman&title=Orexin+receptor+antagonists%3A+Medicinal+chemistry+and+therapeutic+potential"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16dR"><div class="casContent"><span class="casTitleNuber">16d</span><div class="casTitle"><span class="NLM_cas:atitle">Orexin receptor antagonists: medicinal chemistry and therapeutic potential</span></div><div class="casAuthors">Roecker, Anthony J.; Coleman, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">977-987</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Actelion Pharmaceuticals achieved clin. proof-of-concept for the treatment of insomnia in 2007 with the release of Phase II data on Almorexant, a potent dual (OX1R/OX2R) orexin receptor antagonist.  GlaxoSmithKline also released clin. efficacy data on an orexin receptor antagonist in 2007 for the treatment of insomnia.  With these exciting findings, the search for orexin (or hypocretin) receptor antagonists for the treatment of sleep and neurol. disorders has recently increased in intensity in the pharmaceutical industry.  This review will focus on the medicinal chem. of orexin antagonists and the potential therapeutic value of this therapy for the treatment of insomnia.  Receptor subtype selectivity will also be described to highlight the tools currently available to delineate receptor-specific pharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdIppLgKDUZbVg90H21EOLACvtfcHk0ljUrXLbRHgcrQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXps1OhtLs%253D&md5=9e2d3aeb8221c75e2a95232cffdfbf20</span></div><a href="/servlet/linkout?suffix=cit16d&amp;dbid=16384&amp;doi=10.2174%2F156802608784936746&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802608784936746%26sid%3Dliteratum%253Aachs%26aulast%3DRoecker%26aufirst%3DA.%2BJ.%26aulast%3DColeman%26aufirst%3DP.%2BJ.%26atitle%3DOrexin%2520receptor%2520antagonists%253A%2520Medicinal%2520chemistry%2520and%2520therapeutic%2520potential%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2008%26volume%3D8%26spage%3D977%26epage%3D987" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Bergman, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roecker, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercer, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bednar, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiss, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ransom, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrell, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettibone, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemaire, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Preuksaritanont, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winrow, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renger, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koblan, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, P. J.</span><span> </span><span class="NLM_article-title">Proline bis-amides as potent dual orexin receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1425</span><span class="NLM_x">â</span> <span class="NLM_lpage">1430</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=1425-1430&author=J.+M.+Bergmanauthor=A.+J.+Roeckerauthor=S.+P.+Mercerauthor=R.+A.+Bednarauthor=D.+R.+Reissauthor=R.+W.+Ransomauthor=C.+M.+Harrellauthor=D.+J.+Pettiboneauthor=W.+Lemaireauthor=K.+L.+Murphyauthor=C.+Liauthor=T.+Preuksaritanontauthor=C.+J.+Winrowauthor=J.+J.+Rengerauthor=K.+S.+Koblanauthor=G.+D.+Hartmanauthor=P.+J.+Coleman&title=Proline+bis-amides+as+potent+dual+orexin+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBergman%26aufirst%3DJ.%2BM.%26aulast%3DRoecker%26aufirst%3DA.%2BJ.%26aulast%3DMercer%26aufirst%3DS.%2BP.%26aulast%3DBednar%26aufirst%3DR.%2BA.%26aulast%3DReiss%26aufirst%3DD.%2BR.%26aulast%3DRansom%26aufirst%3DR.%2BW.%26aulast%3DHarrell%26aufirst%3DC.%2BM.%26aulast%3DPettibone%26aufirst%3DD.%2BJ.%26aulast%3DLemaire%26aufirst%3DW.%26aulast%3DMurphy%26aufirst%3DK.%2BL.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DPreuksaritanont%26aufirst%3DT.%26aulast%3DWinrow%26aufirst%3DC.%2BJ.%26aulast%3DRenger%26aufirst%3DJ.%2BJ.%26aulast%3DKoblan%26aufirst%3DK.%2BS.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DColeman%26aufirst%3DP.%2BJ.%26atitle%3DProline%2520bis-amides%2520as%2520potent%2520dual%2520orexin%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D1425%26epage%3D1430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Cole, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stroke, I. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, L.-Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hussain, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simhadri, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brescia, M.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waksmunski, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strohl, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tellew, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saunders, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Appell, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henderson, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, M. L.</span><span> </span><span class="NLM_article-title">Synthesis of (3,4-dimethoxyphenoxy)alkylamino acetamides as orexin-2 receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">5420</span><span class="NLM_x">â</span> <span class="NLM_lpage">5423</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=5420-5423&author=A.+G.+Coleauthor=I.+L.+Strokeauthor=L.-Q.+Qinauthor=Z.+Hussainauthor=S.+Simhadriauthor=M.-R.+Bresciaauthor=F.+S.+Waksmunskiauthor=B.+Strohlauthor=J.+E.+Tellewauthor=J.+P.+Williamsauthor=J.+Saundersauthor=K.+C.+Appellauthor=I.+Hendersonauthor=M.+L.+Webb&title=Synthesis+of+%283%2C4-dimethoxyphenoxy%29alkylamino+acetamides+as+orexin-2+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCole%26aufirst%3DA.%2BG.%26aulast%3DStroke%26aufirst%3DI.%2BL.%26aulast%3DQin%26aufirst%3DL.-Q.%26aulast%3DHussain%26aufirst%3DZ.%26aulast%3DSimhadri%26aufirst%3DS.%26aulast%3DBrescia%26aufirst%3DM.-R.%26aulast%3DWaksmunski%26aufirst%3DF.%2BS.%26aulast%3DStrohl%26aufirst%3DB.%26aulast%3DTellew%26aufirst%3DJ.%2BE.%26aulast%3DWilliams%26aufirst%3DJ.%2BP.%26aulast%3DSaunders%26aufirst%3DJ.%26aulast%3DAppell%26aufirst%3DK.%2BC.%26aulast%3DHenderson%26aufirst%3DI.%26aulast%3DWebb%26aufirst%3DM.%2BL.%26atitle%3DSynthesis%2520of%2520%25283%252C4-dimethoxyphenoxy%2529alkylamino%2520acetamides%2520as%2520orexin-2%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D5420%26epage%3D5423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Aissaoui, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koberstain, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zumbrunn, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatfield, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brisbane-Roch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenck, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boss, C.</span><span> </span><span class="NLM_article-title"><i>N</i>-Glycine-sulfonamides as potent dual orexin 1/orexin 2 receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">5729</span><span class="NLM_x">â</span> <span class="NLM_lpage">5733</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=5729-5733&author=H.+Aissaouiauthor=R.+Koberstainauthor=C.+Zumbrunnauthor=J.+Gatfieldauthor=C.+Brisbane-Rochauthor=F.+Jenckauthor=A.+Treiberauthor=C.+Boss&title=N-Glycine-sulfonamides+as+potent+dual+orexin+1%2Forexin+2+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16g&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAissaoui%26aufirst%3DH.%26aulast%3DKoberstain%26aufirst%3DR.%26aulast%3DZumbrunn%26aufirst%3DC.%26aulast%3DGatfield%26aufirst%3DJ.%26aulast%3DBrisbane-Roch%26aufirst%3DC.%26aulast%3DJenck%26aufirst%3DF.%26aulast%3DTreiber%26aufirst%3DA.%26aulast%3DBoss%26aufirst%3DC.%26atitle%3DN-Glycine-sulfonamides%2520as%2520potent%2520dual%2520orexin%25201%252Forexin%25202%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D5729%26epage%3D5733" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Sifferlen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boss, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cottreel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koberstain, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gude, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aissaoui, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weller, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatfield, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brisbane-Roch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenck, F.</span><span> </span><span class="NLM_article-title">Novel pyrazolo-tetrahydropyridines as potent orexin receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1539</span><span class="NLM_x">â</span> <span class="NLM_lpage">1542</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=1539-1542&author=T.+Sifferlenauthor=C.+Bossauthor=E.+Cottreelauthor=R.+Koberstainauthor=M.+Gudeauthor=H.+Aissaouiauthor=T.+Wellerauthor=J.+Gatfieldauthor=C.+Brisbane-Rochauthor=F.+Jenck&title=Novel+pyrazolo-tetrahydropyridines+as+potent+orexin+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16h&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSifferlen%26aufirst%3DT.%26aulast%3DBoss%26aufirst%3DC.%26aulast%3DCottreel%26aufirst%3DE.%26aulast%3DKoberstain%26aufirst%3DR.%26aulast%3DGude%26aufirst%3DM.%26aulast%3DAissaoui%26aufirst%3DH.%26aulast%3DWeller%26aufirst%3DT.%26aulast%3DGatfield%26aufirst%3DJ.%26aulast%3DBrisbane-Roch%26aufirst%3DC.%26aulast%3DJenck%26aufirst%3DF.%26atitle%3DNovel%2520pyrazolo-tetrahydropyridines%2520as%2520potent%2520orexin%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D1539%26epage%3D1542" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16i"><span><span class="NLM_label">(i) </span><span class="NLM_contrib-group">Coleman, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renger, J. J.</span><span> </span><span class="NLM_article-title">Orexin receptor antagonists: a review of promising compounds patented since 2006</span> <span class="citation_source-journal">Expert Opin. Ther. Patents</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">307</span><span class="NLM_x">â</span> <span class="NLM_lpage">324</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16i&amp;dbid=16&amp;doi=10.1021%2Fjm100541c&amp;key=10.1517%2F13543770903567085" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16i&amp;dbid=32&amp;doi=10.1021%2Fjm100541c&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisValurw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=307-324&author=P.+J.+Colemanauthor=J.+J.+Renger&title=Orexin+receptor+antagonists%3A+a+review+of+promising+compounds+patented+since+2006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16iR"><div class="casContent"><span class="casTitleNuber">16i</span><div class="casTitle"><span class="NLM_cas:atitle">Orexin receptor antagonists: a review of promising compounds patented since 2006</span></div><div class="casAuthors">Coleman, Paul J.; Renger, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">307-324</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: The orexin neuropeptide system plays a central role in maintaining arousal and wakefulness.  It has been demonstrated that small mol. antagonists to the orexin receptors promote sleep in preclin. species and in patients with insomnia.  This review provides a summary of published patent applications claiming novel orexin antagonists from 2006 to mid-2009, covering both selective and dual orexin receptor antagonists.  Readers will gain an overview of orexin biol. focusing on genetic and pharmacol. validation of this target for treating sleep disorders.  Addnl., this review discusses the importance of receptor subtype selectivity and the potential role of subtype selective and dual orexin antagonists in treating psychiatric illnesses beyond insomnia.  This review identifies companies that are significant contributors to the patent literature claiming novel orexin receptor antagonists.  The study of the orexin system has emerged as one of the key new fields of investigation in neuroscience.  The demonstration of clin. proof-of-concept for the treatment of primary insomnia by Actelion in early 2007 has spurred significant interest in this field and competition has markedly increased since 2006.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7s9_Nt_Xc1bVg90H21EOLACvtfcHk0lgwSgU9i553bQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisValurw%253D&md5=0a0b10abb4e21347a2293124d6529fb6</span></div><a href="/servlet/linkout?suffix=cit16i&amp;dbid=16384&amp;doi=10.1517%2F13543770903567085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543770903567085%26sid%3Dliteratum%253Aachs%26aulast%3DColeman%26aufirst%3DP.%2BJ.%26aulast%3DRenger%26aufirst%3DJ.%2BJ.%26atitle%3DOrexin%2520receptor%2520antagonists%253A%2520a%2520review%2520of%2520promising%2520compounds%2520patented%2520since%25202006%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Patents%26date%3D2010%26volume%3D20%26spage%3D307%26epage%3D324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Dugovic, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shelton, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aluisio, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraser, I. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutton, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonaventure, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yun, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dvorak, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carruthers, N. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovenberg, T. W.</span><span> </span><span class="NLM_article-title">Blockade of orexin-1 receptors attenuates orexin-2 receptor antagonism-induced sleep promotion in rat</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">330</span><span class="NLM_x">, </span> <span class="NLM_fpage">141</span><span class="NLM_x">â</span> <span class="NLM_lpage">152</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm100541c&amp;key=10.1124%2Fjpet.109.152009" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=330&publication_year=2009&pages=141-152&author=C.+Dugovicauthor=J.+E.+Sheltonauthor=L.+E.+Aluisioauthor=I.+C.+Fraserauthor=X.+Jiangauthor=S.+W.+Suttonauthor=P.+Bonaventureauthor=S.+Yunauthor=X.+Liauthor=B.+Lordauthor=C.+A.+Dvorakauthor=N.+I.+Carruthersauthor=T.+W.+Lovenberg&title=Blockade+of+orexin-1+receptors+attenuates+orexin-2+receptor+antagonism-induced+sleep+promotion+in+rat"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1124%2Fjpet.109.152009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.109.152009%26sid%3Dliteratum%253Aachs%26aulast%3DDugovic%26aufirst%3DC.%26aulast%3DShelton%26aufirst%3DJ.%2BE.%26aulast%3DAluisio%26aufirst%3DL.%2BE.%26aulast%3DFraser%26aufirst%3DI.%2BC.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DSutton%26aufirst%3DS.%2BW.%26aulast%3DBonaventure%26aufirst%3DP.%26aulast%3DYun%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLord%26aufirst%3DB.%26aulast%3DDvorak%26aufirst%3DC.%2BA.%26aulast%3DCarruthers%26aufirst%3DN.%2BI.%26aulast%3DLovenberg%26aufirst%3DT.%2BW.%26atitle%3DBlockade%2520of%2520orexin-1%2520receptors%2520attenuates%2520orexin-2%2520receptor%2520antagonism-induced%2520sleep%2520promotion%2520in%2520rat%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2009%26volume%3D330%26spage%3D141%26epage%3D152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Owen, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">CasteÃ±er, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">BolÃ³s, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estivill, C.</span><span> </span><span class="NLM_article-title">Almorexant</span> <span class="citation_source-journal">Drugs Future</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">5</span><span class="NLM_x">â</span> <span class="NLM_lpage">10</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm100541c&amp;key=10.1358%2Fdof.2009.034.01.1324392" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm100541c&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlvVWhuro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2009&pages=5-10&author=R.+T.+Owenauthor=R.+Caste%C3%B1erauthor=J.+Bol%C3%B3sauthor=C.+Estivill&title=Almorexant"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Almorexant: dual orexin OX1/OX2 antagonist treatment of sleep disorders</span></div><div class="casAuthors">Owen, R. T.; Castaner, R.; Bolos, J.; Estivill, C.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs of the Future</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">5-10</span>CODEN:
                <span class="NLM_cas:coden">DRFUD4</span>;
        ISSN:<span class="NLM_cas:issn">0377-8282</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review.  Almorexant is a novel, selective, orally active dual orexin OX1 and OX2 receptor antagonist.  It is rapidly absorbed and distributed and shows no tendency to accumulate with repeated dosing.  Preclin. studies in rats and dogs have demonstrated a sleep-promoting effect which resembles physiol. sleep; this could be quickly reversed upon sensorimotor stimulation and yet allow resumption of sleep upon its cessation.  Almorexant's sleep-promoting effects were confirmed in volunteers and patients with primary insomnia.  It dose-dependently increased sleep efficiency and decreased sleep latency and wake time after sleep onset.  The compd. was well tolerated, with no significant effects on next-day motor performance, memory or reaction time.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopXHdSyxFfF7Vg90H21EOLACvtfcHk0lgqbp1Y6zf51Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlvVWhuro%253D&md5=61c1f2630f572fbf818dc3c8a299144e</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1358%2Fdof.2009.034.01.1324392&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdof.2009.034.01.1324392%26sid%3Dliteratum%253Aachs%26aulast%3DOwen%26aufirst%3DR.%2BT.%26aulast%3DCaste%25C3%25B1er%26aufirst%3DR.%26aulast%3DBol%25C3%25B3s%26aufirst%3DJ.%26aulast%3DEstivill%26aufirst%3DC.%26atitle%3DAlmorexant%26jtitle%3DDrugs%2520Future%26date%3D2009%26volume%3D34%26spage%3D5%26epage%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Brisbare-Roch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dingemanse, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koberstein, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoever, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aissaoui, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flores, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nayler, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Gerven, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Haas, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weller, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischli, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clozel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenck, F.</span><span> </span><span class="NLM_article-title">Promotion of sleep by targeting the orexin system in rats, dogs and humans</span> <span class="citation_source-journal">Nature Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">150</span><span class="NLM_x">â</span> <span class="NLM_lpage">155</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=150-155&author=C.+Brisbare-Rochauthor=J.+Dingemanseauthor=R.+Kobersteinauthor=P.+Hoeverauthor=H.+Aissaouiauthor=S.+Floresauthor=C.+Muellerauthor=O.+Naylerauthor=J.+van+Gervenauthor=S.+L.+de+Haasauthor=P.+Hessauthor=C.+Qiuauthor=S.+Buchmannauthor=M.+Scherzauthor=T.+Wellerauthor=W.+Fischliauthor=M.+Clozelauthor=F.+Jenck&title=Promotion+of+sleep+by+targeting+the+orexin+system+in+rats%2C+dogs+and+humans"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrisbare-Roch%26aufirst%3DC.%26aulast%3DDingemanse%26aufirst%3DJ.%26aulast%3DKoberstein%26aufirst%3DR.%26aulast%3DHoever%26aufirst%3DP.%26aulast%3DAissaoui%26aufirst%3DH.%26aulast%3DFlores%26aufirst%3DS.%26aulast%3DMueller%26aufirst%3DC.%26aulast%3DNayler%26aufirst%3DO.%26aulast%3Dvan%2BGerven%26aufirst%3DJ.%26aulast%3Dde%2BHaas%26aufirst%3DS.%2BL.%26aulast%3DHess%26aufirst%3DP.%26aulast%3DQiu%26aufirst%3DC.%26aulast%3DBuchmann%26aufirst%3DS.%26aulast%3DScherz%26aufirst%3DM.%26aulast%3DWeller%26aufirst%3DT.%26aulast%3DFischli%26aufirst%3DW.%26aulast%3DClozel%26aufirst%3DM.%26aulast%3DJenck%26aufirst%3DF.%26atitle%3DPromotion%2520of%2520sleep%2520by%2520targeting%2520the%2520orexin%2520system%2520in%2520rats%252C%2520dogs%2520and%2520humans%26jtitle%3DNature%2520Med.%26date%3D2007%26volume%3D13%26spage%3D150%26epage%3D155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span> </span><span class="NLM_article-title">New Data On Orexin Receptor Antagonist Almorexant Shows Therapeutic Potential To Restore Normal Physiological Sleep In Insomnia Patients</span>. Medical News Today<span class="NLM_month">Sep</span><span class="NLM_day">04</span>,<span class="NLM_x"> </span><span class="NLM_year">2007</span><span class="NLM_x">; </span><a href="http://www.medicalnewstoday.com/articles/81354.php" class="extLink">http://www.medicalnewstoday.com/articles/81354.php</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=New+Data+On+Orexin+Receptor+Antagonist+Almorexant+Shows+Therapeutic+Potential+To+Restore+Normal+Physiological+Sleep+In+Insomnia+Patients.+Medical+News+TodaySep04%2C+2007%3B+http%3A%2F%2Fwww.medicalnewstoday.com%2Farticles%2F81354.php."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26atitle%3DNew%2520Data%2520On%2520Orexin%2520Receptor%2520Antagonist%2520Almorexant%2520Shows%2520Therapeutic%2520Potential%2520To%2520Restore%2520Normal%2520Physiological%2520Sleep%2520In%2520Insomnia%2520Patients%26jtitle%3DMedical%2520News%2520Today%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="note"><p class="first last">Following the observation of preclinical toxicity, GSK entered into a deal with Actelion to jointly develop and market Almorexant, see: <a href="http://www.bioworld.com/servlet/com.accumedia.web.Dispatcher?next=bioWorldHeadlines_article&amp;forceid=48183" class="extLink">http://www.bioworld.com/servlet/com.accumedia.web.Dispatcher?next=bioWorldHeadlines_article&forceid=48183</a></p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span> </span><span class="NLM_article-title">Merck 2008 Annual Business BriefingâFinal</span>. Goliath Business News<span class="NLM_month">Dec</span><span class="NLM_day">9</span>,<span class="NLM_x"> </span><span class="NLM_year">2008</span><span class="NLM_x">; </span><a href="http://goliath.ecnext.com/coms2/gi_0199-9773483/Merck-2008-Annual-Business-Briefing.html" class="extLink">http://goliath.ecnext.com/coms2/gi_0199-9773483/Merck-2008-Annual-Business-Briefing.html</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Merck+2008+Annual+Business+Briefing%E2%80%94Final.+Goliath+Business+NewsDec9%2C+2008%3B+http%3A%2F%2Fgoliath.ecnext.com%2Fcoms2%2Fgi_0199-9773483%2FMerck-2008-Annual-Business-Briefing.html."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26atitle%3DMerck%25202008%2520Annual%2520Business%2520Briefing%25E2%2580%2594Final%26jtitle%3DGoliath%2520Business%2520News%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span> </span><span class="NLM_article-title">A Long Term Safety Study of MK4305 in Patients With Primary Insomnia</span>ClinicalTrials.gov<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">; </span><a href="http://clinicaltrials.gov/ct2/show/NCT01021813" class="extLink">http://clinicaltrials.gov/ct2/show/NCT01021813</a></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=A+Long+Term+Safety+Study+of+MK4305+in+Patients+With+Primary+InsomniaClinicalTrials.gov+2009%3B+http%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT01021813"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26atitle%3DA%2520Long%2520Term%2520Safety%2520Study%2520of%2520MK4305%2520in%2520Patients%2520With%2520Primary%2520Insomnia%26jtitle%3DClinicalTrials.gov%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Whitman, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breslin, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brashear, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreier, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogusky, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bednar, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemaire, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruno, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiss, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrell, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraus, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garson, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doran, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prueksaritanont, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winrow, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koblan, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renger, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, P. J.</span><span> </span><span class="NLM_article-title">Discovery of a potent, CNS-penetrant orexin receptor antagonist based on an <i>N,N</i>-disubstituted-1,4-diazepane scaffold that promotes sleep in rats</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1069</span><span class="NLM_x">â</span> <span class="NLM_lpage">1074</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=1069-1074&author=D.+B.+Whitmanauthor=C.+D.+Coxauthor=M.+J.+Breslinauthor=K.+M.+Brashearauthor=J.+D.+Schreierauthor=M.+J.+Boguskyauthor=R.+A.+Bednarauthor=W.+Lemaireauthor=J.+G.+Brunoauthor=G.+D.+Hartmanauthor=D.+R.+Reissauthor=C.+M.+Harrellauthor=R.+L.+Krausauthor=Y.+Liauthor=S.+L.+Garsonauthor=S.+M.+Doranauthor=T.+Prueksaritanontauthor=C.+Liauthor=C.+J.+Winrowauthor=K.+S.+Koblanauthor=J.+J.+Rengerauthor=P.+J.+Coleman&title=Discovery+of+a+potent%2C+CNS-penetrant+orexin+receptor+antagonist+based+on+an+N%2CN-disubstituted-1%2C4-diazepane+scaffold+that+promotes+sleep+in+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWhitman%26aufirst%3DD.%2BB.%26aulast%3DCox%26aufirst%3DC.%2BD.%26aulast%3DBreslin%26aufirst%3DM.%2BJ.%26aulast%3DBrashear%26aufirst%3DK.%2BM.%26aulast%3DSchreier%26aufirst%3DJ.%2BD.%26aulast%3DBogusky%26aufirst%3DM.%2BJ.%26aulast%3DBednar%26aufirst%3DR.%2BA.%26aulast%3DLemaire%26aufirst%3DW.%26aulast%3DBruno%26aufirst%3DJ.%2BG.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DReiss%26aufirst%3DD.%2BR.%26aulast%3DHarrell%26aufirst%3DC.%2BM.%26aulast%3DKraus%26aufirst%3DR.%2BL.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DGarson%26aufirst%3DS.%2BL.%26aulast%3DDoran%26aufirst%3DS.%2BM.%26aulast%3DPrueksaritanont%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DWinrow%26aufirst%3DC.%2BJ.%26aulast%3DKoblan%26aufirst%3DK.%2BS.%26aulast%3DRenger%26aufirst%3DJ.%2BJ.%26aulast%3DColeman%26aufirst%3DP.%2BJ.%26atitle%3DDiscovery%2520of%2520a%2520potent%252C%2520CNS-penetrant%2520orexin%2520receptor%2520antagonist%2520based%2520on%2520an%2520N%252CN-disubstituted-1%252C4-diazepane%2520scaffold%2520that%2520promotes%2520sleep%2520in%2520rats%26jtitle%3DChemMedChem%26date%3D2009%26volume%3D4%26spage%3D1069%26epage%3D1074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="note"><p class="first last">Further investigations by NMR spectroscopy, X-ray crystallography and molecular modeling revealed that <b>4</b> exists both in the solid state and solution in an unusual horseshoe- or U-shaped conformation characterized by a Ï-stacking interaction between the quinazoline and phenyl rings.</p></div><div class="NLM_citation" id="rightTab-cit25a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Cox, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGaughey, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogusky, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitman, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ball, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winrow, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renger, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, P. J.</span><span> </span><span class="NLM_article-title">Conformational analysis of <i>N,N</i>-disubstituted-1,4-diazepane orexin receptor antagonists and implications for receptor binding</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">2997</span><span class="NLM_x">â</span> <span class="NLM_lpage">3001</span><div class="note"><p class="first last">We recently reported that bridged diazepane analogues, whose design and synthesis was inspired by the low energy conformation of <b>4</b>, are also potent DORAs that promote sleep in rats, see:</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=2997-3001&author=C.+D.+Coxauthor=G.+B.+McGaugheyauthor=M.+J.+Boguskyauthor=D.+B.+Whitmanauthor=R.+G.+Ballauthor=C.+J.+Winrowauthor=J.+J.+Rengerauthor=P.+J.+Coleman&title=Conformational+analysis+of+N%2CN-disubstituted-1%2C4-diazepane+orexin+receptor+antagonists+and+implications+for+receptor+binding"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCox%26aufirst%3DC.%2BD.%26aulast%3DMcGaughey%26aufirst%3DG.%2BB.%26aulast%3DBogusky%26aufirst%3DM.%2BJ.%26aulast%3DWhitman%26aufirst%3DD.%2BB.%26aulast%3DBall%26aufirst%3DR.%2BG.%26aulast%3DWinrow%26aufirst%3DC.%2BJ.%26aulast%3DRenger%26aufirst%3DJ.%2BJ.%26aulast%3DColeman%26aufirst%3DP.%2BJ.%26atitle%3DConformational%2520analysis%2520of%2520N%252CN-disubstituted-1%252C4-diazepane%2520orexin%2520receptor%2520antagonists%2520and%2520implications%2520for%2520receptor%2520binding%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D2997%26epage%3D3001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit25b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Coleman, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreier, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGaughey, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogusky, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ball, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrell, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiss, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prueksaritanont, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winrow, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renger, J. J.</span><span> </span><span class="NLM_article-title">Design and synthesis of conformationally constrained <i>N</i>,<i>N</i>-disubstituted-1,4-diazepanes as potent orexin receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2311</span><span class="NLM_x">â</span> <span class="NLM_lpage">2315</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=2311-2315&author=P.+J.+Colemanauthor=J.+D.+Schreierauthor=G.+B.+McGaugheyauthor=M.+J.+Boguskyauthor=C.+D.+Coxauthor=G.+D.+Hartmanauthor=R.+G.+Ballauthor=C.+M.+Harrellauthor=D.+R.+Reissauthor=T.+Prueksaritanontauthor=C.+J.+Winrowauthor=J.+J.+Renger&title=Design+and+synthesis+of+conformationally+constrained+N%2CN-disubstituted-1%2C4-diazepanes+as+potent+orexin+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DColeman%26aufirst%3DP.%2BJ.%26aulast%3DSchreier%26aufirst%3DJ.%2BD.%26aulast%3DMcGaughey%26aufirst%3DG.%2BB.%26aulast%3DBogusky%26aufirst%3DM.%2BJ.%26aulast%3DCox%26aufirst%3DC.%2BD.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DBall%26aufirst%3DR.%2BG.%26aulast%3DHarrell%26aufirst%3DC.%2BM.%26aulast%3DReiss%26aufirst%3DD.%2BR.%26aulast%3DPrueksaritanont%26aufirst%3DT.%26aulast%3DWinrow%26aufirst%3DC.%2BJ.%26aulast%3DRenger%26aufirst%3DJ.%2BJ.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520conformationally%2520constrained%2520N%252CN-disubstituted-1%252C4-diazepanes%2520as%2520potent%2520orexin%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D2311%26epage%3D2315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit25c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Coleman, P. J.; Schreier, J. D.; Roecker, A. J.; Mercer, S. P.; McGaughey, G. B.; Cox, C. D; Hartman, G. D.; Harrell, C. M.; Reiss, D. R.; Garson, S. L.; Anderson, W. B.; Prueksaritanont, T.; Winrow, C. J.; Renger, J. J.</span><span> </span><span class="NLM_article-title">Discovery of 3,9-diazabicyclo[4.2.1]nonanes as potent orexin receptor antagonists with sleep-promoting activity in the rat</span>.  <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span>DOI: <span class="refDoi">Â DOI: 10.1016/j.bmcl.2010.05.047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25c&amp;dbid=16&amp;doi=10.1021%2Fjm100541c&amp;key=10.1016%2Fj.bmcl.2010.05.047" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=P.+J.+Coleman&author=J.+D.+Schreier&author=A.+J.+Roecker&author=S.+P.+Mercer&author=G.+B.+McGaughey&author=C.+D+Cox&author=G.+D.+Hartman&author=C.+M.+Harrell&author=D.+R.+Reiss&author=S.+L.+Garson&author=W.+B.+Anderson&author=T.+Prueksaritanont&author=C.+J.+Winrow&author=J.+J.+Renger&title=Discovery+of+3%2C9-diazabicyclo%5B4.2.1%5Dnonanes+as+potent+orexin+receptor+antagonists+with+sleep-promoting+activity+in+the+rat&doi=10.1016%2Fj.bmcl.2010.05.047"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25c&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.05.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.05.047%26sid%3Dliteratum%253Aachs%26aulast%3DColeman%26aufirst%3DP.%2BJ.%26atitle%3DDiscovery%2520of%25203%252C9-diazabicyclo%255B4.2.1%255Dnonanes%2520as%2520potent%2520orexin%2520receptor%2520antagonists%2520with%2520sleep-promoting%2520activity%2520in%2520the%2520rat%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26doi%3D10.1016%2Fj.bmcl.2010.05.047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="note"><p class="first last">Other vehicles studied included 0.5% aqueous methylcellulose, 10% Tween 80 in water, and 0.1 M citric acid.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="note"><p class="first last">The position of oxidation is not known. For simplicity in visualization, oxidation at the 7-position of the core is shown.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><div class="note"><p class="first last">A large number of the cores made during this effort are described in</p></div><span class="NLM_contrib-group">Coleman, P. J.; Cox, C. D.; Roecker, A. J.</span><span> </span><span class="NLM_article-title">Discovery of Dual Orexin Receptor Antagonists (DORAs) for the Treatment of Insomnia</span>.  <span class="citation_source-journal">Curr. Top. Med. Chem.</span> in press.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=A+large+number+of+the+cores+made+during+this+effort+are+described+inColeman%2C+P.+J.%3B+Cox%2C+C.+D.%3B+Roecker%2C+A.+J.+Discovery+of+Dual+Orexin+Receptor+Antagonists+%28DORAs%29+for+the+Treatment+of+Insomnia.+Curr.+Top.+Med.+Chem.+in+press."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DColeman%26aufirst%3DP.%2BJ.%26atitle%3DDiscovery%2520of%2520Dual%2520Orexin%2520Receptor%2520Antagonists%2520%2528DORAs%2529%2520for%2520the%2520Treatment%2520of%2520Insomnia%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="note"><p class="first last">Dog pharmacokinetic âcassettesâ where utilized wherein 5â6 test compounds plus a standard were dosed IV in DMSO, with the goal being to identify compounds with reduced IV clearance. Promising analogues were then repeated as both IV and PO singles. In general, the data obtained in cassette format was reproduced well in the IV singles. Though some exceptions were noted, this strategy led to a number of diazepanes with improved bioavailability.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Poppelsdorf, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myerly, R. C.</span><span> </span><span class="NLM_article-title">A novel synthesis of homopiperazine and its monomethyl derivatives</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1961</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">131</span><span class="NLM_x">â</span> <span class="NLM_lpage">134</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo01060a031" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1961&pages=131-134&author=F.+Poppelsdorfauthor=R.+C.+Myerly&title=A+novel+synthesis+of+homopiperazine+and+its+monomethyl+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30a&amp;dbid=16384&amp;doi=10.1021%2Fjo01060a031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01060a031%26sid%3Dliteratum%253Aachs%26aulast%3DPoppelsdorf%26aufirst%3DF.%26aulast%3DMyerly%26aufirst%3DR.%2BC.%26atitle%3DA%2520novel%2520synthesis%2520of%2520homopiperazine%2520and%2520its%2520monomethyl%2520derivatives%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1961%26volume%3D26%26spage%3D131%26epage%3D134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit30b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Benalil, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carboni, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaultier, M.</span><span> </span><span class="NLM_article-title">Synthesis of 2,3,6,7-tetrahydro- and 2,3,4,5,6,7-hexahydro-1<i>H</i>-1,4-diazepines via a tandem Michael-type addition-intramolecular aza-Wittig sequence</span> <span class="citation_source-journal">J. Chem. Soc., Perkin Trans 1</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_fpage">1061</span><span class="NLM_x">â</span> <span class="NLM_lpage">1064</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1993&pages=1061-1064&author=A.+Benalilauthor=A.+Guerinauthor=B.+Carboniauthor=M.+Vaultier&title=Synthesis+of+2%2C3%2C6%2C7-tetrahydro-+and+2%2C3%2C4%2C5%2C6%2C7-hexahydro-1H-1%2C4-diazepines+via+a+tandem+Michael-type+addition-intramolecular+aza-Wittig+sequence"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBenalil%26aufirst%3DA.%26aulast%3DGuerin%26aufirst%3DA.%26aulast%3DCarboni%26aufirst%3DB.%26aulast%3DVaultier%26aufirst%3DM.%26atitle%3DSynthesis%2520of%25202%252C3%252C6%252C7-tetrahydro-%2520and%25202%252C3%252C4%252C5%252C6%252C7-hexahydro-1H-1%252C4-diazepines%2520via%2520a%2520tandem%2520Michael-type%2520addition-intramolecular%2520aza-Wittig%2520sequence%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Perkin%2520Trans%25201%26date%3D1993%26spage%3D1061%26epage%3D1064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit30c"><span><span class="NLM_label">(c) </span><div class="note"><p class="first last">Subsequent to our work reported herein, an efficient synthesis of the mono-protected 5-methyldiazepane core was reported, see:</p></div><span class="NLM_contrib-group">Wlodarczyk, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilleron, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Millet, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houssin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">HÃ©nichart, J.-P.</span><span> </span><span class="NLM_article-title">Synthesis of 1,4-diazepin-5-ones under microwave irradiation and their reduction products</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">2583</span><span class="NLM_x">â</span> <span class="NLM_lpage">2586</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2007&pages=2583-2586&author=N.+Wlodarczykauthor=P.+Gilleronauthor=R.+Milletauthor=R.+Houssinauthor=J.-P.+H%C3%A9nichart&title=Synthesis+of+1%2C4-diazepin-5-ones+under+microwave+irradiation+and+their+reduction+products"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWlodarczyk%26aufirst%3DN.%26aulast%3DGilleron%26aufirst%3DP.%26aulast%3DMillet%26aufirst%3DR.%26aulast%3DHoussin%26aufirst%3DR.%26aulast%3DH%25C3%25A9nichart%26aufirst%3DJ.-P.%26atitle%3DSynthesis%2520of%25201%252C4-diazepin-5-ones%2520under%2520microwave%2520irradiation%2520and%2520their%2520reduction%2520products%26jtitle%3DTetrahedron%2520Lett.%26date%3D2007%26volume%3D48%26spage%3D2583%26epage%3D2586" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Leonard, J.; Lygo, B.; Procter, G.</span> <span class="citation_source-book">Advanced Practical Organic Chemistry</span>; <span class="NLM_publisher-name">Blackie</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">1995</span><span class="NLM_x">; </span>p  <span class="NLM_fpage">6</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1995&pages=6&author=J.+Leonard&author=B.+Lygo&author=G.+Procter&title=Advanced+Practical+Organic+Chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DLeonard%26aufirst%3DJ.%26btitle%3DAdvanced%2520Practical%2520Organic%2520Chemistry%26pub%3DBlackie%26date%3D1995%26spage%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="note"><p class="first last">For instance, the (<i>S</i>)-antipode of compound <b>9</b> has OX<sub>1</sub>R <i>K</i><sub>i</sub> = 54 nM and OX<sub>2</sub>R <i>K</i><sub>i</sub> = 8.5 nM, corresponding to 8- and 18-fold losses in potency, respectively, relative to the (<i>R</i>)-antipode. We have confirmed the stereochemistry in the active series is (<i>R</i>) by both X-ray crystallography using anomalous dispersion, as well as an asymmetric synthesis starting from the chiral pool.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="note"><p class="first last">In general, installation of the tolyl methyl group on the benzamide increases potency on both receptors, but has a greater effect on OX<sub>1</sub>R potency.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><div class="note"><p class="first last">We have found that a vehicle of 20% TPGS in water to be an excellent vehicle for improving exposure of BCS class II molecules such as the diazepanes described herein and is also highly compatible with our sleep studies. For a study of the effects that TPGS has on oral absorption, see:</p></div><span class="NLM_contrib-group">Varma, M. V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panchagnula, R.</span><span> </span><span class="NLM_article-title">Enhanced oral paclitaxel absorption with vitamin E-TPGS: effect on solubility and permeability in vitro, in situ and in vivo</span> <span class="citation_source-journal">Eur. J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">445</span><span class="NLM_x">â</span> <span class="NLM_lpage">453</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm100541c&amp;key=10.1016%2Fj.ejps.2005.04.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm100541c&amp;key=15890503" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm100541c&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlsVCltbg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=445-453&author=M.+V.+S.+Varmaauthor=R.+Panchagnula&title=Enhanced+oral+paclitaxel+absorption+with+vitamin+E-TPGS%3A+effect+on+solubility+and+permeability+in+vitro%2C+in+situ+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Enhanced oral paclitaxel absorption with vitamin E-TPGS: Effect on solubility and permeability in vitro, in situ and in vivo</span></div><div class="casAuthors">Varma, Manthena V. S.; Panchagnula, Ramesh</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">4-5</span>),
    <span class="NLM_cas:pages">445-453</span>CODEN:
                <span class="NLM_cas:coden">EPSCED</span>;
        ISSN:<span class="NLM_cas:issn">0928-0987</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Soly. and permeability being important determinants of oral drug absorption, this study was aimed to investigate the effect of Î±-tocopheryl polyethylene glycol 1000 succinate (TPGS) on the soly. and intestinal permeability of paclitaxel in vitro, in situ and in vivo, to est. the absorption enhancement ability of TPGS.  Aq. soly. of paclitaxel is significantly enhanced by TPGS, where a linear increase was demonstrated above a TPGS concn. of 0.1 mg/mL.  Paclitaxel demonstrated asym. transport across rat ileum with significantly greater (26-fold) basolateral-to-apical (B-A) permeability than that in apical-to-basolateral (A-B) direction.  Presence of P-glycoprotein (P-gp) inhibitor, verapamil (200 Î¼M), diminished asym. transport of paclitaxel suggesting the role of P-gp-mediated efflux.  TPGS showed a concn.-dependent increase in A-B permeability and decreased B-A permeability.  The max. efflux inhibition activity was found at a min. TPGS concn. of 0.1 mg/mL, however, further increase in TPGS concn. resulted in decreased A-B permeability with no change in B-A permeability.  Thus, the max. paclitaxel permeability attained with 0.1 mg/mL TPGS was attributed to the interplay between TPGS concn. dependent P-gp inhibition activity and micelle formation.  In situ permeability studies in rats also demonstrated the role of efflux in limiting permeability of paclitaxel and inhibitory efficiency of TPGS.  The plasma concn. of [14C]paclitaxel following oral administration (25 mg/kg) was significantly increased by coadministration of TPGS at a dose of 50 mg/kg in rats.  Bioavailability is enhanced about 4.2- and 6.3-fold when [14C]paclitaxel was administrated with verapamil (25 mg/kg) and TPGS, resp., as compared to [14C]paclitaxel administered alone.  The effect of verapamil on oral bioavailability of [14C]paclitaxel was limited relative to the TPGS, consistent with the in vitro soly. and permeability enhancement ability of TPGS.  In conclusion, the current data suggests that the coadministration of TPGS may improve the bioavailability of BCS class II-IV drugs with low soly. and/or less permeable as a result of significant P-gp-mediated efflux.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwAg2sRFu08rVg90H21EOLACvtfcHk0lhZ1MgrF1O5IA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlsVCltbg%253D&md5=b4cd1a878214885498a601b65ffd57f2</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.ejps.2005.04.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejps.2005.04.003%26sid%3Dliteratum%253Aachs%26aulast%3DVarma%26aufirst%3DM.%2BV.%2BS.%26aulast%3DPanchagnula%26aufirst%3DR.%26atitle%3DEnhanced%2520oral%2520paclitaxel%2520absorption%2520with%2520vitamin%2520E-TPGS%253A%2520effect%2520on%2520solubility%2520and%2520permeability%2520in%2520vitro%252C%2520in%2520situ%2520and%2520in%2520vivo%26jtitle%3DEur.%2520J.%2520Pharm.%2520Sci.%26date%3D2005%26volume%3D25%26spage%3D445%26epage%3D453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="note"><p class="first last">Brain, plasma, and CSF concentrations were measured following a 30 min continuous IV infusion of <b>10</b> at 0.25, 0.75, and 1.5 mg/kg in 25% hydroxypropyl-Î²-cyclodextrin.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Evans, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watt, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicoll-Griffith, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baillie, T. A.</span><span> </span><span class="NLM_article-title">Drugâprotein adducts: an industry perspective on minimizing the potential for drug bioactivation in drug discovery and development</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">â</span> <span class="NLM_lpage">16</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx034170b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2004&pages=3-16&author=D.+C.+Evansauthor=A.+P.+Wattauthor=D.+A.+Nicoll-Griffithauthor=T.+A.+Baillie&title=Drug%E2%88%92protein+adducts%3A+an+industry+perspective+on+minimizing+the+potential+for+drug+bioactivation+in+drug+discovery+and+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36a&amp;dbid=16384&amp;doi=10.1021%2Ftx034170b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx034170b%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DD.%2BC.%26aulast%3DWatt%26aufirst%3DA.%2BP.%26aulast%3DNicoll-Griffith%26aufirst%3DD.%2BA.%26aulast%3DBaillie%26aufirst%3DT.%2BA.%26atitle%3DDrug%25E2%2588%2592protein%2520adducts%253A%2520an%2520industry%2520perspective%2520on%2520minimizing%2520the%2520potential%2520for%2520drug%2520bioactivation%2520in%2520drug%2520discovery%2520and%2520development%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2004%26volume%3D17%26spage%3D3%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit36b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kumar, S.; Baillie, T. A.</span><span> </span><span class="NLM_article-title">Minimizing metabolic activation in drug discovery</span> in  <span class="citation_source-book">Handbook of Drug Metabolism</span>, <span class="NLM_edition">2nd</span> ed.; <span class="NLM_contrib-group">Pearson, P. G.; Wienkers, L. C.</span>, Eds.; <span class="NLM_publisher-name">Informa Healthcare</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">; </span>Chapter 23.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=S.+Kumar&author=T.+A.+Baillieauthor=P.+G.+Pearson&author=L.+C.+Wienkers&title=Handbook+of+Drug+Metabolism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DS.%26atitle%3DMinimizing%2520metabolic%2520activation%2520in%2520drug%2520discovery%26btitle%3DHandbook%2520of%2520Drug%2520Metabolism%26aulast%3DPearson%26aufirst%3DP.%2BG.%26pub%3DInforma%2520Healthcare%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="note"><p class="first last">See the <a class="ref internalNav" href="#sec3" aria-label="Experimental Section">Experimental Section</a> for details.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="note"><p class="first last">GSH-adducts were identified that had a mass spectral signal corresponding to loss of the fluorine atom, suggesting the fluoroquinazoline as a site of bioactivation. The GSH-adduct/IS ratio of compound <b>4</b> is 5.0, suggesting that the nonfluorinated quinazoline also likely undergoes bioactivation and subsequent trapping with GSH.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="note"><p class="first last">As with diazepane DORA <b>4</b>, solution NMR studies of <b>3</b> indicate a very complex situation with several low energy conformations in equilibrium. Studies are underway to characterize the low energy conformations of <b>3</b> and how they fit with our proposed bioactive conformation model.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="note"><p class="first last">Brain, plasma, and CSF concentrations were measured following a 30 min continuous IV infusion of <b>3</b> at 0.25, 0.75, and 1.5, and 2.0 mg/kg in 25% hydroxypropyl-Î²-cyclodextrin. Brain/plasma ratios ranged from 0.6â1.2 and the CSF/plasma ratios ranged from 0.007â0.017. When dosed at 10 mg/kg PO in 20% TPGS, at 1 h post dose the brain/plasma ratio was 0.7 and the CSF/plasma ratio was 0.007.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><div class="note"><p class="first last">A manuscript in preparation will describe the pharmacology of <b>3</b> in more detail, including analysis of its dose-dependent effects on sleep in rats, dogs, and monkeys.</p></div><span class="NLM_contrib-group">Winrow, C. J.</span> unpublished results.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=A+manuscript+in+preparation+will+describe+the+pharmacology+of+3+in+more+detail%2C+including+analysis+of+its+dose-dependent+effects+on+sleep+in+rats%2C+dogs%2C+and+monkeys.Winrow%2C+C.+J.+unpublished+results."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DWinrow%26aufirst%3DC.%2BJ." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="note"><p class="first last">The identities of <b>14</b>â<b>16</b> were confirmed by independent synthesis.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Kunapuli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ransom, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettibone, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerby, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimwood, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuck, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodder, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inglese, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strulovici, B.</span><span> </span><span class="NLM_article-title">Development of an intact cell reporter gene Î²-lactamase assay for G-protein coupled receptors for high-throughput screening</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">314</span><span class="NLM_x">, </span> <span class="NLM_fpage">16</span><span class="NLM_x">â</span> <span class="NLM_lpage">29</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=314&publication_year=2003&pages=16-29&author=P.+Kunapuliauthor=R.+Ransomauthor=K.+L.+Murphyauthor=D.+J.+Pettiboneauthor=J.+Kerbyauthor=S.+Grimwoodauthor=P.+Zuckauthor=P.+Hodderauthor=R.+Lacsonauthor=I.+Hoffmanauthor=J.+Ingleseauthor=B.+Strulovici&title=Development+of+an+intact+cell+reporter+gene+%CE%B2-lactamase+assay+for+G-protein+coupled+receptors+for+high-throughput+screening"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKunapuli%26aufirst%3DP.%26aulast%3DRansom%26aufirst%3DR.%26aulast%3DMurphy%26aufirst%3DK.%2BL.%26aulast%3DPettibone%26aufirst%3DD.%2BJ.%26aulast%3DKerby%26aufirst%3DJ.%26aulast%3DGrimwood%26aufirst%3DS.%26aulast%3DZuck%26aufirst%3DP.%26aulast%3DHodder%26aufirst%3DP.%26aulast%3DLacson%26aufirst%3DR.%26aulast%3DHoffman%26aufirst%3DI.%26aulast%3DInglese%26aufirst%3DJ.%26aulast%3DStrulovici%26aufirst%3DB.%26atitle%3DDevelopment%2520of%2520an%2520intact%2520cell%2520reporter%2520gene%2520%25CE%25B2-lactamase%2520assay%2520for%2520G-protein%2520coupled%2520receptors%2520for%2520high-throughput%2520screening%26jtitle%3DAnal.%2520Biochem.%26date%3D2003%26volume%3D314%26spage%3D16%26epage%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Mosser, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanley, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaul, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bednar, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koblan, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bednar, R. A.</span><span> </span><span class="NLM_article-title">Automation of in vitro dose-inhibition assays using the Tecan Genesis and an integrated software package to support the drug discovery process</span> <span class="citation_source-journal">J. Assoc. Lab. Autom.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">54</span><span class="NLM_x">â</span> <span class="NLM_lpage">62</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm100541c&amp;key=10.1016%2FS1535-5535%2804%2900281-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm100541c&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnsVSlsr8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2003&pages=54-62&author=S.+D.+Mosserauthor=L.+Stanleyauthor=S.+L.+Gaulauthor=B.+Bednarauthor=K.+S.+Koblanauthor=R.+A.+Bednar&title=Automation+of+in+vitro+dose-inhibition+assays+using+the+Tecan+Genesis+and+an+integrated+software+package+to+support+the+drug+discovery+process"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Automation of in vitro dose-inhibition assays utilizing the Tecan Genesis and an integrated software package to support the drug discovery process</span></div><div class="casAuthors">Mosser, Scott D.; Gaul, Stanley L.; Bednar, Bohumil; Koblan, Kenneth S.; Bednar, Rodney A.</div><div class="citationInfo"><span class="NLM_cas:title">JALA</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">54-63</span>CODEN:
                <span class="NLM_cas:coden">JALLFO</span>;
        ISSN:<span class="NLM_cas:issn">1535-5535</span>.
    
            (<span class="NLM_cas:orgname">Association for Laboratory Automation</span>)
        </div><div class="casAbstract">The authors have automated in vitro dose-inhibition assays to evaluate newly synthesized chem. entities and to rapidly produce and disseminate the results with minimal personnel.  A variety of assay methods were automated using the Tecan Genesis Workstation to produce ten-point titrn. curves and generate reproducible KI values.  The authors' integrated software package provides the unique ability to simultaneously inventory and schedule compds. into various in vitro assays.  A worklist generator, in combination with a Gemini script automatically makes variable pre-dilns. of compds., retrieves incubation plates from the Carousel using the RoMa Arm, performs serial dilns. of compds. within the final 96 well incubation plate using disposable tips, and adds essential assay reagents.  The authors' "Expert System for Data Anal." automatically retrieves data from a reader (e.g., TopCount, FLIPR or VIPR), analyzes the data based on a set of rules, and provides value added reports.  An overview of the basic workflow and the integrated software for support of the drug discovery process is described.  The ability of the Tecan Robot to produce dose-inhibition profiles is illustrated and validated by using a radioligand binding assay and a DMSO solubilized fluorescein dye method.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVyPEo0myW4LVg90H21EOLACvtfcHk0liNoFlPMcKlIQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnsVSlsr8%253D&md5=f4a8e1caed4109a299f2566224829ea2</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2FS1535-5535%2804%2900281-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1535-5535%252804%252900281-3%26sid%3Dliteratum%253Aachs%26aulast%3DMosser%26aufirst%3DS.%2BD.%26aulast%3DStanley%26aufirst%3DL.%26aulast%3DGaul%26aufirst%3DS.%2BL.%26aulast%3DBednar%26aufirst%3DB.%26aulast%3DKoblan%26aufirst%3DK.%2BS.%26aulast%3DBednar%26aufirst%3DR.%2BA.%26atitle%3DAutomation%2520of%2520in%2520vitro%2520dose-inhibition%2520assays%2520using%2520the%2520Tecan%2520Genesis%2520and%2520an%2520integrated%2520software%2520package%2520to%2520support%2520the%2520drug%2520discovery%2520process%26jtitle%3DJ.%2520Assoc.%2520Lab.%2520Autom.%26date%3D2003%26volume%3D8%26spage%3D54%26epage%3D62" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Alvarino, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monti, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jantos, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monti, D.</span><span> </span><span class="NLM_article-title">Effect of SX-3228, a selective ligand for the BZ1 receptor, on sleep and waking during the lightâdark cycle in the rat</span> <span class="citation_source-journal">Braz. J. Med. Biol. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">1007</span><span class="NLM_x">â</span> <span class="NLM_lpage">1014</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45a&amp;dbid=16&amp;doi=10.1021%2Fjm100541c&amp;key=10.1590%2FS0100-879X1999000800011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45a&amp;dbid=8&amp;doi=10.1021%2Fjm100541c&amp;key=10454763" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45a&amp;dbid=32&amp;doi=10.1021%2Fjm100541c&amp;key=1%3ACAS%3A528%3ADyaK1MXmtFGhtbo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1999&pages=1007-1014&author=F.+Alvarinoauthor=J.+M.+Montiauthor=H.+Jantosauthor=D.+Monti&title=Effect+of+SX-3228%2C+a+selective+ligand+for+the+BZ1+receptor%2C+on+sleep+and+waking+during+the+light%E2%88%92dark+cycle+in+the+rat"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45aR"><div class="casContent"><span class="casTitleNuber">45a</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of SX-3228, a selective ligand for the BZ1 receptor, on sleep and waking during the light-dark cycle in the rat</span></div><div class="casAuthors">Alvarino, F.; Monti, J. M.; Jantos, H.; Monti, D.</div><div class="citationInfo"><span class="NLM_cas:title">Brazilian Journal of Medical and Biological Research</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1007-1014</span>CODEN:
                <span class="NLM_cas:coden">BJMRDK</span>;
        ISSN:<span class="NLM_cas:issn">0100-879X</span>.
    
            (<span class="NLM_cas:orgname">Associacao Brasileira de Divulgacao Cientifica</span>)
        </div><div class="casAbstract">The effects of the benzodiazepine1 (BZ1) receptor agonist SX-3228 were studied in rats (N = 12) implanted for chronic sleep procedures.  Administration of 0.5, 1.0 and 2.5 mg/kg SX-3228, s.c., to rats 1 h after the beginning of the light phase of the light-dark cycle induced a significant redn. of rapid-eye-movement sleep (REMS) during the third recording hour.  Moreover, slow wave sleep (SWS) was increased during the fourth recording hour after the two largest doses of the compd.  Administration of 0.5, 1.0 and 2.5 mg/kg SX-3228 one hour after the beginning of the dark period of the light-dark cycle caused a significant and maintained (6-h recording period) redn. of waking (W), whereas SWS and light sleep (LS) were increased.  REMS values tended to increase during the entire recording period; however, the increase was statistically significant only for the 1.0 mg/kg dose during the first recording hour.  In addn., a significant and dose-related increase of power d. in the delta and the theta regions was found during nonREM sleep (LS and SWS) in the dark period.  Our results indicate that SX-3228 is a potent hypnotic when given to the rat during the dark period of the light-dark cycle.  Moreover, the sleep induced by SX-3228 during the dark phase closely resembles the physiol. sleep of the rat.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq317lLOTXW1rVg90H21EOLACvtfcHk0liNoFlPMcKlIQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmtFGhtbo%253D&md5=5db1329b791c2d421ffbe718294c66b6</span></div><a href="/servlet/linkout?suffix=cit45a&amp;dbid=16384&amp;doi=10.1590%2FS0100-879X1999000800011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1590%252FS0100-879X1999000800011%26sid%3Dliteratum%253Aachs%26aulast%3DAlvarino%26aufirst%3DF.%26aulast%3DMonti%26aufirst%3DJ.%2BM.%26aulast%3DJantos%26aufirst%3DH.%26aulast%3DMonti%26aufirst%3DD.%26atitle%3DEffect%2520of%2520SX-3228%252C%2520a%2520selective%2520ligand%2520for%2520the%2520BZ1%2520receptor%252C%2520on%2520sleep%2520and%2520waking%2520during%2520the%2520light%25E2%2588%2592dark%2520cycle%2520in%2520the%2520rat%26jtitle%3DBraz.%2520J.%2520Med.%2520Biol.%2520Res.%26date%3D1999%26volume%3D32%26spage%3D1007%26epage%3D1014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit45b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Monti, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jantos, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monti, D.</span><span> </span><span class="NLM_article-title">Increase in waking and reduction of NREM and REM sleep after nitric oxide synthase inhibition: prevention with GABAA or adenosine A1 receptor agonists</span> <span class="citation_source-journal">Behav. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">123</span><span class="NLM_x">, </span> <span class="NLM_fpage">23</span><span class="NLM_x">â</span> <span class="NLM_lpage">35</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2001&pages=23-35&author=J.+M.+Montiauthor=H.+Jantosauthor=D.+Monti&title=Increase+in+waking+and+reduction+of+NREM+and+REM+sleep+after+nitric+oxide+synthase+inhibition%3A+prevention+with+GABAA+or+adenosine+A1+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMonti%26aufirst%3DJ.%2BM.%26aulast%3DJantos%26aufirst%3DH.%26aulast%3DMonti%26aufirst%3DD.%26atitle%3DIncrease%2520in%2520waking%2520and%2520reduction%2520of%2520NREM%2520and%2520REM%2520sleep%2520after%2520nitric%2520oxide%2520synthase%2520inhibition%253A%2520prevention%2520with%2520GABAA%2520or%2520adenosine%2520A1%2520receptor%2520agonists%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D2001%26volume%3D123%26spage%3D23%26epage%3D35" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Lazer, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miao, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, H.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorcek, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spero, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pal, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behnke, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watrous, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Homon, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guindon, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farina, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, J.</span><span> </span><span class="NLM_article-title">Benzoxazolamines and benzothiazolamines: Potent, enantioselective inhibitors of leukotriene biosynthesis with a novel mechanism of action</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">913</span><span class="NLM_x">â</span> <span class="NLM_lpage">923</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00033a008" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=913-923&author=E.+S.+Lazerauthor=C.+K.+Miaoauthor=H.-C.+Wongauthor=R.+Sorcekauthor=D.+M.+Speroauthor=A.+Gilmanauthor=K.+Palauthor=M.+Behnkeauthor=A.+G.+Grahamauthor=J.+M.+Watrousauthor=C.+A.+Homonauthor=J.+Nagelauthor=A.+Shahauthor=Y.+Guindonauthor=P.+R.+Farinaauthor=J.+Adams&title=Benzoxazolamines+and+benzothiazolamines%3A+Potent%2C+enantioselective+inhibitors+of+leukotriene+biosynthesis+with+a+novel+mechanism+of+action"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fjm00033a008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00033a008%26sid%3Dliteratum%253Aachs%26aulast%3DLazer%26aufirst%3DE.%2BS.%26aulast%3DMiao%26aufirst%3DC.%2BK.%26aulast%3DWong%26aufirst%3DH.-C.%26aulast%3DSorcek%26aufirst%3DR.%26aulast%3DSpero%26aufirst%3DD.%2BM.%26aulast%3DGilman%26aufirst%3DA.%26aulast%3DPal%26aufirst%3DK.%26aulast%3DBehnke%26aufirst%3DM.%26aulast%3DGraham%26aufirst%3DA.%2BG.%26aulast%3DWatrous%26aufirst%3DJ.%2BM.%26aulast%3DHomon%26aufirst%3DC.%2BA.%26aulast%3DNagel%26aufirst%3DJ.%26aulast%3DShah%26aufirst%3DA.%26aulast%3DGuindon%26aufirst%3DY.%26aulast%3DFarina%26aufirst%3DP.%2BR.%26aulast%3DAdams%26aufirst%3DJ.%26atitle%3DBenzoxazolamines%2520and%2520benzothiazolamines%253A%2520Potent%252C%2520enantioselective%2520inhibitors%2520of%2520leukotriene%2520biosynthesis%2520with%2520a%2520novel%2520mechanism%2520of%2520action%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26spage%3D913%26epage%3D923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i26"><a href="/doi/suppl/10.1021/jm100541c">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_47887"></div></div></div></div></div><hr /></hr><p class="last">Experimental procedures for compounds <b>8</b>â<b>13</b>, as well as reproductions of the <sup>1</sup>H and <sup>13</sup>C NMR spectra for key compounds. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm100541c/suppl_file/jm100541c_si_001.pdf">jm100541c_si_001.pdf (250.6 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm100541c&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2010.53.issue-14%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Fjm100541c" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm100541c" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright Â© 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">Youâve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679988e32f163d5a","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
